10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

x  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year endedJuly 1, 2017

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 0-22874

Viavi Solutions Inc.

(Exact name of Registrant as specified in its charter)

Delaware	94-2579683
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)

430 North McCarthy Boulevard, Milpitas, California 95035

(Address of principal executive offices including Zip code)

(408) 404-3600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Name of exchange on which registered
Common Stock, par value of $0.001 per share	The NASDAQ Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act:

None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. 

Yes x    No o

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o    No x

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x  No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained to the best of the Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	x	Accelerated filer	o	Non-accelerated filer (Do not check if a smaller reporting company)	o	Smaller reporting company	o	Emerging growth company	o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.									o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o No x

As of December 31, 2016the aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant was approximately $1.9 billion, based upon the closing sale prices of the common stock as reported on the NASDAQ Stock Market LLC. Shares of common stock held by executive officers and directors have been excluded from this calculation because such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

As of July 28, 2017, the Registrant had 227,547,102 shares of common stock outstanding.

Documents Incorporated by Reference: Portions of the Registrant’s Notice of Annual Meeting of Stockholders and Proxy Statement to be filed pursuant to Regulation 14A within 120 days after Registrant’s fiscal year end of July 1, 2017 are incorporated by reference into Part III of this Report.

TABLE OF CONTENTS
			Page
PART I
	ITEM 1.	BUSINESS	3
	ITEM 1A.	RISK FACTORS	12
	ITEM 1B.	UNRESOLVED STAFF COMMENTS	20
	ITEM 2.	PROPERTIES	20
	ITEM 3.	LEGAL PROCEEDINGS	20
	ITEM 4.	MINE SAFETY DISCLOSURE	20
PART II
	ITEM 5.	MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES	21
	ITEM 6.	SELECTED FINANCIAL DATA	24
	ITEM 7.	MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	26
	ITEM 7A.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	46
	ITEM 8.	FINANCIAL STATEMENTS SUPPLEMENTARY DATA	48
	ITEM 9.	CHANGES IN AND DISAGREEMENTS WITH ACOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE	107
	ITEM 9A.	CONTROLS AND PROCEDURES	107
	ITEM 9B.	OTHER INFORMATION	108
PART III
	ITEM 10.	DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE	108
	ITEM 11.	EXECUTIVE COMPENSATION	108
	ITEM 12.	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS	108
	ITEM 13.	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE	108
	ITEM 14.	PRINCIPAL ACCOUNTING FEES AND SERVICES	108
PART IV
	ITEM 15.	EXHIBITS, FINANCIAL STATEMENTS SCHEDULES	109
	ITEM 16.	10-K SUMMARY	112
SIGNATURES			113

1

FORWARD-LOOKING STATEMENTS

Statements contained in this Annual Report on Form 10-K, which we also refer to as the Report, which are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. A forward-looking statement may contain words such as “anticipates,” “believes,” “can,” “can impact,” “could,” “continue,” “estimates,” “expects,” “intends,” “may,” “ongoing,” “plans,” “potential,” “projects,” “should,” “will,” “will continue to be,” “would,” or the negative thereof or other comparable terminology regarding beliefs, plans, expectations or intentions regarding the future. Forward-looking statements include statements such as:

• Our expectations regarding demand for our products, including industry trends and technological advancements that may drive such demand, the role we will play in those advancements and our ability to benefit from such advancements;

• Our plans for growth and innovation opportunities;

• Financial projections and expectations, including profitability of certain business units, plans to reduce costs and improve efficiencies, the effects of seasonality on certain business units, continued reliance on key customers for a significant portion of our revenue, future sources of revenue, competition and pricing pressures, the future impact of certain accounting pronouncements and our estimation of the potential impact and materiality of litigation;

• Our plans for continued development, use and protection of our intellectual property;

• Our strategies for achieving our current business objectives, including related risks and uncertainties;

• Our plans or expectations relating to investments, acquisitions, partnerships and other strategic opportunities;

• Our strategies for reducing our dependence on sole suppliers or otherwise mitigating the risk of supply chain interruptions;

• Our research and development plans and the expected impact of such plans on our financial performance; and

• Our expectations related to our products, including costs associated with the development of new products, product yields, quality and other issues.

Management cautions that forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause our actual results to differ materially from those projected in such forward-looking statements. These forward-looking statements are only predictions and are subject to risks and uncertainties including those set forth in Part I, Item 1A “Risk Factors” and elsewhere in this Annual Report on Form 10-K and in other documents we file with the U.S. Securities and Exchange Commission. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of these forward-looking statements. Forward-looking statements are made only as of the date of this Report and subsequent facts or circumstances may contradict, obviate, undermine or otherwise fail to support or substantiate such statements. We are under no duty to update any of the forward-looking statements after the date of this Form 10-K to conform such statements to actual results or to changes in our expectations.

2

PART I

ITEM 1.    BUSINESS

GENERAL

Overview

Viavi Solutions Inc. (“Viavi,” also referred to as “the Company,” “we,” “our,” and “us”), formerly JDS Uniphase Corporation (“JDSU”), is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises and their ecosystems, supported by a worldwide channel community including Viavi Velocity Solution Partners. Our Velocity program (“Velocity”) allows us to optimize the use of direct or partner sales depending on application and sales volume. Velocity expands our reach into new market segments as well as expands our capability to sell and deliver solutions. Our solutions deliver end-to-end visibility across physical, virtual and hybrid networks, enabling customers to optimize connectivity, quality of experience and profitability. Viavi is also a leader in high performance thin film optical coatings, providing light management solutions to anti-counterfeiting, consumer and industrial, government and healthcare and other markets. On August 1, 2015, we completed the separation (“Separation”) of our optical components and lasers business and created two publicly-traded companies:

• an optical components and commercial lasers company, Lumentum Holdings Inc. (“Lumentum”), consisting of our former Communications and Commercial Optical Products (“CCOP”) segment and the WaveReady product line within our Network Enablement (“NE”) segment; and

• a network and service enablement and optical coatings company, renamed Viavi, consisting of our NE, Service Enablement (“SE”) and Optical Security and Performance Products (“OSP”) segments.

In connection with the Separation we distributed approximately 80.1% of the outstanding shares of Lumentum common stock to our stockholders on August 1, 2015. The Company was renamed Viavi and, at the time of the distribution, retained ownership of approximately 19.9% of Lumentum’s outstanding shares. Activities related to the Lumentum business have been presented as discontinued operations in all periods of the Company’s consolidated financial statements in this Annual Report on Form 10-K and the accompanying disclosures, discussion and analysis herein pertains to the Company’s continuing operations, unless noted otherwise.

To serve our markets, during fiscal 2017 we operated the following business segments:

• Network Enablement

• Service Enablement

• Optical Security and Performance Products

Industry Trends

NE and SE

The telecommunication (“Telecom”) and cable industries are facing substantial business and technology disruptions that are transforming the users’ experience in accessing voice, data, social media and video content. Multiple network technologies are being deployed to meet the needs of increased network capacity and faster transmission speeds across both the physical and the virtual networks and across the airwaves. All forms of the network are being upgraded to faster speeds to achieve multi-gigabit per second (“Gbps”) broadband speeds and faster response time. 100G optical fiber is being deployed in the Metro networks. Optical is being delivered to fiber-to-the-home (“FTTH”) and permeating to everywhere. Cable service providers are investing in high speed connections and increased bandwidth availability with the deployment of DOCSIS 3.1. Telecom operators are upgrading legacy copper digital subscriber line (“DSL”) networks to G.fast technology. Over the airwaves, 4G/Long Term Evolution (“LTE”) wireless technology is expected to expand coverage with advanced LTE and 5G in the next couple years and provide 100x faster speeds than current LTE networks.

With the growing number of connected smart mobile devices, the exponential growth in Internet of Things (“IOT”) devices, and demand for high-speed broadband access to support video and other high-bandwidth applications, capacity and intelligence are increasing at the edge of the network pushing the expansion of the overall network and larger links along with new networks requiring re-architecture for scalability and flexibility. This increased demand for capacity will require networks to be more agile, flexible, programmable and more cost effective. It also will drive the network transition from a hardware-centric approach to a hybrid of physical and virtualized software-centric approach through software defined networking (“SDN”) and network function virtualization (“NFV”). Long term, network providers are pursuing automation to provide enhanced offerings including machine to machine communications, connected cars, mobile payment and security.

3

The convergence of network technologies requires sizable investments from communication service providers (“CSPs”), which consist of telecommunications, cable and cloud service providers. In order to achieve scale and a profitable return on investment, the telecom and cable industries in recent years are experiencing increased consolidation. New entrants have emerged with the rise of cloud service providers, who are increasing their capital expenditures and investing in advanced networks as enterprises are off-loading private corporate networks to the cloud. Traditional service provider capital spending in physical networks has been declining, which impacts the served available market opportunity for our NSE segment. However, the emergence of cloud service providers and virtualized networks create new opportunities for NSE. We believe our NE and SE products and solutions are well positioned to meet these rapidly changing industry trends, given our technology, installed base and product offerings.

OSP

Counterfeiting of banknotes and other goods is on the rise because counterfeiters now have access to a broad range of advanced but relatively low-cost imaging technologies and printing tools giving them the ability to create convincing simulations of actual documents and products for illicit purposes. At the same time, the penalties for counterfeiting can often be relatively modest when compared to the penalties for other crimes. We have decades of anti-counterfeiting expertise leveraging our Optically Variable Pigment (“OVP®”), and more recently our Optically Variable Magnetic Pigment (“OVMP®”) technologies to protect the integrity of banknotes and other high-value documents by delivering optical effects that are very easy for consumers to recognize but also very difficult for counterfeiters to reproduce. We also provide optical technologies for government, healthcare, consumer electronics and industrial markets.

In addition to anti-counterfeiting solutions, we extend our technology expertise to solve complex problems and deliver unique solutions in other industries. For example, we manufacture and sell optical filters for 3D sensing products that separate out ambient light from incoming data to allow devices to be controlled by a person’s movements or gestures.

Sales and Marketing

CSPs make up the majority of NE and SE revenues. We also market and sell our products to network-equipment manufacturers ("NEMs"), original equipment manufacturers (“OEMs”), enterprises, governmental organizations, distributors and strategic partners worldwide. We have a dedicated sales force organized around the markets our segments serve that works directly with customers’ executive, technical, manufacturing and purchasing personnel to determine design, performance, and cost requirements. We are also supported by a worldwide channel community, including Viavi’s Velocity Solution Partners who support our NE and SE segments.

A high level of support is a critical part of our strategy to develop and maintain long-term collaborative relationships with our customers. We develop innovative products by engaging our customers at the initial design phase and continue to build that relationship as our customers’ needs change and develop. Service and support are provided through our offices and those of our partners worldwide.

Corporate Information

We were incorporated in California in 1979 as Uniphase Corporation and reincorporated in Delaware in 1993. We are the product of several significant mergers and acquisitions including, among others, the combination of Uniphase Corporation and JDS FITEL in 1999. In 2000 we acquired Optical Coatings Lab, Inc., which is currently part of our OSP business, and in 2005 we acquired Acterna, Inc. which is currently part of our Network and Service Enablement (“NSE”) business, which consists of our NE and SE segments. Following these acquisitions, we operated as a company comprised of a portfolio of businesses with a focus on optical innovation, communications network and service enablement, commercial lasers and anti-counterfeiting solutions. In August 2015, we separated our portfolio of businesses into two separate publicly-traded companies to gain greater strategic flexibility to address rapidly changing market dynamics. At the same time, we changed our name to Viavi Solutions Inc. Our headquarters are located at 430 North McCarthy Boulevard, Milpitas, CA 95035, and our telephone number is (408) 404-3600. Our website address is www.viavisolutions.com.

We are subject to the requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act, pursuant to which we file annual, quarterly and periodic reports, proxy statements and other information with the SEC. Such periodic reports, proxy statements, and other information are available for inspection and copying at the SEC’s Public Reference Room at 100 F Street, NE., Washington, DC 20549 or may be obtained by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. We also make available free of charge all of our SEC filings on our website at www.viavisolutions.com/investors as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. The information contained on our website is not incorporated by reference into this Annual Report on Form 10-K, and you should not consider any information contained on, or that can be accessed through, our website as part of this Annual Report on Form 10-K or in deciding whether to

4

purchase our common stock. We have included our website address only as an inactive textual reference and do not intend it to be an active link to our website.

Corporate Strategy

Our objective is to continue to be a leading provider for all markets and industries we serve. In support of our business segments, we are pursuing a corporate strategy that we believe will best position us for future opportunities as follows:

• Market leadership in physical and virtualized test and measurement instruments with opportunity to grow market share

• Market leadership in anti-counterfeiting pigments

• Acceleration in OSP growth through diversification in high value applications

• Increase the benefit from the use of our net operating loss carryforwards (“NOL”) by improving our profitability organically and inorganically

• Greater flexibility in capital structure enabling greater capital return to shareholders

Our long term capital allocation strategy, which supports our corporate strategy, is as follows:

• Maintenance and run-rate investments to support operational and capital spending

• Organic investments in initiatives to support revenue growth and productivity

• Return capital to shareholders through share buybacks

• Mergers and acquisition that are synergistic to company strategy and business segments

Although we expect to successfully implement our strategy, internal and/or external factors could impact our ability to meet any, or all, of our objectives. These factors are discussed under Item 1A - Risk Factors.

Business Segments

Following the Separation of the Lumentum business on August 1, 2015, we operated in two broad business categories: NSE and OSP. NSE operates in two reportable segments, NE and SE, whereas OSP operates as a single segment. Our NSE and OSP businesses each are organized with its own engineering, manufacturing and dedicated sales and marketing groups focused on each of the markets we serve to better support our customers and respond quickly to market needs. In addition, our segments share common corporate services that provide capital, infrastructure, resources and functional support, allowing them to focus on core technological strengths to compete and innovate in their markets.

The table below discloses the percentage of our total net revenue attributable to each of our three reportable segments.

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Network Enablement	54.7	%	55.7	%	58.0	%
Service Enablement	16.7		16.9		19.9
Optical Security and Performance Products	28.6		27.4		22.1

Network Enablement

Our NE segment provides an integrated portfolio of testing solutions that access the network to perform build-out and maintenance tasks. These solutions include instruments, software and services to design, build, turn-up, certify, troubleshoot, and optimize networks. They also support more profitable, higher-performing networks and help speed time-to-revenue.

Our solutions address lab and production environments, field deployment and service assurance for wireless and wireline networks, including storage networks. Our test instrument portfolio is one of the largest in the industry, with hundreds of thousands of units in active use by major NEMs, operators and services providers worldwide. Designed to be mobile, these products include instruments and software that access the network to perform installation and maintenance tasks that help service provider technicians assess the performance of network elements and segments and verify the integrity of the information being transmitted across the network. These instruments are highly intelligent and have user interfaces that are designed to simplify operations and minimize the training required to operate them. Our NE solutions are also used by NEMs in the design and production of next-generation network equipment.

Viavi also offers a range of product support and professional services designed to comprehensively address our customers’ requirements. These services include repair, calibration, software support and technical assistance for our products. We offer

5

product and technology training as well as consulting services. Our professional services, provided in conjunction with system integration projects, include project management, installation and implementation.

Markets

Viavi’sNE segment provides solutions for CSPs, as well as NEMs and data center providers that deliver and/or operate broadband/IP networks (fixed and mobile) supporting voice, video and data services as well as a wide range of applications. These solutions support the development and production of network equipment, the deployment of next generation network technologies and services, and ensure a higher-quality customer experience.

Customers

NE customers include CSPs, NEMs, government organizations and large corporate customers, such as major telecom, mobility and cable operators, chip and infrastructure vendors, storage-device manufacturers, storage-network and switch vendors, and deployed private enterprise customers. Our customers include Alcatel-Lucent International, América Móvil, S.A.B. de C.V., AT&T Inc., CenturyLink, Inc., Cisco Systems, Inc., Comcast Corporation, Nokia Solutions and Networks, Reliance Industries, Time Warner Inc. and Verizon Communications Inc.

No single customer accounted for more than 10% of Viavi net revenue from continuing operations during fiscal 2017, 2016 or 2015.

Trends

Several network technology trends are taking place to support the growing bandwidth demand and are impacting the way NEMs and CSPs design, build and deploy new network systems. These trends are driving shifts in capital spending with the deployment of 100G Metro optical fiber, cable upgrade to DOCSIS 3.1, DSL copper line upgrade to G.fast as well as increased wireless deployment of 4G/LTE and emergence of advanced LTE and 5G. As service providers face pricing pressure on their average revenue per user (“ARPU”) metrics, they are turning to our NE products solutions to reduce customer service call truck rolls through faster installation and repair completion and improve user satisfaction.

Strategy

We plan to maintain market leadership in NE reinforced by:

• Scaling NE through share gain, consolidation, and expansion into adjacent markets

• Scale down, highly focused investment in SE that is synergistic with and leverages our NE position

• “Go deep” corporate development model to drive operating leverage

Competition

Our NE segment competes against various companies, including Anritsu Corporation, EXFO Inc., Keysight Technologies Inc., VeEX Inc., and Spirent Communications plc. While we face multiple competitors for each of our product families, we continue to have one of the broadest portfolios of wireline and wireless products available in the network enablement industry.

Offerings

Viavi’s NE solutions include instruments and software that support the development and production of network systems in the lab. These solutions activate, certify, troubleshoot and optimize networks that are differentiated through superior efficiency, reliable performance and greater customer satisfaction. Designed to be mobile, these products include instruments and software that access the network to perform installation and maintenance tasks. They help service provider technicians assess the performance of network elements and segments and verify the integrity of the information being transmitted across the network. These instruments are highly intelligent and have user interfaces that are designed to simplify operations and minimize the training required to operate them. Our NE solutions are also used by NEMs in the design and production of next-generation network equipment. Thorough testing by NEMs plays a critical role in producing the components and equipment that are the building blocks of network infrastructure. We leverage our installed base and knowledge of network management methods and procedures to develop these advanced customer experience solutions.

The Company also offers a range of product support and professional services designed to comprehensively address our customers’ requirements. These services include repair, calibration, software support and technical assistance for our products. We offer product and technology training as well as consulting services. Our professional services, provided in conjunction with system integration projects, include project management, installation and implementation.

6

During the first quarter of fiscal 2017, we re-grouped our NE products and associated services from three product groupings to two as described below:

Field Instruments: Primarily consisting of (a) Access and Cable products; (b) Fiber Instrument products; (c) Metro products; and (d) RF Test products.

Lab Instruments: Primarily consisting of (a) Capacity Advisor products; (b) Fiber Optic Production Lab Test; (c) Optical Transport products; and (d) Storage Network Test products.

Additionally, following the Separation we no longer sell products or services from the WaveReady product line.

For the purposes of providing year-over-year variance analysis in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Item 7 of this Annual Report on Form 10-K, we have reflected these changes for all prior periods presented so that they are comparable with our current groupings.

Service Enablement

SE provides embedded systems and enterprise performance management solutions that give global CSPs, enterprises and cloud operators visibility into network, service and application data. These solutions - which primarily consist of instruments, microprobes and software - monitor, collect and analyze network data to reveal the actual customer experience and identify opportunities for new revenue streams and network optimization.

Our portfolio of SE solutions addresses the same lab and production environments, field deployment and service assurance for wireless and fixed communications networks, including storage networks, as our NE portfolio. Our solutions let carriers remotely monitor performance and quality of network, service and applications performance throughout the entire network. This provides our customers with enhanced network management, control, and optimization that allow network operators to initiate service to new customers faster, decrease the need for technicians to make on-site service calls, help to make necessary repairs faster and, as a result, lower costs while providing higher quality and more reliable services. Remote monitoring decreases operating expenses, while early detection helps increase uptime, preserve revenue, and helps operators better monetize their networks.

Markets

Our SE segment provides solutions and services primarily for communication service providers and enterprises that deliver and/or operate broadband/IP networks (fixed and mobile) supporting voice, video and data services as well as a wide range of applications. These solutions provide network and application visibility to enable more cost-effective ways to provide a higher-quality customer experience.

Customers

SE customers include similar CSPs, NEMs, government organizations, large corporate customers, and storage-segment customers that are served by our NE segment.

Trends

Our Service Enablement solutions portfolio grew as a result of several acquisitions made during the past several years to address the network industry shift to a more agile, flexible, programmable, and cost-effective virtualized software-centric network. Our Data Center (formerly called Enterprise) product and solutions offerings address customers’ needs to support data center network traffic through application and performance monitoring.

While the network industry is shifting towards SDN and NFV, in fiscal 2016 we experienced a decline in SE net revenue compared to fiscal 2015 and certain growth products will require a longer investment cycle than originally expected. In accordance with the authoritative guidance, the Company recorded a goodwill impairment charge of $91.4 million related to our SE segment in fiscal 2016. Refer to “Note 8. Goodwill” included in Item 8 of this Annual Report on Form 10-K.

Strategy

Consistent with the communication on our last Analyst Day on September 15, 2016, we have taken steps to follow the “Big NE, Focused SE” strategy to emphasize Virtualized Instruments and Assurance and invest in areas of tight integration and synergies with NE to align with industry macro trends and focus the SE portfolio on products and solutions we believe will provide meaningful return on investment (“ROI”) and drive profitability.

7

Competition

Our NE and SE segments compete against many of the same companies. Competitors of SE include NetScout Systems, Inc. Riverbed Technology, and Spirent Communications plc. While we face multiple competitors for each of our product families, we continue to have one of the broadest portfolios of wireline and wireless monitoring solutions available in the service enablement industry.

Offerings

Viavi’s SE solutions are embedded network systems-including microprobes and software-that collect and analyze network data to reveal the actual customer experience and identify opportunities for new revenue streams. These solutions provide enhanced network management, control, optimization and differentiation for our customers. Using these solutions, our customers are able to access and analyze the growing amount of network data from a single console, simplifying the process of deploying, provisioning and managing network equipment and services. These capabilities allow network operators to initiate service to new customers faster, decrease the need for technicians to make on-site service calls, help to make necessary repairs faster and, as a result, lower costs while providing higher quality and more reliable services.

During the first quarter of fiscal 2017, we re-grouped our SE products and associated services from three product groupings to two as described below:

Data Center: Consisting of our Network Instrument products.

Assurance: Primarily consisting of our (a) Mature Products (Legacy Assurance, Legacy Wireline, Protocol Test, Video Assurance products and RAN (formerly component of Wireless)) (b) Growth Products (Xsight, Packet Portal products, Location Intelligence (formerly components of Wireless)).

For the purposes of providing year-over-year variance analysis in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Item 7 of this Annual Report on Form 10-K, we have reflected these changes for all prior periods presented so that they are comparable with our current groupings.

In the second half fiscal 2017, Viavi implemented our Focused NSE restructuring plan as part of its strategy to improve profitability in the Company’s NSE business by narrowing the scope and focus of the SE business. The smaller, more focused SE segment includes Data Center products, mobile assurance products like Xsight and Location Intelligence and invest in development of automation and virtualized network. The SE segment also retains the more mature Assurance product portfolio that is largely maintenance and service contract.

Optical Security and Performance Products

Our OSP segment leverages its core optical coating technologies and volume manufacturing capability to design, manufacture, and sell products targeting anti-counterfeiting, consumer and industrial, government, healthcare and other markets.

Our security offerings for the currency market include OVP®, OVMP® and banknote thread substrates. OVP® enables a color-shifting effect used by banknote issuers and security printers worldwide for anti-counterfeiting applications on banknotes and other high-value documents. Our technologies are deployed on the banknotes of more than 100 countries today. OSP also develops and delivers overt and covert anti-counterfeiting products that utilize its proprietary printing platform and are targeted primarily at the pharmaceutical and consumer-electronics markets.

Leveraging our expertise in spectral management and our unique high-precision coating capabilities, OSP provides a range of products and technologies for the consumer and industrial market, including, for example, 3D sensing optical filters.

OSP value-added solutions meet the stringent requirements of commercial and government customers. Our products are used in a variety of aerospace and defense applications, including optics for guidance systems, laser eye protection and night vision systems. These products, including coatings and optical filters, are optimized for each specific application.

Markets

Our OSP segment delivers overt and covert features to protect governments and brand owners against counterfeiting, with a primary focus on the currency market. OSP also produces precise, high-performance, optical thin-film coatings for a variety of applications in consumer electronics, government, healthcare and other markets. For example, optical filters are used in 3D sensing products and other applications.

8

In addition, we offer custom color solutions that include innovative optically-based color-shifting and other features that provide product enhancement for brands in the automotive and other industries.

Customers

OSP serves customers such as 3M Company, FLIR Systems, Inc., IDT Corporation, Lockheed Martin Corporation, Seiko Epson Corporation, SICPA Holding SA Company (SICPA) and STMicroelectronics Holding N.V.. Following the separation from Lumentum, one OSP customer generated more than 10% of Viavi net revenue from continuing operations. During fiscal 2017, 2016 and 2015, net revenue from SICPA represented 20.6%, 21.0% and 16.4%, respectively, of Viavi net revenue from continuing operations.

Trends

Counterfeiting of banknotes and other goods is on the rise because counterfeiters now have access to a broad range of advanced but relatively low-cost imaging technologies and printing tools, giving them the ability to create convincing simulations of actual documents and products for illicit purposes. At the same time, the penalties for counterfeiting can often be relatively modest when compared to the penalties for other crimes. As a result of these trends, demand is increasing for sophisticated overt anti-counterfeiting features, such as Viavi’s OVP® and OVMP® technologies, which are easy for consumers to validate without the use of special tools but are difficult to create or simulate using conventional printing technology.

The aerospace, defense, consumer electronics and medical/environmental instrumentation markets require customized, high-precision coated products and optical components that selectively absorb, transmit or reflect light to meet the performance requirements of sophisticated systems. Our custom optics products offer an array of advanced technologies and precision optics-from the UV to the far IR portion of the light spectrum to meet the specific requirements of our customers.

3D sensing is an emerging technology, where OSP’s optical filters plan to be deployed in smartphones for facial recognition biometric authentication. 3D sensing optical filters separate out ambient light from incoming data to allow devices to be controlled by a person’s movements, gestures or features. Other potential technology markets for OSP’s optical filters include augmented/virtual reality, sensors deployed in autonomous vehicles and Internet of Things (IoT).

Strategy

Our strategy is to leverage proprietary pigments and optical coating technologies to build market leadership in large, high value applications.

• Defend and expand core anti-counterfeiting product offering

• Expand into high value existing and emerging automotive, military and industrial applications

• Selectively target high volume consumer 3D sensing applications

Competition

OSP’s competitors include providers of anti-counterfeiting features such as Giesecke & Devrient, De La Rue plc; special-effect pigments like Merck KGA; coating companies such as Nidek, Toppan, and Toray and optics companies such as Materion and Deposition Sciences.

Offerings

Viavi’s OSP business provides innovative optical security and performance products which serve a variety of applications for customers in the anti-counterfeiting, consumer and industrial, government, healthcare and other markets.

Anti-counterfeiting: Viavi’s OVP® technology has become a standard used by many governments worldwide for currency protection. This technology provides a color-shifting effect that enables intuitive visual verification of banknotes. We also provide other technologies to the banknote market including OVMP®, a technology that delivers depth and other visual effects for intuitive overt verification. In addition, our proprietary printing processes deliver anti-counterfeiting solutions for security labels, used by the pharmaceutical and consumer electronics industries for brand protection.

For product differentiation and brand enhancement, we provide custom color solutions for a variety of applications using our ChromaFlair® and SpectraFlair® pigments to create color effects that emphasize body contours, create dynamic environments, or enhance products in motion. These pigments are added to paints, plastics or textiles for products and packaging.

Consumer and Industrial: Our OSP business manufactures and sells optical filters for 3D sensing products that separate out ambient light from incoming data to allow devices to be controlled by a person’s movements or gestures.

9

Government: Viavi products are used in a variety of aerospace and defense applications, including optics for guidance systems, laser eye protection and night vision systems. These products, including coatings and optical filters, are optimized for each specific application.

Healthcare and Other Markets: Viavi provides multicavity and linear variable optical filters on a variety of substrates for applications including, thermal imaging, and spectroscopy and pollution monitoring. We also develop and manufacture miniature spectrometers that leverage our linear variable optical filters for use in applications for agriculture, pharmaceuticals, government and other markets.

Acquisitions

As part of our strategy, we are committed to the ongoing evaluation of strategic opportunities and, where appropriate, the acquisition of additional products, technologies or businesses that are complementary to, or strengthen, our existing products.

In January 2014, we completed the acquisition of Network Instruments, a privately-held U.S. company and leading developer of enterprise network and application-performance management solutions for global 2000 companies. The acquisition diversified our position as a key solutions provider to the enterprise, data center and cloud networking markets. Network Instruments helps enterprises simplify the management and optimization of their networks with high-performance solutions that provide actionable intelligence and deep network visibility. We acquired all outstanding shares of Network Instruments for a total purchase price of approximately $208.5 million in cash. This acquisition was integrated into our SE segment.

 In December 2013, we acquired certain technology and other assets from Trendium, a privately-held provider of real-time intelligence software solutions for customer experience assurance (“CEA”), asset optimization and monetization of big data for 4G/LTE mobile network operators. The addition of Trendium employees and technology enabled the Company to introduce a new paradigm of CEA in our Assurance solutions, enabling operators of 4G/LTE networks to achieve a real and relevant improvement in customer satisfaction while maximizing productivity and profitability for dynamic converged 4G/LTE networks and beyond. We acquired certain technology and other assets from Trendium for a total purchase price of approximately $26.1 million in cash. This acquisition was integrated into SE segment.

Restructuring Programs

We continue to engage in targeted restructuring events intended to consolidate our operations, and align our businesses in response to market conditions and our current investment strategy. In fiscal 2017, we initiated a restructuring plan within the NE and SE business segments as part of our continued strategy to improve profitability in NSE business by narrowing the scope of the SE business and reducing costs by streamlining NSE operations. We also continued to restructure and reorganize our segments to eliminate certain positions by consolidating and shifting resources in our sales, manufacturing and R&D functions to focus on our strategic growth areas and optimize our operational efficiency.

Please refer to Management’s Discussion and Analysis of Financial Condition and Results of Operations under Item 7 and “Note 11. Restructuring and Related Charges” under Item 8 of this Annual Report on Form 10-K for further discussion on these charges.

Research and Development

During fiscal 2017, 2016 and 2015, we incurred R&D expenses of $136.3 million, $166.4 million, and $173.3 million, respectively. The number of employees engaged in R&D was approximately 600 as of July 1, 2017.

We devote substantial resources to R&D to develop new and enhanced products to serve our markets. Once the design of a product is complete, our engineering efforts shift to enhancing both product performance and our ability to manufacture it in greater volume and at lower cost.

In our NE and SE segments, we develop portable test instruments for field service technicians, systems and software used in Network Operations Centers, and instruments used in the development, testing and production of communications network components, modules and equipment. We are increasing our focus on IP-based service assurance and customer experience management, and test instruments for wireless networks and services, while continuing to develop tools for fiber optic, optical transport, Ethernet, broadband access, video test and storage network testing. We have centers of excellence for product marketing and development in Asia, Europe and North America.

In our OSP segment, our R&D efforts concentrate on developing more innovative technologies and products for customers in the anti-counterfeiting, consumer electronics, government, healthcare and automotive markets. Our strength in the banknote anti-counterfeiting market is complemented by our advances in developing novel pigments and foils for a variety of applications. Other areas of R&D focus for OSP include our efforts to leverage our optical coating technology expertise to develop applications

10

for the government and defense markets as well as efforts related to new products for 3D sensing and smart phone sensors. OSP has also introduced an innovative handheld spectrometer solution with applications in the agriculture, healthcare and defense markets.

Manufacturing

As of July 1, 2017 significant manufacturing facilities for our NE, SE and OSP segments were located in China, France, Germany, Korea and the United States and our significant contract manufacturing partners were located in China and Mexico.

Sources and Availability of Raw Materials

Viavi uses various suppliers and contract manufacturers to supply parts and components for the manufacture and support of multiple product lines. Although our intention is to establish at least two sources of supply for materials whenever possible, for certain components we have sole or limited source supply arrangements. We may not be able to procure these components from alternative sources at acceptable prices within a reasonable time, or at all; therefore, the loss or interruption of such arrangements could impact our ability to deliver certain products on a timely basis.

Patents and Proprietary Rights

Intellectual property rights apply to our various products include patents, trade secrets and trademarks. We do not intend to broadly license our intellectual property rights unless we can obtain adequate consideration or enter into acceptable patent cross-license agreements. As of July 1, 2017, we owned approximately 740 U.S. patents and 1015 foreign patents and have 535 patent applications pending throughout the world.

Backlog

We consider our backlog balance to be an estimate of future revenue to be earned from contractually committed product and service arrangements. As of July 1, 2017 and July 2, 2016, our backlog was approximately $177 million and $234 million, respectively.

Due to possible changes in product delivery schedules and cancellation of product orders, and because our sales often reflect orders shipped in the same quarter in which they are received, our backlog at any particular date is not necessarily indicative of actual revenue or the level of orders for any succeeding period.

Employees

We employed approximately 2,700 employees as of July 1, 2017, which included approximately 900 employees in manufacturing, 600 employees in R&D, 750 employees in sales and marketing, and 450 employees in general and administration. This compared to a workforce of approximately 3,000 as of July 2, 2016, and 4,900 as of June 27, 2015 which also included employees who transferred to Lumentum as part of the Separation. On August 1, 2015, approximately 1,700 employees were transferred to Lumentum as part of the separation of the Lumentum business which included approximately 850 employees from manufacturing, 550 employees from R&D, 150 employees from sales and marketing and 150 employees from general and administration.

Similar to other technology companies, we rely upon our ability to use “Full Value Awards” (as defined below) and other forms of stock-based compensation as key components of our executive and employee compensation structure. Full Value Awards refer to Restricted Stock Units (“RSUs”) and performance-based RSUs that are granted with the exercise price equal to zero and are converted to shares immediately upon vesting. The performance-based RSUs are also referred to as Market Stock Units (“MSUs”) and have vesting requirements tied to the performance of the Company’s stock as compared to the NASDAQ telecommunications index, and could vest at a higher or lower rate or not at all, based on this relative performance. Historically, these components have been critical to our ability to retain important personnel and offer competitive compensation packages. Without these components, we would be required to significantly increase cash compensation levels or develop alternative compensation structures to retain our key employees.

Outside of the United States, our businesses are subject to labor laws that differ from those in the United States. The Company follows statutory requirements, and in certain European countries it is common for a works council, consisting of elected employees, to represent the sites when discussing matters such as compensation, benefits or terminations of employment. We consider our employee relations to be good.

11

ITEM 1A. RISK FACTORS 

We have a history of net losses, and our future profitability is not assured.

We earned net income of $166.9 million in fiscal 2017 including recognized gross gains on sales of Lumentum common stock of $203.0 million. We also incurred net losses of $99.2 million and $88.1 million in fiscal 2016 and 2015, respectively. Historically, Viavi operated as a portfolio company comprised of many product lines, with diverse operating metrics and markets. As a result, our profitability in a particular period was impacted by revenue, product mix and operational costs that varied significantly across our product portfolio and business segments. While we completed the separation of our Lumentum business in 2015, this variability continues to be a factor across our remaining business segments.

Additionally, for the last several years, we have undergone multiple manufacturing, facility, organizational and product line transitions. We expect some of these activities to continue for the foreseeable future. These activities are costly and may impair our profitability objectives. Specific factors that may undermine our financial objectives include, among others:

• uncertain future telecom carrier and cable operator capital and R&D spending levels, which particularly affects our NE and SE segments; 

• adverse changes to our product mix, both fundamentally (resulting from new product transitions, the declining profitability of certain legacy products and the termination of certain products with declining margins, among other things) and due to quarterly demand fluctuations; 

• pricing pressure across our NSE product lines due to competitive forces, increasingly from Asia, and to a highly concentrated customer base for many of our product lines, which may offset some of the cost improvements; 

• our OSP operating margin may experience some downward pressure as a result of higher mix of 3D sensing products and increased operating expenses;

• limited availability of components and resources for our products which leads to higher component prices;

• increasing commoditization of previously differentiated products, and the attendant negative effect on average selling prices and profit margins;

• execution challenges, which limit revenue opportunities and harm profitability, market opportunities and customer relations; 

• decreased revenue associated with terminated or divested product lines; 

• redundant costs related to periodic transitioning of manufacturing and other functions to lower-cost locations; 

• ongoing costs associated with organizational transitions, consolidations and restructurings, which are expected to continue in the nearer term; 

• continuing high levels of selling, general and administrative, (“SG&A”) expenses; and

• cyclical demand for our currency products.

Taken together, these factors limit our ability to predict future profitability levels and to achieve our long-term profitability objectives. If we fail to achieve profitability expectations, the price of our debt and equity securities, as well as our business and financial condition, may be materially adversely impacted.

The separation of the Lumentum business could result in substantial tax liability to us and our stockholders.

One of the conditions for completing the Separation was our receipt of a tax opinion from our advisors substantially to the effect that, for U.S. federal income tax purposes, the Separation will qualify as a tax-free distribution under certain sections of the Internal Revenue Code. If any of the factual representations and assumptions made in connection with obtaining the tax opinion were inaccurate or incomplete in any material respect, then we will not be able to rely on the tax opinion. Furthermore, the tax opinion is not binding on the Internal Revenue Service (IRS) or the courts. Accordingly, the IRS or the courts may challenge the conclusions stated in the tax opinion and such challenge could prevail.

If, notwithstanding our receipt of the tax opinion, the Separation is determined to be taxable, then (i) we would be subject to tax as if we sold the stock distributed in the Separation in a taxable sale for its fair market value; and (ii) each stockholder who received stock distributed in the Separation would be treated as receiving a distribution of property in an amount equal to the fair market value of the stock that would generally result in tax liabilities for each stockholder, which may be substantial.

12

Management turnover creates uncertainties and could harm our business.

We hired a new President and Chief Executive Officer in February 2016 and a new Chief Financial Officer in September 2015. In addition, during fiscal years 2016 and 2017 we made leadership changes in several other key functions throughout the Company, including sales, HR, IT and others. The extent of our management changes could adversely impact our results of operations and our customer relationships and may make recruiting for future management positions more difficult. If we are unable to attract and retain qualified executives and employees, or to successfully integrate any newly-hired personnel within our organization, we may be unable to achieve our operating objectives, which could negatively impact our financial performance and results of operations.

Restructuring

We continue to restructure and realign our cost base with current and anticipated future market conditions. Significant risks associated with these actions that may impair our ability to achieve the anticipated cost reductions or that may disrupt our business include delays in the implementation of anticipated workforce reductions in highly regulated locations outside of the U.S. and the failure to meet operational targets due to the loss of key employees. In addition, our ability to achieve the anticipated cost savings and other benefits from these actions within the expected timeframe is subject to many estimates and assumptions. These estimates and assumptions are subject to significant economic, competitive and other uncertainties, some of which are beyond our control. If these estimates and assumptions are incorrect, if we experience delays, or if other unforeseen events occur, our business and results of operations could be adversely affected.

Our operating results may be adversely affected by unfavorable economic and market conditions.

Global macroeconomic and geopolitical risks could adversely impact customer business conditions that could decrease or delay capital spending among communications service providers, enterprise budgets and consumer demand. This could also result in increased price competition for our products, increase our risk of excess and obsolete inventories and higher overhead costs as a percentage of revenue.

Impairment in the carrying value of goodwill or other assets could negatively affect our results of operations or net worth.

We have significant long-lived assets recorded on our balance sheet. We evaluate intangible assets and goodwill for impairment at least annually, or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. We monitor factors or indicators, such as unfavorable variances from forecasted cash flows, established business plans or volatility inherent to external markets and industries that would require an impairment test. The test for impairment of intangible assets requires a comparison of the carrying value of the asset or asset group with their estimated undiscounted future cash flows. If the carrying value of the asset or asset group is considered impaired, an impairment charge is recorded for the amount by which the carrying value of the asset or asset group exceeds its fair value. The test for impairment of goodwill requires a comparison of the carrying value of the reporting unit for which goodwill is assigned with the fair value of the reporting unit calculated based on discounted future cash flows. When testing goodwill for impairment during the fourth quarter of fiscal 2016, we concluded that the carrying value of the SE reporting unit was higher than its fair value. Accordingly step two of the impairment analysis was performed which indicated that the entire SE goodwill balance was impaired resulting in an impairment charge of $91.4 million. This charge does not impact our liquidity, cash flows from operations, future operations, or compliance with debt covenants. Although the analysis indicated only the SE reporting unit was impaired, we will continue to monitor the remaining reporting units which had an excess fair value over carrying value as of the date of annual impairment assessment. As of July 1, 2017 our NE and OSP reporting goodwill balances were $143.3 million and $8.3 million, respectively. Refer to Note 8 and Note 9 of the Notes to the Consolidated Financial Statements and “Critical Accounting Policies and Estimates” in Management's Discussion and Analysis of Financial Condition and Results of Operations for further discussion of the impairment testing of goodwill and long-lived assets.

We will continue to evaluate the recoverability of the carrying amount of our goodwill and long-lived assets on an ongoing basis, and we may incur substantial impairment charges, which would adversely affect our financial results. There can be no assurance that the outcome of such reviews in the future will not result in substantial impairment charges. Impairment assessment inherently involves judgment as to assumptions about expected future cash flows and the impact of market conditions on those assumptions. Future events and changing market conditions may impact our assumptions as to prices, costs, holding periods or other factors that may result in changes in our estimates of future cash flows. Although we believe the assumptions we used in testing for impairment are reasonable, significant changes in any one of our assumptions could produce a significantly different result. If, in any period, our stock price decreases to the point where the fair value of the Company, as determined by our market capitalization, is less than our book value, this too could indicate a potential impairment and we may be required to record an impairment charge in that period.

Rapid technological change in our industry presents us with significant risks and challenges, and if we are unable to keep up with the rapid changes, our customers may purchase less of our products which could adversely affect our operating results.

13

The manufacture, quality and distribution of our products, as well as our customer relations, may be affected by several factors, including the rapidly changing market for our products, supply issues and internal restructuring efforts. We expect the impact of these issues will become more pronounced as we continue to introduce new product offerings and when overall demand increases.

Our success depends upon our ability to deliver both our current product offerings and new products and technologies on time and at acceptable cost to our customers. The markets for our products are characterized by rapid technological change, frequent new product introductions, substantial capital investment, changes in customer requirements and a constantly evolving industry. Our future performance will depend on the successful development, introduction and market acceptance of new and enhanced products that address these issues and provide solutions that meet our customers’ current and future needs. As a technology company, we also constantly encounter quality, volume and cost concerns such as:

• Our continuing cost reduction programs, which include site and organization consolidations, asset divestitures, outsourcing the manufacture of certain products to contract manufacturers, other outsourcing initiatives, and reductions in employee headcount, require the re-establishment and re-qualification by our customers of complex manufacturing lines, as well as modifications to systems, planning and operational infrastructure. During this process, we have experienced, and may continue to experience, additional costs, delays in re-establishing volume production levels, planning difficulties, inventory issues, factory absorption concerns and systems integration problems.

• We have experienced variability of manufacturing yields caused by difficulties in the manufacturing process, the effects from a shift in product mix, changes in product specifications and the introduction of new product lines. These difficulties can reduce yields or disrupt production and thereby increase our manufacturing costs and adversely affect our margin. 

• We may incur significant costs to correct defective products (despite rigorous testing for quality both by our customers and by us), which could include lost future sales of the affected product and other products, and potentially severe customer relations problems, litigation and damage to our reputation. 

• We are dependent on a limited number of vendors, who are often small and specialized, for raw materials, packages and standard components. We also rely on contract manufacturers around the world to manufacture certain of our products. Our business and results of operations have been, and could continue to be adversely affected by this dependency. Specific concerns we periodically encounter with our suppliers include stoppages or delays of supply, insufficient vendor resources to supply our requirements, substitution of more expensive or less reliable products, receipt of defective parts or contaminated materials, increases in the price of supplies, and an inability to obtain reduced pricing from our suppliers in response to competitive pressures. Additionally, the ability of our contract manufacturers to fulfill their obligations may be affected by economic, political or other forces that are beyond our control. Any such failure could have a material impact on our ability to meet customers’ expectations and may materially impact our operating results. 

• New product programs and introductions involve changing product specifications and customer requirements, unanticipated engineering complexities, difficulties in reallocating resources and overcoming resource limitations and with their increased complexity, which expose us to yield and product risk internally and with our suppliers.

These factors have caused considerable strain on our execution capabilities and customer relations. We have and could continue to see (a) periodic difficulty responding to customer delivery expectations for some of our products, (b) yield and quality problems, particularly with some of our new products and higher volume products, and (c) additional funds and other resources required to respond to these execution challenges. From time to time, we have had to divert resources from new product R&D and other functions to assist with resolving these matters. If we do not improve our performance in all of these areas, our operating results will be harmed, the commercial viability of new products may be challenged and our customers may choose to reduce or terminate their purchases of our products and purchase additional products from our competitors.

We rely on a limited number of customers for a significant portion of our sales.

We believe that we will continue to rely upon a limited number of customers for a significant portion of our revenues for the foreseeable future. Any failure by us to continue capturing a significant share of these customers could materially harm our business. Dependence on a limited number of customers exposes us to the risk that order reductions from any one customer can have a material adverse effect on periodic revenue. Further, to the extent that there is consolidation among communications equipment manufacturers and service providers, we will have increased dependence on fewer customers who may be able to exert increased pressure on our prices and other contract terms. Customer consolidation activity and periodic manufacturing and inventory initiatives could also create the potential for disruptions in demand for our products as a consequence of such customers streamlining, reducing or delaying purchasing decisions.

We have a strategic alliance with SICPA, our principal customer for our light interference microflakes that are used to, among other things, provide security features in currency. Under a license and supply agreement, we rely exclusively on SICPA to market

14

and sell one of these product lines, optically variable pigment, for document authentication applications worldwide. The agreement requires SICPA to purchase minimum quantities of these pigments over the term of the agreement. If SICPA fails to purchase these quantities, as and when required by the agreement, our business and operating results (including, among other things, our revenue and gross margin) will be harmed as we may be unable to find a substitute marketing and sales partner or develop these capabilities ourselves.

Our forecasts related to our growth strategy in 3D sensing and other applications may prove to be inaccurate.

Growth forecasts are subject to significant uncertainty and are based on assumptions and estimates which may not prove to be accurate. Our estimate of the market opportunity related to 3D sensing is subject to significant uncertainty and is based on assumptions and estimates, including our internal analysis, industry experience and third-party data. Accordingly, our estimated market opportunity may prove to be materially inaccurate. In addition, our growth and ability to serve a significant portion of this estimated market is subject to many factors, including our success in implementing our business strategy and expansion of 3D sensing and other applications for consumer electronics. We cannot assure you that we will be able to serve a significant portion of this market and the growth forecasts should not be taken as indicative of our future growth.

Movement towards virtualized networks and software solutions may result in lower demand for our hardware products and increased competition.

The markets for our NE and SE segments are increasingly looking towards virtualized networks and software solutions. While we are devoting substantial resources to meet these needs, this trend may result in lower demand for our legacy hardware products. Additionally barriers to entry are generally lower for software solutions, which may lead to increased competition for our products and services.

We face a number of risks related to our strategic transactions.

Our strategy continues to include periodic acquisitions and divestitures of businesses and technologies. Strategic transactions of this nature involve numerous risks, including the following:

• inadequate internal control procedures and disclosure controls to comply with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002, or poor integration of a target company’s or business’s procedures and controls; 

• diversion of management’s attention from normal daily operations of the business; 

• potential difficulties in completing projects associated with in-process R&D; 

• difficulties in entering markets in which we have no or limited prior experience and where competitors have stronger market positions; 

• difficulties in obtaining or providing sufficient transition services and accurately projecting the time and cost associated with providing these services; 

• an acquisition may not further our business strategy as we expected or we may overpay for, or otherwise not realize the expected return on, our investments; 

• insufficient net revenue to offset increased expenses associated with acquisitions; 

• potential loss of key employees of the acquired companies; and 

• difficulty in forecasting revenues and margins.

Acquisitions may also cause us to:

• issue common stock that would dilute our current stockholders’ percentage ownership and may decrease earnings per share; 

• assume liabilities, some of which may be unknown at the time of the acquisitions; 

• record goodwill and non-amortizable intangible assets that will be subject to impairment testing and potential periodic impairment charges; 

• incur additional debt to finance such acquisitions; 

• incur amortization expenses related to certain intangible assets; or

• acquire, assume, or become subject to litigation related to the acquired businesses or assets.

15

Certain of our products are subject to governmental and industry regulations, certifications and approvals.

The commercialization of certain of the products we design, manufacture and distribute through our OSP segment may be more costly due to required government approval and industry acceptance processes. Development of applications for our light interference and diffractive microflakes may require significant testing that could delay our sales. For example, certain uses in cosmetics may be regulated by the U.S. Food and Drug Administration, which has extensive and lengthy approval processes. Durability testing by the automobile industry of our decorative microflakes used with automotive paints can take up to three years. If we change a product for any reason, including technological changes or changes in the manufacturing process, prior approvals or certifications may be invalid and we may need to go through the approval process again. If we are unable to obtain these or other government or industry certifications in a timely manner, or at all, our operating results could be adversely affected.

We face risks related to our international operations and revenue.

Our customers are located throughout the world. In addition, we have significant operations outside North America, including product development, manufacturing, sales and customer support operations.

Our international presence exposes us to certain risks, including the following:

• currency fluctuations; 

• our ability to comply with a wide variety of laws and regulations of the countries in which we do business, including, among other things, customs, import/export, anti-bribery, anti-competition, tax and data privacy laws, which may be subject to sudden and unexpected changes; 

• difficulties in establishing and enforcing our intellectual property rights; 

• tariffs and other trade barriers; 

• political, legal and economic instability in foreign markets, particularly in those markets in which we maintain manufacturing and product development facilities; 

• difficulties in staffing and management;

• language and cultural barriers; 

• seasonal reductions in business activities in the countries where our international customers are located; 

• integration of foreign operations; 

• longer payment cycles; 

• difficulties in management of foreign distributors; and 

• potential adverse tax consequences.

Net revenue from customers outside the Americas accounted for 53.3%, 48.9% and 44.3% of our total net revenue, for fiscal 2017, 2016 and 2015 respectively. We expect that net revenue from customers outside North America will continue to account for a significant portion of our total net revenue. Lower sales levels that typically occur during the summer months in Europe and some other overseas markets may materially and adversely affect our business. In addition, the revenues we derive from many of our customers depend on international sales and further expose us to the risks associated with such international sales.

Our business and operations would be adversely impacted in the event of a failure of our information technology infrastructure.

We rely upon the capacity, reliability and security of our information technology infrastructure and our ability to expand and continually update this infrastructure in response to our changing needs. In some cases, we rely upon third party hosting and support services to meet these needs. The growing cyber risk environment means that individuals, companies, and organizations of all sizes, including Viavi, are increasingly subject to the threat of intrusions on their networks and systems by a wide range of actors on an ongoing and regular basis. Any failure to manage, expand and update our information technology infrastructure, any failure in the extension or operation of this infrastructure, or any failure by our hosting and support partners in the performance of their services could materially and adversely harm our business.

Despite our implementation of security measures and those of our third-party vendors, our systems are vulnerable to damages from computer viruses, natural disasters, unauthorized access and other similar disruptions. Any system failure, accident or security breach could result in disruptions to our operations. To the extent that any disruptions or security breach results in a loss or damage to our data, or in inappropriate disclosure of confidential information, it could cause significant damage to our reputation and

16

affect our relationships with our customers and ultimately harm our business. In addition, we may be required to incur significant costs to protect against damage caused by these disruptions or security breaches in the future.

Failure to maintain effective internal controls may adversely affect our stock price.

Effective internal controls are necessary for us to provide reliable financial reports and to effectively prevent fraud. The Company is required to annually evaluate the effectiveness of the design and operation of its internal controls over financial reporting. Based on these evaluations, the Company may conclude that enhancements, modifications, or changes to internal controls are necessary or desirable. In addition, our independent registered public accounting firm must report on the effectiveness of our internal control over financial reporting. While management evaluates the effectiveness of the Company’s internal controls on a regular basis, these controls may not always be effective. In August 2016 we determined that we had a material weakness related to an error in the determination of interim income taxes which caused our independent registered public accounting firm to issue a qualified report on our Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended July 2, 2016. As a result, management initiated a thorough and detailed remediation plan which included enhanced processes and designed controls to ensure a more precise review of the interim income tax provisions beginning in the first quarter of fiscal 2017. As of July 1, 2017, the remediation plan has been completed and the material weakness has been remediated.

There are inherent limitations on the effectiveness of internal controls, including collusion, management override, and failure in human judgment. In addition, control procedures are designed to reduce rather than eliminate financial statement risk. Additionally, if we or our independent registered public accounting firm are not satisfied with our internal control over financial reporting or the level at which these controls are documented, designed, operated or reviewed in the future, or if our independent registered public accounting firm interprets the requirements, rules and/or regulations differently from our interpretation, then they may issue a qualified report. Furthermore, we may discover that the internal controls of businesses we acquire are inadequate or changes to our existing businesses may impact the effectiveness of our internal controls. These situations could require us to make changes to our internal controls and could cause our independent registered public accounting firm to issue a qualified report, which could result in a loss of investor confidence in the reliability of our financial statements, and could negatively impact our stock price.

In August 2013, we issued $650.0 million of 0.625% Senior Convertible Notes due 2033, and in March 2017, we issued $460.0 million of 1.00% Senior Convertible Notes due 2024. The issuance of the Notes could dilute our existing stockholders and lower our reported earnings per share.

We issued $650.0 million of indebtedness in August 2013 in the form of 0.625% Senior Convertible Notes due 2033 (the “2033 Notes”) of which $610.0 million are outstanding as of July 1, 2017 and $460.0 million of indebtedness in March 2017 in the form of 1.00% Senior Convertible Notes due 2024 (the “2024 Notes” and, together with the 2033 Notes, the “Notes”). The issuance of the Notes substantially increased our principal payment obligations. Additionally, in fiscal 2016 we contributed $137.6 million in cash to Lumentum in connection with the Separation, subject to the requirements as set forth in the Contribution Agreement between the Company and Lumentum Operations LLC. Following the Separation we have substantially lower cash flow which increased our leverage. The degree to which we are leveraged could materially and adversely affect our ability to successfully obtain financing for working capital, acquisitions or other purposes and could make us more vulnerable to industry downturns and competitive pressures. In addition, the holders of the Notes are entitled to convert the Notes into shares of our common stock or a combination of cash and shares of common stock under certain circumstances which would dilute our existing stockholders and lower our reported per share earnings.

If we have insufficient proprietary rights or if we fail to protect those we have, our business would be materially harmed.Our intellectual property rights may not be adequate to protect our products or product roadmaps.

We seek to protect our products and our product roadmaps in part by developing and/or securing proprietary rights relating to those products, including patents, trade secrets, know-how and continuing technological innovation. The steps taken by us to protect our intellectual property may not adequately prevent misappropriation or ensure that others will not develop competitive technologies or products. Other companies may be investigating or developing other technologies that are similar to our own. It is possible that patents may not be issued from any of our pending applications or those we may file in the future and, if patents are issued, the claims allowed may not be sufficiently broad to deter or prohibit others from making, using or selling products that are similar to ours. We do not own patents in every country in which we sell or distribute our products, and thus others may be able to offer identical products in countries where we do not have intellectual property protection. In addition, the laws of some territories in which our products are or may be developed, manufactured or sold, including Europe, Asia-Pacific or Latin America, may not protect our products and intellectual property rights to the same extent as the laws of the United States.

Any patents issued to us may be challenged, invalidated or circumvented. Additionally, we are currently a licensee in all of our operating segments for a number of third-party technologies, software and intellectual property rights from academic institutions, our competitors and others, and are required to pay royalties to these licensors for the use thereof. Unless we are able

17

to obtain such licenses on commercially reasonable terms, patents or other intellectual property held by others could inhibit our development of new products, impede the sale of some of our current products, substantially increase the cost to provide these products to our customers, and could have a significant adverse impact on our operating results. In the past, licenses generally have been available to us where third-party technology was necessary or useful for the development or production of our products. In the future licenses to third-party technology may not be available on commercially reasonable terms, if at all.

Our products may be subject to claims that they infringe the intellectual property rights of others.

Lawsuits and allegations of patent infringement and violation of other intellectual property rights occur in our industry on a regular basis. We have received in the past, and anticipate that we will receive in the future, notices from third parties claiming that our products infringe their proprietary rights. Over the past several years there has been a marked increase in the number and potential severity of third-party patent infringement claims, primarily from two distinct sources. First, large technology companies, including some of our customers and competitors, are seeking to monetize their patent portfolios and have developed large internal organizations that have approached us with demands to enter into license agreements. Second, patent-holding companies, entities that do not make or sell products (often referred to as “patent trolls”), have claimed that our products infringe upon their proprietary rights. We will continue to respond to these claims in the course of our business operations. In the past, the resolution of these disputes has not had a material adverse impact on our business or financial condition, however this may not be the case in the future. Further, the litigation or settlement of these matters, regardless of the merit of the claims, could result in significant expense to us and divert the efforts of our technical and management personnel, whether or not we are successful. If we are unsuccessful, we could be required to expend significant resources to develop non-infringing technology or to obtain licenses to the technology that is the subject of the litigation. We may not be successful in such development, or such licenses may not be available on terms acceptable to us, if at all. Without such a license, we could be enjoined from future sales of the infringing product or products, which could adversely affect our revenues and operating results.

The use of open source software in our products, as well as those of our suppliers, manufacturers and customers, may expose us to additional risks and harm our intellectual property position.

Certain of the software and/or firmware that we use and distribute (as well as that of our suppliers, manufacturers and customers) may be, be derived from, or contain, “open source” software, which is software that is generally made available to the public by its authors and/or other third parties. Such open source software is often made available under licenses which impose obligations in the event the software or derivative works thereof are distributed or re-distributed. These obligations may require us to make source code for the derivative works available to the public, and/or license such derivative works under a particular type of license, rather than the forms of license customarily used to protect our own software products. While we believe we have complied with our obligations under the various applicable licenses for open source software, in the event that a court rules that these licenses are unenforceable, or in the event the copyright holder of any open source software were to successfully establish in court that we had not complied with the terms of a license for a particular work, we could be required to release the source code of that work to the public and/or stop distribution of that work. Additionally, open source licenses are subject to occasional revision. In the event future iterations of open source software are made available under a revised license, such license revisions may adversely affect our ability to use such future iterations.

We face certain litigation risks that could harm our business.

We are and may become subject to various legal proceedings and claims that arise in or outside the ordinary course of business. The results of complex legal proceedings are difficult to predict. Moreover, many of the complaints filed against us do not specify the amount of damages that plaintiffs seek, and we therefore are unable to estimate the possible range of damages that might be incurred should these lawsuits be resolved against us. While we are unable to estimate the potential damages arising from such lawsuits, certain of them assert types of claims that, if resolved against us, could give rise to substantial damages. Thus, an unfavorable outcome or settlement of one or more of these lawsuits could have a material adverse effect on our financial condition, liquidity and results of operations. Even if these lawsuits are not resolved against us, the uncertainty and expense associated with unresolved lawsuits could seriously harm our business, financial condition and reputation. Litigation is costly, time-consuming and disruptive to normal business operations. The costs of defending these lawsuits have been significant, will continue to be costly and may not be covered by our insurance policies. The defense of these lawsuits could also result in continued diversion of our management’s time and attention away from business operations, which could harm our business. For additional discussion regarding litigation, see the “Legal Proceedings” portion of this Annual Report.

We may be subject to environmental liabilities which could increase our expenses and harm our operating results.

We are subject to various federal, state and foreign laws and regulations governing the environment, including those governing pollution and protection of human health and the environment and, recently, those restricting the presence of certain substances in electronic products and holding producers of those products financially responsible for the collection, treatment, recycling and disposal of certain products. Such laws and regulations have been passed in several jurisdictions in which we operate, are often

18

complex and are subject to frequent changes. We will need to ensure that we comply with such laws and regulations as they are enacted, as well as all environmental laws and regulations, and as appropriate or required, that our component suppliers also comply with such laws and regulations. If we fail to comply with such laws, we could face sanctions for such noncompliance, and our customers may refuse to purchase our products, which would have a materially adverse effect on our business, financial condition and results of operations.

With respect to compliance with environmental laws and regulations in general, we have incurred and in the future could incur substantial costs for the cleanup of contaminated properties, either those we own or operate or to which we have sent wastes in the past, or to comply with such environmental laws and regulations. Additionally, we could be subject to disruptions to our operations and logistics as a result of such clean-up or compliance obligations. If we were found to be in violation of these laws, we could be subject to governmental fines and liability for damages resulting from such violations. If we have to make significant capital expenditures to comply with environmental laws, or if we are subject to significant expenditures in connection with a violation of these laws, our financial condition or operating results could be materially adversely impacted.

We are subject to provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act that could subject us to additional costs and liabilities.

We are subject to the SEC rules implementing the requirements of Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act which establish disclosure and reporting requirements for companies who use “conflict” minerals mined from the Democratic Republic of Congo and adjoining countries in their products. Complying with the disclosure requirements requires substantial diligence efforts to determine the source of any conflict minerals used in our products and may require third-party auditing of our diligence process. These efforts may require internal resources that would otherwise be directed towards operational activities.

Since our supply chain is complex, we may face reputational challenges if we are unable to sufficiently verify the origins of the conflict minerals used in our products. Additionally, if we are unable to satisfy those customers who require that all of the components of our products are certified as conflict free, they may choose a competitor’s products which could materially impact our financial condition and operating results.

Certain provisions in our charter and under Delaware laws could hinder a takeover attempt.

We are subject to the provisions of Section 203 of the Delaware General Corporation Law prohibiting, under some circumstances, publicly-held Delaware corporations from engaging in business combinations with some stockholders for a specified period of time without the approval of the holders of substantially all of our outstanding voting stock. Such provisions could delay or impede the removal of incumbent directors and could make more difficult a merger, tender offer or proxy contest involving us, even if such events could be beneficial, in the short-term, to the interests of the stockholders. In addition, such provisions could limit the price that some investors might be willing to pay in the future for shares of our common stock. Our certificate of incorporation and bylaws contain provisions providing for the limitations of liability and indemnification of our directors and officers, allowing vacancies on our board of directors to be filled by the vote of a majority of the remaining directors, granting our board of directors the authority to establish additional series of preferred stock and to designate the rights, preferences and privileges of such shares (commonly known as “blank check preferred”) and providing that our stockholders can take action only at a duly called annual or special meeting of stockholders, which may only be called by the Chairman of the board, the Chief Executive Officer or the board of directors. These provisions may also have the effect of deterring hostile takeovers or delaying changes in control or change in our management.

Our ability to use our net operating loss carryforwards to offset future taxable income may be subject to certain limitations.

As of July 1, 2017, we had U.S. federal and state net operating losses, or NOLs, of $5,115.1 million and $762.2 million, respectively, and U.S. federal and state tax credit carryforwards of $103.9 million and $40.7 million respectively, which may be utilized against future income taxes. Utilization of these NOLs and tax credit carryforwards may be subject to a substantial annual limitation if the ownership change limitations under Sections 382 and 383 of the Internal Revenue Code and similar state provisions are triggered by changes in the ownership of our capital stock. In general, an ownership change occurs if there is a cumulative change in our ownership by “5-percent shareholders” that exceeds 50 percentage points over a rolling three-year period. Similar rules may apply under state tax laws. Accordingly, purchases of our capital stock by others could limit our ability to utilize our NOLs and tax credit carryforwards in the future.

Furthermore, we may not be able to generate sufficient taxable income to utilize our NOLs and tax credit carryforwards before they expire. Due to uncertainty regarding the timing and extent of our future profitability, we continue to record a valuation allowance to offset our U.S. and certain of our foreign deferred tax assets because of uncertainty related to our ability to utilize our NOLs and tax credit carryforwards before they expire.

If any of these events occur, we may not derive some or all of the expected benefits from our NOLs and tax credit carryforwards.

19

ITEM 1B.    UNRESOLVED STAFF COMMENTS 

None.

ITEM 2.    PROPERTIES 

We own and lease various properties in the United States and in 21 other countries around the world. We use the properties for executive and administrative offices, data centers, product development offices, customer service offices, and manufacturing facilities. Our corporate headquarters of approximately 54,000 square feet is located in Milpitas, California. As of July 1, 2017, our leased and owned properties in total were approximately 1.3 million square feet, of which approximately 18,000 square feet is owned. Larger leased sites include properties located in China, France, Germany, and the United States. We believe our existing properties, including both owned and leased sites, are in good condition and suitable for the conduct of our business.

While we believe our existing facilities are adequate to meet our immediate needs, it may become necessary to lease, acquire, or sell additional or alternative space to accommodate future business needs.

ITEM 3.    LEGAL PROCEEDINGS 

We are subject to a variety of claims and suits that arise from time to time in the ordinary course of our business. While management currently believes that resolving claims against us, individually or in aggregate, will not have a material adverse impact on our financial position, results of operations or statement of cash flows, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future. If an unfavorable final outcome to occur, it may have a material adverse impact on our financial position, results of operations or cash flows for the period in which the effect becomes reasonably estimable.

ITEM 4.    MINE SAFETY DISCLOSURES

None.

20

PART II 

ITEM 5.    MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 

Our common stock is traded on the NASDAQ Global Select Market under the symbol “VIAV.” Prior to the separation of the Lumentum business, our common stock was traded on the NASDAQ Global Select Market under the symbol “JDSU.” As of July 28, 2017 we had 227,547,102 shares of common stock outstanding. The closing price on July 28, 2017 was $11.00.

On August 1, 2015, we completed the previously announced distribution of approximately 80.1% of the outstanding shares of Lumentum common stock to Viavi’s stockholders (the “Distribution”). JDSU was renamed Viavi Solutions Inc. and, at the time of the Distribution, retained ownership of approximately 19.9% of Lumentum’s outstanding shares. We agreed not to liquidate the retained shares during the first six months following the Distribution. However, in connection with a private letter ruling from the Internal Revenue Service, we committed to liquidate these shares within three years from the Distribution. We have sold all of our ownership of Lumentum common stock as of July 1, 2017. The Distribution was made to Viavi’s stockholders of record as of the close of business on July 27, 2015 (the “Record Date”), who received one share of Lumentum common stock for every five shares of Viavi common stock held as of the close of business on the Record Date and not sold prior to August 4, 2015. Viavi stockholders received cash in lieu of any fractional shares of Lumentum common stock. Our trading commenced “regular-way” trading on August 4, 2015 on NASDAQ under the ticker symbol “VIAV.”

The following table summarizes the high and low intraday sales prices for our common stock as reported on the NASDAQ Global Select Market during fiscal 2017 and 2016. The stock prices in the following table prior to August 4, 2015, the date of “regular-way” trading commenced following the Lumentum separation, have not been adjusted for the distribution.

	High		Low
Fiscal 2017
Fourth Quarter	$	11.89	$	9.46
Third Quarter	11.15		8.13
Second Quarter	8.76		6.99
First Quarter	7.94		6.36
Fiscal 2016
Fourth Quarter	$	7.20	$	5.93
Third Quarter	6.94		4.68
Second Quarter	6.56		5.45
First Quarter subsequent to August 3, 2015	6.88		4.99
First Quarter through August 3, 2015	12.00		10.68

As of July 29, 2017, we had 3,716 holders of record of our common stock. We have not paid cash dividends on our common stock and do not anticipate paying cash dividends in the foreseeable future.

During the fourth quarter of the fiscal 2017we made the following repurchases of our common stock (in millions, except shares and per share amounts):

Period	Total Number of Shares Purchased	Average Price Paid per share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
April 2, 2017 to April 29, 2017 (1)	8,000	$	9.50	8,000	$	53.8
April 30, 2017 to May 27, 2017	—	—		—	53.8
May 28, 2017 to July 1, 2017 (1)	30,430	10.92		30,430	53.5
	38,430	$	10.62	38,430	$	53.5

(1) Repurchases were made in open market transactions pursuant to the program announced in February 2016. In February 2016, the Company's Board of Directors authorized a stock repurchase program under which the Company may purchase shares of its common stock worth up to an aggregate purchase price of $100.0 million through open market or private transactions.In September 2016, the Board of Directors increased the Company’s previously authorized stock

21

repurchase program from $100 million to $150 million. Under the revised repurchase authorization, the Company may repurchase up to $150 million of the Company’s common stock from time to time at the discretion of the Company’s management. This stock repurchase authorization expires on December 31, 2017.

STOCK PERFORMANCE GRAPH

The information contained in the following graph shall not be deemed to be “soliciting material” or to be “filed” with the Securities and Exchange Commission, nor shall such information be incorporated by reference into any future filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically incorporates it by reference in such filing.

The following graph and table set forth the total cumulative return, assuming reinvestment of dividends, on an investment of $100 in June 2012 and ending June 2017 in: (i) our Common Stock, (ii) the S&P 500 Index, (iii) the NASDAQ Stock Market (U.S.) Index, and (iv) the NASDAQ Telecommunications Index. The table below includes our stock performance prior to the separation of the Lumentum business as traded on the NASDAQ Global Select Market under the symbol “JDSU.” Historical stock price performance is not necessarily indicative of future stock price performance. For the purpose of this graph, the distribution of approximately 80.1% of the outstanding common stock of Lumentum to our stockholders, pursuant to which Lumentum became an independent company, is treated as a non-taxable cash dividend of $21.15 for every five shares of Viavi common stock held, an amount equal to the closing price of Lumentum common stock on August 4, 2015 which was deemed reinvested in Viavi common stock at the closing price on August 4, 2015.

*$100 invested on 6/30/12 in stock or index.

22

	6/12		6/13		6/14		6/15		6/16		6/17
Viavi	$	100.00	$	130.82	$	113.36	$	105.27	$	101.13	$	160.62
S&P 500	100.00		117.92		143.91		151.46		154.08		177.91
NASDAQ Composite	100.00		115.95		150.19		169.91		164.99		209.21
NASDAQ Telecommunications	100.00		124.28		141.30		143.68		142.22		161.85

23

ITEM 6.    SELECTED FINANCIAL DATA 

This table sets forth selected financial data of Viavi (in millions, except share and per share amounts) for the periods indicated. This data should be read in conjunction with and is qualified by reference to “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Item 7 of this Annual Report on Form 10-K and our audited consolidated financial statements, including the notes thereto and the other financial information included in Item 8 of this Annual Report on Form 10-K. The selected financial data presented in this section is not intended to replace the consolidated financial statements included in this report.

	Years Ended
	July 1, 2017		July 2, 2016			June 27, 2015			June 28, 2014			June 29, 2013
	(8)(10)		(8)(9)(10)			(7)(8)			(5)(6)(8)			(1)(2)(3)(4)(8)
Consolidated Statements of Operations Data:
Net revenue	$	811.4	$	906.3		$	873.9		$	926.9		$	909.1
Income (loss) from continuing operations, net of tax	165.3		(50.4		)	(131.4		)	(74.6		)	11.0
Income (loss) from discontinued operations, net of tax	1.6		(48.8		)	43.3			56.8			46.0
Net income (loss)	$	166.9	$	(99.2	)	$	(88.1	)	$	(17.8	)	$	57.0
Net income (loss) per share from - basic:
Continuing operations	$	0.72	$	(0.22	)	$	(0.57	)	$	(0.32	)	$	0.04
Discontinued operations	0.01		(0.20		)	0.19			0.24			0.20
Net income (loss)	$	0.73	$	(0.42	)	$	(0.38	)	$	(0.08	)	$	0.24
Net income (loss) per share from - diluted:
Continuing operations	$	0.70	$	(0.22	)	$	(0.57	)	$	(0.32	)	$	0.04
Discontinued operations	0.01		(0.20		)	0.19			0.24			0.20
Net income (loss)	$	0.71	$	(0.42	)	$	(0.38	)	$	(0.08	)	$	0.24

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015		June 28, 2014		June 29, 2013
	(8)(10)		(8)(9)		(7)(8)		(5)(6)		(2)(3)(4)
Consolidated Balance Sheets Data:
Cash and cash equivalents, short-term investments, and restricted cash	$	1,447.8	$	979.8	$	825.6	$	881.3	$	515.9
Working capital	1,438.2		985.3		1,004.6		1,001.1		682.6
Total assets	2,110.5		1,678.1		2,210.6		2,342.7		1,715.2
Long-term obligations	1,095.3		762.4		722.8		746.6		206.2
Total stockholders’ equity	786.4		689.3		1,101.4		1,187.7		1,161.3

(1) During the first quarter of fiscal 2013, we entered into a definitive agreement to sell the hologram business (“Hologram Business”) within our OSP segment, which subsequently closed on October 12, 2012. As a result, the operations of the Hologram Business have been presented as discontinued operations for the period presented. 

(2) During the third quarter of fiscal 2013, we acquired Arieso Ltd. (“Arieso”) in a transaction accounted for in accordance with the authoritative guidance on business combinations. The Consolidated Statements of Operations for fiscal 2013 included the results of Arieso subsequent to March 7, 2013 and the Consolidated Balance Sheet as of June 29, 2013 included Arieso’s financial position. 

(3) During the third quarter of fiscal 2013, we approved a strategic plan to exit NSE’s legacy low-speed wireline product line, which resulted in a $2.2 million charge for accelerated amortization of related intangibles, of which $1.8 million and $0.4 million are included in amortization of acquired technologies and amortization of other intangibles in the Consolidated Statement of Operations, respectively. In addition, we incurred $11.3 million of inventory-related charges included in cost of revenues in the Consolidated Statement of Operations, primarily related to the write-off of inventory no longer being sold due to the legacy low-speed wireline product line exit. 

24

(4) During the fourth quarter of fiscal 2013, we determined that it is more likely than not that a portion of the deferred tax assets of a non-U.S. jurisdiction will be realized after considering all positive and negative evidence. Accordingly, a deferred tax valuation allowance release of $107.9 million was recorded as an income tax benefit during the quarter. 

(5) During the third quarter of fiscal 2014, we recognized $21.7 million of uncertain tax benefits related to deferred tax assets due to the expiration of the statute of limitations in a non-U.S. jurisdiction. 

(6) During the third quarter of fiscal 2014, we acquired Network Instruments in a transaction accounted for in accordance with the authoritative guidance on business combinations. The Consolidated Statement of Operations for fiscal 2014 included the results of operations from Network Instruments subsequent to January 6, 2014 and the Consolidated Balance Sheet as of June 28, 2014 included Network Instruments’ financial position.

(7) In the third quarter of fiscal 2015, we recognized a $21.8 million tax benefit upon the settlement of an audit in a non-U.S. jurisdiction.

(8) During the first quarter of fiscal 2016, we completed the Separation. As a result, the operations of the Lumentum business have been presented as discontinued operations in all periods of the Company’s Consolidated Statements of Operations and in the Consolidated Balance Sheet as of June 27, 2015.

(9) During the fourth quarter of fiscal 2016, the Company recorded a $91.4 million goodwill impairment charge related to the SE reporting unit in the Consolidated Statements of Operations.Refer to “Note 8. Goodwill” for more information.

(10) During fiscal year ended 2017 and 2016, the Company recorded $203.0 million and $71.5 million, respectively, gross realized gains on the sale of Lumentum common stock that was retained as part of the Separation. Refer to “Note 7. Investments, Forward Contracts and Fair Value Measurements”for more information.

25

ITEM 7.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion of our financial condition and results of operations in conjunction with the financial statements and the notes thereto included elsewhere in this Annual Report on Form 10-K. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Annual Report on Form 10-K, particularly in “Risk Factors” and “Forward-Looking Statements.”

Our Industries and Developments

Viavi, formerly JDSU, is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises and their ecosystems, supported by a worldwide channel community including Viavi Velocity Solution Partners (“Velocity”). Our Velocity program allows us to optimize the use of direct or partner sales depending on application and sales volume. Its strategy is to expand our reach into new market segments as well as expand our capability to sell and deliver solutions. Our solutions deliver end-to-end visibility across physical, virtual and hybrid networks, enabling customers to optimize connectivity, quality of experience and profitability. Viavi is also a leader in high performance thin film optical coatings, providing light management solutions to anti-counterfeiting, consumer and industrial, government and healthcare and other markets. On August 1, 2015, we completed the separation of our optical components and lasers business and created two publicly traded companies:

• an optical components and commercial lasers company named Lumentum, consisting of our CCOP segment and the WaveReady product line formerly within our NE segment; and

• a network and service enablement and optical coatings company, renamed Viavi, consisting of our NE, SE and OSP segments.

In connection with the Separation we distributed approximately 80.1% of the outstanding shares of Lumentum common stock to our stockholders on August 1, 2015. The Company was renamed Viavi and, at the time of the distribution, retained ownership of approximately 19.9% of Lumentum’s outstanding shares. Activities related to the Lumentum business have been presented as discontinued operations in all periods of the Company’s consolidated financial statements in this Annual Report on Form 10-K and the accompanying disclosures, discussion and analysis herein pertains to the Company’s continuing operations, unless noted otherwise.

To serve our markets, during fiscal 2017 we operated the following business segments:

•Network Enablement

•Service Enablement

•Optical Security and Performance Products

Network Enablement

NE provides an integrated portfolio of testing solutions that access the network to perform build-out and maintenance tasks. These solutions include instruments, software and services to design, build, activate, certify, troubleshoot and optimize networks. They also support more profitable, higher-performing networks and facilitate time-to-revenue.

Our solutions address lab and production environments, field deployment and service assurance for wireless and fixed communications networks, including storage networks. Our test instrument portfolio is one of the largest in the industry, with hundreds of thousands of units in active use by major NEMs, operators and services providers worldwide. Designed to be mobile, these products include instruments and software that access the network to perform installation and maintenance tasks. They help service provider technicians assess the performance of network elements and segments and verify the integrity of the information being transmitted across the network. These instruments are highly intelligent and have user interfaces that are designed to simplify operations and minimize the training required to operate them. Our NE solutions are also used by network-equipment manufacturers (“NEMs”) in the design and production of next-generation network equipment.

Viavi also offers a range of product support and professional services designed to comprehensively address our customers’ requirements. These services include repair, calibration, software support and technical assistance for our products. We offer product and technology training as well as consulting services. Our professional services, provided in conjunction with system integration projects, include project management, installation and implementation.

26

NE customers include CSPs, NEMs, government organizations and large corporate customers, such as major telecom, mobility and cable operators, chip and infrastructure vendors, storage-device manufacturers, storage-network and switch vendors, and deployed private enterprise customers. Our customers include Alcatel-Lucent International, América Móvil, S.A.B. de C.V., AT&T Inc., CenturyLink, Inc., Cisco Systems, Inc., Comcast Corporation, Nokia Solutions and Networks, Reliance Industries, Time Warner Inc. and Verizon Communications Inc..

Service Enablement

SE provides embedded systems and enterprise performance management solutions that give global CSPs, enterprises and cloud operators visibility into network, service and application data. These solutions - which primarily consist of instruments, microprobes and software - monitor, collect and analyze network data to reveal the actual customer experience and identify opportunities for new revenue streams and network optimization.

Our portfolio of SE solutions addresses the same lab and production environments, field deployment and service assurance for wireless and fixed communications networks, including storage networks, as our NE portfolio. Our solutions let carriers remotely monitor performance and quality of network, service and applications performance throughout the entire network. This provides our customers with enhanced network management, control, and optimization that allow network operators to initiate service to new customers faster, decrease the need for technicians to make on-site service calls, help to make necessary repairs faster and, as a result, lower costs while providing higher quality and more reliable services. Remote monitoring decreases operating expenses, while early detection helps increase uptime, preserve revenue, and helps operators better monetize their networks.

SE customers include similar CSPs, NEMs, government organizations, large corporate customers, and storage-segment customers that are served by our NE segment.

Optical Security and Performance Products

Our OSP segment leverages its core optical coating technologies and volume manufacturing capability to design, manufacture, and sell products targeting anti-counterfeiting, consumer and industrial, government, healthcare and other markets.

Our security offerings for the currency market include OVP®, OVMP® and banknote thread substrates. OVP® enables a color-shifting effect used by banknote issuers and security printers worldwide for anti-counterfeiting applications on banknotes and other high-value documents. Our technologies are deployed on the banknotes of more than 100 countries today. OSP also develops and delivers overt and covert anti-counterfeiting products that utilize its proprietary printing platform and are targeted primarily at the pharmaceutical and consumer-electronics markets.

Leveraging our expertise in spectral management and our unique high-precision coating capabilities, OSP provides a range of products and technologies for the consumer and industrial market, including, for example, 3D sensing optical filters.

OSP value-added solutions meet the stringent requirements of commercial and government customers. Our products are used in a variety of aerospace and defense applications, including optics for guidance systems, laser eye protection and night vision systems. These products, including coatings and optical filters, are optimized for each specific application.

OSP serves customers such as FLIR Systems, Kingston Digital, L-3 Communications, Lockheed Martin and SICPA.

Recently Issued Accounting Pronouncements

Refer to “Note 2. Recently Issued Accounting Pronouncements” regarding the effect of certain recent accounting pronouncements on our consolidated financial statements.

Critical Accounting Policies and Estimates

The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses, and the related disclosures. We base our estimates on historical experience, our knowledge of economic and market factors and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments used in the preparation of our financial statements are, by their nature, uncertain and unpredictable, and depend upon, among other things, many factors outside of our control, such as demand for our products and economic conditions. Accordingly, our estimates and judgments may prove to be incorrect and actual results may differ from these estimates under different assumptions or conditions. We believe the following critical accounting policies are affected by significant estimates, assumptions and judgments used in the preparation of our consolidated financial statements:

27

Revenue Recognition

We recognize revenue when it is realized or realizable and earned. We consider revenue realized or realizable and earned when there is persuasive evidence of an arrangement, delivery has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. Delivery does not occur until products have been shipped or services have been provided, risk of loss has transferred and in cases where formal acceptance is required, customer acceptance has been obtained or customer acceptance provisions have lapsed. In situations where a formal acceptance is required but the acceptance only relates to whether the product meets its published specifications, revenue is recognized upon delivery provided all other revenue recognition criteria are met.

Historical return rates are monitored on a product-by-product basis. In addition, some distributor agreements allow for partial return of products and/or price protection under certain conditions within limited time periods. Such return rights are generally limited to contractually defined, short-term stock rotation and defective or damaged product. We maintain reserves for sales returns and price adjustments based on historical experience and other qualitative factors. As new products or distributors are introduced, these historical rates are used to establish initial sales returns reserves and are adjusted as better information becomes available. We also have market development incentive programs for certain distributors whereby rebates are offered based upon exceeding volume goals. Estimated rebates, sales returns and other such allowances are deducted from revenue.

In addition to the aforementioned general policies, the following are the specific revenue recognition policies for multiple-element arrangements and for each major category of revenue.

Multiple-Element Arrangements

When a sales arrangement contains multiple deliverables, such as sales of products that include services, the multiple deliverables are evaluated to determine whether there are one or more units of accounting. Where there is more than one unit of accounting, then the entire fee from the arrangement is allocated to each unit of accounting based on the relative selling price. Under this approach, the selling price of a unit of accounting is determined by using a selling price hierarchy which requires the use of vendor-specific objective evidence (“VSOE”) of fair value if available, third-party evidence (“TPE”) if VSOE is not available, or management’s best estimate of selling price (“BESP”) if neither VSOE nor TPE is available. Revenue is recognized when the revenue recognition criteria for each unit of accounting are met.

We establish VSOE of selling price using the price charged for a deliverable when sold separately. TPE of selling price is established by evaluating similar and interchangeable competitor goods or services in sales to similarly situated customers. When VSOE or TPE are not available then we use BESP. Generally, we are not able to determine TPE because our product strategy differs from that of others in our markets, and the extent of customization varies among comparable products or services from our peers. We establish BESP using historical selling price trends and considering multiple factors including, but not limited to geographies, market conditions, competitive landscape, internal costs, gross margin objectives, and pricing practices.

The determination of BESP is made through consultation with and approval by the Pricing Committee. We may modify or develop new pricing practices and strategies in the future. As these pricing strategies evolve, we may modify our pricing practices in the future, which may result in changes in BESP. The aforementioned factors may result in a different allocation of revenue to the deliverables in multiple element arrangements from the current fiscal year, which may change the pattern and timing of revenue recognition for these elements but will not change the total revenue recognized for the arrangement.

To the extent a deliverable(s) in a multiple-element arrangement is subject to specific guidance (for example, software that is subject to the authoritative guidance on software revenue recognition), we allocate the fair value of the units of accounting using relative selling price and that unit of accounting is accounted for in accordance with the specific guidance. Some of our product offerings include hardware that are integrated with or sold with software that delivers the functionality of the equipment. We believe this equipment is not considered software-related and would therefore be excluded from the scope of the authoritative guidance on software revenue recognition.

Hardware

Revenue from hardware sales is typically recognized when the product meet delivery criteria.

Services

Revenue from services and system maintenance is recognized on a straight-line basis over the services term. Revenue from professional service engagements is recognized once its delivery obligation is fulfilled. Revenue related to extended warranty and product maintenance contracts is deferred and recognized on a straight-line basis over the delivery period. We also generate service revenue from hardware repairs and calibration which is recognized as revenue upon completion of the service.

28

Software

The Company’s software arrangements generally consist of a perpetual license fee, installation services and Post-Contract Support (“PCS”) as well as other non-software deliverables.

VSOE of fair value for PCS is established based on the renewal rate or the bell curve methodology. Non-software and software-related arrangements are bifurcated based on a relative selling price using BESP. The software related elements are bifurcated into separate units of accounting if VSOE of fair value has been established for the undelivered element(s) and the functionality of the delivered element(s) is not dependent on the undelivered element(s).

Revenue from multiple-element software arrangements that include installation services, is deferred until installation service obligation for the software solution is fulfilled. If VSOE has been established for the undelivered elements, the software, installation services and non-software elements are recognized upon completion of delivery and the PCS is recognized ratably over the remaining support contract term. If VSOE has not been established for the undelivered element, the software related elements are recognized ratably over the remaining support period.  

Investments

Our investments in debt securities and marketable equity securities are primarily classified as available-for-sale investments or trading securities and are recorded at fair value. The cost of securities sold is based on the specific identification method. Unrealized gains and losses on available-for-sale investments, net of tax, are reported as a separate component within our Consolidated Statements of Stockholders’ Equity. Unrealized gains or losses on trading securities resulting from changes in fair value are recognized in current earnings. Our short-term investments, which are classified as current assets, include certain securities with stated maturities of longer than twelve months as they are highly liquid and available to support current operations. We periodically review our investments for impairment. If a debt security’s market value is below amortized cost and we either intend to sell the security or it is more likely than not that we will be required to sell the security before its anticipated recovery, we record an other-than-temporary impairment charge to investment income (loss) for the entire amount of the impairment. If a debt security’s market value is below amortized cost and we do not expect to recover the entire amortized cost of the security, we separate the other-than-temporary impairment into the portion of the loss related to credit factors, or the credit loss portion, and the portion of the loss that is not related to credit factors, or the non-credit loss portion. The credit loss portion is the difference between the amortized cost of the security and our best estimate of the present value of the cash flows expected to be collected from the debt security. The non-credit loss portion is the residual amount of the other-than-temporary impairment. The credit loss portion is recorded as a charge to income (loss), and the non-credit loss portion is recorded as a separate component of other comprehensive income (loss).

Inventory Valuation

We assess the value of our inventory on a quarterly basis and write down those inventories that are obsolete or in excess of our forecasted usage to their estimated realizable value. Our estimates of realizable value are based upon our analysis and assumptions including, but not limited to, forecasted sales levels by product, expected product lifecycle, product development plans and future demand requirements. Our product line management personnel play a key role in our excess review process by providing updated sales forecasts, managing product transitions and working with manufacturing to maximize recovery of excess inventory. If actual market conditions are less favorable than our forecasts or actual demand from our customers is lower than our estimates, we may be required to record additional inventory write-downs. If actual market conditions are more favorable than anticipated, inventory previously written down may be sold, resulting in lower cost of sales and higher income from operations than expected in that period.

Goodwill Valuation

We test goodwill for possible impairment on an annual basis in our fourth quarter and at any other time if events occur or circumstances indicate that the carrying amount of goodwill may not be recoverable. Circumstances that could trigger an impairment test include, but are not limited to, a significant adverse change in the business climate or legal factors, an adverse action or assessment by a regulator, change in customers, target market and strategy, unanticipated competition, loss of key personnel, or the likelihood that a reporting unit or significant portion of a reporting unit will be sold or otherwise disposed.

The authoritative guidance allows an entity to assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If an entity determines that as a result of the qualitative assessment that it is more likely than not (i.e. greater than 50% likelihood) that the fair value of a reporting unit is less than its carrying amount, then the quantitative test is required. Otherwise, no further testing is required. The quantitative goodwill impairment test requires us to estimate and compare the fair value of our reporting units with their carrying values.

29

In the fourth quarter of fiscal 2017, we early adopted the new authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) that eliminated the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, any impairment charge would be based on the excess of a reporting unit's carrying amount over its fair value as determined under the quantitative goodwill impairment test.

Application of the goodwill impairment test requires judgments, including: identification of the reporting units, assigning assets and liabilities to reporting units, assigning goodwill to reporting units, a qualitative assessment to determine whether there are any impairment indicators, and determining the fair value of each reporting unit. We generally estimate the fair value of a reporting unit using a combination of the income approach, which estimates the fair value based on the future discounted cash flows, and the market approach, which estimates the fair value based on comparable market prices. Our significant estimates in the income approach include our weighted average cost of capital, long-term rate of growth and profitability of the reporting unit’s business, and working capital effects. The market approach estimates the fair value of the business based on a comparison of the reporting unit to comparable publicly traded companies in similar lines of business. Significant estimates in the market approach include identifying similar companies with comparable business factors such as size, growth, profitability, risk and return on investment, and assessing comparable revenue and operating income multiples in estimating the fair value of the reporting unit.

We base our estimates on historical experience and on various assumptions about the future that we believe are reasonable based on available information. Unanticipated events and circumstances may occur that affect the accuracy of our assumptions, estimates and judgments. For example, if the price of our common stock were to significantly decrease combined with other adverse changes in market conditions, thus indicating that the underlying fair value of our reporting units may have decreased, we might be required to reassess the value of our goodwill in the period such circumstances were identified.

In the fourth quarter of fiscal 2017, we performed the goodwill impairment test in accordance with the authoritative guidance for NE and OSP reporting units, and determined no indicator of impairment. As of July 1, 2017, the SE reporting unit did not have any goodwill, which was fully impaired in the fourth quarter of fiscal 2016. Refer to “Note 8. Goodwill” for more information.

Long-lived Asset Valuation (Property, Plant and Equipment and Intangible Assets)

We test long-lived assets for recoverability, at the asset group level, when events or changes in circumstances indicate that their carrying amounts may not be recoverable. Circumstances which could trigger a review include, but are not limited to, significant decreases in the market price of the asset, significant adverse changes in the business climate or legal factors, accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset, current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset, or current expectation that the asset will more likely than not be sold or disposed of significantly before the end of its estimated useful life. 

Recoverability is assessed based on the difference between the carrying amount of the asset and the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset. An impairment loss is recognized when the carrying amount is not recoverable and exceeds fair value.

Income Taxes

In accordance with the authoritative guidance on accounting for income taxes, we recognize income taxes using an asset and liability approach. This approach requires the recognition of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in our consolidated financial statements or tax returns. The measurement of current and deferred taxes is based on provisions of the enacted tax law and the effects of future changes in tax laws or rates are not anticipated.

The authoritative guidance provides for recognition of deferred tax assets if the realization of such deferred tax assets is more likely than not to occur based on an evaluation of both positive and negative evidence and the relative weight of the evidence. With the exception of certain international jurisdictions, we have determined that at this time it is more likely than not that deferred tax assets attributable to the remaining jurisdictions will not be realized, primarily due to uncertainties related to our ability to utilize our net operating loss carryforwards before they expire. Accordingly, we have established a valuation allowance for such deferred tax assets. If there is a change in our ability to realize our deferred tax assets for which a valuation allowance has been established, then our tax provision may decrease in the period in which we determine that realization is more likely than not. Likewise, if we determine that it is not more likely than not that our deferred tax assets will be realized, then a valuation allowance may be established for such deferred tax assets and our tax provision may increase in the period in which we make the determination.

The authoritative guidance on accounting for uncertainty in income taxes prescribes the recognition threshold and measurement attributes for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Additionally, it provides guidance on recognition, classification, and disclosure of tax positions. We are subject to

30

income tax audits by the respective tax authorities in all of the jurisdictions in which we operate. The determination of tax liabilities in each of these jurisdictions requires the interpretation and application of complex and sometimes uncertain tax laws and regulations. We recognize liabilities based on our estimate of whether, and the extent to which, additional tax liabilities are more likely than not. If we ultimately determine that the payment of such a liability is not necessary, then we reverse the liability and recognize a tax benefit during the period in which the determination is made that the liability is no longer necessary.

The recognition and measurement of current taxes payable or refundable and deferred tax assets and liabilities requires that we make certain estimates and judgments. Changes to these estimates or a change in judgment may have a material impact on our tax provision in a future period.

Restructuring Accrual

In accordance with authoritative guidance on accounting for costs associated with exit or disposal activities, generally costs associated with restructuring activities are recognized when they are incurred. However, in the case of leases, the expense is estimated and accrued when the property is vacated. Given the significance of, and the timing of the execution of such activities, this process is complex and involves periodic reassessments of estimates made from the time the property was vacated, including evaluating real estate market conditions for expected vacancy periods and sub-lease income. Additionally, a liability for post-employment benefits for workforce reductions related to restructuring activities is recorded when payment is probable and, the amount is reasonably estimable. We continually evaluate the adequacy of the remaining liabilities under our restructuring initiatives. Although we believe that these estimates accurately reflect the costs of our restructuring plans, actual results may differ, thereby requiring us to record additional provisions or reverse a portion of such provisions.

Pension and Other Postretirement Benefits

The funded status of our retirement-related benefit plans is recognized in the Consolidated Balance Sheets. The funded status is measured as the difference between the fair value of plan assets and the benefit obligation at fiscal year end, the measurement date. For defined benefit pension plans, the benefit obligation is the projected benefit obligation (“PBO”); and for the non-pension postretirement benefit plan, the benefit obligation is the accumulated postretirement benefit obligation (“APBO”). The PBO represents the actuarial present value of benefits expected to be paid upon our employee’s retirement. The APBO represents the actuarial present value of postretirement benefits attributed to employee services already rendered. Unfunded or partially funded plans, with the benefit obligation exceeding the fair value of plan assets, are aggregated and recorded as a retirement and non-pension postretirement benefit obligation equal to this excess. The current portion of the retirement-related benefit obligation represents the actuarial present value of benefits payable in the next 12 months in excess of the fair value of plan assets, measured on a plan-by-plan basis. This liability is recorded in other current liabilities in the Consolidated Balance Sheets.

Net periodic pension cost is recorded in the Consolidated Statements of Operations and includes service cost, interest cost, expected return on plan assets, amortization of prior service cost (credit) and (gains) losses previously recognized as a component of accumulated other comprehensive income. Service cost represents the actuarial present value of participant benefits attributed to services rendered by employees in the current year. Interest cost represents the time value of money cost associated with the passage of time. (Gains) losses arise as a result of differences between actual experience and assumptions or as a result of changes in actuarial assumptions. Prior service cost (credit) represents the cost of or credit resulting from benefit improvements attributable to prior service granted in plan amendments. (Gains) losses and prior service cost (credit) not recognized as a component of net periodic pension cost in the Consolidated Statements of Operations as they arise are recognized as a component of accumulated other comprehensive income (loss) on the Consolidated Balance Sheets, net of tax. Those (gains) losses and prior service cost (credit) are subsequently recognized as a component of net periodic pension cost pursuant to the recognition and amortization provisions of the authoritative guidance.

The measurement of the benefit obligation and net periodic pension cost is based on our estimates and actuarial valuations, provided by third-party actuaries, which are approved by our management. These valuations reflect the terms of the plans and use participant-specific information such as compensation, age and years of service, as well as certain assumptions, including estimates of discount rates, expected return on plan assets, rate of compensation increases, and mortality rates. We evaluate these assumptions periodically but not less than annually. In estimating the expected return on plan assets, we consider historical returns on plan assets, diversification of plan investments, adjusted for forward-looking considerations, inflation assumptions and the impact of the active management of the plan’s invested assets.

Beginning in the fourth quarter of fiscal 2016, we measure our benefit obligation and plan assets using the month-end date of June 30, which is closest to our fiscal year-end.

31

Loss Contingencies

We are subject to the possibility of various loss contingencies arising in the ordinary course of business. We consider the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies. An estimated loss is accrued when it is probable that an asset has been impaired or a liability has been incurred and the amount of loss can be reasonably estimated. We regularly evaluate current information available to us to determine whether such accruals should be adjusted and whether new accruals are required.

RESULTS OF OPERATIONS

The results of operations for the current period are not necessarily indicative of results to be expected for future periods. The following table summarizes selected Consolidated Statements of Operations items as a percentage of net revenue:

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Segment net revenue:
NE	54.7	%	55.7	%	58.0	%
SE	16.7		16.9		19.9
OSP	28.6		27.4		22.1
Net revenue	100.0		100.0		100.0
Cost of revenues	38.3		37.4		36.8
Amortization of acquired technologies	1.8		1.9		3.7
Gross profit	59.9		60.7		59.5
Operating expenses:
Research and development	16.8		18.4		19.8
Selling, general and administrative	37.0		38.7		43.1
Impairment of goodwill	—		10.1		—
Amortization of other intangibles	1.7		1.6		2.2
Restructuring and related charges	2.7		1.2		3.1
Total operating expenses	58.2		70.0		68.2
Income (loss) from operations	1.7		(9.3	)	(8.7	)
Interest and other income, net	1.6		0.3		0.5
Gain on sale of investments	25.0		7.8		—
Interest expense	(5.3	)	(3.9	)	(3.8	)
Income (loss) from continuing operations before income taxes	23.0		(5.1	)	(12.0	)
Provision for income taxes	2.6		0.5		3.0
Income (loss) from continuing operations, net of taxes	20.4		(5.6	)	(15.0	)
Income (loss) from discontinued operations, net of taxes	0.2		(5.3	)	4.9
Net income (loss)	20.6	%	(10.9	)%	(10.1	)%

32

Financial Data for Fiscal 2017, 2016 and 2015

The following table summarizes selected Consolidated Statement of Operations items (in millions, except for percentages):

	2017			2016			Change			Percent Change		2016			2015			Change			Percent Change
Segment net revenue:
NE	$	444.0		$	504.6		$	(60.6	)	(12.0	)%	$	504.6		$	506.8		$	(2.2	)	(0.4	)%
SE	135.2			153.6			(18.4		)	(12.0	)	153.6			174.3			(20.7		)	(11.9	)
OSP	232.2			248.1			(15.9		)	(6.4	)	248.1			192.8			55.3			28.7
Net revenue	$	811.4		$	906.3		$	(94.9	)	(10.5	)%	$	906.3		$	873.9		$	32.4		3.7	%
Amortization of acquired technologies	$	14.3		$	17.3		$	(3.0	)	(17.3	)%	$	17.3		$	31.9		$	(14.6	)	(45.8	)%
Percentage of net revenue	1.8		%	1.9		%						1.9		%	3.7		%
Gross profit	486.0			549.7			$	(63.7	)	(11.6	)%	549.7			520.1			$	29.6		5.7	%
Gross margin	59.9		%	60.7		%						60.7		%	59.5		%
Amortization of intangibles	14.0			14.6			(0.6		)	(4.1	)%	14.6			19.5			(4.9		)	(25.1	)%
Percentage of net revenue	1.7		%	1.6		%						1.6		%	2.2		%
Research and development	136.3			166.4			(30.1		)	(18.1	)%	166.4			173.3			(6.9		)	(4.0	)%
Percentage of net revenue	16.8		%	18.4		%						18.4		%	19.8		%
Selling, general and administrative	300.5			351.1			(50.6		)	(14.4	)%	351.1			376.3			(25.2		)	(6.7	)%
Percentage of net revenue	37.0		%	38.7		%						38.7		%	43.1		%
Impairment of goodwill	—			91.4			(91.4		)	100.0	%	91.4			—			91.4			100.0	%
Percentage of net revenue	—		%	10.1		%						10.1		%	—		%
Restructuring and related charges	21.6			10.5			11.1			105.7	%	10.5			26.8			(16.3		)	(60.8	)%
Percentage of net revenue	2.7		%	1.2		%						1.2		%	3.1		%
Interest and other income, net	13.1			2.5			10.6			424.0	%	2.5			3.7			(1.2		)	(32.4	)%
Percentage of net revenue	1.6		%	0.3		%						0.3		%	0.5		%
Interest expense	(43.2		)	(35.7		)	(7.5		)	21.0	%	(35.7		)	(33.3		)	(2.4		)	7.2	%
Percentage of net revenue	(5.3		)%	(3.9		)%						(3.9		)%	(3.8		)%
Gain on sale of investments	203.1			71.6			131.5			183.7	%	71.6			0.1			71.5			71,500.0	%
Percentage of net revenue	25.0		%	7.8		%						7.8		%	—		%
Provision for income taxes	21.3			4.5			16.8			373.3	%	4.5			26.1			(21.6		)	(82.8	)%
Percentage of net revenue	2.6		%	0.5		%						0.5		%	3.0		%
Income (loss) from discontinued operations, net of taxes	1.6			(48.8		)	50.4			(103.3	)%	(48.8		)	43.3			(92.1		)	(212.7	)%
Percentage of net revenue	0.2		%	(5.3		)%						(5.3		)%	4.9		%

Foreign Currency Impact on Results of Operations

While the majority of our net revenue and operating expenses are denominated in U.S. dollar, a portion of our international operations are denominated in currencies other than the U.S. dollar. Changes in foreign exchange rates may significantly affect revenue and expenses. While we use foreign currency hedging contracts to mitigate some foreign currency exchange risk, these activities are limited in the protection that they provide us and can themselves result in losses. We have presented below “constant

33

dollar” comparisons of our net sales and operating expenses which exclude the impact of currency exchange rate fluctuations. Constant dollar net revenue and operating expenses are non-GAAP financial measures, which is information derived from consolidated financial information but not presented in our financial statements prepared in accordance with U.S. GAAP. Our management believes these non-GAAP measures, when considered in conjunction with the corresponding U.S. GAAP measures, may facilitate a better understanding of changes in net revenue and operating expenses.

Fiscal 2017 and 2016

If currency exchange rates had been constant in fiscal 2017 and fiscal 2016, our consolidated net revenue in “constant dollars” would have increased by approximately $4 million, or 0.5% of net revenue, which primarily impacted our NE and SE segments. The impact of foreign currency fluctuations on net revenue was not indicative of the impact on net income due to the offsetting foreign currency impact on operating costs and expenses. If currency exchange rates had been constant in fiscal 2017 and fiscal 2016, our consolidated operating expenses in “constant dollars” would have increased by approximately $4 million, or 0.5% of net revenue.

Fiscal 2016 and 2015

If currency exchange rates had been constant in fiscal 2016 and fiscal 2015, our consolidated net revenue in “constant dollars” would have increased by approximately $22 million, or 2.5% of net revenue, which primarily impacted our NE and SE segments. The impact of foreign currency fluctuations on net revenue was not indicative of the impact on net income due to the offsetting foreign currency impact on operating costs and expenses. If currency exchange rates had been constant in fiscal 2016 and fiscal 2015, our consolidated operating expenses in “constant dollars” would have increased by approximately $16 million, or 1.8% of net revenue.

The Results of Operations are presented in accordance with U.S. GAAP and not using constant dollars. Refer to Item 7A. Qualitative and Quantitative Disclosures about Market Risk of this Annual Report on Form 10-K for further details on foreign currency instruments and our related risk management strategies.

Net Revenue

Following the Separation, revenue from our service offerings exceeds 10% of our total consolidated net revenue and is presented separately in our Consolidated Statements of Operations. Service revenue primarily consists of maintenance and support, extended warranty, professional services and post-contract support in addition to other services such as calibration and repair services. When evaluating the performance of our segments, Management focuses on total net revenue, gross profit and operating income and not the product or service categories. Consequently, the following discussion of business segment performance focuses on total net revenue, gross profit, and operating income consistent with our approach for managing the business.

Fiscal 2017 and 2016

Net revenue decreased by $94.9 million, or 10.5%, during fiscal 2017 compared to fiscal 2016. There has not been any significant changes in our pricing strategy. This decrease was primarily due to decreases across the three segments as discussed below.

Product revenues decreased by $82.4 million, or 10.2%, during fiscal 2017 compared to fiscal 2016. This decrease was primarily due to end market demand weakness in our NE Field Instruments and our planned restructuring to narrow the scope of SE segment as we exited certain SE product lines. The OSP segment experienced lower demand for our Anti-Counterfeiting product offerings driven by decreased banknote volume.

Service revenues decreased $12.5 million, or 12.8%, during fiscal 2017 compared to fiscal 2016. This decrease was due to a decline in support contract renewals for SE segment, resulting from our continued run-off of our more mature Assurance portfolio solutions, as well as reduction in revenue from repair services in our NE segment.

NE net revenue decreased by $60.6 million, or 12.0%, during fiscal 2017 compared to fiscal 2016. This decrease was driven by a $53.2 million net decrease in Field Instruments offerings and a $6.9 million net decrease in our Lab Instruments offerings. Most of the Field Instruments product offerings experienced decreases due to weaker demand in North America from communication service providers. This was offset by increased demand for Cable products driven by a DOCSIS 3.1 technology upgrade cycle. The decrease in our Lab Instruments was primarily due to weak spending by NEMs and slowdown in spending by Chinese telecommunication companies impacting our lab customers.

SE net revenue decreased by $18.4 million, or 12.0%, during fiscal 2017 compared to fiscal 2016. This decrease was primarily driven by $13.7 million of net revenue decreases from our Assurance offerings. The decrease was attributable to the planned restructuring that narrowed the scope of SE segment and our more mature Assurance product offerings being negatively impacted by service maintenance contracts expiration, partially offset by increase in Growth Assurance product offerings. Additionally, a

34

net revenue decrease of $4.7 million from our Data Center primarily relating to prior large deals that did not recur in the current period.

OSP net revenue decreased by $15.9 million, or 6.4%, during fiscal 2017 compared to fiscal 2016. This decrease was primarily driven by net revenue decreases from our Anti-Counterfeiting product line. The Company expects the anti-counterfeiting business to continue to follow its historical pattern of cyclicality as currency customers continually rebalance their inventories relative to market demand. The decrease was partially offset by net revenue growth in our Consumer and Industrial product lines.

Fiscal 2016 and 2015

Net revenue increased by $32.4 million, or 3.7%, during fiscal 2016 compared to fiscal 2015. This increase was primarily due to an increase in our OSP segment, partially offset by decreases in our SE and NE segments as discussed below.

Product revenues increased by $37.6 million, or 4.9%, during fiscal 2016 compared to fiscal 2015. This increase was driven by $62.4 million of product revenue increases from our OSP and NE segments, primarily due to higher demand for our Anti-Counterfeiting product line in our OSP segment as discussed below. This was partially offset by a $24.8 million product revenue decrease from our SE segment primarily due to a decline in our more mature Assurance solutions.

Service revenues decreased $5.2 million, or 5.1%, during fiscal 2016 compared to fiscal 2015. This decrease was driven by a $9.6 million decline in service revenue from our NE segment primarily related to the release of new product offerings impacting the timing of renewals for support and maintenance contracts, coupled with lower revenue from repair services. This was partially offset by $4.4 million of service revenue increases from SE driven by maintenance and support contracts for our Data Center offerings.

NE net revenue remained relatively flat, decreasing by $2.2 million or 0.4%, during fiscal 2016 compared to fiscal 2015. This was driven by $21.7 million of net revenue decreases from our Field Instruments offerings, partially offset by $19.5 million of net revenue increases from our Lab Instruments offerings. Field Instruments net revenue decreased in the fiscal 2016 primarily as the prior period net revenue from a significant ramp for a one-time project from a key customer, coupled with lower services revenue. This was partially offset by strength in our fiber lab and field test instruments driven by “FTTH” and “Fiber for Wireless Backhaul” deployments in North America and 100G deployments globally as well as higher demand for our optical transport products.

SE net revenue decreased by $20.7 million, or 11.9%, during fiscal 2016 compared to fiscal 2015. This decrease was driven by $23.5 million of net revenue decreases from our Assurance offerings primarily due to a change in product mix as our more mature offerings declined at a steeper pace than the growth in our new offerings. This was partially offset by$2.8 millionof net revenue increases from our Data Center offerings.

OSP net revenue increased by $55.3 million, or 28.7%, during fiscal 2016 compared to fiscal 2015. This increase was driven by net revenue increases primarily from our Anti-Counterfeiting product line driven by cyclical demand for our currency products resulting from an increase in currency reprinting and banknote redesigns over the normal run-rate in fiscal 2016, coupled with net revenue growth in our Consumer and Industrial and Government product lines.

Going forward, we expect to continue to encounter a number of industry and market risks and uncertainties that may limit our visibility, and consequently, our ability to predict future revenue, profitability and general financial performance, and that could create quarter over quarter variability in our financial measures. For example, while the majority of our net revenue and expenses are denominated in U.S. dollars, a portion of our international operations are denominated in foreign currencies. The strengthening of the U.S. dollar relative to foreign currencies could negatively impact reported revenue and expenses.

Additionally, we have seen demand for our NE and SE products affected by macroeconomic uncertainty. We cannot predict when or to what extent these uncertainties will be resolved. Our revenues, profitability, and general financial performance may also be affected by: (a) pricing pressures due to, among other things, a highly concentrated customer base, increasing competition, particularly from Asia-based competitors, and a general commoditization trend for certain products; (b) product mix variability in our NE and SE markets, which affects revenue and gross margin; (c) fluctuations in customer buying patterns, which cause demand, revenue and profitability volatility; and (d) the current trend of communication industry consolidation, which is expected to continue, that directly affects our NE and SE customer bases and adds additional risk and uncertainty to our financial and business projections.

In fiscal 2018, we expect to continue to see a decline in net revenue from our more mature Assurance product offerings within our SE segment. In our OSP segment, we expect Anti-Counterfeiting net revenue to moderate in first half of fiscal 2018 due to customer inventory rebalancing to realign with end market demand before rebounding in second half of fiscal 2018. We also expect to initially ship 3D sensing products in the first half fiscal of fiscal 2018 with a greater revenue ramp in second half of fiscal 2018.

35

Revenue by Region

We operate in three geographic regions: Americas, Asia-Pacific and Europe Middle East and Africa (“EMEA”). Net revenue is assigned to the geographic region and country where our product is initially shipped. For example, certain customers may request shipment of our product to a contract manufacturer in one country, which may differ from the location of their end customers. The following table presents net revenue by the three geographic regions we operate in and net revenue from countries that exceeded 10% of our total net revenue (dollars in millions):

	Years Ended
	July 1, 2017				July 2, 2016				June 27, 2015
Americas:
United States	$	307.3	37.9	%	$	396.6	43.8	%	$	424.3	48.5	%
Other Americas	71.3		8.8	%	66.0		7.3	%	62.5		7.2	%
Total Americas	$	378.6	46.7	%	$	462.6	51.1	%	$	486.8	55.7	%
Asia-Pacific
Greater China	$	100.8	12.4	%	$	103.2	11.3	%	$	83.1	9.5	%
Other Asia	72.4		8.9	%	63.1		7.0	%	61.4		7.0	%
Total Asia-Pacific	$	173.2	21.3	%	$	166.3	18.3	%	$	144.5	16.5	%
EMEA:
Switzerland	$	124.0	15.3	%	$	135.6	15.0	%	$	97.7	11.2	%
Other EMEA	135.6		16.7	%	141.8		15.6	%	144.9		16.6	%
Total EMEA	$	259.6	32.0	%	$	277.4	30.6	%	$	242.6	27.8	%
Total net revenue	$	811.4	100.0	%	$	906.3	100.0	%	$	873.9	100.0	%

Net revenue from customers outside the Americas for the fiscal years ended 2017, 2016 and 2015 represented 53.3%, 48.9% and 44.3% of net revenue, respectively. We expect revenue from customers outside of United States to continue to be an important part of our overall net revenue and an increasing focus for net revenue growth opportunities.

Gross Margin

Gross margin in fiscal 2017decreased 0.8 percentage points to 59.9% from 60.7% in fiscal 2016. This decrease was primarily due to reduction in NE and SE gross margin as discussed below in the “Operating Segment Information” section.

Gross margin in fiscal 2016increased 1.2 percentage points to 60.7% from 59.5% in fiscal 2015. This increase was primarily due to a $14.6 million reduction in amortization of developed technology driven by certain intangible assets becoming fully amortized during fiscal 2015, coupled with an improvement in gross margin from our OSP segment primarily due to favorable product mix with higher anti-counterfeiting revenue in fiscal 2016. This was partially offset by lower gross margin in our SE segment and a change in overall segment mix as our OSP segment, whose products generally carry a lower gross margin than our NE and SE products, represented a higher percentage of our total net revenue in fiscal 2016.

As discussed in more detail under “Net Revenue” above, we sell products in certain markets that are consolidating, undergoing product, architectural and business model transitions, have high customer concentrations, are highly competitive (increasingly due to Asia-Pacific-based competition), are price sensitive and/or are affected by customer seasonal and mix variant buying patterns. We expect these factors to continue to result in variability of our gross margin.

Research and Development

R&D expense decreased by $30.1 million, or 18.1%, during fiscal 2017 compared to fiscal 2016. This decrease was primarily driven by net cost savings realized from our strategic restructuring activities pertaining to the NSE business in the fourth quarter of fiscal 2016 and the third quarter of fiscal 2017 and internal reorganizations to align our investment strategy following the Separation, coupled with a $2.7 million net reduction in stock-based compensation primarily due to modification of equity awards in connection with the Separation that did not recur this period. As a percentage of net revenue R&D decreased by 1.6 percentage points during fiscal 2017 compared to fiscal 2016 as the Company continues to execute targeted cost savings initiatives.

36

R&D expense decreased by $6.9 million, or 4.0%, during fiscal 2016 compared to fiscal 2015. This decrease was primarily due to a $3.6 million in-process research and development (“IPR&D”) impairment charge in the prior year related to a fiscal 2014 acquisition, coupled with $4.0 million net cost savings realized from our strategic restructuring activities related to site consolidations, reorganizations, and the insourcing or outsourcing of R&D activities to align our investment strategy following the Separation. This was partially offset by various other incremental expenses incurred, including additional cost as fiscal 2016 was a 53-week fiscal year and contained one additional week compared to fiscal 2015. As a percentage of net revenue, R&D decreased 1.4 percentage points in fiscal 2016 compared to fiscal 2015 as the Company continues to execute targeted cost savings initiatives.

We believe that continuing our investments in R&D is critical to attaining our strategic objectives. We plan to continue to invest in R&D and new products that will further differentiate us in the marketplace.

Selling, General and Administrative

SG&A expense decreased by $50.6 million, or 14.4%, in fiscal 2017 compared to fiscal 2016. This decrease was primarily due to (a) a $16.8 million reduction in labor and facilities expenses driven by lower headcount and site consolidations associated with our strategic restructuring activities and ongoing cost reduction efforts, (b) a $5.3 million net reduction in stock-based compensation primarily due to the impact of Separation related activities on equity awards that did not recur this year and (c) a $3.9 million reduction in costs related to Viavi-specific activities to complete the Separation. As a percentage of net revenue, SG&A decreased by 1.7 percentage points in fiscal 2017 primarily driven by our strategic cost reduction efforts to optimize our expense structure.

SG&A expense decreased by $25.2 million, or 6.7%, in fiscal 2016 compared to fiscal 2015. This decrease was primarily due to $30.5 million reduction in labor, benefits and facilities expenses driven by lower headcount and site consolidations associated with our strategic restructuring activities and ongoing cost reduction efforts coupled with incremental charge from modification of equity awards pursuant to Change of Control Benefits Plan covering spin-off in the prior year that were not there this fiscal year. This was partially offset by an $8.4 million charge in fiscal 2016 related to a litigation ruling impacting our pension obligation. As a percentage of net revenue, SG&A decreased by 4.4 percentage points in fiscal 2016 primarily driven by our strategic cost reduction efforts to optimize our expense structure.

We intend to continue to focus on reducing our SG&A expense as a percentage of net revenue. However, we have in the recent past experienced, and may continue to experience in the future, certain charges unrelated to our core operating performance, such as mergers and acquisitions-related expenses and litigation expenses, which could increase our SG&A expenses and potentially impact our profitability expectations in any particular quarter.

Impairment of Goodwill

In the fourth quarter of fiscal 2017, we performed the goodwill impairment test in accordance with the authoritative guidance for NE and OSP reporting units, and determined no indicator of impairment. As of July 1, 2017, the SE reporting unit did not have any goodwill, which was fully impaired in the fourth quarter of fiscal 2016 . Refer to “Note 8. Goodwill” for more information.

Amortization of Acquired Technologies and Intangibles

Amortization of acquired technologies and intangibles for fiscal 2017 decreased $3.6 million, or 11.3%, to $28.3 million from $31.9 million in fiscal 2016. This decrease is primarily due to impact from foreign exchange and acquisition related intangible assets becoming fully amortized in 2016 and 2017.

Amortization of acquired technologies and intangibles for fiscal 2016 decreased $19.5 million, or 37.9%, to $31.9 million from $51.4 million in fiscal 2015. This decrease is driven by a $14.6 million reduction in amortization of developed technology primarily due to acquisition related intangible assets becoming fully amortized in the fourth quarter of fiscal 2015.

Acquired In-Process Research and Development (“IPR&D”)

In accordance with authoritative guidance, we recognize IPR&D at fair value as of the acquisition date, and subsequently account for it as an indefinite-lived intangible asset until completion or abandonment of the associated research and development efforts. We periodically review the stage of completion and likelihood of success of each IPR&D project. The nature of the efforts required to develop IPR&D projects into commercially viable products principally relates to the completion of all planning, designing, prototyping, verification and testing activities that are necessary to establish that the products can be produced to meet their design specifications, including functions, features and technical performance requirements.

During fiscal 2014 we acquired IPR&D through the acquisitions of Network Instruments and Trendium. The status of our significant IPR&D projects from acquisitions was as follows:

37

Network Instruments Acquisition

Network Instruments was acquired in the third quarter of fiscal 2014 and was accounted for in accordance with the authoritative guidance on business combinations. At the time of acquisition, Network Instruments was in the process of developing next generation integrated network software solutions. During the first quarter of fiscal 2015, we completed our IPR&D project related to the acquisition of Network Instruments. Accordingly, $1.7 million was transferred from indefinite life intangible assets to acquired developed technology intangible assets and began amortizing over its useful life of fifty-two months.

Trendium Acquisition

Trendium was acquired in the second quarter of fiscal 2014 and was accounted for in accordance with the authoritative guidance on business combinations. At the time of acquisition, Trendium was in the process of developing network probe software and next generation service assurance solutions. During fiscal 2015, we recorded a $3.6 million IPR&D impairment charge related to the fiscal 2014 acquisition of Trendium in accordance with the authoritative accounting guidance. The charge was recorded to research and development expense in the Consolidated Statements of Operations. During fiscal 2016, we completed our IPR&D project related to the acquisition of Trendium. Accordingly, $1.8 million was transferred from indefinite life intangible assets to acquired developed technology intangible assets and began amortizing over its useful life of thirty-six months.

Restructuring and Related Charges

From time to time we have initiated strategic restructuring events primarily intended to reduce costs, consolidate our operations, rationalize the manufacturing of our products and align our businesses in response to market conditions. We estimate annualized gross cost savings of approximately $43.0 million excluding any one-time charges as a result of the restructuring activities initiated in the past year. Refer to “Note 11. Restructuring and Related Charges” for more information.

As of July 1, 2017, our total restructuring accrual was $11.0 million.

During fiscal 2017, we recorded $21.6 million in restructuring and related charges. These charges are combination of new and previously announced restructuring plans and are primarily the result of the following:

i. During the fourth quarter of fiscal 2017, Management approved a plan within the OSP business segment to realign its operations and exit from the printed security product offering. As a result, a restructuring charge of $0.8 million was recorded for severance and employee benefits for approximately 30 employees in manufacturing and SG&A functions located in the United States. Payments related to the severance and benefits accrual are expected to be paid by the end of the third quarter of fiscal 2018.

ii. During the second and third quarters of fiscal 2017, Management approved a plan within the NE and SE business segments as part of Viavi’s continued strategy to improve profitability in the Company’s Network and Service Enablement (NSE) business by narrowing the scope of the Service Enablement business and reducing costs by streamlining NSE operations. As a result, a restructuring charge of $21.0 million was recorded for severance and employee benefits for approximately 300 employees in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia. Payments related to the severance and benefits accrual are expected to be paid by the end of second quarter of fiscal 2018.

During fiscal 2016, we recorded $10.5 million in restructuring and related charges. The charges are a combination of new and previously announced restructuring plans and are primarily the result of the following:

i. During May and June of fiscal 2016, Management approved a plan within the NE and SE business segment and Shared Services function for organizational alignment and consolidation in as part of Viavi’s continued commitment for a more cost effective organization. As a result, a restructuring charge of $8.8 million was recorded for severance and employee benefits for approximately 190 employees primarily in manufacturing, R&D, and SG&A functions located in North America, Latin America, Europe and Asia. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the first quarter of fiscal 2018.

ii. During the second quarter of fiscal 2016, Management approved a plan primarily impacting the NE and SE business segments as part of Viavi’s ongoing commitment for an agile and more efficient operating structure. As a result, a restructuring charge of $2.4 million was recorded for severance and employee benefits for approximately 50 employees primarily in manufacturing, R&D, and SG&A functions located in North America, Latin America, Europe and Asia. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the second quarter of fiscal 2018.

iii. A restructuring benefit of $1.0 million primarily related to a reduction in the number of employees impacted by the Central Finance and IT Restructuring Plan.

38

During fiscal 2015, we recorded $26.8 million in restructuring and related charges. The charges are a combination of new and previously announced restructuring plans and are primarily the result of the following:

i. During the second, third and fourth quarters of fiscal 2015, Management approved a plan to eliminate certain positions in its shared services functions in connection with the Company’s plan to split into two separate public companies. Further, Management consolidated its operations, sales and R&D organizations and eliminated positions within the NE and SE segments to align to the Company’s product market strategy and lower manufacturing costs in connection with the Separation. As a result, a restructuring charge of $24.9 million was recorded for severance and employee benefits for approximately 330 employees in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the third quarter of fiscal 2018.

ii. A restructuring charge of $1.9 million for previously announced restructuring plans.

Our restructuring and other lease exit cost obligations are net of sublease income or lease settlement estimates of approximately $2.1 million. Our ability to generate sublease income, as well as our ability to terminate lease obligations and recognize the anticipated related savings, is highly dependent upon the economic conditions, particularly commercial real estate market conditions in certain geographies, at the time we negotiate the lease termination and sublease arrangements with third parties as well as the performances by such third parties of their respective obligations. While the amount we have accrued represents the best estimate of the remaining obligations we expect to incur in connection with these plans, estimates are subject to change. Routine adjustments are required and may be required in the future as conditions and facts change through the implementation period. If adverse macroeconomic conditions continue, particularly as they pertain to the commercial real estate market, or if, for any reason, tenants under subleases fail to perform their obligations, we may be required to reduce estimated future sublease income and adjust the estimated amounts of future settlement agreements, and accordingly, increase estimated costs to exit certain facilities. Amounts related to the lease expense, net of anticipated sublease proceeds, will be paid over the respective lease terms through fiscal 2019.

Interest and Other Income, Net

Interest and other income, net was $13.1 million in fiscal 2017 as compared to $2.5 million in fiscal 2016. This $10.6 million increase was primarily driven by (i) an increase in interest income of $5.2 million primarily due to higher cash and short-term investment balances coupled with higher yield, (ii) a $3.5 million more favorable foreign exchange impact as the balance sheet hedging program provided a more favorable offset to the remeasurement of underlying foreign exchange exposures during the current period, (iii) a $3.0 million gain on sale of other assets. This was partially offset by $1.1 million loss on extinguishment of debt.

Interest and other income, net was $2.5 million in fiscal 2016 as compared to $3.7 million in fiscal 2015. This $1.2 million change was primarily driven by $3.6 million of more gains recorded during fiscal 2015 mostly related to our receipt of proceeds from the Fair Fund established to provide compensation for losses incurred from investments in Nortel securities in connection with the SEC’s claims against Nortel as well as higher sublease rental income. This was partially offset by (i) a $1.3 million more interest income during fiscal 2016 due to balance in higher-yielding investment vehicles in our investment portfolios, (ii) a decrease in foreign exchange loss of $1.2 million during fiscal 2016 as the balance sheet hedging program provided a more favorable offset to the remeasurement of underlying foreign exchange exposures.

Gain on Sale of Investments

During fiscal 2017, the Company sold approximately 7.2 million shares of the 11.7 million shares of Lumentum common stock which was retained as part of the Separation. We recognized a gross realized gain of $203.0 million from the sale.

During fiscal 2016, the Company sold approximately 4.5 million shares of the 11.7 million shares of Lumentum common stock which was retained as part of the Separation. We recognized a gross realized gain of $71.5 million from the sale.

As of July 1, 2017, the Company has sold all ownership of Lumentum’s common stock. Refer to “Note 7. Investments, Forward Contracts and Fair Value Measurements” for more information.

Interest Expense

Interest expense increased by $7.5 million, or 21.0%, during fiscal 2017 compared to fiscal 2016. This was primarily due to the increase of $1.5 million in accretion of unamortized debt discount and debt issuance cost related to the 2033 Notes. Additionally, interest expense of $5.7 million was incurred in relation to the 2024 Notes newly issued in March 2017.

Interest expense increased by $2.4 million, or 7.2%, during fiscal 2016 compared to fiscal 2015. This was primarily due to the accretion of unamortized debt discount related to the 2033 Notes.

39

Provision for (Benefit from) Income Tax

Fiscal 2017 Tax Expense/Benefit

We recorded an income tax expense of $21.3 million for fiscal 2017. The expected tax expense derived by applying the federal statutory rate to our income before income taxes for fiscal 2017 differed from the income tax expense recorded primarily as a result of domestic and foreign losses that were not realized due to valuation allowances.

Based on a jurisdiction by jurisdiction review of anticipated future income and due to the continued economic uncertainty in the industry, management has determined that in many of our jurisdictions, it is more likely than not that our net deferred tax assets will not be realized in those jurisdictions. During fiscal 2017, the valuation allowance for deferred tax assets decreased by $76.5 million primarily due the utilization of deferred tax assets and the increase in deferred tax liabilities as result of the issuance of convertible debt. We are routinely subject to various federal, state and foreign audits by taxing authorities. We believe that adequate amounts have been provided for any adjustments that may result from these examinations.

Fiscal 2016 Tax Expense/Benefit

We recorded an income tax expense of $4.5 million for fiscal 2016. The expected tax benefit derived by applying the federal statutory rate to our loss before income taxes for fiscal 2016 differed from the income tax expense recorded primarily as a result of domestic and foreign losses that were not realized due to valuation allowances and a tax expense of $8.9 million related to a one-time increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the Separation. The tax expense was partially offset by a deferred tax benefit of $9.5 million related to the write off of tax deductible goodwill and a tax benefit of $20.7 million related to the income tax intraperiod tax allocation rules for discontinued operations and other comprehensive income.

Based on a jurisdiction by jurisdiction review of anticipated future income and due to the continued economic uncertainty in the industry, Management has determined that in many of our jurisdictions, it is more likely than not that our net deferred tax assets will not be realized in those jurisdictions. During fiscal 2016, the valuation allowance for deferred tax assets decreased by $160.2 million primarily due to the Lumentum transaction. We are routinely subject to various federal, state and foreign audits by taxing authorities. We believe that adequate amounts have been provided for any adjustments that may result from these examinations.

Fiscal 2015 Tax Expense/Benefit

We recorded an income tax expense of $26.1 million for fiscal 2015. The expected tax benefit derived by applying the federal statutory rate to our loss before income taxes for fiscal 2015 differed from the income tax expense recorded primarily as a result of domestic and foreign losses that were not realized due to valuation allowances.

Based on a jurisdiction by jurisdiction review of anticipated future income and due to the continued economic uncertainty in the industry, Management has determined that in many of our jurisdictions, it is more likely than not that our net deferred tax assets will not be realized in those jurisdictions. During fiscal 2015, the valuation allowance for deferred tax assets increased by $12.7 million. The increase was primarily related to the increases in the deferred tax assets and intangible amortization. We are routinely subject to various federal, state and foreign audits by taxing authorities. We believe that adequate amounts have been provided for any adjustments that may result from these examinations.

Discontinued Operations

Our discontinued operations activities during fiscal 2017, 2016 and 2015 related to the Separation on August 1, 2015 and activities in fiscal 2016 related to the sale of the hologram business (“Hologram Business”).

Lumentum Separation

As a result of the Separation, the financial results of Lumentum are presented as discontinued operations during fiscal 2017, 2016 and 2015. Net revenue attributable to the Lumentum discontinued operations was $66.5 million and $835.2 million during fiscal 2016 and 2015, respectively. Net income (loss) attributable to the Lumentum discontinued operations was $1.6 million,$(49.0) million, and $43.3 million during fiscal 2017, 2016 and 2015, respectively. Refer to “Note 3. Discontinued Operations” for more information.

Hologram Business Disposition

During fiscal 2016, we recorded $0.3 million of net income from discontinued operations related to the Hologram Business related to proceeds received following a favorable arbitration ruling to resolve a dispute regarding the amount we were owed under an earnout clause in connection with the sale in 2013.

40

Operating Segment Information (in millions):

	2017			2016			Change			Percentage Change		2016			2015			Change			Percentage Change
NE
Net revenue	$	444.0		$	504.6		$	(60.6	)	(12.0	)%	$	504.6		$	506.8		$	(2.2	)	(0.4	)%
Gross profit	286.3			329.7			(43.4		)	(13.2	)%	329.7			333.9			(4.2		)	(1.3	)%
Gross margin	64.5		%	65.3		%						65.3		%	65.9		%
SE
Net revenue	$	135.2		$	153.6		$	(18.4	)	(12.0	)%	$	153.6		$	174.3		$	(20.7	)	(11.9	)%
Gross profit	86.2			99.4			(13.2		)	(13.3	)%	99.4			119.2			(19.8		)	(16.6	)%
Gross margin	63.8		%	64.7		%						64.7		%	68.4		%
NSE
Net revenue	$	579.2		$	658.2		$	(79.0	)	(12.0	)%	$	658.2		$	681.1		$	(22.9	)	(3.4	)%
Operating income (loss)	7.3			12.7			(5.4		)	(42.5	)%	12.7			(0.1		)	12.8			(12,800.0	)%
Operating margin	1.3		%	1.9		%						1.9		%	—		%
OSP
Net revenue	$	232.2		$	248.1		$	(15.9	)	(6.4	)%	$	248.1		$	192.8		$	55.3		28.7	%
Operating income	100.3			102.9			(2.6		)	(2.5	)%	102.9			68.1			34.8			51.1	%
Operating margin	43.2		%	41.5		%						41.5		%	35.3		%

Network Enablement

NE gross margin decreased 0.8 percentage points during fiscal 2017 to 64.5% from 65.3% in fiscal 2016. This decrease was primarily due to a decline in revenue from high margin product lines within our Field Instruments product offerings, resulting in unfavorable product mix, and partially offset by favorable manufacturing costs.

NE gross margin decreased 0.6 percentage points during fiscal 2016 to 65.3% from 65.9% in fiscal 2015. This decrease was primarily due to unfavorable product mix, coupled with a decline in net revenue as discussed above.

Service Enablement

SE gross margin decreased 0.9 percentage points during fiscal 2017 to 63.8% from 64.7% in fiscal 2016. This gross margin decrease was due to unfavorable product mix, primarily as a result of lower revenue levels from the continued run-off of our more mature but higher margin Assurance solutions.

SE gross margin decreased 3.7 percentage points during fiscal 2016 to 64.7% from 68.4% in fiscal 2015. This gross margin erosion was primarily driven by lower revenue levels and unfavorable product mix from the continued run-off of our more mature, but high margin, Assurance solutions. This was coupled with gross margin dilution driven by initial acceptances being received in the second half of fiscal 2016 for growth Assurance solutions resulting in recognition of revenue at lower margin from hardware components included in these solutions.

Network and Service Enablement (“NSE”)

NSE operating margin decreased 0.6 percentage points during fiscal 2017 to 1.3% from 1.9% in fiscal 2016. The decrease in operating margin was primarily due to decline in NE and SE revenue and gross margin as discussed above, partially offset by decrease in operating expenses as a percentage of net revenue. The reduction in operating expenses as a percentage of net revenue, which was largely from reductions in research and development spending and helped mitigate the impact from the decline in NE and SE revenue and gross margin, is driven by lower headcount as a result of the strategic restructuring plans initiated in prior and current years and our ongoing cost reduction initiatives.

NSE operating margin increased 1.9 percentage points during fiscal 2016 compared to a break-even operating margin in fiscal 2015. The increase in operating margin was primarily due to a decrease in operating expenses as a percentage of net revenue,

41

largely from reductions in general and administrative spending, driven by lower headcount as a result of strategic restructuring plans initiated in current and prior years and our ongoing cost reduction initiatives. This was partially offset by a decline in NE and SE gross margin as discussed above.

Optical Security and Performance Products

OSP operating margin increased 1.7 percentage points during fiscal 2017 to 43.2% from 41.5% in fiscal 2016. OSP gross margin remained relatively flat year over year. The increase in operating margin was primarily driven by our ongoing cost reduction initiatives which reduced operating expense as a percentage of revenue.

OSP operating margin increased 6.2 percentage points during fiscal 2016 to 41.5% from 35.3% in fiscal 2015. The increase in operating margin was primarily due to an improvement in gross margin driven by an increase in revenue from our higher margin Anti-Counterfeiting product line, as discussed above, coupled with a reduction in operating expenses as a percentage of net revenue.

Liquidity and Capital Resources

Our cash investments are made in accordance with an investment policy approved by the Audit Committee of our Board of Directors. In general, our investment policy requires that securities purchased be rated A-1/P-1, A/A2 or better. Our policy allows an allocation to securities rated A-2/P-2, BBB/Baa2 or better, so long as such allocation below A-1/P-1, A/A2 but minimum A-2/P-2, BBB/Baa2 does not exceed 10% of any investment portfolio. Securities that are downgraded subsequent to purchase are evaluated and may be sold or held at management’s discretion. No security may have an effective maturity that exceeds 37 months, and the average duration of our holdings may not exceed 18 months. At any time, no more than 5.0% or $5.0 million, whichever is greater, of each of our investment portfolios may be concentrated in a single issuer other than the U.S. or sovereign governments or agencies. Our investments in debt securities and marketable equity securities are primarily classified as available-for-sale investments or trading assets and are recorded at fair value. The cost of securities sold is based on the specific identification method. Unrealized gains and losses on available-for-sale investments are recorded as other comprehensive income (loss) and are reported as a separate component of stockholders’ equity. We did not hold any investments in auction rate securities, mortgage backed securities, collateralized debt obligations, or variable rate demand notes at July 1, 2017 and virtually all debt securities held were minimum BBB/Baa2. As of July 1, 2017, U.S. entities owned approximately 76.0% of our cash and cash equivalents, short-term investments and restricted cash.

As of July 1, 2017, the majority of our cash investments have maturities of 90 days or less and are of high credit quality. Although we intend to hold these investments to maturity, in the event that we are required to sell any of these securities under adverse market conditions, losses could be recognized on such sales. During the year endedJuly 1, 2017, we have not realized material investment losses but can provide no assurance that the value or the liquidity of our investments will not be impacted by adverse conditions in the financial markets. In addition, we maintain cash balances in operating accounts that are with third party financial institutions. These balances in the U.S. may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. While we monitor the cash balances in our operating accounts and adjust the cash balances as appropriate, these cash balances could be impacted if the underlying financial institutions fail.

On March 3, 2017, the Company issued $400 million aggregate principal amount of 1.00% Senior Convertible Notes due 2024 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. On March 22, 2017, the Company issued an additional $60 million upon exercise of the over-allotment option of the initial purchasers. The total proceeds from the 2024 Notes amounted to $451.1 million after issuance costs. The 2024 Notes are an unsecured obligation of the Company and bear interest at an annual rate of 1.00% payable in cash semi-annually in arrears on March 1 and September 1 of each year. The 2024 Notes mature on March 1, 2024 unless earlier converted or repurchased. Refer to “Note 10. Debt” for more information.

During fiscal 2017, the Company repurchased $40.0 million aggregate principal amount of the 2033 Notes for $45.4 million in cash. In connection with the repurchase, a loss on extinguishment of $1.1 million was recognized in interest and other income, net in compliance with the authoritative guidance. After giving effect to the repurchase, the total amount of 2033 Notes outstanding as of July 1, 2017 was $610.0 million.

Year Ended July 1, 2017

As of July 1, 2017 our combined balance of cash and cash equivalents, short-term investments and restricted cash increased by $468.0 million to $1,447.8 million from $979.8 million as of July 2, 2016.

Cash provided by operating activities was $80.0 million, consisted of net income of $166.9 million adjusted for non-cash charges (e.g., depreciation, amortization of intangibles, stock-based compensation, amortization of debt issuance cost and discount, and loss on extinguishment of debt) which totaled $139.4 million, including changes in deferred tax balances less gain on sales

42

of investments of $203.1 million, offset by changes in operating assets and liabilities that used $23.2 million. Changes in our operating assets and liabilities related primarily to a decrease in deferred revenue of $27.4 million due to amortization of support agreements and the release of revenue upon customer acceptance, an increase in other current and non-current assets of $17.4 million primarily due to change in forward contract that were effectively closed but not settled at year end and other prepayments, a decrease in accrued payroll and related expenses of $15.4 million due to timing of salary and bonus payments, a decrease in accounts payable of $14.8 million due to higher payment activity and lower overall spend. This was partially offset by cash inflows from an increase in accrued expenses and other current and non-current liabilities of $29.1 million primarily due to customer deposit offset by restructuring payments and a decrease in accounts receivable of $24.5 million primarily driven by timing of collections.

Cash provided by investing activities was $113.7 million, primarily resulting from $831.5 million of proceeds from the sales and maturities of available-for-sale investments and other assets, which included proceeds of $265.0 million from the sale of 7.2 million shares of Lumentum common stock in fiscal 2017, partially offset by $679.4 million of purchases of available-for-sale investments and $38.6 million of cash used for capital expenditures. As of July 1, 2017, the Company has sold all of our ownership of Lumentum common stock.

Cash provided by financing activities was $325.3 million, primarily resulting from $451.1 million net proceeds from issuance of 2024 Notes and $12.4 million in proceeds from the exercise of stock options and the issuance of common stock under our employee stock purchase plan, partially offset by $92.0 million of cash used to repurchase common stock under our share repurchase programs and $45.4 million used for repurchase of our 2033 Notes. 

Year Ended July 2, 2016

As of July 2, 2016 our combined balance of cash and cash equivalents, short-term investments and restricted cash increased by $140.4 million to $979.8 million from $839.4 million as of June 27, 2015, including cash and cash equivalents and short-term investments of $13.8 million transferred to Lumentum. Additionally, the cash provided by and used in operating, investing and financing activities below contains activities related to Lumentum through the separation date.

 Cash provided by operating activities was $52.9 million, consisted of net loss of $99.2 million adjusted for non-cash charges (e.g., depreciation, amortization and stock-based compensation, goodwill impairment) which totaled $239.8 million, including changes in our deferred tax balance less gain on sale of investment of $71.6 million, offset by changes in operating assets and liabilities that used $16.1 million. Our cash provided by operating activities was also impacted by our Separation related activities. Changes in our operating assets and liabilities related primarily to a decrease in accrued payroll and related expenses of $25.2 million due to timing of salary and bonus payments, a decrease in accounts payable of $2.1 million due to higher payment activity and a decrease in accrued expenses and other current and non-current liabilities of $10.8 million primarily due to separation related liabilities for both employee severance and third party payments paid after Separation. This was partially offset by cash inflows from a decrease in accounts receivable of $23.4 million primarily driven by timing of collections of Lumentum related accounts receivable prior to the Separation.

Cash provided by investing activities was $244.2 million, primarily resulting from $689.0 million of proceeds from the sales and maturities of available-for-sale investments and other assets, which included proceeds of $109.7 million from the sale of 4.5 million shares of Lumentum common stock in fiscal 2016, and a $14.0 million decrease in restricted cash, partially offset by $422.4 million of purchases of available-for-sale investments and $35.5 million of cash used for capital expenditures.

Cash used in financing activities was $147.7 million, primarily resulting from activities related to the Separation during first quarter of fiscal 2016 and $44.5 million used in share repurchase programs. In accordance with the Contribution Agreement, the Company made cash contributions of $137.6 million Lumentum, which was partially offset by $35.8 million from the sale of Lumentum Series A Preferred Stock to Amada Holdings Co., Ltd. (“Amada”) pursuant to a binding commitment under the Securities Purchase Agreement. Cash used in financing activities also include payment of financing obligations of $5.9 million primarily related to holdback payment related to a 2013 acquisition, partially offset by $4.5 million in proceeds from the exercise of stock options and the issuance of common stock under our employee stock purchase plan. 

Year Ended June 27, 2015

As of June 27, 2015 our combined balance of cash and cash equivalents, short-term investments and restricted cash decreased by $41.9 million to $839.4 million, which includes $13.8 million which was transferred to Lumentum as part of the Separation, from $881.3 million as of June 28, 2014. Additionally, the cash provided by and used in operating, investing and financing activities during fiscal 2015 below contains activities related to Lumentum.

Cash provided by operating activities was $82.3 million, consisted of net loss of $88.1 million adjusted for non-cash charges (e.g., depreciation, amortization and stock-based compensation) which totaled $243.5 million, including changes in our deferred

43

tax and other tax liabilities balances which are non-cash in nature, partially offset by changes in operating assets and liabilities that used $73.1 million. Our cash provided by operating activities was also impacted by our Separation related activities including our restructuring events. Changes in our operating assets and liabilities related primarily to a decrease in accrued payroll and related expenses of $32.4 million due to timing of salary and bonus payments, an increase in accounts receivable of $12.5 million primarily due to collections timing, a decrease in accounts payable of $10.1 million due to higher payment activity and a decrease in accrued expenses and other current and non-current liabilities of $6.8 million.

Cash used in investing activities was $5.8 million, primarily resulting from $562.7 million of purchases of available-for-sale investments and $101.5 million of cash used for capital expenditures, partially offset by $652.4 million of proceeds from the sales and maturities of available-for-sale investments and other assets and a $6.0 million decrease in restricted cash.

Cash used in financing activities was $7.3 million, primarily resulting from holdback payments of $22.2 million related to our acquisitions in fiscal 2015 and $4.8 million of cash used to repurchase our common stock, partially offset by $20.8 million of proceeds from the exercise of stock options and the issuance of common stock under our employee stock purchase plan.

Contractual Obligations

The following summarizes our contractual obligations at July 1, 2017, and the effect such obligations are expected to have on our liquidity and cash flow over the next five years (in millions):

	Payments due by period
	Total		Less than 1 year		1 - 3 years		3 - 5 years		More than 5 years
Contractual Obligations
Asset retirement obligations—expected cash payments	$	3.6	$	0.3	$	0.9	$	1.5	$	0.9
Long-term debt:
2033 Notes	610.0		—		610.0		—		—
2024 Notes	460.0		—		—		—		460.0
Estimated interest payments	37.9		8.4		11.1		9.2		9.2
Purchase obligations (1)	56.8		48.0		7.0		1.8		—
Operating lease obligations (1)	64.4		18.8		28.9		16.2		0.5
Pension and post-retirement benefit payments (2)	106.2		7.5		11.6		11.8		75.3
Total	$	1,338.9	$	83.0	$	669.5	$	40.5	$	545.9

(1) Refer to “Note 16. Commitments and Contingencies” for more information. 

(2) Refer to “Note 15. Employee Pension and Other Benefit Plans” for more information. 

As of July 1, 2017, we have accrued on our Consolidated Balance Sheet $3.7 million in connection with restructuring and related activities relating to our operating lease obligations disclosed above, of which $2.0 million was included in other current liabilities and $1.7 million was included in other non-current liabilities.

Purchase obligations represent legally-binding commitments to purchase inventory and other commitments made in the normal course of business to meet operational requirements. Of the $56.8 million of purchase obligations as of July 1, 2017, $10.1 million are related to inventory and the other $46.7 million are non-inventory items.

As of July 1, 2017, our other non-current liabilities primarily relate to asset retirement obligations, pension and financing obligations which are presented in various lines in the preceding table.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements, as such term is defined in rules promulgated by the SEC, that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Liquidity and Capital Resources Requirement

44

We believe that our existing cash balances and investments will be sufficient to meet our liquidity and capital spending requirements over the next twelve months. However, there are a number of factors that could positively or negatively impact our liquidity position, including:

• global economic conditions which affect demand for our products and services and impact the financial stability of our suppliers and customers;

• changes in accounts receivable, inventory or other operating assets and liabilities which affect our working capital;

• increase in capital expenditure to support the revenue growth opportunity of our business;

• changes in customer payment terms and patterns, which typically results in customers delaying payments or negotiating favorable payment terms to manage their own liquidity positions;

• timing of payments to our suppliers;

• factoring or sale of accounts receivable;

• volatility in fixed income and credit market which impact the liquidity and valuation of our investment portfolios;

• volatility in foreign exchange market which impacts our financial results;

• possible investments or acquisitions of complementary businesses, products or technologies;

• issuance or repurchase of debt or equity securities, which may include open market purchases of our 2033 Notes prior to their maturity or of our common stock;

• potential funding of pension liabilities either voluntarily or as required by law or regulation; and

• compliance with covenants and other terms and conditions related to our financing arrangements.

Employee Equity Incentive Plan

 Our stock option and Full Value Award program is a broad-based, long-term retention program that is intended to attract and retain employees and align stockholder and employee interests. As of July 1, 2017, we have available for issuance 15.4 million shares of common stock for grant primarily under our Amended and Restated 2003 Equity Incentive Plan (the “2003 Plan”) and 2005 Acquisition Equity Incentive Plan (the “2005 Plan”). The exercise price for the options is equal to the fair market value of the underlying stock at the date of grant. Options generally become exercisable over a three- or four-year period and, if not exercised, expire from five to ten years post grant date. Full Value Awards refer to RSUs and performance-based RSUs that are granted with the exercise price equal to zero and are converted to shares immediately upon vesting. The performance-based RSUs, or MSUs, have vesting requirements tied to the performance of the Company’s stock as compared to the NASDAQ telecommunications index, and could vest at a higher or lower rate or not at all, based on this relative performance. Full Value Awards are expected to vest over one to four years. The fair value of the time-based Full Value Awards is based on the closing market price of our common stock on the grant date of the award. Refer to “Note 14. Stock-Based Compensation” for more information.

Employee Defined Benefit Plans and Other Post-retirement Benefits

The Company sponsors significant qualified and non-qualified pension plans for certain past and present employees in the U.K. and Germany. The Company also is responsible for the non-pension post-retirement benefit obligation assumed from a past acquisition. Most of these plans have been closed to new participants and no additional service costs are being accrued, except for certain plans in Germany assumed in connection with an acquisition during fiscal 2010.

The U.K. plan is partially funded and the other plans, which were initially established as “pay-as-you-go” plans, are unfunded. As of July 1, 2017, our pension plans were underfunded by $105.1 million since the PBO exceeded the fair value of plan assets. Similarly, we had a liability of $1.1 million related to our non-pension post-retirement benefit plan.

We anticipate future annual outlays related to the German plans will approximate estimated future benefit payments. These future benefit payments have been estimated based on the same actuarial assumptions used to measure our projected benefit obligation and currently are forecasted to range between $4.7 million and $6.8 million per annum. In addition, we expect to contribute approximately $1.0 million to the U.K. plan during fiscal 2018.

During fiscal 2017 we contributed GBP 0.5 million, or approximately USD 0.6 million, while in fiscal 2016, we contributed GBP 0.5 million or approximately USD 0.7 million to our U.K. pension plan. These contributions allowed the Company to comply with regulatory funding requirements.

45

A key actuarial assumption in calculating the net periodic cost and the PBO is the discount rate. Changes in the discount rate impact the interest cost component of the net periodic benefit cost calculation and PBO due to the fact that the PBO is calculated on a net present value basis. Decreases in the discount rate will generally increase pre-tax cost, recognized expense and the PBO. Increases in the discount rate tend to have the opposite effect. We estimate a 50 basis point (“BPS”) decrease or increase in the discount rate would cause a corresponding increase or decrease, respectively, in the PBO of approximately $9.5 million based upon data as of July 1, 2017.

ITEM 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 

Foreign Exchange Risk

We utilize foreign exchange forward contracts to hedge foreign currency risk associated with foreign currency denominated monetary assets and liabilities, primarily certain short-term intercompany receivables and payables. Our foreign exchange forward contracts are accounted for as derivatives whereby the fair value of the contracts are reflected as other current assets or other current liabilities and the associated gains and losses are reflected in interest and other income, net in the Consolidated Statements of Operations. Our hedging programs reduce, but do not eliminate, the impact of currency exchange rate movements. The gains and losses on those derivatives are expected to be offset by re-measurement gains and losses on the foreign currency denominated monetary assets and liabilities.

As of July 1, 2017, the Company had forward contracts that were effectively closed but not settled with the counterparties by year end. Therefore, the fair value of these contracts of $7.3 million and $1.3 million is reflected as prepayments and other current assets and other current liabilities in the Consolidated Balance Sheets as of July 1, 2017, respectively.

The forward contracts outstanding and not effectively closed, with a term of less than 120 days, were transacted near year end; therefore, the fair value of the contracts is not significant. As of July 1, 2017 and July 2, 2016, the notional amounts of the forward contracts the Company held to purchase foreign currencies were $134.3 million and $110.0 million, respectively, and the notional amounts of forward contracts the Company held to sell foreign currencies were $25.4 million and $55.2 million, respectively.

The counterparties to these hedging transactions are creditworthy multinational banks. The risk of counterparty nonperformance associated with these contracts is not considered to be material. Notwithstanding our efforts to mitigate some foreign exchange risks, we do not hedge all of our foreign currency exposures, and there can be no assurances that our mitigating activities related to the exposures that we do hedge will adequately protect us against the risks associated with foreign currency fluctuations.

Investments

We maintain an investment portfolio in a variety of financial instruments, including, but not limited to, U.S. government and agency securities, corporate obligations, money market funds, asset-backed securities, and other investment-grade securities. The majority of these investments pay a fixed rate of interest. The securities in the investment portfolio are subject to market price risk due to changes in interest rates, perceived issuer creditworthiness, marketability, and other factors. These investments are generally classified as available-for-sale and, consequently, are recorded on our Consolidated Balance Sheets at fair value with unrealized gains or losses reported as a separate component of Other comprehensive (loss) income.

Investments in both fixed-rate and floating-rate interest earning instruments carry a degree of interest rate risk. The fair market values of our fixed-rate securities decline if interest rates rise, while floating-rate securities may produce less income than expected if interest rates fall. Due in part to these factors, our future investment income may be less than expectations because of changes in interest rates or we may suffer losses in principal if we sell securities that have experienced a decline in market value because of changes in interest rates. As of July 1, 2017, a hypothetical 100 basis point increase or decrease in interest rates would not result in a material change in the fair value of our available-for-sale debt instruments held that are sensitive to changes in interest rates, which includes U.S. treasuries, U.S. agencies, municipals, asset-backed securities and corporate securities.

We seek to mitigate the credit risk of our portfolio of fixed-income securities by holding only high-quality, investment-grade obligations with effective maturities of 37 months or less. We also seek to mitigate marketability risk by holding only highly liquid securities with active secondary or resale markets. However, the investments may decline in value or marketability due to changes in perceived credit quality or changes in market conditions.

Long-term Debt

The fair value of our 2024 and 2033 Notes is subject to interest rate and market price risk due to the convertible feature of the Notes and other factors. Generally, the fair value of fixed interest rate debt will increase as interest rates fall and decrease as interest rates rise. The fair value of the Notes may also increase as the market price of Viavi stock rises and decrease as the market

46

price of our stock falls. Changes in interest rates and Viavi stock price affect the fair value of the Notes but does not impact our financial position, cash flows or results of operations. Based on quoted market prices, as of July 1, 2017, the fair value of the 2024 Notes was approximately $481.7 million. and the fair value of the 2033 Notes was approximately $676.1 million. Refer to “Note 10. Debt” for more information.

47

ITEM 8.    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

To the Board of Directors and Stockholders of Viavi Solutions Inc.

In our opinion, the accompanying consolidated balance sheets and the related consolidated statements of operations, of comprehensive income (loss), of stockholders’ equity and of cash flows present fairly, in all material respects, the financial position of Viavi Solutions Inc. and its subsidiaries as of July 1, 2017 and July 2, 2016, and the results of their operations and their cash flows for each of the three years in the period ended July 1, 2017in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of July 1, 2017, based on criteria established in Internal Control - Integrated Framework (2013)issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company's management is responsible for these financial statements, for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on these financial statements and on the Company's internal control over financial reporting based on our integrated audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ PRICEWATERHOUSECOOPERS LLP

San Jose, California

August 29, 2017

48

VIAVI SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except per share data)

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Revenues:
Product revenue	$	726.4		$	808.8		$	771.2
Service revenue	85.0			97.5			102.7
Total net revenues	811.4			906.3			873.9
Cost of revenues:
Product cost of revenues	260.9			278.1			259.1
Service cost of revenues	50.2			61.2			62.8
Amortization of acquired technologies	14.3			17.3			31.9
Total cost of revenues	325.4			356.6			353.8
Gross profit	486.0			549.7			520.1
Operating expenses:
Research and development	136.3			166.4			173.3
Selling, general and administrative	300.5			351.1			376.3
Impairment of goodwill	—			91.4			—
Amortization of other intangibles	14.0			14.6			19.5
Restructuring and related charges	21.6			10.5			26.8
Total operating expenses	472.4			634.0			595.9
Income (loss) from operations	13.6			(84.3		)	(75.8		)
Interest and other income, net	13.1			2.5			3.7
Gain on sale of investments	203.1			71.6			0.1
Interest expense	(43.2		)	(35.7		)	(33.3		)
Income (loss) from continuing operations before income taxes	186.6			(45.9		)	(105.3		)
Provision for income taxes	21.3			4.5			26.1
Income (loss) from continuing operations, net of taxes	$	165.3		$	(50.4	)	$	(131.4	)
Income (loss) from discontinued operations, net of taxes	1.6			(48.8		)	43.3
Net income (loss)	$	166.9		$	(99.2	)	$	(88.1	)
Net income (loss) per share from - basic:
Continuing operations	$	0.72		$	(0.22	)	$	(0.57	)
Discontinued operations	0.01			(0.20		)	0.19
Net income (loss)	$	0.73		$	(0.42	)	$	(0.38	)
Net income (loss) per share from - diluted:
Continuing operations	$	0.70		$	(0.22	)	$	(0.57	)
Discontinued operations	0.01			(0.20		)	0.19
Net income (loss)	$	0.71		$	(0.42	)	$	(0.38	)
Shares used in per-share calculation - basic	229.9			234.0			232.7
Shares used in per-share calculation - diluted	234.5			234.0			232.7

See accompanying notes to consolidated financial statements.

49

VIAVI SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in millions)

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Net income (loss)	$	166.9		$	(99.2	)	$	(88.1	)
Other comprehensive (loss) income:
Net change in cumulative translation adjustment, net of tax	4.8			(32.0		)	(55.4		)
Net change in available-for-sale investments, net of tax:
Unrealized holding gains (losses) arising during period	92.1			177.3			(0.4		)
Less: reclassification adjustments included in net income (loss)	(201.9		)	(69.6		)	—
Net change in defined benefit obligation, net of tax:
Unrealized actuarial gains (loss) arising during period	0.7			(10.6		)	(3.7		)
Amortization of actuarial losses	1.9			0.7			0.4
Net change in accumulated other comprehensive (loss) income	(102.4		)	65.8			(59.1		)
Comprehensive income (loss)	$	64.5		$	(33.4	)	$	(147.2	)

See accompanying notes to consolidated financial statements.

50

VIAVI SOLUTIONS INC.

CONSOLIDATED BALANCE SHEETS

(in millions, except share and par value data)

	July 1, 2017			July 2, 2016
ASSETS
Current assets:
Cash and cash equivalents	$	1,004.4		$	482.9
Short-term investments	432.2			484.7
Restricted cash	11.2			12.2
Accounts receivable, net	120.4			148.4
Inventories, net	48.0			51.4
Prepayments and other current assets	50.8			32.1
Total current assets	1,667.0			1,211.7
Property, plant and equipment, net	136.9			133.0
Goodwill	151.6			152.1
Intangibles, net	31.1			59.9
Deferred income taxes	109.5			108.8
Other non-current assets	14.4			12.6
Total assets	$	2,110.5		$	1,678.1
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	32.6		$	47.0
Accrued payroll and related expenses	43.8			44.9
Deferred revenue	60.2			78.6
Accrued expenses	30.8			24.9
Other current liabilities	61.4			31.0
Total current liabilities	228.8			226.4
Long-term debt	931.4			583.3
Other non-current liabilities	163.9			179.1
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred Stock, $0.001 par value; 1 million shares authorized; 1 share at July 1, 2017 and July 2, 2016, issued and outstanding	—			—
Common Stock, $0.001 par value; 1 billion shares authorized; 228 million shares at July 1, 2017 and 232 million shares at July 2, 2016, issued and outstanding	0.2			0.2
Additional paid-in capital	70,184.4			70,059.8
Accumulated deficit	(69,305.8		)	(69,380.7		)
Accumulated other comprehensive (loss) income	(92.4		)	10.0
Total stockholders’ equity	786.4			689.3
Total liabilities and stockholders’ equity	$	2,110.5		$	1,678.1

See accompanying notes to consolidated financial statements.

51

VIAVI SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
OPERATING ACTIVITIES:
Net income (loss)	$	166.9		$	(99.2	)	$	(88.1	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation expense	29.4			38.1			80.8
Amortization of acquired technologies and other intangibles	28.3			32.5			59.2
Stock-based compensation	33.2			44.0			66.9
Amortization of debt issuance costs and accretion of debt discount	34.6			28.8			27.3
Amortization of discount and premium on investments, net	0.8			0.8			3.2
Impairment of goodwill	—			91.4			—
Gain on sales of investments	(203.1		)	(71.6		)	(0.1		)
Loss on disposal of long-lived assets	5.7			1.5			1.1
Loss on extinguishment of debt	1.1			—			—
Other	4.8			2.1			7.1
Changes in operating assets and liabilities, net of impact of Lumentum distribution:
Accounts receivable	24.5			23.4			(12.5		)
Inventories	(1.6		)	(2.6		)	(6.0		)
Other current and non-currents assets	(17.4		)	5.1			(9.0		)
Accounts payable	(14.8		)	(2.1		)	(10.1		)
Income taxes payable	(0.2		)	(1.5		)	(21.3		)
Deferred revenue, current and non-current	(27.4		)	(2.4		)	3.2
Deferred taxes, net	1.5			0.6			19.8
Accrued payroll and related expenses	(15.4		)	(25.2		)	(32.4		)
Accrued expenses and other current and non-current liabilities	29.1			(10.8		)	(6.8		)
Net cash provided by operating activities	80.0			52.9			82.3
INVESTING ACTIVITIES:
Purchases of available-for-sale investments	(679.4		)	(422.4		)	(562.7		)
Maturities of available-for-sale investments	470.4			395.7			574.8
Sales of available-for-sale investments	355.2			287.3			71.4
Changes in restricted cash	0.2			14.0			6.0
Acquisition of businesses, net of cash acquired	—			(0.9		)	—
Capital expenditures	(38.6		)	(35.5		)	(101.5		)
Proceeds from the sale of assets	5.9			6.0			6.2
Net cash provided by (used in) investing activities	113.7			244.2			(5.8		)
FINANCING ACTIVITIES:
Proceeds from sale of Lumentum Holdings Inc. Series A Preferred Stock	—			35.8			—
Cash contribution to Lumentum Holdings Inc.	—			(137.6		)	—
Proceeds from issuance of senior convertible debt	460.0			—			—
Payment of debt issuance costs	(8.9		)	—			—
Repurchase and retirement of common stock	(92.0		)	(44.5		)	(4.8		)
Payment of financing obligations	(0.8		)	(5.9		)	(23.3		)
Redemption of convertible debt	(45.4		)	—			—
Proceeds from exercise of employee stock options and employee stock purchase plan	12.4			4.5			20.8
Net cash provided by (used in) financing activities	325.3			(147.7		)	(7.3		)
Effect of exchange rates on cash and cash equivalents	2.5			(14.4		)	(18.5		)
Net increase in cash and cash equivalents	521.5			135.0			50.7
Cash and cash equivalents at beginning of period	482.9			347.9		*	297.2
Cash and cash equivalents at end of period	$	1,004.4		482.9			$	347.9	*
Supplemental disclosure of cash flow information
Cash paid for interest	$	6.7		$	6.6		$	6.5
Cash paid for taxes	$	23.1		$	31.8		$	23.8

*Cash and cash equivalents at June 27, 2015 included $13.4 million in current assets of the discontinued operations of Lumentum Holdings Inc.

See accompanying notes to consolidated financial statements.

52

VIAVI SOLUTIONS INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in millions)

	Common Stock				Additional Paid-In Capital			Accumulated Deficit			Accumulated Other Comprehensive Income (Loss)			Total
	Shares		Amount
Balance at June 28, 2014	230.4		$	0.2	$	69,957.0		$	(68,780.6	)	$	11.1		$	1,187.7
Net loss	—		—		—			(88.1		)	—			(88.1		)
Comprehensive loss	—		—		—			—			(59.1		)	(59.1		)
Shares issued under employee stock plans, net of tax effects	5.3		—		(1.2		)	—			—			(1.2		)
Stock-based compensation	—		—		66.9			—			—			66.9
Repurchases of common stock	(0.4	)	—		—			(4.8		)	—			(4.8		)
Balance at June 27, 2015	235.3		$	0.2	$	70,022.7		$	(68,873.5	)	$	(48.0	)	$	1,101.4
Net loss	—		—		—			(99.2		)				(99.2		)
Distribution of Lumentum Holdings Inc.	—		—		—			(363.5		)	(7.8		)	(371.3		)
Comprehensive income	—		—		—			—			65.8			65.8
Shares issued under employee stock plans, net of tax effects	4.5		—		(6.9		)	—			—			(6.9		)
Stock-based compensation	—		—		44.0			—			—			44.0
Repurchases of common stock	(7.3	)	—		—			(44.5		)	—			(44.5		)
Balance at July 2, 2016	232.5		$	0.2	$	70,059.8		$	(69,380.7	)	$	10.0		$	689.3
Net income	—		—		—			166.9			—			166.9
Comprehensive loss	—		—		—			—			(102.4		)	(102.4		)
Shares issued under employee stock plans, net of tax effects	5.6		—		(1.9		)	—			—			(1.9		)
Stock-based compensation	—		—		33.2			—			—			33.2
Repurchases of common stock	(10.5	)	—		—			(92.0		)	—			(92.0		)
Issuance of senior convertible notes	—		—		99.9			—			—			99.9
Reacquisition of 2033 Notes equity component	—		—		(6.6		)	—			—			(6.6		)
Balance at July 1, 2017	227.6		$	0.2	$	70,184.4		$	(69,305.8	)	$	(92.4	)	$	786.4

See accompanying notes to consolidated financial statements.

53

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1. Basis of Presentation

Description of Business

Viavi Solutions Inc. (“Viavi,” also referred to as “the Company,” “we,” “our,” and “us”), formerly JDS Uniphase Corporation (“JDSU”), is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises and their ecosystems, supported by a worldwide channel community including Viavi Velocity Solution Partners. The Velocity program (“Velocity”) allows the Company to optimize the use of direct or partner sales depending on application and sales volume. Velocity expands the Company’s reach into new market segments as well as expands the capability to sell and deliver solutions. Viavi’s solutions deliver end-to-end visibility across physical, virtual and hybrid networks, enabling customers to optimize connectivity, quality of experience and profitability. Viavi is also a leader in high performance thin film optical coatings, providing light management solutions to anti-counterfeiting, consumer and industrial, government and healthcare and other markets.

Lumentum Separation

On August 1, 2015 (the “Separation Date”), Viavi completed the distribution of approximately 80.1% of the outstanding shares of Lumentum Holdings Inc. (“Lumentum”) common stock (the “Distribution”). Concurrent with the Distribution, JDSU was renamed Viavi Solutions Inc. and, at the time of the Distribution, retained ownership of approximately 19.9% of Lumentum’s outstanding shares. Lumentum was formed to hold Viavi’s communications and commercial optical products business segment (“CCOP”) and the WaveReady product line and, as a result of the Distribution, is now an independent public company trading under the symbol “LITE” on The Nasdaq Stock Market (“NASDAQ”). The Distribution was made to Viavi’s stockholders of record as of the close of business on July 27, 2015 (the “Record Date”), who received one share of Lumentum common stock for every five shares of Viavi common stock held as of the close of business on the Record Date and not sold prior to August 4, 2015, the ex-dividend date. The historical results of operations and the financial position have been recasted to present the Lumentum business as discontinued operations as described in “Note 3. Discontinued Operations.” Unless noted otherwise, discussion in the Notes to Consolidated Financial Statements pertains to continuing operations.

Fiscal Years

The Company utilizes a 52-53 week fiscal year ending on the Saturday closest to June 30th. The Company’s fiscal 2017 was a 52-week year ending on July 1, 2017. The Company’s fiscal 2016 and 2015 were 53-week and 52-week fiscal years ending on July 2, 2016, and June 27, 2015, respectively.

Principles of Consolidation

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the Company and its wholly-owned subsidiaries. All inter-company accounts and transactions have been eliminated.

Use of Estimates

The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements, the reported amount of net revenues and expenses and the disclosure of commitments and contingencies during the reporting periods. The Company bases estimates on historical experience and on various assumptions about the future that are believed to be reasonable based on available information. The Company’s reported financial positions or results of operations may be materially different under changed conditions or when using different estimates and assumptions, particularly with respect to significant accounting policies. If estimates or assumptions differ from actual results, subsequent periods are adjusted to reflect more current information.

Cash and Cash Equivalents

The Company considers highly liquid instruments such as treasury bills, commercial paper and other money market instruments with original maturities of 90 days or less at the time of purchase to be cash equivalents. Cash equivalents also include certain term deposit with financial institutions that the Company can liquidate with 30-day advance notice without incurring penalty.

54

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Restricted Cash

At July 1, 2017 and July 2, 2016, the Company’s short-term restricted cash balances were $11.2 million and $12.2 million, respectively, and the Company’s long-term restricted cash balances were $6.8 million and $6.0 million, respectively. These balances primarily include interest-bearing investments in bank certificates of deposit and money market funds which act as collateral supporting the issuance of letters of credit and performance bonds for the benefit of third parties. Refer to the Company’s “Note 16. Commitments and Contingencies” for more information.

Investments

The Company’s investments in debt securities and marketable equity securities, including the Company’s ownership of Lumentum’s common stock, are primarily classified as available-for-sale investments or trading securities and are recorded at fair value. The cost of securities sold is based on the specific identification method. Unrealized gains and losses resulting from changes in fair value on available-for-sale investments, net of tax, are reported within accumulated other comprehensive income (loss), a separate component of stockholders’ equity. Unrealized gains or losses on trading securities resulting from changes in fair value are recognized in current earnings. The Company’s short-term investments, which are classified as current assets, include certain securities with stated maturities of longer than twelve months as they are highly liquid and available to support current operations.

The Company periodically reviews these investments for impairment. If a debt security’s fair value is below amortized cost and the Company either intends to sell the security or it is more likely than not that the Company will be required to sell the security before its anticipated recovery, the Company records an other-than-temporary impairment charge to current earnings for the entire amount of the impairment; if a debt security’s fair value is below amortized cost and the Company does not expect to recover the entire amortized cost of the security, the Company separates the other-than-temporary impairment into the portion of the loss related to credit factors, or the credit loss portion, and the portion of the loss that is not related to credit factors, or the non-credit loss portion. The credit loss portion is the difference between the amortized cost of the security and the Company’s best estimate of the present value of the cash flows expected to be collected from the debt security. The non-credit loss portion is the residual amount of the other-than-temporary impairment. The credit loss portion is recorded as a charge to income (loss), and the non-credit loss portion is recorded as a separate component of other comprehensive (loss) income.

Fair Value of Financial Instruments

The carrying amounts of certain of the Company’s financial instruments, including cash equivalents, accounts receivable, accounts payable, and deferred compensation liability, approximate fair value because of their short maturities. Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. There is an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the assumptions about the factors that market participants would use in valuing the asset or liability.

Estimates of fair value of fixed-income securities are based on third party, market-based pricing sources which the Company believes to be reliable. These estimates represent the third parties’ good faith opinion as to what a buyer in the marketplace would pay for a security in a current sale. For instruments that are not actively traded, estimates may be based on current treasury yields adjusted by an estimated market credit spread for the specific instrument. The fair market value of the Company’s 0.625% Senior Convertible Notes due 2033 and 1.00% Senior Convertible Notes due 2024 fluctuates with interest rates and with the market price of the stock, but does not affect the carrying value of the debt on the balance sheet. Refer to the Company’s “Note 10. Debt” for more information.

Inventories

Inventory is valued at standard cost, which approximates actual cost computed on a first-in, first-out basis, not in excess of net realizable market value. The Company assesses the valuation on a quarterly basis and writes down the value for estimated excess and obsolete inventory based upon estimates of future demand, including warranty requirements. Our inventories include material, labor, and manufacturing overhead costs.

55

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Property, Plant and Equipment

Property, plant and equipment are stated at cost. Depreciation is computed by the straight-line method over the following estimated useful lives of the assets: 10 to 50 years for building and improvements, 2 to 20 years for machinery and equipment, and 2 to 5 years for furniture, fixtures, software and office equipment. Leasehold improvements are amortized by the straight-line method over the shorter of the estimated useful lives of the assets or the term of the lease. Demonstration units, which are Company products used for demonstration purposes for customers and/or potential customers and generally not intended to be sold, have an estimated useful life of 3 to 5 years and are amortized by the straight-line method.

Costs related to software acquired, developed or modified solely to meet the Company’s internal requirements and for which there are no substantive plans to market are capitalized in accordance with the authoritative guidance on accounting for the costs of computer software developed or obtained for internal use. Only costs incurred after the preliminary planning stage of the project and after management has authorized and committed funds to the project are eligible for capitalization. Costs capitalized for computer software developed or obtained for internal use are included in property, plant and equipment, net on the Consolidated Balance Sheets.

Goodwill

Goodwill represents the excess of the purchase price of an acquired enterprise or assets over the fair value of the identifiable assets acquired and liabilities assumed. The Company tests for impairment of goodwill on an annual basis in the fourth quarter and at any other time when events occur or circumstances indicate that the carrying amount of goodwill may not be recoverable. Refer to “Note 8. Goodwill” for more information.

Circumstances that could trigger an impairment test include, but are not limited to, a significant adverse change in the business climate or legal factors, an adverse action or assessment by a regulator, change in customers, target market and strategy, unanticipated competition, loss of key personnel, or the likelihood that a reporting unit or significant portion of a reporting unit will be sold or otherwise disposed.

An assessment of qualitative factors may be performed to determine whether it is necessary to perform the quantitative goodwill impairment test. If the result of the qualitative assessment is that it is more likely than not (i.e., greater than 50% likelihood) that the fair value of a reporting unit is less than its carrying amount, then the quantitative test is required. Otherwise, no further testing is required.

Under the quantitative test, if the carrying amount of the reporting unit goodwill exceeds the implied fair value of that goodwill, an impairment loss is recorded in the Consolidated Statements of Operations as “impairment of goodwill.” Measurement of the fair value of a reporting unit is based on one or more of the following fair value measures: using present value techniques of estimated future cash flows, or using valuation techniques based on multiples of earnings or revenue, or a similar performance measure.

In the fourth quarter of fiscal 2017, the Company early adopted the new accounting guidance issued by the FASB that eliminated the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, any impairment charge would be based on the excess of a reporting unit's carrying amount over its fair value.

Intangible Assets

Intangible assets consist primarily of purchased intangible assets through acquisitions. Purchased intangible assets primarily include acquired developed technologies (developed and core technology), customer relationships, proprietary know-how, trade secrets, and trademarks and trade names. Intangible assets are amortized using the straight-line method over the estimated economic useful lives of the assets, which is the period during which expected cash flows support the fair value of such intangible assets. Refer to “Note 9. Acquired Developed Technology and Other Intangibles” for more information.

Long-lived Asset Valuation (Property, Plant and Equipment and Intangible Assets Subject to Amortization)

Long-lived assets held and used

The Company tests long-lived assets for recoverability, at the asset group level, when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to, significant decreases in the market price of the asset, significant adverse changes in the business climate or legal factors, accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset,

56

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset, or current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life.

 Recoverability is assessed based on the difference between the carrying amount of the asset and the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset. An impairment loss is recognized when the carrying amount is not recoverable and exceeds the fair value.

Pension and Other Postretirement Benefits

In the fourth quarter of fiscal 2016 the Company early adopted the authoritative guidance issued by the FASB that provides a practical expedient permitting an entity to measure defined benefit plan assets and obligations using the month-end that is closest to the entity’s fiscal year-end and apply that practical expedient consistently from year to year. The Company has adopted the month-end date of June 30, which is the closest month-end to the Company’s fiscal year as the measurement date for all of the Company's qualified and the non-qualified pension plans in certain countries beginning in fiscal 2016. Measurement dates for prior periods are not impacted. 

The funded status of the Company’s retirement-related benefit plans is recognized on the Consolidated Balance Sheets. The funded status is measured as the difference between the fair value of plan assets and the benefit obligation at fiscal year end, the measurement date. For defined benefit pension plans, the benefit obligation is the projected benefit obligation (“PBO”) and for the non-pension postretirement benefit plan the benefit obligation is the accumulated postretirement benefit obligation (“APBO”). The PBO represents the actuarial present value of benefits expected to be paid upon its employee’s retirement. The APBO represents the actuarial present value of postretirement benefits attributed to employee services already rendered. Unfunded or partially funded plans, with the benefit obligation exceeding the fair value of plan assets, are aggregated and recorded as a retirement and non-pension postretirement benefit obligation equal to this excess. The current portion of the retirement-related benefit obligation represents the actuarial present value of benefits payable in the next 12 months in excess of the fair value of plan assets, measured on a plan-by-plan basis. This liability is recorded in other current liabilities in the Consolidated Balance Sheets.

Net periodic pension cost is recorded in the Consolidated Statements of Operations and includes service cost, interest cost, expected return on plan assets, amortization of prior service cost (credit), and (gains) losses previously recognized as a component of accumulated other comprehensive income (loss). Service cost represents the actuarial present value of participant benefits attributed to services rendered by employees in the current year. Interest cost represents the time value of money cost associated with the passage of time. (Gains) losses arise as a result of differences between actual experience and assumptions or as a result of changes in actuarial assumptions. Prior service cost (credit) represents the cost of benefit improvements attributable to prior service granted in plan amendments. (Gains) losses and prior service cost (credit) not recognized as a component of net periodic pension cost in the Consolidated Statements of Operations as they arise are recognized as a component of accumulated other comprehensive income (loss) on the Consolidated Balance Sheets, net of tax. Those (gains) losses and prior service cost (credit) are subsequently recognized as a component of net periodic pension cost pursuant to the recognition and amortization provisions of the authoritative guidance.

The measurement of the benefit obligation and net periodic pension cost is based on the Company’s estimates and actuarial valuations provided by third-party actuaries, and are approved by management. These valuations reflect the terms of the plans and use participant-specific information such as compensation, age and years of service, as well as certain assumptions, including estimates of discount rates, expected return on plan assets, rate of compensation increases, and mortality rates. The Company evaluates these assumptions periodically but not less than annually. In estimating the expected return on plan assets, the Company considers historical returns on plan assets, diversification of plan investments, adjusted for forward-looking considerations, inflation assumptions and the impact of the active management of the plan’s invested assets.

Concentration of Credit and Other Risks

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments, restricted cash, trade receivables and foreign currency forward contracts. The Company’s cash and cash equivalents and short-term investments are held in safekeeping by large, creditworthy financial institutions. The Company invests its excess cash primarily in U.S. government and agency bonds securities, corporate securities, money market funds, asset-backed securities, other investment-grade securities and certificates of deposit. The Company has established guidelines relative to credit ratings, diversification and maturities that seek to maintain safety and liquidity of these investments. The Company’s foreign exchange derivative instruments expose the Company to credit risk to the extent that the counterparties may be unable to

57

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

meet the terms of the agreements. The Company seeks to mitigate such risk by limiting its counterparties to major financial institutions and by spreading such risk across several major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from such risk is monitored by the Company on an ongoing basis.

The Company performs credit evaluations of its customers’ financial condition and generally does not require collateral from its customers. These evaluations require significant judgment and are based on a variety of factors including, but not limited to, current economic trends, historical payment, bad debt write-off experience, and financial review of the customer.

The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. When the Company becomes aware that a specific customer is unable to meet its financial obligations, the Company records a specific allowance to reflect the level of credit risk in the customer’s outstanding receivable balance. In addition, the Company records additional allowances based on certain percentages of aged receivable balances. These percentages take into account a variety of factors including, but not limited to, current economic trends, historical payment and bad debt write-off experience. The Company classifies bad debt expenses as selling, general and administrative (“SG&A”) expense.

The Company is not able to predict changes in the financial stability of its customers. Any material change in the financial status of any one customer or a group of customers could have a material adverse effect on the Company’s results of operations and financial condition. Although such losses have been within management’s expectations to date, there can be no assurance that such allowances will continue to be adequate. The Company has significant trade receivables concentrated in the telecommunications industry. While the Company’s allowance for doubtful accounts balance is based on historical loss experience along with anticipated economic trends, unanticipated financial instability in the telecommunications industry could lead to higher than anticipated losses.

As of July 1, 2017 and July 2, 2016, one customer represented 10% or more of our total accounts receivable, net.

During fiscal 2017, 2016 and 2015, certain customers generated 10% or more of total net revenues. Refer to "Note 17. Operating Segments and Geographic Information" for more information.

The Company relies on a limited number of suppliers for a number of key components contained in our products. The Company also relies on a limited number of significant independent contract manufacturers for the production of certain key components and subassemblies contained in our products.

The Company generally uses a rolling twelve month forecast based on anticipated product orders, customer forecasts, product order history and backlog to determine its materials requirements. Lead times for the parts and components that the Company orders vary significantly and depend on factors such as the specific supplier, contract terms and demand for a component at a given time. If the forecast does not meet actual demand, the Company may have excess or shortfalls of some materials and components, as well as excess inventory purchase commitments. The Company could experience reduced or delayed product shipments or incur additional inventory write-downs and cancellation charges or penalties, which would increase costs and could have a material adverse impact on the Company’s results of operations.

Foreign Currency Forward Contracts

The Company conducts its business and sells its products to customers primarily in North America, Europe and Asia. In the normal course of business, the Company’s financial position is routinely subject to market risks associated with foreign currency rate fluctuations due to balance sheet positions in foreign currencies. The Company evaluates foreign exchange risks and utilizes foreign currency forward contracts to reduce such risks, hedging the gains or losses generated by the re-measurement of significant foreign currency denominated monetary assets and liabilities. The fair value of these contracts is reflected as other current assets or other current liabilities and the change in fair value of these foreign currency forward contracts is recorded as gain or loss in the Company’s Consolidated Statements of Operations as a component of interest and other income, net. The gain or loss from the change in fair value of these foreign currency forward contracts largely offsets the change in fair value of the foreign currency denominated monetary assets and liabilities, which is also recorded as a component of interest and other income, net.

Foreign Currency Translation

Assets and liabilities of non-U.S. subsidiaries that operate in a local currency environment, where that local currency is the functional currency, are translated into U.S. dollars at exchange rates in effect at the balance sheet date, with the resulting translation adjustments directly recorded as a component of accumulated other comprehensive income (loss) on the Consolidated Balance Sheets. Income and expense accounts are translated at the prior month end exchange rates, which are deemed to approximate the

58

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

exchange rate when the income and expense are recognized. Gains and losses from re-measurement of monetary assets and liabilities that are denominated in currencies other than the respective functional currencies are included in the Consolidated Statements of Operations as a component of interest and other income, net.

Revenue Recognition

The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when it has persuasive evidence of an arrangement, delivery has occurred, the sales price is fixed or determinable and collectibility is reasonably assured. Delivery does not occur until products have been shipped or services have been provided, risk of loss has transferred and in cases where formal acceptance is required, customer acceptance has been obtained or customer acceptance provisions have lapsed. In situations where a formal acceptance is required but the acceptance only relates to whether the product meets its published specifications, revenue is recognized upon delivery provided that all other revenue recognition criteria are met. Historical return rates are monitored on a product-by-product basis. In addition, some distributor agreements allow for partial return of products and/or price protection under certain conditions within limited time periods. Such return rights are generally limited to contractually defined, short-term stock rotation and defective or damaged product. We maintain reserves for sales returns and price adjustments based on historical experience and other qualitative factors. As new products or distributors are introduced, these historical rates are used to establish initial sales returns reserves and are adjusted as better information becomes available. We also have market development incentive programs for certain distributors whereby rebates are offered based upon exceeding volume goals. Estimated rebates, sales returns and other such allowances are deducted from revenue.

In addition to the aforementioned general policies, the following are the specific revenue recognition policies for multiple-element arrangements and for each major category of revenue.

Multiple-Element Arrangements

When a sales arrangement contains multiple deliverables, such as sales of products that include services, the multiple deliverables are evaluated to determine whether there are one or more units of accounting. Where there is more than one unit of accounting, then the entire fee from the arrangement is allocated to each unit of accounting based on the relative selling price. Under this approach, the selling price of a unit of accounting is determined by using a selling price hierarchy which requires the use of vendor-specific objective evidence (“VSOE”) of fair value if available, third-party evidence (“TPE”) if VSOE is not available, or best estimate of selling price (“BESP”) if neither VSOE nor TPE is available. Revenue is recognized when the revenue recognition criteria for each unit of accounting are met.

The Company establishes VSOE of selling price using the price charged for a deliverable when sold separately and, in remote circumstances, using the price established by management having the relevant authority. TPE of selling price is established by evaluating similar and interchangeable competitor goods or services in sales to similarly situated customers. When VSOE or TPE is not available, the Company then uses BESP. Generally, the Company is not able to determine TPE because its product strategy differs from that of others in our markets, and the extent of customization varies among comparable products or services from its peers. The Company establishes BESP using historical selling price trends and considering multiple factors including, but not limited to geographies, market conditions, competitive landscape, internal costs, gross margin objectives, and pricing practices. When determining BESP, the Company applies significant judgment in establishing pricing strategies and evaluating market conditions and product lifecycles.

To the extent a deliverable(s) in a multiple-element arrangement is subject to specific guidance (for example, software that is subject to the authoritative guidance on software revenue recognition), the Company allocates the fair value of the units of accounting using relative selling price and that unit of accounting is accounted for in accordance with the specific guidance. Some product offerings include hardware that are integrated with or sold with software that delivers the functionality of the equipment. The Company believes this equipment is not considered software-related and would therefore be excluded from the scope of the authoritative guidance on software revenue recognition.

Hardware

Revenue from hardware sales is recognized when the product is shipped to the customer and when there are no unfulfilled obligations from the Company that affect the customer’s final acceptance of the arrangement. Any cost of warranties and remaining obligations that are inconsequential or perfunctory are accrued when the corresponding revenue is recognized.

Services

59

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Revenue from services and system maintenance is recognized on a straight-line basis over the term of the service. Revenue from professional service engagements is recognized once its delivery obligation is fulfilled. Revenue related to extended warranty and product maintenance contracts is deferred and recognized on a straight-line basis over the delivery period. The Company also generates service revenue from hardware repairs and calibration which is recognized as revenue upon completion of the service.

Software

The Company’s software arrangements generally consist of a perpetual license fee, installation services and Post-Contract Support (“PCS”) as well as other non-software deliverables.

VSOE of fair value for PCS is established based on the renewal rate or the bell curve methodology. Non-software and software-related arrangements are bifurcated based on a relative selling price using BESP. The software related elements are bifurcated into separate units of accounting if VSOE of fair value has been established for the undelivered element(s) and the functionality of the delivered element(s) is not dependent on the undelivered element(s).

Revenue from multiple-element software arrangements that include installation services, is deferred until installation service obligation for the software solution is fulfilled. If VSOE has been established for the undelivered elements, the software, installation services and non-software elements are recognized upon completion of delivery and the PCS is recognized ratably over the remaining support contract term. If VSOE has not been established for the undelivered element, the software related elements are recognized ratably over the remaining support period.

Warranty

The Company provides reserves for the estimated costs of product warranties at the time revenue is recognized. It estimates the costs of its warranty obligations based on its historical experience of known product failure rates, use of materials to repair or replace defective products and service delivery costs incurred in correcting product failures. In addition, from time to time, specific warranty accruals may be made if unforeseen technical problems arise.

Shipping and Handling Costs

The Company records costs related to shipping and handling of revenue in cost of sales for all periods presented.

Advertising Expense

The Company expenses advertising costs as incurred. Advertising costs totaled $2.1 million, $2.6 million and $1.7 million in fiscal 2017, 2016 and 2015, respectively.

Research and Development (“R&D”) Expense

Costs related to R&D, which primarily consists of labor and benefits, supplies, facilities, consulting and outside service fees, are charged to expense as incurred. The authoritative guidance allows for capitalization of software development costs incurred after a product’s technological feasibility has been established until the product is available for general release to the public. To date, the period between achieving technological feasibility, which the Company has defined as the establishment of a working model and typically occurs when beta testing commences, and the general availability of such software has been very short. Accordingly, software development costs have been expensed as incurred.

Stock-Based Compensation

Stock-based compensation is measured at grant date, and recognized in expense over the requisite service period based on the fair value of the equity award. The fair value of the time-based Full Value Awards is based on the closing market price of the Company’s common stock on the grant date of the award. The Company uses the Monte Carlo simulation to estimate the fair value of Full Value Awards with market conditions (“MSUs”). The Company estimates the fair value of stock options and employee stock purchase plan awards (“ESPP”) using the Black-Scholes Merton (“BSM”) option-pricing model. This option-pricing model requires the input of assumptions, including the award’s expected life and the price volatility of the underlying stock.

The Company estimates the expected forfeiture rate pursuant to the authoritative guidance, and only recognizes expense for those shares expected to vest. When estimating forfeitures, the Company considers voluntary termination behavior as well as future workforce reduction programs. Estimated forfeiture is trued up to actual forfeiture as the equity awards vest. The total fair value

60

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

of the equity awards, net of forfeiture, is recorded on a straight-line basis over the requisite service period of the awards for each separately vesting period of the award, except for MSUs, which are amortized based upon graded vesting method.

Income Taxes

In accordance with the authoritative guidance on accounting for income taxes, the Company recognizes income taxes using an asset and liability approach. This approach requires the recognition of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in its consolidated financial statements or tax returns. The measurement of current and deferred taxes is based on provisions of the enacted tax law and the effects of future changes in tax laws or rates are not anticipated.

The authoritative guidance provides for recognition of deferred tax assets if the realization of such deferred tax assets is more likely than not to occur based on an evaluation of both positive and negative evidence and the relative weight of the evidence. With the exception of certain international jurisdictions, the Company has determined that at this time it is more likely than not that deferred tax assets attributable to the remaining jurisdictions will not be realized, primarily due to uncertainties related to its ability to utilize its net operating loss carryforwards before they expire. Accordingly, the Company has established a valuation allowance for such deferred tax assets. If there is a change in the Company’s ability to realize its deferred tax assets for which a valuation allowance has been established, then its tax provision may decrease in the period in which it determines that realization is more likely than not. Likewise, if the Company determines that it is not more likely than not that our deferred tax assets will be realized, then a valuation allowance may be established for such deferred tax assets and the Company’s tax provision may increase in the period in which we make the determination.

The authoritative guidance on accounting for uncertainty in income taxes prescribes the recognition threshold and measurement attributes for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Additionally, it provides guidance on recognition, classification, and disclosure of tax positions. The Company is subject to income tax audits by the respective tax authorities in all of the jurisdictions in which it operates. The determination of tax liabilities in each of these jurisdictions requires the interpretation and application of complex and sometimes uncertain tax laws and regulations. The Company recognizes liabilities based on its estimate of whether, and the extent to which, additional tax liabilities are more likely than not. If the Company ultimately determines that the payment of such a liability is not necessary, then it reverses the liability and recognizes a tax benefit during the period in which the determination is made that the liability is no longer necessary.

The recognition and measurement of current taxes payable or refundable and deferred tax assets and liabilities requires that the Company make certain estimates and judgments. Changes to these estimates or a change in judgment may have a material impact on the Company’s tax provision in a future period.

Restructuring Accrual

In accordance with authoritative guidance on accounting for costs associated with exit or disposal activities, generally costs associated with restructuring activities are recognized when they are incurred. However, in the case of operating and direct financing leases, the expense is estimated and accrued when the property is vacated. Given the significance of, and the timing of the execution of such activities, this process is complex and involves periodic reassessments of estimates made from the time the property was vacated, including evaluating real estate market conditions for expected vacancy periods and sub-lease income.

Additionally, a liability for post-employment benefits for workforce reductions related to restructuring activities is recorded when payment is probable, and the amount is reasonably estimable. The Company continually evaluates the adequacy of the remaining liabilities under its restructuring initiatives. Although the Company believes that these estimates accurately reflect the costs of its restructuring plans, actual results may differ, thereby requiring the Company to record additional liabilities or reverse a portion of existing liabilities.

Loss Contingencies

The Company is subject to the possibility of various loss contingencies arising in the ordinary course of business. The Company considers the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as its ability to reasonably estimate the amount of loss in determining loss contingencies. An estimated loss is accrued when it is probable that an asset has been impaired or a liability has been incurred and the amount of loss can be reasonably estimated. The Company regularly evaluates current information available to determine whether such accruals should be adjusted and whether new accruals are required.

61

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Asset Retirement Obligations (“ARO”)

ARO are legal obligations associated with the retirement of long-lived assets pertaining to leasehold improvements. These liabilities are initially recorded at fair value and the related asset retirement costs are capitalized by increasing the carrying amount of the related assets by the same amount as the liability. Asset retirement costs are subsequently depreciated over the useful lives of the related assets. Subsequent to initial recognition, the Company records period-to-period changes in the ARO liability resulting from the passage of time and revisions to either the timing or the amount of the original estimate of undiscounted cash flows. The Company derecognizes ARO liabilities when the related obligations are settled. As of July 1, 2017 and July 2, 2016, the Consolidated Balance Sheets included ARO of $0.3 million and $0.2 million, respectively, in other current liabilities and $3.3 million and $3.5 million, respectively, in other non-current liabilities. The activities and balances for ARO are as follows (in millions):

	Balance at Beginning of Period		Liabilities Incurred	Liabilities Settled		Accretion Expense	Revisions to Estimates		Balance at End of Period
Year ended July 1, 2017	$	3.7	0.1	(0.1	)	0.2	(0.3	)	$	3.6
Year ended July 2, 2016	$	4.4	0.4	(0.9	)	0.2	(0.4	)	$	3.7

Note 2. Recently Issued Accounting Pronouncements

In May 2017, the Financial Accounting Standards Board (“FASB”) issued guidance that clarifies the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under the relevant authoritative guidance. The guidance is to be applied prospectively, and is effective for the Company in the first quarter of fiscal 2019. Early adoption is permitted. The Company does not anticipate the adoption of this guidance to have a material impact on its consolidated financial statements, absent any award(s) modified on or after adoption date.

In November 2016, the FASB issued guidance that will require that the amounts generally described as restricted cash and restricted cash equivalents would be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period amounts shown on the statement of cash flows. The new guidance also requires certain disclosures to supplement the statement of cash flows. The guidance is effective for the Company in the first quarter of fiscal 2019. Other than changes in the presentation within the statements of cash flows and additional required disclosures, the adoption of this new accounting guidance will not have an impact on the consolidated financial statements.

In October 2016, the FASB issued guidance that requires entities to recognize at the transaction date the income tax consequences of intra-entity transfer of an asset other than inventory. The guidance is effective for the Company in the first quarter of fiscal 2019. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In June 2016, the FASB issued guidance that changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. The guidance is effective for the Company in the first quarter of fiscal 2021 and earlier adoption is permitted. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In March 2016, the FASB issued guidance which simplifies several aspects of accounting for share-based payment award transactions including income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The guidance is effective for the Company in the first quarter of fiscal 2018. The most significant impact from this guidance upon adoption for the Company relates to the classification of employee tax paid by withholding shares of restricted stock units on the statements of cash flows and excess tax benefit. Upon adoption, the related cash flows will be classified as financing activity, from the current classification as operating activity and all prior periods presented will be retrospectively adjusted to reflect this change. The employee tax paid by withholding shares totaled $14.3 million and $11.4 million in fiscal 2017 and 2016, respectively. In addition, the guidance requires that the excess tax benefits to be recorded on the income statement as opposed to additional paid-in-capital. Due to the Company’s valuation allowance on its deferred tax assets, no income tax benefit is expected to be recognized upon adoption. All other aspects of the guidance are not expected to have a material effect on the Company’s consolidated financial statements.

62

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

In February 2016, the FASB issued guidance regarding both operating and financing leases, requiring lessees to recognize on their balance sheets “right-of-use assets” and corresponding lease liabilities, measured on a discounted basis over the lease term. Virtually all leases will be subject to this treatment except leases that meet the definition of a “short-term lease.” The guidance requires a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The guidance is effective for the Company in the first quarter of fiscal 2020. While the Company is not yet in a position to assess the full impact of the application of the new guidance, the Company expects adoption of this guidance will materially increase the assets and liabilities recorded on its Consolidated Balance Sheets.

In May 2014, the FASB issued new authoritative guidance related to revenue recognition from contracts with customers. This new guidance will replace current U.S. GAAP guidance on this topic and eliminate industry-specific guidance. The new guidance provides a unified model to determine when and how revenue is recognized. The core principle of the new guidance is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This new guidance allows for either full retrospective adoption or modified retrospective adoption. The FASB deferred the effective date for this new guidance by one year to December 15, 2017 for annual reporting periods beginning after such date. Earlier application of this new guidance is permitted. The Company currently anticipates adopting the guidance in the first quarter of fiscal 2019 using the full retrospective method, reflecting the application of the new standard in each prior reporting period.

In preparation for the implementation and adoption of the new guidance, the Company has established a cross-functional team and implementation plan to identify processes, systems and internal controls over financial reporting impacted by the new guidance. The implementation plan includes comparison of the Company’s historical accounting policies and practices to the requirements of the new guidance, and identifying differences from applying the requirements of the new guidance to the Company’s contracts, consolidated financial statements and related disclosures.

While the Company’s assessment of the potential impacts of the new guidance is not yet complete, initially the Company believes the most significant impact on the accounting for contracts with customers will be for certain arrangements that include sales of software solutions bundled with post-contract support (PCS) and/or services, where VSOE has not been established for the PCS and/or the services. Due to lack of VSOE under the current guidance, the Company defers recognition of any revenue attributable to such arrangements until the services lacking VSOE are complete. Such revenue is then recognized ratably over the remaining support term. The requirement to have VSOE for undelivered elements to enable the separation of the revenue for delivered software is eliminated under the new guidance and the Company will be required to allocate total contract revenue to each element (referred to as a distinct performance obligation under the new standard) based on either an established or estimated standalone selling price. Accordingly, a portion of the revenue for these types of contracts with customers will be recognized when the software or software solution is transferred to the customer. Dependent on contract-specific terms, the Company expects the actual revenue recognition treatment and timing will vary under the new guidance for some of these arrangements. The Company will continue to evaluate the impact of this new guidance on its consolidated financial statements and related disclosures.

Note 3. Discontinued Operations

On August 1, 2015, the Company completed the separation of the Lumentum business (the “Separation”) and made a tax-free distribution of approximately 80.1% of the outstanding shares of Lumentum common stock to Viavi shareholders who received one share of Lumentum common stock for every five shares of Viavi common stock held as of the close of business on July 27, 2015 (the “Record Date”) and not sold prior to August 4, 2015 (the “ex-dividend date”). In connection with the Separation Viavi agreed to contribute $137.6 million all of which was contributed during fiscal 2016. As of the Distribution, Viavi retained ownership of approximately 19.9%, or 11.7 million shares, of Lumentum’s outstanding common stock. Lumentum was formed to hold Viavi’s CCOP business and the WaveReady product line. As a result of the Distribution, Lumentum is now an independent public company trading under the symbol “LITE” on The Nasdaq Stock Market (“NASDAQ”). The Company agreed not to liquidate the retained shares during the first six months following the Distribution. However, in connection with a private letter ruling from the Internal Revenue Service, the Company committed to liquidate these shares within three years from the Distribution. As of July 1, 2017, the Company had sold all of its ownership of Lumentum’s common stock. Refer to “Note 7. Investments, Forward Contracts and Fair Value Measurements” for more information.

In connection with the Separation, the Company entered into a Contribution Agreement, Separation and Distribution Agreement, a Tax Matters Agreement, Employee Matters Agreement, Securities Purchase Agreement, a Supply Agreement, and an Intellectual Property Matters Agreement with Lumentum and others.

63

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The Contribution Agreement identifies the assets to be transferred, the liabilities to be assumed and the contracts to be assigned and it provides for when and how these transfers, assumptions and assignments will occur.

The Separation and Distribution Agreement governs the separation of the CCOP and WaveReady business, the transfer of assets and other matters related to Viavi’s relationship with Lumentum.

The Tax Matters Agreement governs the respective rights, responsibilities and obligations of Lumentum and Viavi with respect to tax liabilities and benefits, tax attributes, tax contests, tax returns, and certain other tax matters.

The Employee Matters Agreement governs the compensation and employee benefit obligations with respect to the current and former employees and non-employee directors of Lumentum and Viavi, and generally allocates liabilities and responsibilities relating to employee compensation, benefit plans and programs. The Employee Matters Agreement provides that employees of Lumentum will no longer participate in benefit plans sponsored or maintained by Viavi.

The Securities Purchase Agreement with the Company, Lumentum and Amada Holdings Co., Ltd. (“Amada”) set forth terms whereby the Company received 40,000 shares of Lumentum’s Series A Preferred Stock (“Series A Preferred Stock”) pursuant to a binding commitment to sell the Series A Preferred Stock to Amada following the Separation. Upon Separation, in connection with the agreement, during the first quarter of fiscal 2016 the Company sold 35,805 shares of the Series A Preferred Stock to Amada for $35.8 million and the remaining 4,195 shares of the Series A Preferred Stock were canceled. The $35.8 million is included as a part of financing activities in the Statement of Cash Flows.

The Supply Agreement outlines that Viavi will supply test equipment to Lumentum and Lumentum will supply components related to the Company’s metro, fiber and optical product lines and development services related to smart transceivers. The most significant component of the Supply Agreement is $15.0 million related to the sale of certain optical test equipment to Lumentum from the date of the agreement through July 2, 2016, of which the company recorded $14.1 million of net revenue during the fiscal year ended July 2, 2016.

The Intellectual Property Matters Agreement outlines the intellectual property rights and technology transferred to Lumentum upon the Separation, as well as the intellectual property and technology both companies can license from each other. In addition it outlines non-compete restrictions between Viavi and Lumentum.

As the separation of the Lumentum business represented a strategic shift that had and will have a major effect on the Company’s operations and financial results, the results of operations of the Lumentum business are presented separately as discontinued operations for the years endedJuly 1, 2017 , July 2, 2016 and June 27, 2015 in accordance with the authoritative guidance.

As of the Separation Date, Lumentum became a stand-alone public company that separately reports its financial results. Due to the difference between the basis of presentation for discontinued operations and the basis of presentation as a stand-alone company, the financial results of Lumentum included within discontinued operations for the Company may not be indicative of actual financial results of Lumentum as a stand-alone company.

In connection with the Separation, $7.8 million of accumulated other comprehensive loss, net of income taxes, related to foreign currency translation adjustments and the pension plan obligation was transferred to Lumentum on the Separation Date.

The Company also transferred deferred tax assets of $29.5 million, deferred tax liabilities of $1.0 million, current income tax payables of $3.3 million, an income tax receivable of $1.3 million and other long-term liabilities related to uncertain tax positions totaling $0.1 million on the Separation date. The Company utilized approximately $1.0 billion of federal net operating losses to offset income recognized as a result of the Separation and the license of Lumentum’s intellectual property to a foreign subsidiary.

The removal of Lumentum’s net assets and equity related adjustments upon the Separation are presented as an increase of Viavi's accumulated deficit in the Consolidated Statements of Stockholders’ Equity and represents a non-cash financing activity, excluding the cash transferred. Refer to “Note 14. Stock-Based Compensation” for information on modifications to stock-based compensation awards as a result of the Distribution.

64

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following table summarizes results from discontinued operations of the Lumentum business included in the Consolidated Statement of Operations (in millions):

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Net revenues	$	—		$	66.5		$	835.2
Cost of revenues	—			49.8			569.1
Amortization of acquired technologies	—			0.6			7.5
Gross profit	—			16.1			258.6
Operating expenses:
Research and development	—			12.5			139.9
Selling, general and administrative	(0.8		)	24.7			87.5
Restructuring charges	—			0.1			7.7
Total operating expenses	(0.8		)	37.3			235.1
Income (loss) from operations	0.8			(21.2		)	23.5
Interest and other income, net	—			—			(1.1		)
Income (loss) before income taxes	0.8			(21.2		)	22.4
(Benefit from) provision for income taxes	(0.8		)	27.8			(20.9		)
Net income (loss) from discontinued operations (1)	$	1.6		$	(49.0	)	$	43.3

(1)  No income or expense relating to the Lumentum business was recorded after the Separation Date.

During the fiscal year ended July 1, 2017, the Net income from discontinued operations had a benefit of $0.8 million related to the true up of contractual obligations between the company and Lumentum per the Tax Matters Agreement and the Company recognized a tax benefit of $0.8 million relating to the income taxes incurred as a result of the Separation.

During the fiscal year endedJuly 2, 2016, the income tax provision for discontinued operations of $27.8 million included approximately $6.2 million cash taxes that are due to federal and state authorities as a result of the Separation. In addition, approximately $19.0 million of the income tax provision for discontinued operations related to the income tax intraperiod tax allocation rules in relation to continuing operations and other comprehensive income.

Net income (loss) from discontinued operations also includes other costs incurred by the Company to separate Lumentum. These costs include transaction charges, advisory and consulting fees, of $16.5 million and $21.4 million for the years endedJuly 2, 2016 and June 27, 2015, respectively.

The following table presents supplemental cash flow information: depreciation expense, amortization expense, stock-based compensation expense and capital expenditures of the Lumentum business (in millions):

	Years Ended
	July 2, 2016		June 27, 2015
Operating activities:
Depreciation expense	$	3.7	$	43.4
Amortization expense	0.6		7.9
Stock-based compensation expense	1.6		19.4
Investing activities:
Capital expenditures	$	5.8	$	55.9

(1) No depreciation expense, amortization expense, stock based compensation expense and capital expenditures relating to the Lumentum business are presented after the Separation Date.

65

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Note 4. Earnings Per Share

Basic net income (loss) per share is computed by dividing net income (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by dividing net income (loss) for the period by the weighted average number of shares of common stock and potentially dilutive common stock outstanding during the period. The dilutive effect of outstanding ESPP, Full Value Awards, and options is reflected in diluted net income (loss) per share by application of the treasury stock method. The calculation of diluted net income (loss) per share excludes all anti-dilutive common shares.

The following table sets forth the computation of basic and diluted net income (loss) per share (in millions, except per share data):

	Years Ended
	July 1, 2017		July 2, 2016			June 27, 2015
Numerator:
Income (loss) from continuing operations, net of taxes	$	165.3	$	(50.4	)	$	(131.4	)
Income (loss) from discontinued operations, net of taxes	1.6		(48.8		)	43.3
Net income (loss)	$	166.9	$	(99.2	)	$	(88.1	)
Denominator:
Weighted-average number of common shares outstanding
Basic	229.9		234.0			232.7
Effect of dilutive securities from stock-based benefit plans	4.6		—			—
Diluted	234.5		234.0			232.7
Net income (loss) per share from - basic:
Continuing operations	$	0.72	$	(0.22	)	$	(0.57	)
Discontinued operations	0.01		(0.20		)	0.19
Net income (loss)	$	0.73	$	(0.42	)	$	(0.38	)
Net income (loss) per share from - diluted:
Continuing operations	$	0.70	$	(0.22	)	$	(0.57	)
Discontinued operations	0.01		(0.20		)	0.19
Net income (loss)	$	0.71	$	(0.42	)	$	(0.38	)

The following table sets forth the weighted-average potentially dilutive securities excluded from the computation of the diluted net income (loss) per share because their effect would have been anti-dilutive (in millions):

	Years Ended
	July 1, 2017 (2)(3)	July 2, 2016 (1)(2)	June 27, 2015 (1)(2)
Stock options and ESPP	0.9	3.4	3.6
Full Value Awards	0.6	10.9	10.3
Total potentially dilutive securities	1.5	14.3	13.9

(1) As the Company incurred a net loss from continuing operations in the period, potential dilutive securities from employee stock options, employee stock purchase plan (“ESPP”) and restricted stock units (“RSUs”) have been excluded from the diluted net loss per share computations as their effects were deemed anti-dilutive.

(2) The Company’s 0.625% Senior Convertible Notes due 2033 are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $11.28 per share is payable in cash,

66

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

shares of the Company’s common stock or a combination of both at the Company’s election. Refer to “Note 10. Debt” for more details.

(3) The Company’s 1.00% Senior Convertible Notes due 2024 are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $13.22 per share is payable in cash, shares of the Company’s common stock or a combination of both at the Company’s election. Refer to “Note 10. Debt” for more details.

Note 5. Accumulated Other Comprehensive Income (Loss)

 The Company’s accumulated other comprehensive income (loss) consists of the accumulated net unrealized gains and losses on available-for-sale investments, foreign currency translation adjustments and change in unrealized components of defined benefit obligations.

At July 1, 2017 and July 2, 2016, the changes in accumulated other comprehensive income (loss) by component net of tax were as follows (in millions):

	Unrealized gains (losses)  on available-for-sale  investments (1)			Foreign currency translation adjustments			Change in unrealized components of defined benefit obligations, net of tax (2)			Total
Beginning balance as of July 2, 2016	$	104.5		$	(70.1	)	$	(24.4	)	$	10.0
Other comprehensive income before reclassification	92.1			4.8			0.7			97.6
Amounts reclassified from accumulated other comprehensive income (loss)	(201.9		)	—			1.9			(200.0		)
Net current period other comprehensive (loss) income	(109.8		)	4.8			2.6			(102.4		)
Ending balance as of July 1, 2017	$	(5.3	)	$	(65.3	)	$	(21.8	)	$	(92.4	)

(1) Activity before reclassifications to the Consolidated Statements of Operations during the year ended July 1, 2017 primarily relates to a $92.6 million unrealized gain on the marketable equity securities of Lumentum held by Viavi. The amount reclassified out of accumulated other comprehensive income (loss) represents the gross realized gain from available-for-sale securities included as “gain on sale of investments" in the Consolidated Statement of Operations for the year ended July 1, 2017. There was no tax impact for the fiscal year 2017.

(2) Activity before reclassifications to the Consolidated Statements of Operations during the year ended July 1, 2017 relates to the unrealized actuarial gain of $2.1 million, net of income tax expense of $1.4 million. The amount reclassified out of accumulated other comprehensive income (loss) represents the amortization of actuarial losses included as a component of selling, general and administrative expense (“SG&A”) in the Consolidated Statement of Operations for the year ended July 1, 2017. Refer to “Note 15. Employee Pension and Other Benefit Plans” for more details on the computation of net periodic cost for pension plans.

Note 6. Balance Sheet and Other Details

Accounts receivable reserves and allowances

The components of accounts receivable reserves and allowances were as follows (in millions):

	July 1, 2017		July 2, 2016
Allowance for doubtful accounts	$	1.6	$	2.2
Sales allowance	3.4		2.5
Total accounts receivable reserves and allowances	$	5.0	$	4.7

67

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The activities and balances for allowance for doubtful accounts are as follows (in millions):

	Balance at Beginning of Period		Charged to Costs and Expenses			Deduction (1)			Balance at End of Period
Year Ended July 1, 2017	$	2.2	$	(0.2	)	$	(0.4	)	$	1.6
Year Ended July 2, 2016	2.4		0.3			(0.5		)	2.2
Year Ended June 27, 2015	2.9		0.3			(0.8		)	2.4

(1) Represents the effect of currency translation adjustments and write-offs of uncollectible accounts, net of recoveries.

Inventories, net

The components of inventories, net were as follows (in millions):

	July 2, 2016		July 2, 2016
Finished goods	$	24.9	$	29.1
Work in process	10.3		7.5
Raw materials	12.8		14.8
Inventories, net	$	48.0	$	51.4

Prepayments and other current assets

The components of prepayments and other current assets were as follows (in millions):

	July 1, 2017		July 2, 2016
Prepayments	$	8.3	$	10.4
Other current assets	42.5		21.7
Prepayments and other current assets	$	50.8	$	32.1

Property, plant and equipment, net

The components of property, plant and equipment, net were as follows (in millions):

	July 1, 2017			July 2, 2016
Land	$	14.5		$	14.6
Buildings and improvements	31.4			32.4
Machinery and equipment	225.8			218.7
Furniture, fixtures, software and office equipment	111.2			120.5
Leasehold improvements	58.1			54.3
Construction in progress	17.8			10.3
Property, plant and equipment, gross	458.8			450.8
Less: Accumulated depreciation	(321.9		)	(317.8		)
Property, plant and equipment, net	$	136.9		$	133.0

68

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Other current liabilities

The components of other current liabilities were as follows (in millions):

	July 1, 2017		July 2, 2016
Customer prepayments	$	35.2	$	0.4
Restructuring accrual	8.8		13.3
Income tax payable	3.3		3.3
Warranty accrual	2.9		2.6
VAT liabilities	2.2		2.3
Deferred compensation plan	2.0		2.4
Other	7.0		6.7
Other current liabilities	$	61.4	$	31.0

Other non-current liabilities

The components of other non-current liabilities were as follows (in millions):

	July 1, 2017		July 2, 2016
Pension and post-employment benefits	$	99.4	$	103.0
Financing obligation	27.8		28.7
Long-term deferred revenue	14.0		22.7
Other	22.7		24.7
Other non-current liabilities	$	163.9	$	179.1

Interest and other income, net

The components of interest and other income, net were as follows (in millions):

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Interest income	$	11.1		5.9			$	4.6
Foreign exchange gains (loss), net	0.9			(2.6		)	(3.8		)
Proceeds from Nortel (1)	—			—			2.2
Loss on extinguishment of debt (2)	(1.1		)	—			—
Other income (expense), net	2.2			(0.8		)	0.7
Interest and other income, net	$	13.1		$	2.5		$	3.7

(1) During fiscal 2015, the Company received proceeds of $2.2 million from the Fair Fund established to provide compensation for losses incurred in connection with investments in Nortel Networks Corporation (“Nortel”) securities from the SEC’s claims against Nortel.

(2) During fiscal 2017, the Company repurchased $40.0 million aggregate principal amount of the 2033 Notes for $45.4 million in cash. In connection with the repurchase, a loss on extinguishment of $1.1 million was recognized. Refer to “Note 10. Debt” for more information.

69

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Note 7. Investments, Forward Contracts and Fair Value Measurements

Available-For-Sale Investments

The Company’s investments in marketable debt securities were primarily classified as available-for-sale investments. As of July 1, 2017, the Company’s available-for-sale securities were as follows (in millions):

	Amortized Cost/ Carrying Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Available-for-sale securities:
U.S. treasuries	$	56.8	$	—	$	(0.1	)	$	56.7
U.S. agencies	45.0		—		(0.1		)	44.9
Municipal bonds and sovereign debt instruments	4.4		—		—			4.4
Asset-backed securities	71.5		—		(0.4		)	71.1
Corporate securities	326.1		0.1		(0.2		)	326.0
Certificates of deposit	6.0		—		—			6.0
Total available-for-sale securities	$	509.8	$	0.1	$	(0.8	)	$	509.1

The Company generally classifies debt securities as cash equivalents, short-term investments or other non-current assets based on the stated maturities; however, certain securities with stated maturities of longer than twelve months which are highly liquid and available to support current operations are also classified as short-term investments. As of July 1, 2017, of the total estimated fair value, $78.2 million was classified as cash equivalents, $430.2 million was classified as short-term investments and $0.7 million was classified as other non-current assets.

As of July 1, 2017, the Company had sold all of its ownership of Lumentum common stock in connection with the Separation. The Lumentum common stock was previously classified as available-for-sale marketable equity securities. During fiscal 2017, the Company sold 7.2 million Lumentum common shares and recognized gross gains of $203.0 million, reflected in "gain on sale of investments" in the Company’s Consolidated Statements of Operations. The sale resulted in no tax effect. The realized gain is also reflected within the operating activities section of the Consolidated Statements of Cash Flows, while the cash proceeds received are reflected in “sales of available-for-sale investments” within the investing activities section.

 In addition to the amounts presented above, as of July 1, 2017, the Company’s short-term investments classified as trading securities related to the deferred compensation plan were $2.0 million, of which $0.5 million was invested in debt securities, $0.3 million was invested in money market instruments and funds and $1.2 million was invested in equity securities. Trading securities are reported at fair value, with the unrealized gains or losses resulting from changes in fair value recognized in the Company’s Consolidated Statements of Operations as a component of interest and other income, net.

During the year endedJuly 1, 2017, July 2, 2016 and June 27, 2015, the Company recorded no other-than-temporary impairment charges in each respective period.

70

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of July 1, 2017, the Company’s total gross unrealized losses on available-for-sale securities, aggregated by type of investment instrument, were as follows (in millions):

	Less than 12 Months			Greater than 12 Months			Total
U.S. treasuries and agencies	$	(0.2	)	—			$	(0.2	)
Asset-backed securities	(0.1		)	$	(0.3	)	$	(0.4	)
Corporate securities	(0.2		)	—			(0.2		)
Total gross unrealized losses	$	(0.5	)	$	(0.3	)	$	(0.8	)

As of July 1, 2017, contractual maturities of the Company’s debt securities classified as available-for-sale securities were as follows (in millions):

	Amortized Cost/Carrying Cost		Estimated Fair Value
Amounts maturing in less than 1 year	$	365.3	$	365.2
Amounts maturing in 1 - 5 years	143.5		143.2
Amounts maturing in more than 5 years	1.0		0.7
Total debt available-for-sale securities	$	509.8	$	509.1

 As of July 2, 2016, the Company’s available-for-sale securities were as follows (in millions):

	Amortized Cost/ Carrying Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Debt securities:
U.S. treasuries	$	46.1	$	—	$	—		$	46.1
U.S. agencies	24.9		—		—			24.9
Municipal bonds and sovereign debt instruments	2.0		—		—			2.0
Asset-backed securities	50.4		0.1		(0.3		)	50.2
Corporate securities	224.5		0.2		(0.1		)	224.6
Total debt securities	347.9		0.3		(0.4		)	347.8
Marketable equity securities	62.1		109.2		—			171.3
Total available-for-sale securities	$	410.0	$	109.5	$	(0.4	)	$	519.1

 As of July 2, 2016, of the total estimated fair value of debt securities, $36.1 million was classified as cash equivalents, $311.1 million was classified as short-term investments and $0.6 million was classified as other non-current assets.

Marketable equity securities consisted of the Company’s ownership of 7.2 million shares of Lumentum common stock remaining as of July 2, 2016 in connection with the Separation. These securities are stated at fair value, with change in unrealized gains and losses reported in other comprehensive income, net of tax and are classified as short-term investments on the Consolidated Balance Sheet as of July 2, 2016 at $171.3 million. The Company sold 4.5 million Lumentum common shares during the third and fourth quarters of fiscal 2016 and recognized gross realized gain of $71.5 million, reflected in "Gain on sale of investments" in the Company’s Consolidated Statements of Operations. The sale resulted in $2.0 million tax effect related to the intraperiod tax allocation rules. 

In addition to the amounts presented above, as of July 2, 2016, the Company’s short-term investments classified as trading securities, related to the deferred compensation plan, were $2.4 million, of which $0.3 million was invested in debt securities, $0.8 million was invested in money market instruments and funds and $1.3 million was invested in equity securities.

71

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

As of July 2, 2016, the Company’s total gross unrealized losses on available-for-sale securities, aggregated by type of investment instrument, were as follows (in millions):

	Less than 12 Months			Greater than 12 Months			Total
Asset-backed securities	$	—		$	(0.3	)	$	(0.3	)
Corporate securities	(0.1		)	—			(0.1		)
Total gross unrealized losses	$	(0.1	)	$	(0.3	)	$	(0.4	)

Fair Value Measurements

Assets measured at fair value as of July 1, 2017 and July 2, 2016 are summarized below (in millions):

	Fair Value Measurement as of						Fair Value Measurement as of
	July 1, 2017						July 2, 2016
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Debt available-for-sale securities:
U.S. treasuries	$	56.7	$	56.7	$	—	$	46.1	$	46.1	$	—
U.S. agencies	44.9		—		44.9		24.9		—		24.9
Municipal bonds and sovereign debt instruments	4.4		—		4.4		2.0		—		2.0
Asset-backed securities	71.1		—		71.1		50.2				50.2
Corporate securities	326.0		—		326.0		224.6		—		224.6
Certificate of deposits	6.0		—		6.0		—
Total debt available-for-sale securities	509.1		56.7		452.4		347.8		46.1		301.7
Marketable equity securities	—		—		—		171.3		171.3		—
Money market funds	726.4		726.4		—		274.4		274.4		—
Trading securities	2.0		2.0		—		2.4		2.4		—
Foreign currency forward contracts	7.3		—		7.3		—
Total assets (1)	$	1,244.8	$	785.1	$	459.7	$	795.9	$	494.2	$	301.7
Liability:
Foreign currency forward contracts	1.3		—		1.3		—		—		—
Total liabilities (2)	$	1.3	$	—	$	1.3	$	—	$	—	$	—

(1) $789.2 million in cash and cash equivalents, $432.2 million in short-term investments, $11.0 million in restricted cash, $7.3 million in other current assets, and $5.1 million in other non-current assets on the Company’s Consolidated Balance Sheets as of July 1, 2017. $295.4 million in cash and cash equivalents, $484.7 million in short-term investments, $11.3 million in restricted cash, and $4.5 million in other non-current assets on the Company’s Consolidated Balance Sheets as of July 2, 2016.

(2) $1.3 million in other current liabilities on the Company’s Consolidated Balance Sheets as of July 1, 2017.

72

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. There is an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the assumptions about the factors that market participants would use in valuing the asset or liability.

The Company’s cash and investment instruments are classified within Level 1 or Level 2 of the fair value hierarchy based on quoted prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.

• Level 1 includes financial instruments for which quoted market prices for identical instruments are available in active markets. Level 1 assets of the Company include money market funds, U.S. Treasury securities, and marketable equity securities as they are traded with sufficient volume and frequency of transactions. 

• Level 2 includes financial instruments for which the valuations are based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 2 instruments of the Company generally include certain U.S. and foreign government and agency securities, commercial paper, corporate and municipal bonds and notes, asset-backed securities, certificates of deposit, and foreign currency forward contracts. To estimate their fair value, the Company utilizes pricing models based on market data. The significant inputs for the valuation model usually include benchmark yields, reported trades, broker and dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data, and industry and economic events. 

• Level 3 includes financial instruments for which fair value is derived from valuation based on inputs that are unobservable and significant to the overall fair value measurement. As of July 1, 2017 and July 2, 2016, the Company did not hold any Level 3 investment securities.

Non-Designated Foreign Currency Forward Contracts

The Company has foreign subsidiaries that operate and sell the Company’s products in various markets around the world. As a result, the Company is exposed to foreign exchange risks. The Company utilizes foreign exchange forward contracts to manage foreign currency risk associated with foreign currency denominated monetary assets and liabilities, primarily certain short-term intercompany receivables and payables, and to reduce the volatility of earnings and cash flows related to foreign-currency transactions. The Company does not use these foreign currency forward contracts for trading purposes.

As of July 1, 2017, the Company had forward contracts that were effectively closed but not settled with the counterparties by year end. Therefore, the fair value of these contracts of $7.3 million and $1.3 million is reflected as prepayments and other current assets and other current liabilities in the Consolidated Balance Sheets as of July 1, 2017, respectively.

The forward contracts outstanding and not effectively closed, with a term of less than 120 days, were transacted near year end; therefore, the fair value of the contracts is not significant. As of July 1, 2017 and July 2, 2016, the notional amounts of the forward contracts the Company held to purchase foreign currencies were $134.3 million and $110.0 million, respectively, and the notional amounts of forward contracts the Company held to sell foreign currencies were $25.4 million and $55.2 million, respectively.

The change in the fair value of these foreign currency forward contracts is recorded as gain or loss in the Company’s Consolidated Statements of Operations as a component of interest and other income, net. The cash flows related to the settlement of foreign currency forward contracts are classified as operating activities. The foreign exchange forward contracts earned a gain of $3.3 million and incurred a loss of $9.6 million for the years ended July 1, 2017 and July 2, 2016 respectively.

73

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Note 8. Goodwill

The following table presents the changes in goodwill allocated to the Company’s reportable segments (in millions):

	Network Enablement			Service Enablement			Optical Security and Performance Products		Total
Balance as of June 27, 2015 (1)	$	154.5		$	92.7		$	8.3	$	255.5
Goodwill allocation - WaveReady (3)	(6.0		)	—			—		$	(6.0	)
Currency translation and other adjustments	(4.7		)	(1.3		)	—		$	(6.0	)
Goodwill impairment charge	—			(91.4		)	—		(91.4		)
Balance as of July 2, 2016 (2)	$	143.8		$	—		$	8.3	$	152.1
Currency translation	(0.5		)	—			—		$	(0.5	)
Balance as of July 1, 2017 (4)	$	143.3		$	—		$	8.3	$	151.6

(1) Gross goodwill balances for NE, SE and OSP were $456.4 million, $273.9 million and $92.8 million, respectively as of June 27, 2015. Accumulated impairment for NE, SE and OSP was $301.9 million, $181.2 million and $84.5 million, respectively as of June 27, 2015.

(2) Gross goodwill balances for NE, SE and OSP were $445.7 million, $272.6 million and $92.8 million, respectively as of July 2, 2016. Accumulated impairment for NE, SE and OSP was $301.9 million, $272.6 million and $84.5 million, respectively as of July 2, 2016.

(3) Amount represents a release of the relative fair value of goodwill in our NE reporting unit related to the WaveReady products line, which is now a part of Lumentum as of the Separation Date. Refer to “Note 3. Discontinued Operations” for more information about the Separation.

(4) Gross goodwill balances for NE, SE and OSP were $445.2 million, $272.6 million and $92.8 million, respectively as of July 1, 2017. Accumulated impairment for NE, SE and OSP was $301.9 million, $272.6 million and $84.5 million, respectively as of July 1, 2017.

The following table presents gross goodwill and aggregate impairment balances for the fiscal years ended July 1, 2017, and July 2, 2016 (in millions):

	years ended
	July 1, 2017			July 2, 2016
Gross goodwill balance	$	810.6		$	811.1
Accumulated impairment losses	(659.0		)	(659.0		)
Net goodwill balance	$	151.6		$	152.1

Impairment of Goodwill

The Company reviews goodwill for impairment annually during the fourth quarter of the fiscal year or more frequently if events or circumstances indicate that an impairment loss may have occurred. The Company determined that, based on its organizational structure and the financial information that is provided to and reviewed by management during fiscal 2017 and 2016, its reporting units were NE, SE and OSP.

Fiscal 2017

During the fourth quarter of fiscal 2017, the Company early adopted the new authoritative guidance that eliminated the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, any impairment charge would be based on the excess of a reporting unit's carrying amount over its fair value.

During the fourth quarter of fiscal 2017, the Company performed the quantitative goodwill impairment test in accordance with the authoritative guidance for impairment test of the NE reporting unit. The fair value of NE was determined based on a

74

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

combination of the income approach, which estimates the fair value based on the future discounted cash flows, and the market approach, which estimates the fair value based on multiples of earnings or revenue, or a similar performance measure. Based on the first step of the analysis, the Company determined that the fair value of NE is above its carrying amount.

The Company reviewed goodwill of the OSP reporting unit under the qualitative assessment of the authoritative guidance for impairment testing. The Company concluded that it was more likely than not that the fair value of OSP exceeded its carrying amount. In assessing the qualitative factors, the Company considered the impact of key factors, including changes in industry and competitive environment, market capitalization, earnings multiples, budgeted-to-actual operating performance from prior year, and consolidated company stock price and performance. As such, it was not necessary to perform the first step of the goodwill impairment test at this time.

The Company recorded no impairment charge in accordance with its annual impairment test.

Fiscal 2016

Interim Review

During the first quarter of fiscal 2016, the Company released the relative fair value of goodwill in its NE reporting unit related to the WaveReady products line which became part of Lumentum as of the Separation Date. In connection with this change in the NE reporting unit, the Company performed a goodwill impairment test for its NE reporting unit under the qualitative assessment of the authoritative guidance for impairment testing. The Company concluded that it was more likely than not that the fair value of the NE reporting unit exceeded its carrying amount. There were no events or changes in circumstances which triggered an impairment review for the remaining reporting units.

Annual Review

During the fourth quarter the Company performed the goodwill impairment test for all its reporting units under the two-step quantitative goodwill impairment test in accordance with the authoritative guidance. Other than noted above, there were no other triggering events during the interim periods of fiscal 2016. Thus, the Company reviewed goodwill for impairment during the fourth quarter, in line with the completion of its annual operating plan for fiscal 2017.

Under the first step of the authoritative guidance for impairment testing, the fair value of the NE and OSP reporting units was determined based on a combination of the income approach, which estimates the fair value based on the future discounted cash flows, and the market approach, which estimates the fair value based on multiples of earnings or revenue, or a similar performance measure. The market approach estimates the fair value of the business based on a comparison of the reporting unit to comparable publicly traded companies in similar lines of business. Due to lack of comparability with its peer companies, the fair value of the SE reporting unit was determined only utilizing the income approach. The Company assumed a cash flow period of 10 years, long-term annual growth rates of 3.0% to 7.0%, discount rates of 14.0% to 17.0% and terminal value growth rates of 3.0% to 5.0%. The Company believes that the assumptions and rates used in the impairment test are reasonable, but they are judgmental, and variations in any of the assumptions or rates could result in materially different calculations of impairment amounts. The determination of the estimated fair value of goodwill required the use of significant unobservable inputs which are considered Level 3 fair value measurements. The sum of the fair values of the reporting units was reconciled to the Company’s current market capitalization plus an estimated control premium. Based on the first step of the authoritative guidance for impairment testing, the Company concluded that the fair value of all reporting units, except SE, were in excess of their carrying value. The fair value of the SE reporting unit was lower than the carrying value based on the completion of its annual operating plan for fiscal 2017 in the fourth quarter which revealed a longer investment cycle being needed for certain growth products within SE, coupled with a decline in the reporting unit’s revenue and operating profitability in fiscal 2016 as compared to fiscal 2015 when goodwill was last tested for impairment.

The second step of the goodwill impairment test involved performing a hypothetical purchase price allocation to determine the implied fair value of the SE reporting unit’s goodwill. This process is complex and required judgment in the development of assumptions that affected the determination of the fair value of the SE reporting unit’s individual assets and liabilities, including previously unrecognized intangible assets. Based on the step two analysis, the Company determined that all of the SE goodwill balance of $91.4 million was impaired and therefore recorded an impairment charge in the fourth quarter of fiscal 2016 in the accompanying Consolidated Statements of Operations. Prior to completing the goodwill impairment test, the Company tested the recoverability of the SE long-lived assets (other than goodwill) and concluded that such assets were not impaired.

75

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Fiscal 2015

Interim Review

As the Company reorganized its NSE segment into two reportable segments, NE and SE, during the first quarter of fiscal 2015, goodwill allocated to the new NE and SE reporting units was reviewed under the two-step quantitative goodwill impairment test in accordance with the authoritative guidance.

The fair value of the new reporting units was determined based on a combination of the income approach, which estimates the fair value based on the future discounted cash flows, and the market approach, which estimates the fair value based on multiples of earnings or revenue, or a similar performance measure. Based on the first step of the analysis, the Company determined that the fair value of each reporting unit is significantly above its carrying amount. As such, the Company was not required to perform step two of the analysis. The Company recorded no impairment charge as a result of the interim period impairment test performed during the three months ended September 27, 2014. There were no events or changes in circumstances which triggered an impairment review for the remaining reporting units.

Annual Review

During the fourth quarter, the Company reviewed the goodwill of all its reporting units under the qualitative assessment of the authoritative guidance for impairment testing. The Company concluded that it was more likely than not that the fair value of the reporting units with goodwill exceeded its carrying amount. In assessing the qualitative factors, the Company considered the impact of key factors, including changes in industry and competitive environment, budgeted-to-actual operating performance from prior year, and consolidated company stock price and performance. As such, it was not necessary to perform the two-step goodwill impairment test at that time and the Company recorded no impairment charge as a result of its annual impairment test.

Note 9. Acquired Developed Technology and Other Intangibles

The following tables present details of the Company’s acquired developed technology, customer relationships and other intangibles (in millions):

As of July 1, 2017	Gross Carrying Amount		Accumulated Amortization			Net
Acquired developed technology	$	369.3	$	(352.0	)	$	17.3
Customer relationships	94.9		(81.3		)	13.6
Other (1)	9.9		(9.7		)	0.2
Total intangibles	$	474.1	$	(443.0	)	$	31.1

As of July 2, 2016	Gross Carrying Amount		Accumulated Amortization			Net
Acquired developed technology	$	369.3	$	(337.3	)	$	32.0
Customer relationships	95.6		(68.0		)	27.6
Other (1)	10.8		(10.5		)	0.3
Total intangibles	475.7		(415.8		)	59.9

(1) Other intangibles consist of customer backlog, non-competition agreements, patents, proprietary know-how and trade secrets, trademarks and trade names.

Fiscal 2016

During the first quarter of fiscal 2016, the Company completed its in-process research and development (“IPR&D”) project related to the fiscal 2014 acquisition of Trendium. Accordingly, $1.8 million was transferred from indefinite life intangible assets to acquired developed technology intangible assets with a useful life of thirty-six months.

Fiscal 2015

76

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

During fiscal 2015, the Company completed its IPR&D project related to the fiscal 2014 acquisition of Network Instruments. Accordingly, $1.7 million was transferred from indefinite life intangible assets to acquired developed technology intangible assets and the Company began amortizing over its useful life of fifty-two months. Also during fiscal 2015, the Company recorded a $3.6 million IPR&D impairment charge for an ongoing project related to the fiscal 2014 acquisition of Trendium in accordance with the authoritative accounting guidance. The charge was recorded to Research and development (“R&D”) expense in the Consolidated Statements of Operations.

During fiscal 2017, 2016 and 2015, the Company recorded $28.3 million, $31.9 million and $51.4 million, respectively, of amortization related to acquired developed technology and other intangibles. The following table presents details of the Company’s amortization (in millions):

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Cost of revenues	$	14.3	$	17.3	$	31.9
Operating expense	14.0		14.6		19.5
Total	$	28.3	$	31.9	$	51.4

Based on the carrying amount of acquired developed technology, customer relationships and other intangibles as of July 1, 2017, and assuming no future impairment of the underlying assets, the estimated future amortization is as follows (in millions):

Fiscal Years
2018	$	20.1
2019	9.3
2020	1.4
2021	0.3
Total amortization	$	31.1

Note 10. Debt

As of July 1, 2017 and July 2, 2016, the Company’s long-term debt on the Consolidated Balance Sheets represented the carrying amount of the liability component, net of unamortized debt discounts and issuance cost, of the Senior Convertible Notes as discussed below. The following table presents the carrying amounts of the liability and equity components (in millions):

	July 1, 2017			July 2, 2016
Principal amount of 0.625% Senior Convertible Notes	$	610.0		$	650.0
Principal amount of 1.00% Senior Convertible Notes	460.0			—
Unamortized discount of liability component	(129.4		)	(61.7		)
Unamortized debt issuance cost (1)	(9.2		)	(5.0		)
Carrying amount of liability component	$	931.4		$	583.3
Carrying amount of equity component (2)	$	229.7		$	134.4

(1) In April 2015, the Financial Accounting Standards Board ("FASB") issued new authoritative guidance to simplify the presentation of debt issuance costs by requiring debt issuance costs to be presented as a deduction from the corresponding liability, consistent with debt discounts or premiums. This guidance was effective for the Company in the first quarter of fiscal 2017 for its convertible debt, and was applied retrospectively for all periods reported.

(2) Included in additional paid-in-capital on the Consolidated Balance Sheets.

The Company was in compliance with all debt covenants and held no short term debt as of July 1, 2017 and July 2, 2016.

1.00% Senior Convertible Notes (“2024 Notes”)

77

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

On March 3, 2017, the Company issued $400 million aggregate principal amount of 1.00% Senior Convertible Notes due 2024 (the “2024 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. On March 22, 2017, the Company issued an additional $60 million upon exercise of the over-allotment option of the initial purchasers. The total proceeds from the 2024 Notes amounted to $451.1 million after issuance costs. The 2024 Notes are an unsecured obligation of the Company and bear interest at an annual rate of 1.00% payable in cash semi-annually in arrears on March 1 and September 1 of each year. The 2024 Notes mature on March 1, 2024 unless earlier converted or repurchased.

Under certain circumstances and during certain periods, the 2024 Notes may be converted at the option of the holders into cash up to the principal amount, with the remaining amount converted into cash, shares of the Company’s common stock, or a combination of cash and shares of the Company’s common stock at the Company’s election. The initial conversion price is $13.22 per share, representing a 32.5% premium to the closing sale price of the Company’s common stock on the pricing date, February 27, 2017, which will be subject to customary anti-dilution adjustments.

The 2024 Notes may be converted at any time on or prior to the close of business on the business day immediately preceding December 1, 2023, in multiples of $1,000 principal amount, at the option of the holder only under the following circumstances: (i) on any date during any calendar quarter beginning after June 30, 2017 (and only during such calendar quarter) if the closing price of Viavi’s common stock was more than 130% of the then current conversion price for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading-day period ending on the last trading day of the previous calendar quarter, (ii)if the Company distributes to all or substantially all holders of our common stock rights or warrants (other than pursuant to a stockholder rights plan) entitling them to purchase, for a period of 45 calendar days or less, shares of our common stock at a price less than the average closing sale price of our common stock for the ten trading days preceding the declaration date for such distribution, (iii) if the Company distributes to all or substantially all holders of our common stock, cash or other assets, debt securities or rights to purchase our securities (other than pursuant to a stockholder rights plan), at a per share value exceeding 10% of the closing sale price of our common stock on the trading day preceding the declaration date for such distribution, (iv) if the Company is party to a specified transaction, a fundamental change or a make-whole fundamental change (each as defined in the Indenture), or (v) during the five consecutive business-day period immediately following any 10 consecutive trading-day period in which the trading price per $1,000 principal amount of the Notes for each day during such 10 consecutive trading-day period was less than 98% of the product of the closing sale price of Viavi’s common stock and the applicable conversion rate on such date. During the periods from, and including, December 1, 2023 until the close of business on the business day immediately preceding the maturity date, holders of the Notes may convert the Notes regardless of the circumstances described in the immediately preceding sentence.

Holders of the 2024 Notes may require Viavi to repurchase for cash all or a portion of the Notes upon the occurrence of a fundamental change (as defined in the Indenture) at a repurchase price equal to 100% of the principal amount of the 2024 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the date of repurchase.

The Indenture provides for customary events of default, including payment defaults, breaches of covenants, failure to pay certain judgments and certain events of bankruptcy, insolvency and reorganization. If an event of default occurs and is continuing, the principal amount of the 2024 Notes, plus accrued and unpaid interest, if any, may be declared immediately due and payable, subject to certain conditions set forth in the Indenture. These amounts automatically become due and payable if an event of default relating to certain events of bankruptcy, insolvency or reorganization occurs.

In accordance with the authoritative accounting guidance, the Company separated the 2024 Notes into liability and equity components. The carrying value of the liability component at issuance was calculated as the present value of its cash flows using a discount rate of 4.8% based on the 7-year swap rate plus credit spread as of the issuance date. The credit spread for the Company is based on the historical average “yield to worst” rate for BB rated issuers. The difference between the 2024 Notes principal and the carrying value of the liability component, representing the value of conversion premium assigned to the equity component, was recorded as a debt discount on the issuance date and is being accreted using the effective interest rate of 4.8% over the period from the issuance date through March 1, 2024 as a non-cash charge to interest expense. The carrying value of the liability component was determined to be $358.1 million, and the equity component, or debt discount, of the 2024 Notes was determined to be $101.9 million. As of July 1, 2017, the expected remaining term of the 2024 Notes is 6.7 years.

In connection with the issuance of the 2024 Notes, the Company incurred $8.9 million of issuance costs, which were bifurcated into the debt issuance costs (attributable to the liability component) of $6.9 million and the equity issuance costs (attributable to the equity component) of $2.0 million based on their relative values. The debt issuance costs were capitalized and are being amortized to interest expense using the effective interest rate method from issuance date through March 1, 2024. The equity issuance costs were netted against the equity component in additional paid-in capital at the issuance date. As of July 1, 2017, the unamortized

78

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

portion of the debt issuance costs related to the 2024 Notes was $6.6 million, which was included as a direct reduction from the carrying amount of the debt on the Consolidated Balance Sheets.

Based on quoted market prices as of July 1, 2017, the fair value of the 2024 Notes was approximately $481.7 million. The 2024 Notes are classified within Level 2 as they are not actively traded in markets.

0.625% Senior Convertible Notes (“2033 Notes”)

On August 21, 2013, the Company issued $650.0 million aggregate principal amount of 0.625% Senior Convertible Notes due 2033 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The proceeds from the 2033 Notes amounted to $636.3 million after issuance costs. The 2033 Notes are an unsecured obligation of the Company and bear interest at an annual rate of 0.625% payable in cash semi-annually in arrears on February 15 and August 15 of each year. The 2033 Notes mature on August 15, 2033 unless earlier converted, redeemed or repurchased.

Under certain circumstances and during certain periods, the 2033 Notes may be converted at the option of the holders into cash up to the principal amount, with the remaining amount converted into cash, shares of the Company’s common stock, or a combination of cash and shares of the Company’s common stock at the Company’s election. The initial conversion price is $18.83 per share, representing a 40.0% premium to the closing sale price of the Company’s common stock on the pricing date, August 15, 2013, which will be subject to customary anti-dilution adjustments. Holders may convert the 2033 Notes at any time on or prior to the close of business on the business day immediately preceding February 15, 2033, and other than during the period from, and including, February 15, 2018 until the close of business on the business day immediately preceding August 20, 2018, in multiples of $1,000 principal amount, under the following circumstances:

• on any date during any calendar quarter beginning after December 31, 2013 (and only during such calendar quarter) if the closing price of the Company’s common stock was more than 130% of the then current conversion price for at least 20 trading days during the 30 consecutive trading-day period ending the last trading day of the previous calendar quarter; 

• if the 2033 Notes are called for redemption; 

• upon the occurrence of specified corporate events; 

• if the Company is party to a specified transaction, a fundamental change or a make-whole fundamental change (each as defined in the indenture of the 2033 Notes); or 

• during the five consecutive business-day period immediately following any 10 consecutive trading-day period in which the trading price per $1,000 principal amount of the 2033 Notes for each day of such 10 consecutive trading-day period was less than 98% of the product of the closing sale price of the Company’s common stock and the applicable conversion rate on such date.

During the periods from, and including, February 15, 2018 until the close of business on the business day immediately preceding August 20, 2018 and from, and including, February 15, 2033 until the close of business on the business day immediately preceding the maturity date, holders may convert the 2033 Notes at any time, regardless of the foregoing circumstances.

In the fourth quarter of fiscal 2015, holders of the 2033 Notes were given notice of the planned separation of the Lumentum business and the right to convert any debentures they own from the date of notice through the end of the business day preceding the ex-dividend date. No holders of the 2033 Notes exercised the conversion right before it expired.

Following the separation of the Lumentum business on August 1, 2015, the conversion price per share was adjusted pursuant to the terms of the 2033 Notes relating to the occurrence of a spin-off event. Effective as of the end of the business day on August 17, 2015, the initial conversion price per share was adjusted to $11.28 per share of the Company’s common stock traded on NASDAQ under the ticker symbol “VIAV.”

Holders of the 2033 Notes may require the Company to purchase all or a portion of the 2033 Notes on each of August 15, 2018, August 15, 2023 and August 15, 2028, or upon the occurrence of a fundamental change, in each case, at a price equal to 100% of the principal amount of the 2033 Notes to be purchased, plus accrued and unpaid interest to, but excluding the purchase date. The Company may redeem all or a portion of the 2033 Notes for cash at any time on or after August 20, 2018, at a redemption price equal to 100% of the principal amount of the 2033 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.

79

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

In accordance with the authoritative accounting guidance, the Company separated the 2033 Notes into liability and equity components. The carrying value of the liability component at issuance was calculated as the present value of its cash flows using a discount rate of 5.4% based on the 5-year swap rate plus credit spread as of the issuance date. The credit spread for the Company is based on the historical average “yield to worst” rate for BB rated issuers. The difference between the 2033 Notes principal and the carrying value of the liability component, representing the value of conversion premium assigned to the equity component, was recorded as a debt discount on the issuance date and is being accreted using the effective interest rate of 5.4% over the period from the issuance date through August 15, 2018 as a non-cash charge to interest expense. The carrying value of the liability component was determined to be $515.6 million, and the equity component, or debt discount, of the 2033 Notes was determined to be $134.4 million. As of July 1, 2017, the expected remaining term of the 2033 Notes is 1.1 years.

In connection with the issuance of the 2033 Notes, the Company incurred $13.7 million of issuance costs, which were bifurcated into the debt issuance costs, attributable to the liability component of $10.9 million and the equity issuance costs, attributable to the equity component of $2.8 million based on their relative values. The debt issuance costs were capitalized and are being amortized to interest expense using the effective interest rate method from issuance date through August 15, 2018. The equity issuance costs were netted against the equity component in additional paid-in capital at the issuance date. As of July 1, 2017, the unamortized portion of the debt issuance costs related to the 2033 Notes was $2.6 million, which was included as a direct reduction from the carrying amount of the debt on the Consolidated Balance Sheets.

During fiscal 2017, the Company repurchased $40.0 million aggregate principal amount of the notes for $45.4 million in cash. In connection with the repurchase, a loss on extinguishment of $1.1 million was recognized in interest and other income, net in compliance with the authoritative guidance. After giving effect to the repurchase, the total amount of 0.625% Senior Convertible Notes outstanding as of July 1, 2017 was $610.0 million.

Based on quoted market prices as of July 1, 2017 and July 2, 2016, the fair value of the 2033 Notes was approximately $676.1 million and $633.0 million. The 2033 Notes are classified within Level 2 as they are not actively traded in markets.

Interest Expense

The following table presents the interest expense for contractual interest, amortization of debt issuance cost and accretion of debt discount (in millions):

	Years ended
	July 1, 2017		July 2, 2016
Interest expense-contractual interest	$	5.5	$	4.1
Amortization of debt issuance cost	2.5		2.1
Accretion of debt discount	32.1		26.7

80

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Note 11. Restructuring and Related Charges

The Company has initiated various strategic restructuring events primarily intended to reduce its costs, consolidate its operations, rationalize the manufacturing of its products and align its businesses in response to market conditions. As of July 1, 2017 and July 2, 2016, the Company’s total restructuring accrual was $11.0 million and $18.0 million, respectively. During fiscal years 2017, 2016 and 2015 the Company recorded restructuring and related charges of $21.6 million, $10.5 million and $26.8 million, respectively. The Company’s restructuring charges can include severance and benefit costs to eliminate a specified number of positions, facilities and equipment costs to vacate facilities and consolidate operations, and lease termination costs. The timing of associated cash payments is dependent upon the type of restructuring charge and can extend over multiple periods.

Summary of Restructuring Plans

The adjustments to the accrued restructuring expenses related to all of the Company’s restructuring plans described below for the fiscal year endedJuly 1, 2017 were as follows (in millions):

	Balance as of July 2, 2016		Fiscal Year 2017 Charges (Releases)			Cash Settlements			Non-cash Settlements and Other Adjustments			Balance as of July 1, 2017
Fiscal 2017 Plan
OSP Restructuring Plan (1)	$	—	$	0.8		$	—		$	—		$	0.8
Focused NSE Restructuring Plan (1) (2)	—		21.3			(16.5		)	0.1			4.9
Other Plans (2)	—		0.4			(0.4		)	—			—
Fiscal 2016 Plan
NE, SE and Shared Services Agile Restructuring Plan (1) (2)	8.6		(0.7		)	(7.7		)	—			0.2
NE and SE Agile Restructuring Plan (1)	0.8		(0.1		)	(0.3		)	—			0.4
Fiscal 2015 Plan
NE, SE and Shared Service Separation Restructuring Plan (1) (2)	1.4		(0.2		)	(1.1		)	—			0.1
Plans Prior to Fiscal 2015
NE Product Strategy Restructuring Plan (1)	1.5		—			(0.5		)	(0.1		)	0.9
NE Lease Restructuring Plan (2)	4.0		0.1			(1.5		)	—			2.6
Other Plans (1) (2)	1.7		—			(0.6		)	—			1.1
Total	$	18.0	$	21.6		$	(28.6	)	$	—		$	11.0

(1) Plan type includes workforce reduction cost.

(2) Plan type includes lease exit cost.

As of July 1, 2017 and July 2, 2016, $2.2 million and $4.7 million, respectively, of our restructuring liability was long-term in nature and included as a component of Other non-current liabilities, with the remaining short-term portion included as a component of Other current liabilities on the Consolidated Balance Sheets.

Fiscal 2017 Plans

OSP Restructuring Plan

During the fourth quarter of fiscal 2017, Management approved a plan within the OSP business segment to realign its operations and exit from the printed security product portfolio. As a result, a restructuring charge of $0.8 million was recorded for severance and employee benefits for approximately 30 employees in manufacturing and SG&A functions locatedin the United States. Payments related to the severance and benefits accrual are expected to be paid by the end of the third quarter of fiscal 2018.

Focused NSE Restructuring Plan

81

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

During the third and second quarters of fiscal 2017, Management approved a plan within the NE and SE business segments as part of Viavi’s continued strategy to improve profitability in the Company’s Network and Service Enablement (NSE) business by narrowing the scope of the Service Enablement business and reducing costs by streamlining NSE operations. As a result, a restructuring charge of $21.0 million was recorded for severance and employee benefits for approximately 300 employees in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia. Payments related to the severance and benefits accrual are expected to be paid in the second quarter of fiscal 2018.

Fiscal 2016 Plans

NE, SE and Shared Service Agile Restructuring Plan

During the fourth quarter of fiscal 2016, Management approved a plan within the NE and SE business segment and Shared Services function for organizational alignment and consolidation as part of the Company’s continued commitment for a more cost effective organization. As a result, approximately 170 employees primarily in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the first quarter of fiscal 2018.

NE and SE Agile Restructuring Plan

During the second quarter of fiscal 2016, Management approved a plan primarily impacting the NE and SE business segments as part of Company’s ongoing commitment for an agile and more efficient operating structure. As a result, approximately 40 employees primarily in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the second quarter of fiscal 2018.

Fiscal 2015 Plans

NE, SE and Shared Service Separation Restructuring Plan

During the second, third and fourth quarters of fiscal 2015, Management approved a plan to eliminate certain positions in its shared services functions in connection with the Company’s plan to split into two separate public companies. Further, Management consolidated its operations, sales and R&D organizations and eliminated positions within the NE and SE segments to align to the Company’s product market strategy and lower manufacturing costs in connection with the Separation. As a result, approximately 330 employees in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the third quarter of fiscal 2018. During the fourth quarter of fiscal 2015, Management also approved a plan in the NE and SE segment to exit the space in Roanoke, Virginia. As of July 2, 2016, the Company exited the workspace in Roanoke under the plan and all payment were paid by the end of the fourth quarter of fiscal 2017.

Plans Prior to Fiscal 2015

NE Product Strategy Restructuring Plan

During the third quarter of fiscal 2014, Management approved a NE plan to realign its services, support and product resources in response to market conditions in the mobile assurance market and to increase focus on software products and next generation solutions through acquisitions and R&D. As a result, approximately 60 employees primarily in SG&A and manufacturing functions located in North America, Latin America, Asia and Europe were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the first quarter of fiscal 2020.

NE Lease Restructuring Plan

During the second quarter of fiscal 2014, Management approved a NE plan to exit the remaining space in Germantown, Maryland. As of June 28, 2014, the Company exited the space in Germantown under the plan. The fair value of the remaining contractual obligations, net of sublease income, as of July 1, 2017 was $2.6 million. Payments related to the Germantown lease costs are expected to be paid by the end of the second quarter of fiscal 2019.

As of July 1, 2017, the restructuring accrual for other plans that commenced prior to fiscal year 2015 was $1.1 million, which consists of immaterial accruals from various restructuring plans.

82

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Note 12. Income Taxes

The Company’s income (loss) before income taxes consisted of the following (in millions):

	Years Ended
	July 1, 2017		July 2, 2016			June 27, 2015
Domestic	$	94.7	$	(110.9	)	$	(173.1	)
Foreign	91.9		65.0			67.8
Income (loss) before income taxes	$	186.6	$	(45.9	)	$	(105.3	)

The Company’s income tax expense (benefit) consisted of the following (in millions):

	Years Ended
	July 1, 2017		July 2, 2016			June 27, 2015
Federal:
Current	$	—	$	—		$	0.1
Deferred	1.0		(26.2		)	2.3
	1.0		(26.2		)	2.4
State:
Current	0.2		—			(0.1		)
Deferred	—		(1.5		)	0.1
	0.2		(1.5		)	—
Foreign:
Current	18.0		21.3			17.9
Deferred	2.1		10.9			5.8
	20.1		32.2			23.7
Total income tax expense	$	21.3	$	4.5		$	26.1

The federal deferred tax expense primarily relates to the amortization of tax deductible goodwill. The foreign current expense primarily relates to the Company’s profitable operations in certain foreign jurisdictions. The foreign deferred tax expense primarily relates to the use of deferred tax assets in profitable foreign jurisdictions.

There was no material tax benefit associated with exercise of stock options for the fiscal years ended July 1, 2017, July 2, 2016 and June 27, 2015.

83

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

A reconciliation of the Company’s income tax expense (benefit) at the federal statutory rate to the income tax expense at the effective tax rate is as follows (in millions):

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Income tax expense (benefit) computed at federal statutory rate	$	65.3		$	(16.1	)	$	(36.8	)
Goodwill impairment	—			19.4			—
Intraperiod allocation	—			(20.7		)	—
Foreign rate differential	(6.6		)	(2.0		)	(2.3		)
Valuation allowance	(27.4		)	18.2			56.7
Research and experimentation benefits and other tax credits	(1.4		)	(1.1		)	(0.9		)
Reversal of previously accrued taxes	(0.2		)	—			(0.8		)
Permanent items	(9.1		)	6.7			8.0
Other	0.7			0.1			2.2
Income tax expense	$	21.3		$	4.5		$	26.1

The components of the Company’s net deferred taxes consisted of the following (in millions):

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Gross deferred tax assets:
Tax credit carryforwards	$	150.6		$	141.0		$	131.4
Net operating loss carryforwards	1,875.4			1,846.3			2,226.1
Capital loss carryforwards	102.4			145.9			4.1
Inventories	5.4			6.1			6.7
Accruals and reserves	30.3			27.4			30.2
Investments	0.7			34.4			0.7
Other	51.9			60.3			55.5
Acquisition-related items	55.5			65.2			59.9
Gross deferred tax assets	2,272.2			2,326.6			2,514.6
Valuation allowance	(2,097.8		)	(2,174.3		)	(2,334.5		)
Deferred tax assets	174.4			152.3			180.1
Gross deferred tax liabilities:
Acquisition-related items	(6.5		)	(13.2		)	(20.9		)
Undistributed foreign earnings	(3.0		)	—			(4.7		)
Other	(57.3		)	(31.1		)	(44.5		)
Deferred tax liabilities	(66.8		)	(44.3		)	(70.1		)
Total net deferred tax assets	$	107.6		$	108.0		$	110.0

As of July 1, 2017, the Company had federal, state and foreign tax net operating loss carryforwards of $5,115.1 million, $762.2 million and $624.0 million, respectively, and federal, state and foreign research and other tax credit carryforwards of $103.9 million, $40.7 million and $1.4 million, respectively. Under current guidance, approximately $117.7 million of the net operating losses when realized, would have been credited to additional paid-in capital. The Company’s policy is to account for the utilization of tax attributes under a with-and-without approach. Upon the Company’s adoption of the new guidance on share-based payment awards in fiscal 2018, we expect our deferred tax assets related to the $117.7 million net operating losses to increase which will

84

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

be offset by a corresponding increase in our valuation allowance. The tax net operating loss, tax credit and capital loss carryforwards will start to expire in calendar 2018 and at various other dates through 2037 if not utilized. Utilization of the tax net operating losses may be subject to a substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code and similar state and foreign provisions. Loss carryforward limitations may result in the expiration or reduced utilization of a portion of the Company’s net operating losses.

U.S. income and foreign withholding taxes associated with the repatriation of earnings of foreign subsidiaries have not been provided on $373.3 million of undistributed earnings for certain foreign subsidiaries. The Company intends to reinvest these earnings indefinitely outside of the United States. The Company estimates that an additional $21.5 million of U.S. income or foreign withholding taxes would have to be provided if these earnings were repatriated back to the U.S.

The valuation allowance decreased by $76.5 million in fiscal 2017, decreased by $160.2 million in fiscal 2016, and increased by $12.7 million in fiscal 2015. The decrease during fiscal 2017 was primarily due to the utilization of deferred tax assets and the increase in deferred tax liabilities as result of the issuance of convertible debt. The decrease during fiscal 2016 was primarily related to the Lumentum transaction. The increase during fiscal 2015 was primarily related to an increase in the deferred tax assets and intangible amortization. The following table provides information about the activity of our deferred tax valuation allowance (in millions):

Deferred Tax Valuation Allowance	Balance at Beginning of Period		Additions Charged to Expenses or Other Accounts(1)		Deductions Credited to Expenses or Other Accounts(2)			Balance at End of Period
Year Ended July 1, 2017	$	2,174.3	$	44.7	$	(121.2	)	$	2,097.8
Year Ended July 2, 2016	$	2,334.5	$	227.5	$	(387.7	)	$	2,174.3
Year Ended June 27, 2015	$	2,321.8	$	39.5	$	(26.8	)	$	2,334.5

(1) Additions include current year additions charged to expenses and current year build due to increases in net deferred tax assets, return to provision true-ups, other adjustments.

(2) Deductions include current year releases credited to expenses and current year reductions due to decreases in net deferred tax assets, return to provision true-ups, other adjustments and increases in deferred tax liabilities.

Under current guidance, approximately $514.7 million of the valuation allowance as of July 1, 2017 was attributable to pre-fiscal 2006 windfall stock option deductions, the benefit of which would have been credited to paid-in-capital if and when realized through a reduction in income tax payable. Beginning with fiscal 2006, the Company began to track the windfall stock option deductions off-balance sheet. If and when realized, the tax benefit associated with those deductions would have been credited to additional paid-in-capital. Upon the Company’s adoption of the new guidance on share-based payment awards in fiscal 2018, the benefit if realized will no longer be credited to additional paid-in capital.

During fiscal 2016, the Company recognized a tax expense of $8.9 million related to a one-time increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the Separation. The tax expense was partially offset by a deferred tax benefit of $9.5 million related to the write off of tax deductible goodwill and a tax benefit of $20.7 million related to the income tax intraperiod tax allocation rules for discontinued operations and other comprehensive income.

85

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

A reconciliation of unrecognized tax benefits between June 28, 2014 and July 1, 2017 is as follows (in millions):

Balance at June 28, 2014	$	38.3
Additions based on tax positions related to current year	1.9
Reductions for lapse of statute of limitations	(3.3		)
Reductions due to foreign currency rate fluctuations	(0.1		)
Balance at June 27, 2015	36.8
Additions based on tax positions related to current year	5.1
Reductions for lapse of statute of limitations	(0.2		)
Balance at July 2, 2016	41.7
Additions based on tax positions related to current year	1.6
Additions based on tax positions related to prior year	0.9
Reduction based on tax positions related to prior year	(3.5		)
Reductions for lapse of statute of limitations	(1.8		)
Balance at July 1, 2017	$	38.9

The unrecognized tax benefits relate primarily to the allocations of revenue and costs among the Company’s global operations and the validity of some U.S. tax credits. Included in the balance of unrecognized tax benefits at July 1, 2017 are $3.0 million of tax benefits that, if recognized, would impact the effective tax rate. Also included in the balance of unrecognized tax benefits at July 1, 2017 are $36.0 million of tax benefits that, if recognized, would result in adjustments to the valuation allowance and are included in deferred taxes and other non-current tax liabilities, net in the Consolidated Balance Sheets.

The Company’s policy is to recognize accrued interest and penalties related to unrecognized tax benefits within the income tax provision. The amount of interest and penalties accrued as of July 1, 2017 and July 2, 2016 was approximately $1.8 million and $1.7 million, respectively. During fiscal 2017, the Company’s accrued interest and penalties increased by $0.1 million primarily relating to the lapse of statute in a non-US jurisdiction. The unrecognized tax benefits that may be recognized during the next twelve months is approximately $0.1 million.

The Company is routinely subject to various federal, state and foreign audits by taxing authorities. The Company believes that adequate amounts have been provided for any adjustments that may result from these examinations.

The following table summarizes the Company’s major tax jurisdictions and the tax years that remain subject to examination by such jurisdictions as of July 1, 2017:

Tax Jurisdictions	Tax Years
United States	2014 and onward
Canada	2016 and onward
China	2012 and onward
France	2014 and onward
Germany	2014 and onward
Korea	2012 and onward
United Kingdom	2016 and onward

Note 13. Stockholders' Equity

Repurchase of Common Stock

Fiscal 2017

In September 2016, the Board of Directors increased the Company’s previously authorized stock repurchase program from $100 million to $150 million. Under the revised repurchase authorization, the Company may repurchase up to $150 million of

86

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

the Company’s common stock from time to time at the discretion of the Company’s management. This stock repurchase authorization expires on December 31, 2017.

During fiscal 2017, the Company repurchased approximately 10.5 million shares of common stock in open market purchases at an average price of $8.75 per share under the stock repurchase program authorized on February 1, 2016. The total purchase price of these repurchases under the stock repurchase program of $92.0 million was reflected as a decrease to common stock based on the stated par value per share with the remainder charged to accumulated deficit.

Fiscal 2016

In November 2015, the Company entered into a $40.0 million accelerated share repurchase agreement (the “ASR”) with a financial institution that was completed during the third quarter of fiscal 2016. Upon making the upfront payment of $40.0 million, the Company received an initial delivery of 5.3 million shares from the financial institution during the second quarter of fiscal 2016, which were retired and recorded as a $32.0 million reduction to stockholder’s equity on the Consolidated Balance Sheet. During the third quarter of fiscal 2016 the ASR was completed and an additional 1.3 million shares were delivered from the financial institution, based on the final settlement price of $6.05 per share, which were retired and recorded as an $8.0 million reduction to stockholder’s equity on the Consolidated Balance Sheet. The Company reflects the repurchase of common stock under the ASR in the period the shares are delivered for the purposes of calculating earnings per share.

On February 1, 2016, the Company’s Board of Directors authorized a stock repurchase program under which the Company may purchase shares of its common stock worth up to an aggregate purchase price of $100.0 million through open market or private transactions between February 1, 2016 and February 1, 2017. During the fourth quarter of fiscal 2016, the Company repurchased approximately 0.7 million shares of common stock in open market purchases at an average price of $6.60 per share under the stock repurchase program authorized on February 1, 2016. The total purchase price of these repurchases under the stock repurchase program of $4.5 million was reflected as a decrease to common stock based on the stated par value per share with the remainder charged to accumulated deficit.

Fiscal 2015

During the first quarter of fiscal 2015, the Company repurchased approximately 0.4 million shares of common stock in open market purchases at an average price of $11.93 per share under the stock repurchase program authorized on May 21, 2014. The total purchase price of these repurchases under the stock repurchase program of $60.0 million was reflected as a decrease to common stock based on the stated par value per share with the remainder charged to accumulated deficit.

All common shares repurchased during fiscal 2017, 2016 and 2015 under this program have been canceled and retired.

Preferred Stock

The Company’s Board of Directors has authority to issue up to 1,000,000 shares of undesignated preferred stock and to determine the powers, preferences and rights and the qualifications, limitations or restrictions granted to or imposed upon any wholly unissued shares of undesignated preferred stock and to fix the number of shares constituting any series and the designation of such series, without the consent of the Company’s stockholders. The preferred stock could be issued with voting, liquidation, dividend and other rights superior to those of the holders of common stock. Subsequent issuance of any preferred stock by the Company’s Board of Directors, under some circumstances, could have the effect of delaying, deferring or preventing a change in control.

Note 14. Stock-Based Compensation

Stock-Based Benefit Plans

Stock Option Plans

As of July 1, 2017, the Company had 8.8 million shares of stock options and Full Value Awards issued and outstanding to employees and directors under the Restated 2005 Acquisition Equity Incentive Plan (“the 2005 Plan”), Restated 2003 Equity Incentive Plan (“the 2003 Plan”), inducement grants in connection with the appointment of our new CEO in fiscal 2016 and various other plans the Company assumed through acquisitions. The exercise price for stock options is equal to the fair value of the underlying stock at the date of grant. The Company issues new shares of common stock upon exercise of stock options. Options generally become exercisable over a three- or four-year period and, if not exercised, expire from five to ten years after the date of grant.

87

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

On November 14, 2012, the Company’s shareholders approved two amendments to the 2003 Plan. The first amendment increased the number of shares that may be issued under this plan by 10,000,000 shares. The second amendment extended the 2003 Plan’s terms for an additional ten year period after the date of approval of the amendment. On December 5, 2014, the Company’s shareholders approved another amendment to the 2003 Plan to increase the number of shares that may be issued under the plan by 9,000,000 shares. On August 1, 2015, following the Separation, the number of shares available for grant and all outstanding awards were automatically adjusted pursuant to the terms of the 2003 Plan and the 2005 Plan.

As of July 1, 2017, 15.4 million shares of common stock, primarily under the 2003 Plan and the 2005 Plan, were available for grant.

Employee Stock Purchase Plans

In June 1998, the Company adopted the 1998 Employee Stock Purchase Plan, as amended (the “1998 Purchase Plan”). The 1998 Purchase Plan, which became effective August 1, 1998, provides eligible employees with the opportunity to acquire an ownership interest in the Company through periodic payroll deductions and provides a discounted purchase price as well as a look-back period. The 1998 Purchase Plan is structured as a qualified employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986. However, the 1998 Purchase Plan is not intended to be a qualified pension, profit sharing or stock bonus plan under Section 401(a) of the Internal Revenue Code of 1986 and is not subject to the provisions of the Employee Retirement Income Security Act of 1974. The 1998 Purchase Plan will terminate upon the earlier of August 1, 2018 or the date on which all shares available for issuance have been sold. On August 1, 2015, following the Separation, the number of shares available for issuance was automatically adjusted pursuant to the terms of the 1998 Purchase Plan. As of July 1, 2017, 4.8 million shares remained available for issuance. The 1998 Purchase Plan provides a 5% discount and a six month look-back period.

Full Value Awards

Full Value Awards refer to RSUs (time-based, non-performance shares) and MSUs (market-based, performance shares) that are granted with the exercise price equal to zero and are converted to shares immediately upon vesting. These Full Value Awards are performance-based with market conditions, time-based or a combination of both and expected to vest over one to four years. The fair value of the time-based Full Value Awards is based on the closing market price of the Company’s common stock on the date of award.

Stock-Based Compensation

The impact on the Company’s results of operations of recording stock-based compensation expense by function for fiscal 2017, 2016 and 2015 was as follows (in millions):

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Cost of revenue	$	3.6	$	4.8	$	4.2
Research and development	5.7		8.4		8.1
Selling, general and administrative	23.9		29.2		35.2
Total stock-based compensation expense	$	33.2	$	42.4	$	47.5

Approximately $0.7 million of stock-based compensation expense was capitalized to inventory at July 1, 2017.

Impact on Stock-based Compensation Due to Separation

In connection with the separation of the Lumentum business on August 1, 2015 and in accordance with the Employee Matters Agreement, the Company made certain adjustments to the exercise price and number of shares underlying stock-based compensation awards with the intention of preserving the economic value of the awards for Viavi employees. These adjustments resulted in a modification of equity awards with total incremental stock-based compensation of $13.6 million, to be amortized over the remaining service periods of the underlying awards.

88

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Unless otherwise noted, share amounts and grant-date fair values for periods prior to the Separation Date represent the Company’s historical information and have not been adjusted to remove grants made to employees who transferred to Lumentum as part of the Separation. Refer to “Note 3. Discontinued Operations” for more information about the Separation.

Impact on Stock-based Compensation Due to Amendments in the Change of Control Benefits Plan

During the year ended June 27, 2015, the Company amended its Change of Control Benefits Plan (the “Plan”) to add a spin-off of certain Company assets to the circumstances that could trigger benefits under the Plan, as well as other revisions. The Chief Executive Officer of the Company and the Chairman of the Compensation Committee approved the separation of certain executives in the current fiscal year. Pursuant to the Plan, upon termination, all unvested equity awards that have been granted or issued to certain terminated executives become immediately vested and stock options shall become fully exercisable with an extended exercise period of two years from the termination date.

The amendments resulted in a modification of equity awards for six executives and total incremental stock-based compensation of $6.3 million, which was amortized over the period between the modification date and the termination dates of the executives.

Stock Option Activity

The following is a summary of stock option activities (amount in millions except per share amounts):

	Options Outstanding
	Number of Shares		Weighted-Average Exercise Price (1)
Balance as of June 28, 2014	3.5		$	10.13
Exercised	(0.9	)	7.58
Canceled	(0.1	)	14.54
Balance as of June 27, 2015	2.5		10.84
Granted	1.2		5.95
Exercised	(0.7	)	4.74
Canceled	(0.4	)	10.52
Net adjustment due to the separation	0.5
Balance as of July 2, 2016	3.1		5.91
Granted	—		—
Exercised	(1.6	)	5.66
Canceled	—		—
Balance as of July 1, 2017	1.5		$	6.16
Expected to vest	1.4		$	6.18

(1) Weighted average exercise price is calculated using exercise prices prior to the Separation and after the Separation.

The total intrinsic value of options exercised during the year ended July 1, 2017 was $5.9 million. In connection with these exercises, the tax benefit realized by the Company was immaterial due to the fact that the Company has no material benefit in foreign jurisdictions and a full valuation allowance on its domestic deferred tax assets. As of July 1, 2017, $1.5 million of unrecognized stock-based compensation expense related to stock options remains to be amortized. That cost is expected to be recognized over an estimated amortization period of 2.6 years.

89

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The following table summarizes significant ranges of outstanding and exercisable options as of July 1, 2017, adjusted to reflect the impact of the Lumentum separation.

	Options Outstanding						Options Exercisable
Range of Exercise Prices	Number of Shares	Weighted Average Remaining Contractual Term (in years)	Weighted Average Exercise Price		Aggregate Intrinsic Value (in millions)		Number of Shares	Weighted Average Remaining Contractual Term (in years)	Weighted Average Exercise Price		Aggregate Intrinsic Value (in millions)
$3.28 - $3.28	104,352	0.12	$	3.28			104,352	0.12	$	3.28
$5.74 - $5.74	132,544	0.92	5.74				132,544	0.92	5.74
$5.95 - $5.95	1,180,257	6.62	5.95				295,065	6.62	5.95
$11.82 - $11.82	107,412	1.87	11.82				107,412	1.87	11.82
	1,524,565	5.35	$	6.16	$	6.8	639,373	3.58	$	6.46	$	2.7

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value, based on the Company’s closing stock price of $10.53 as of July 1, 2017, which would have been received by the option holders had all option holders exercised their options as of that date. The total number of in-the-money options exercisable as of July 1, 2017 was 0.5 million.

Employee Stock Purchase Plan Activity

The expense related to the plan is recorded on a straight-line basis over the relevant subscription period.

The following summarizes the shares issued and the fair market value at purchase date, pursuant to the Company’s ESPP during the year ended July 1, 2017:

Purchase date	July 29, 2016		January 31, 2017
Shares issued	410,737		269,102
Fair market value at purchase date	$	4.76	$	6.77

As of July 1, 2017, there was $0.1 million of unrecognized stock-based compensation cost related to ESPP remains to be amortized. The cost will be recognized in the first quarter of fiscal 2018.

90

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Full Value Awards Activity

A summary of the status of the Company’s non-vested Full Value Awards as of July 1, 2017 and changes during the same period is presented below (amount in millions, except per share amounts):

	Full Value Awards
	Performance Shares (1)		Non-Performance Shares		Total Number of Shares		Weighted-average grant-dated fair value
Non-vested at June 28, 2014	1.1		8.3		9.4		$	13.19
Awards granted	0.7		5.3		6.0		11.78
Awards vested	(0.8	)	(4.4	)	(5.2	)	12.96
Awards forfeited	—		(1.4	)	(1.4	)	13.10
Non-vested at June 27, 2015	1.0		7.8		8.8		12.36
Awards granted	0.7		6.1		6.8		5.75
Awards vested	(0.7	)	(4.8	)	(5.5	)	6.01
Awards forfeited	(0.4	)	(1.8	)	(2.2	)	7.89
Net adjustment due to the separation	0.4		1.1		1.5
Non-vested at July 2, 2016	1.0		8.4		9.4		6.55
Awards granted	0.6		3.7		4.3		7.86
Awards vested	(0.6	)	(4.5	)	(5.1	)	6.66
Awards forfeited	—		(1.3	)	(1.3	)	6.83
Non-vested at July 1, 2017	1.0		6.3		7.3		$	7.17

(1) Performance Shares refer to the Company’s MSU awards, where the actual number of shares awarded upon vesting may be higher or lower than the target amount depending on the achievement of the relevant market conditions. The majority of MSUs vest in equal annual installments over three to four years based on the attainment of certain total shareholder return performance measures and the employee’s continued service through the vest date. The aggregate grant-date fair value of MSUs granted during fiscal 2017, 2016 and 2015 were estimated to be $3.3 million, $3.7 million and $9.4 million respectively, and were calculated using a Monte Carlo simulation.

As of July 1, 2017, $31.4 million of unrecognized stock-based compensation cost related to Full Value Awards remains to be amortized. That cost is expected to be recognized over an estimated amortization period of 1.75 years.

Full Value Awards are converted into shares upon vesting. Shares equivalent in value to the minimum withholding taxes liability on the vested shares are withheld by the Company for the payment of such taxes. During fiscal 2017, 2016 and 2015, the Company paid $14.3 million, $11.4 million and $22.1 million, respectively, and classified the payments as operating cash outflows in the Consolidated Statements of Cash Flows.

Valuation Assumptions

The Company estimates the fair value of the MSUs on the date of grant using a Monte Carlo simulation with the following assumptions:

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Volatility of common stock	33.2	%	33.8	%	40.8	%
Average volatility of peer companies	36.9	%	52.9	%	53.4	%
Average correlation coefficient of peer companies	0.1856		0.1103		0.2156
Risk-free interest rate	0.7	%	0.8	%	0.6	%

91

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The Company estimates the fair value of Stock Options and ESPP using a BSM valuation model. The fair value is estimated on the date of grant using the BSM option valuation model with the following weighted-average assumptions:

	Stock Options		Employee Stock Purchase Plans
	July 2, 2016		July 1, 2017		July 2, 2016		June 27, 2015
Expected term (in years)	5.2		0.5		0.5		0.5
Expected volatility	42.3	%	33.4	%	45.7	%	37.9	%
Risk-free interest rate	1.2	%	0.5	%	0.4	%	0.1	%

Expected Term: The Company's expected term for stock options was calculated utilizing the simplified method in accordance with the authoritative guidance. The Company used the simplified method as the Company does not have sufficient historical share option exercise data due to the limited number of shares granted as well as changes in the Company's business following the Separation, rendering existing historical experience less reliable in formulating expectations for current grants. The Company’s expected term for ESPP is in line with the six month look-back period of its ESPP.

Expected Volatility: The Company has limited trading history following the Separation; therefore, the expected volatility for stock options was based on the historical volatility of the Company's common stock and its peers. For grants prior to the Separation and for ESPP grants, the Company determined that a combination of the implied volatility of its traded options and historical volatility of its stock price based on the expected term of the equity instrument most appropriately reflects market expectation of future volatility. Implied volatility is based on traded options of the Company’s common stock with a remaining maturity of four and a half months or greater.

Risk-Free Interest Rate: The Company bases the risk-free interest rate used in the BSM valuation method on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term.

Expected Dividend: The BSM valuation model calls for a single expected dividend yield as an input. The Company has not paid and does not anticipate paying any dividends in the near future.

Note 15. Employee Pension and Other Benefit Plans

Employee 401(k) Plans

The Company sponsors the Viavi Solutions 401(k) Plan (the “401(k) Plan”), a Defined Contribution Plan under ERISA, which provides retirement benefits for its eligible employees through tax deferred salary deductions. The 401(k) Plan allows employees to contribute up to 50% of their annual compensation, with contributions limited to $18,000 in calendar year 2017 as set by the Internal Revenue Service.

For all eligible participants who have completed 180 days of service with Viavi, the 401(k) Plan provided for a 100% match of employees’ contributions up to the first 3% of annual compensation and 50% match on the next 2% of compensation. All matching contributions are made in cash and vest immediately. The Company’s matching contributions to the 401(k) Plan were $4.1 million, $4.7 million, and $4.8 million in fiscal 2017, 2016 and 2015, respectively.

Deferred Compensation Plan

The Company also provides for the benefit of certain eligible employees in the U.S. a non-qualified retirement plan. This plan is designed to permit employee deferral of a portion of salaries in excess of certain tax limits and deferral of bonuses. This plan’s assets are designated as trading securities on the Company’s Consolidated Balance Sheets. Refer to “Note 7. Investments, Forward Contracts and Fair Value Measurements” for more information. Effective January 1, 2011, the Company suspended all employee contributions into the plan.

Employee Defined Benefit Plans

The Company sponsors significant qualified and non-qualified pension plans for certain past and present employees in the U.K. and Germany. The Company also is responsible for the non-pension post-retirement benefit obligation assumed from a past acquisition. In connection with the Separation, the Company transferred the liabilities and assets of the Switzerland defined benefit pension plans to Lumentum in the amount of $6.7 million and $4.6 million, respectively.

92

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Most of the plans have been closed to new participants and no additional service costs are being accrued, except for certain plans in Germany assumed in connection with an acquisition during fiscal 2010. Benefits are generally based upon years of service and compensation or stated amounts for each year of service. As of July 1, 2017, the U.K. plan was partially funded while the other plans were unfunded. The Company’s policy for funded plans is to make contributions equal to or greater than the requirements prescribed by law or regulation. For unfunded plans, the Company pays the post-retirement benefits when due. Future estimated benefit payments are summarized below. No other required contributions are expected in fiscal 2018, but the Company, at its discretion, can make contributions to one or more of the defined benefit plans.

The Company accounts for its obligations under these pension plans in accordance with the authoritative guidance which requires the Company to record its obligation to the participants, as well as the corresponding net periodic cost. The Company determines its obligation to the participants and its net periodic cost principally using actuarial valuations provided by third-party actuaries. The obligation the Company records on its Consolidated Balance Sheets is reflective of the total PBO and the fair value of plan assets.

The following table presents the components of the net periodic benefit cost for the pension and benefits plans (in millions):

	Years Ended
Pension Benefits	2017			2016			2015
Service cost	$	0.3		$	0.2		$	0.2
Interest cost	2.1			3.0			3.7
Expected return on plan assets	(1.1		)	(1.5		)	(1.6		)
Recognized net actuarial losses	1.9			0.7			0.4
Provision for legal proceeding	—			8.4			—
Net periodic cost	$	3.2		$	10.8		$	2.7

The Company’s accumulated other comprehensive income includes unrealized net actuarial (gains)/losses. The amount expected to be recognized in net periodic benefit cost during fiscal 2018 is $1.4 million. Refer to “Note 16. Commitments and Contingencies” for further information on the provision for legal proceeding.

93

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The changes in the benefit obligations and plan assets of the pension and benefits plans were (in millions):

	Pension Benefit Plans
	2017			2016
Change in benefit obligation
Benefit obligation at beginning of year	$	134.6		$	121.2
Service cost	0.3			0.2
Interest cost	2.1			3.0
Actuarial (gains) losses	(1.2		)	14.5
Benefits paid	(4.2		)	(4.7		)
Provision for legal proceeding	—			8.4
Foreign exchange impact	1.8			(8.0		)
Benefit obligation at end of year	$	133.4		$	134.6
Change in plan assets
Fair value of plan assets at beginning of year	$	27.2		$	30.2
Actual return on plan assets	2.0			1.8
Employer contributions	4.0			4.6
Benefits paid	(4.2		)	(4.7		)
Foreign exchange impact	(0.7		)	(4.7		)
Fair value of plan assets at end of year	$	28.3		$	27.2
Funded status	$	(105.1	)	$	(107.4	)
Accumulated benefit obligation	$	133.0		$	133.9

	Pension Benefit Plans
	2017			2016
Amount recognized in the Consolidated Balance Sheets at end of year:
Current liabilities	$	6.8		$	5.5
Non-current liabilities	98.3			101.9
Net amount recognized at end of year	$	105.1		$	107.4
Amount recognized in accumulated other comprehensive income (loss) at end of year:
Actuarial losses, net of tax	$	(21.8	)	$	(24.4	)
Net amount recognized at end of year	$	(21.8	)	$	(24.4	)
Other changes in plan assets and benefit obligations recognized in other comprehensive income (loss):
Net actuarial gain (loss)	$	0.7		$	(10.6	)
Amortization of accumulated net actuarial losses	1.9			0.7
Total recognized in other comprehensive income (loss)	$	2.6		$	(9.9	)

As of July 1, 2017 and July 2, 2016, the liability balances related to the post retirement benefit plan were $1.1 million and $1.1 million respectively. The liability balances were included in other non-current liabilities on the Consolidated Balance Sheets.

During fiscal 2017, the Company contributed GBP 0.5 million or approximately USD 0.6 million, while in fiscal 2016, the Company contributed GBP 0.5 million or approximately USD 0.7 million to its U.K. pension plan. These contributions allowed the Company to comply with regulatory funding requirements.

94

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Assumptions

Underlying both the calculation of the PBO and net periodic cost are actuarial valuations. These valuations use participant-specific information such as salary, age, years of service, and assumptions about interest rates, compensation increases and other factors. At a minimum, the Company evaluates these assumptions annually and makes changes as necessary.

The discount rate reflects the estimated rate at which the pension benefits could be effectively settled. In developing the discount rate, the Company considered the yield available on an appropriate AA corporate bond index, adjusted to reflect the term of the scheme’s liabilities as well as a yield curve model developed by the Company’s actuaries.

The expected return on assets was estimated by using the weighted average of the real expected long term return (net of inflation) on the relevant classes of assets based on the target asset mix and adding the chosen inflation assumption.

The following table summarizes the weighted average assumptions used to determine net periodic cost and benefit obligation for the Company’s U.K. and German pension plans:

	Pension Benefit Plans
	2017		2016		2015
Weighted-average assumptions used to determine net period cost:
Discount rate	2.1	%	2.1	%	3.0	%
Expected long-term return on plan assets	4.8		5.3		5.8
Rate of pension increase	2.2		2.3		2.3
Weighted-average assumptions used to determine benefit obligation at end of year:
Discount rate	2.0	%	1.7	%	2.6	%
Rate of pension increase	2.3		2.1		2.2

Investment Policies and Strategies

The Company’s investment objectives for its funded pension plan are to ensure that there are sufficient assets available to pay out members’ benefits as and when they arise and that should the plan be discontinued at any point in time there would be sufficient assets to meet the discontinuance liabilities.

To achieve the objectives, the trustees of the U.K. pension plan are responsible for regularly monitoring the funding position and managing the risk by investing in assets expected to outperform the increase in value of the liabilities in the long term and by investing in a diversified portfolio of assets in order to minimize volatility in the funding position. The trustees invest in a range of frequently traded funds (“pooled funds”) rather than direct holdings in individual securities to maintain liquidity, achieve diversification and reduce the potential for risk concentration. The funded plan assets are managed by professional third-party investment managers.

95

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Fair Value Measurement of Plan Assets

The following table sets forth the U.K. plan assets at fair value and the percentage of assets allocations as of July 1, 2017 (in millions, except percentage data):

							Fair value measurement as of
							July 1, 2017
	Target Allocation		Total		Percentage of Plan Assets		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Global equity	40	%	$	11.7	41.3	%	$	—	$	11.7
Fixed income	40	%	10.7		37.8	%	—		10.7
Other	20	%	5.8		20.5	%	—		5.8
Cash			0.1		0.4	%	0.1		—
Total assets			$	28.3	100.0	%	$	0.1	$	28.2

The following table sets forth the plan’s assets at fair value and the percentage of assets allocations as of July 2, 2016 (in millions, except percentage data).

							Fair value measurement as of
							July 2, 2016
	Target Allocation		Total		Percentage of Plan Assets		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Global equity	40	%	$	10.5	38.6	%	$	—	$	10.5
Fixed income	40	%	10.7		39.3	%	—		10.7
Other	20	%	5.4		19.9	%	—		5.4
Cash			0.6		2.2	%	0.6		—
Total assets			$	27.2	100.0	%	$	0.6	$	26.6

The Company’s pension assets consist of multiple institutional funds (“pension funds”) of which the fair values are based on the quoted prices of the underlying funds. Pension funds are classified as Level 2 assets since such funds are not directly traded in active markets.

Global equity consists of several index funds that invest primarily in U.K. equities and other overseas equities.

Fixed income consists of several funds that invest primarily in index-linked Gilts (over 5 year), sterling-denominated investment grade corporate bonds, and overseas government bonds.

Other consists of several funds that primarily invest in global equities, bonds, private equity, global real estate and infrastructure funds.

96

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Future Benefit Payments

The following table reflects the total expected benefit payments to defined benefit pension plan participants. These payments have been estimated based on the same assumptions used to measure the Company’s PBO at year end and include benefits attributable to estimated future compensation increases.

(in millions)	Pension Benefit Plans
2018	$	7.5
2019	6.1
2020	5.5
2021	5.7
2022	6.1
2023 - 2027	29.7
Thereafter	44.5
Total	$	105.1

Timing of the payment relating to the legal proceeding, which is included in the above table under “Thereafter,” is not yet determined. Refer to “Note 16. Commitments and Contingencies” for further information.

Note 16. Commitments and Contingencies

Operating Leases

The Company leases certain real and personal property from unrelated third parties under non-cancelable operating leases that expire at various dates through fiscal 2023. Certain leases require the Company to pay property taxes, insurance and routine maintenance, and include escalation clauses. As of July 1, 2017, future minimum annual lease payments under non-cancelable operating leases were as follows (in millions):

2018	$	18.8
2019	16.7
2020	12.2
2021	10.1
2022	6.1
Thereafter	0.5
Total minimum operating lease payments	$	64.4

Included in the future minimum lease payments table above is $3.7 million related to lease commitments in connection with the Company’s restructuring and related activities. Refer to “Note 11. Restructuring and Related Charges” for more information.

The aggregate future minimum rentals to be received under non-cancelable subleases totaled $2.9 million as of July 1, 2017. Rental expense relating to building and equipment was $12.1 million, $13.8 million and $14.3 million in fiscal 2017, 2016 and 2015, respectively.

Purchase Obligations

Purchase obligations of $56.8 million as of July 1, 2017, represent legally-binding commitments to purchase inventory and other commitments made in the normal course of business to meet operational requirements. Although open purchase orders are considered enforceable and legally binding, the terms generally allow the option to cancel, reschedule and adjust the requirements based on the Company’s business needs prior to the delivery of goods or performance of services. Obligations to purchase inventory and other commitments are generally expected to be fulfilled within one year.

The Company depends on a limited number of contract manufacturers, subcontractors, and suppliers for raw materials, packages and standard components. The Company generally purchases these single or limited source products through standard

97

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

purchase orders or one-year supply agreements and has no significant long-term guaranteed supply agreements with such vendors. While the Company seeks to maintain a sufficient safety stock of such products and maintains on-going communications with its suppliers to guard against interruptions or cessation of supply, the Company’s business and results of operations could be adversely affected by a stoppage or delay of supply, substitution of more expensive or less reliable products, receipt of defective parts or contaminated materials, increases in the price of such supplies, or the Company’s inability to obtain reduced pricing from its suppliers in response to competitive pressures.

Financing Obligations - Eningen and Santa Rosa

Eningen

On December 16, 2011, the Company executed and closed the sale and leaseback transaction of certain buildings and land in Eningen, Germany (the “Eningen Transactions”). The Company sold approximately 394,217 square feet of land, nine buildings with approximately 386,132 rentable square feet, and parking areas. The Company leased back approximately 158,154 rentable square feet comprised of two buildings and a portion of a basement of another building (the “Leased Premises”). The lease term is 10 years with the right to cancel a certain portion of the lease after 5 years.

Concurrent with the sale and lease back, the Company has provided collateral in case of a default by the Company relative to future lease payments for the Leased Premises. Due to this continuing involvement, the related portion of the cash proceeds and transaction costs, associated with the Leased Premises and other buildings which the Company continues to occupy, was recorded under the financing method in accordance with the authoritative guidance on leases and sales of real estate. Accordingly, the carrying value of these buildings and associated land will remain on the Company’s books and the buildings will continue to be depreciated over their remaining useful lives. The portion of the proceeds received have been recorded as a financing obligation, a portion of the lease payments are recorded as a decrease to the financing obligation and a portion is recognized as interest expense. Imputed rental income from the buildings sold but not leased back and currently being occupied is recorded as a reduction in the financing obligation.

As of July 1, 2017, of the total financing obligation related to the Eningen Transactions, $0.1 million was included in Other current liabilities, and $3.9 million was included in Other non-current liabilities. As of July 2, 2016, of the total financing obligation related to the Eningen Transactions, $0.1 million was included in Other current liabilities, and $4.0 million was included in Other non-current liabilities.

Santa Rosa

On August 21, 2007, the Company entered into a sale and lease back of certain buildings and land in Santa Rosa, California (the “Santa Rosa Transactions”). The Company sold approximately 45 acres of land, 13 buildings with approximately 492,000 rentable square feet, a building pad, and parking areas. The Company leased back 7 buildings with approximately 286,000 rentable square feet. The net cash proceeds received from the transaction were $32.2 million. The lease terms range from a one-year lease with multiple renewal options to a ten-year lease with twofive-year renewal options.

The Company has an ongoing obligation to remediate environmental matters, impacting the entire site, as required by the North Coast Regional Water Quality Control Board which existed at the time of sale. Concurrent with the sale and lease back, the Company has issued an irrevocable letter of credit for $3.8 million as security for the remediation of the environmental matter that remains in effect until the issuance of a notice of no further action letter from the North Coast Regional Water Quality Control Board. In addition, the lease agreement for one building included an option to purchase at fair market value, at the end of the lease term. Due to these various forms of continuing involvement the transaction was recorded under the financing method in accordance with the authoritative guidance on leases and sales of real estate.

Accordingly, the value of the buildings and land will remain on the Company’s books and the buildings will continue to be depreciated over their remaining useful lives. The proceeds received have been recorded as a financing obligation, a portion of the lease payments are recorded as a decrease to the financing obligation and a portion is recognized as interest expense. Imputed rental income from the buildings sold but not leased back is recorded as a reduction in the financing obligation.

As of July 1, 2017, $0.8 million was included in Other current liabilities, and $23.9 million was included in Other non-current liabilities. As of July 2, 2016, $0.8 million was included in Other current liabilities, and $24.7 million was included in Other non-current liabilities.

98

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The lease payments due under the agreement reset to fair market rental rates upon the Company’s execution of the renewal options.

Guarantees

In accordance with authoritative guidance which requires that upon issuance of a guarantee, the guarantor must recognize a liability for the fair value of the obligation it assumes under that guarantee. In addition, disclosures about the guarantees that an entity has issued, including a tabular reconciliation of the changes of the entity’s product warranty liabilities, are required.

The Company from time to time enters into certain types of contracts that contingently require the Company to indemnify parties against third-party claims. These contracts primarily relate to: (i) divestiture agreements, under which the Company may provide customary indemnifications to purchasers of the Company’s businesses or assets; (ii) certain real estate leases, under which the Company may be required to indemnify property owners for environmental and other liabilities, and other claims arising from the Company’s use of the applicable premises; and (iii) certain agreements with the Company’s officers, directors and employees, under which the Company may be required to indemnify such persons for liabilities arising out of their employment relationship.

The terms of such obligations vary. Generally, a maximum obligation is not explicitly stated. Because the obligated amounts of these types of agreements often are not explicitly stated, the overall maximum amount of the obligations cannot be reasonably estimated. Historically, the Company has not been obligated to make significant payments for these obligations, and no liabilities have been recorded for these obligations on the Consolidated Balance Sheets as of July 1, 2017 and July 2, 2016.

Outstanding Letters of Credit and Performance Bonds

As of July 1, 2017, the Company had standby letters of credit of $15.3 million and performance bonds of $2.7 million collateralized by restricted cash.

Product Warranties

In general, the Company offers a three-year warranty for most of its products. The Company provides reserves for the estimated costs of product warranties at the time revenue is recognized. The Company estimates the costs of its warranty obligations based on its historical experience of known product failure rates, use of materials to repair or replace defective products and service delivery costs incurred in correcting product failures. In addition, from time to time, specific warranty accruals may be made if unforeseen technical problems arise with specific products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.

The following table presents the changes in the Company’s warranty reserve during fiscal years 2017 and 2016 (in millions):

	Year Ended
	July 1, 2017			July 2, 2016
Balance as of beginning of period	$	4.9		$	3.7
Provision for warranty	4.2			3.9
Utilization of reserve	(3.8		)	(3.3		)
Adjustments related to pre-existing warranties (including changes in estimates)	0.5			0.6
Balance as of end of period	$	5.8		$	4.9

Legal Proceedings

In June 2016, the Company received a court decision regarding the validity of an amendment to a pension deed of trust related to one of its foreign subsidiaries which the Company contends contained an error requiring the Company to increase the pension plan’s benefit. The Company had subsequently further amended the deed to rectify the error. The court ruled that the amendment increasing the pension plan benefit was valid until the subsequent amendment. Prior to this decision, the Company, in consultation with outside legal counsel, believed that the pension deed of trust document was invalid or, alternatively, that the subsequent rectification should be applied retroactively. Under both scenarios, the Company believed that the likelihood of an increase in plan benefits was remote. While the Company is pursuing other legal arguments in this matter, such as appealing the court decision and pursuing a claim against the U.K. law firm responsible for the error, the Company determined that the likelihood of loss to be probable as of July 2, 2016 and July 1, 2017 and estimated the increase in liability to range from GBP 5.7 million

99

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(USD 7.4 million) to GBP 8.4 million (USD 10.9 million). The Company accrued GBP 5.7 million (USD 7.4 million), in accordance with authoritative guidance on contingencies. The accrual is included as a component of selling, general and administrative expense and included in pension and post-employment benefits, which is a component of other non-current liabilities, in the Company’s Consolidated Statement of Operations and Consolidated Balance Sheets, respectively.

The Company is subject to a variety of claims and suits that arise from time to time in the ordinary course of our business. While management currently believes that resolving claims against the Company, individually or in aggregate, will not have a material adverse impact on its financial position, results of operations or statement of cash flows, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future. Were an unfavorable final outcome to occur, there exists the possibility of a material adverse impact on the Company’s financial position, results of operations or cash flows for the period in which the effect becomes reasonably estimable.

100

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Note 17. Operating Segments and Geographic Information

The Company evaluates its reportable segments in accordance with the authoritative guidance on segment reporting. The Company’s Chief Executive Officer is the Company’s Chief Operating Decision Maker (“CODM”) pursuant to the guidance. The CODM allocates resources to the segments based on their business prospects, competitive factors, net revenue and operating results.

The Company’s reportable segments are:

(i) Network Enablement (“NE”):

NE provides testing solutions that access the network to perform build-out and maintenance tasks. These solutions include instruments, software and services to design, build, activate, certify, troubleshoot and optimize networks. The company also offers a range of product support and professional services such as repair, calibration, software support and technical assistance for our products

(ii) Service Enablement (“SE”):

SE solutions are embedded systems that yield network, service and application performance data. These solutions—including instruments, microprobes and software—monitor, collect and analyze network data to reveal the actual customer experience and to identify opportunities for new revenue streams and network optimization.

(iii) Optical Security and Performance Products (“OSP”):

OSP provides innovative, precision, high performance optical products for anti-counterfeiting, government, industrial, automotive and consumer electronic markets, including 3D sensing applications.

Changes to Segment Reporting

Following the Separation in the first quarter of fiscal 2016, the Company made changes to its segment measures to reflect how the CODM manages the business post-separation as described below.

The CODM manages the Company in two broad business categories: Network and Service Enablement ("NSE") and OSP. NSE operates in two segments, NE and SE, whereas OSP operates as a single segment. The CODM evaluates segment performance of the NSE business based on NE and SE segment gross margin and NSE operating margin as a whole. Operating expenses associated with the NSE business are not allocated to the NE and SE segments within NSE, as they are managed centrally at the business unit level. The CODM evaluates segment performance of the OSP business based on OSP segment operating margin. In addition, prior to the first quarter of fiscal 2016, the Company did not allocate certain corporate-level operating expenses associated with its shared-service function to its segment results. Beginning in the first quarter of fiscal 2016, the Company has allocated these corporate-level operating expenses to its segment results, with the exception of certain non-core operating and non-operating activities as discussed below.

The Company does not allocate stock-based compensation, acquisition-related charges, amortization of intangibles, restructuring and related charges, impairment of goodwill, non-operating income and expenses, or other charges unrelated to core operating performance to its segments because Management does not include this information in its measurement of the performance of the operating segments. These items are presented as “Reconciling Items” in the table below. Additionally, the Company does not specifically identify and allocate all assets by operating segment.

As a result of the Separation, the Company excluded the results of the Lumentum business which historically consisted of the CCOP segment and the WaveReady product line within the NE segment for all periods presented. Refer to “Note 3. Discontinued Operations” for more information on the Separation. Additionally, the Company’s Video Assurance product line was moved out of its NE segment and into its SE segment during the first quarter of fiscal 2016.

The segment information for all periods presented has been revised to be comparable with the changes implemented in the first quarter of fiscal 2016 in the Company’s segment reporting measures.

101

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Information on reportable segments is as follows (in millions):

	Year Ended July 1, 2017
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Reconciling Items			Consolidated GAAP Measures
Net revenue	$	444.0		$	135.2		$	579.2		$	232.2		$	811.4		$	—		$	811.4
Gross profit	286.3			86.2			372.5			133.8			506.3			(20.3		)	486.0
Gross margin	64.5		%	63.8		%	64.3		%	57.6		%	62.4		%				59.9		%
Operating income							7.3			100.3			107.6			(94.0		)	13.6
Operating margin							1.3		%	43.2		%	13.3		%				1.7		%
	Year Ended July 2, 2016
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Reconciling Items			Consolidated GAAP Measures
Net revenue	$	504.6		$	153.6		$	658.2		$	248.1		$	906.3		$	—		$	906.3
Gross profit	329.7			99.4			429.1			143.1			572.2			(22.5		)	549.7
Gross margin	65.3		%	64.7		%	65.2		%	57.7		%	63.1		%				60.7		%
Operating income (loss)							12.7			102.9			115.6			(199.9		)	(84.3		)
Operating margin							1.9		%	41.5		%	12.8		%				(9.3		)%
	Year Ended June 27, 2015
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Reconciling Items			Consolidated GAAP Measures
Net revenue	$	506.8		$	174.3		$	681.1		$	192.8		$	873.9		$	—		$	873.9
Gross profit	333.9			119.2			453.1			104.3			557.4			(37.3		)	520.1
Gross margin	65.9		%	68.4		%	66.5		%	54.1		%	63.8		%				59.5		%
Operating income (loss)							(0.1		)	68.1			68.0			(143.8		)	(75.8		)
Operating margin							—		%	35.3		%	7.8		%				(8.7		)%

102

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Corporate reconciling items impacting gross profit:
Total segment gross profit	$	506.3		$	572.2		$	557.4
Stock-based compensation	(3.6		)	(4.8		)	(4.2		)
Amortization of intangibles	(14.3		)	(17.3		)	(31.9		)
Other charges unrelated to core operating performance	(2.4		)	(0.4		)	(1.2		)
GAAP gross profit	$	486.0		$	549.7		$	520.1
Corporate reconciling items impacting operating income:
Total segment operating income	$	107.6		$	115.6		$	68.0
Stock-based compensation	(33.2		)	(42.4		)	(47.5		)
Amortization of intangibles	(28.3		)	(31.9		)	(51.4		)
Impairment of goodwill	—			(91.4		)	—
Other charges unrelated to core operating performance (1)(2)(3)	(10.9		)	(23.7		)	(18.1		)
Restructuring and related charges	(21.6		)	(10.5		)	(26.8		)
GAAP operating income (loss) from continuing operations	$	13.6		$	(84.3	)	$	(75.8	)

(1) During the year ended July 1, 2017, other charges unrelated to core operating performance primarily consisted of $5.7 million loss on disposal of long-lived assets and $1.5 million of Viavi-specific charges related to the Separation.

(2) During the year endedJuly 2, 2016, other charges unrelated to core operating performance primarily consisted of (a) an $8.4 million charge related to a litigation ruling impacting our U.K. pension obligation, (b) $5.0 million of Viavi-specific charges related to the Separation and (c) $3.5 million of non-recurring incremental severance and related costs upon the exit of a key executive.

(3) During the year endedJune 27, 2015, other charges unrelated to core operating performance primarily consisted of $9.8 million of Viavi-specific charges related to the Separation and $3.6 million IPR&D impairment charge for an ongoing project related to the fiscal 2014 acquisition of Trendium as discussed in “Note 9. Acquired Developed Technology and Other Intangibles.”

103

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The Company operates primarily in three geographic regions: Americas, Asia-Pacific, and Europe, Middle East and Africa (“EMEA”). Net revenue is assigned to the geographic region and country where our product is initially shipped. For example, certain customers may request shipment of our product to a contract manufacturer in one country, which may differ from the location of their end customers. The following table presents net revenue by the three geographic regions we operate in and net revenue from countries that exceeded 10% of our total net revenue (dollars in millions):

	Years Ended
	July 1, 2017				July 2, 2016				June 27, 2015
Americas:
United States	$	307.3	37.9	%	$	396.6	43.8	%	$	424.3	48.5	%
Other Americas	71.3		8.8	%	$	66.0	7.3	%	$	62.5	7.2	%
Total Americas	$	378.6	46.7	%	$	462.6	51.1	%	$	486.8	55.7	%
Asia-Pacific
Greater China	$	100.8	12.4	%	$	103.2	11.3	%	$	83.1	9.5	%
Other Asia	72.4		8.9	%	63.1		7.0	%	61.4		7.0	%
Total Asia-Pacific	$	173.2	21.3	%	$	166.3	18.3	%	$	144.5	16.5	%
EMEA:
Switzerland	$	124.0	15.3	%	$	135.6	15.0	%	$	97.7	11.2	%
Other EMEA	135.6		16.7	%	141.8		15.6	%	144.9		16.6	%
Total EMEA	$	259.6	32.0	%	$	277.4	30.6	%	$	242.6	27.8	%
Total net revenue	$	811.4	100.0	%	$	906.3	100.0	%	$	873.9	100.0	%

Following the separation from Lumentum, one customer served by our OSP segment generated 10% or more of Viavi net revenue from continuing operations during fiscal 2017, 2016 and 2015 as summarized below (in millions):

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Customer A - OSP customer	$	166.8	$	190.1	$	143.0

Property, plant and equipment, net were identified based on the operations in the corresponding geographic areas (in millions):

	Years Ended
	July 1, 2017		July 2, 2016
United States	$	76.0	$	85.6
Other Americas	4.4		4.3
China	41.1		27.3
Other Asia-Pacific	5.0		4.8
Germany	7.9		7.9
Other EMEA	2.5		3.1
Total property, plant and equipment, net	$	136.9	$	133.0

104

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Note 18. Selected Quarterly Financial Information (unaudited)

The following table presents the Company’s selected quarterly financial information from the Consolidated Statements of Operations for fiscal 2017 and 2016 (in millions, except per share data):

	July 1, 2017		April 1, 2017		December 31, 2016		October 1, 2016		July 2, 2016			April 2, 2016		January 2, 2016		October 3, 2015
	(1) (2)		(2)		(2)		(2)		(1)(2)(3)			(1)(2)		(1)		(1)
Net revenue	$	198.1	$	196.0	$	206.5	$	210.8	$	224.1		$	220.4	$	232.1	$	229.7
Gross profit	119.2		117.0		124.7		125.1		136.1			131.3		141.8		140.5
Net income(loss) from continuing operations, net of tax	12.1		26.0		49.2		78.0		(64.5		)	28.8		1.0		(15.7		)
Net income (loss) from discontinued operations, net of tax	1.6		—		—		—		(3.4		)	5.0		3.0		(53.4		)
Net income (loss)	$	13.7	$	26.0	$	49.2	$	78.0	$	(67.9	)	$	33.8	$	4.0	$	(69.1	)
Net income (loss) per share from - basic:
Continuing operations (4)	$	0.05	$	0.11	$	0.21	$	0.34	$	(0.28	)	$	0.13	$	0.01	$	(0.07	)
Discontinued operations (4)	0.01		—		—		—		(0.01		)	0.02		0.01		(0.22		)
Net income (loss) (4)	$	0.06	$	0.11	$	0.21	$	0.34	$	(0.29	)	$	0.15	$	0.02	$	(0.29	)
Net income (loss) per share from - diluted:
Continuing operations (4)	$	0.05	$	0.11	$	0.21	$	0.33	$	(0.28	)	$	0.12	$	0.01	$	(0.07	)
Discontinued operations (4)	0.01		—		—		—		(0.01		)	0.02		0.01		(0.22		)
Net income (loss) (4)	$	0.06	$	0.11	$	0.21	$	0.33	$	(0.29	)	$	0.14	$	0.02	$	(0.29	)
Shares used in per-share calculation (basic)	227.3		229.4		230.5		232.4		232.7			232.0		234.9		236.0
Shares used in per-share calculation (diluted)	232.5		234.6		234.2		236.8		232.7			234.6		237.1		236.0

(1) During the first quarter of fiscal 2016, we completed the Separation. As a result, the operations of the Lumentum business have been presented as discontinued operations in all periods of the Company’s Consolidated Statement of Operations.

(2) During fiscal year ended 2017 and 2016, the Company recorded $203.0 million and $71.5 million, respectively, gain on sale of Lumentum common stock which was retained as part of the Separation of Lumentum. Refer to “Note 7. Investments, Forward Contracts and Fair Value Measurements”for more information.

(3) During the fourth quarter of fiscal 2016, the Company recorded a $91.4 million goodwill impairment charge related to the SE reporting unit.

(4) Net income (loss) per share is computed independently for each of the fiscal quarters presented. Therefore, the sum of the quarterly basic and diluted net income (loss) per share amounts may not equal the annual basic and diluted net income (loss) per share amount for the full fiscal years.

Note 19. Subsequent Events

Repurchase of Common Stock

Subsequent to our fiscal year ended July 1, 2017, the Company repurchased approximately 0.3 million shares of common stock purchases at an average price of $10.58 per share under the stock repurchase program authorized on February 1, 2016. All common shares repurchased have been canceled and retired.

105

VIAVI SOLUTIONS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Repurchase of 2033 Notes

Subsequent to our fiscal year ended July 1, 2017, the Company repurchased $146.5 million of our 2033 Notes for $162.0 million in cash.

Acquisition of Trilithic, Inc.

On August 9, 2017, the Company acquired Trilithic, Inc. (“Trilithic”), a privately-held provider of electronic test and measurement equipment for telecommunications service providers and will be part of NE operating segment. The Company acquired Trilithic for $55.0 million in cash, net of cash acquired, subject to working capital adjustments. The acquisition will be accounted for as a business combination in accordance with the authoritative guidance.

Due to the closing of this acquisition subsequent to the period end, the Company is currently determining the fair value of assets acquired and liabilities assumed necessary to develop the purchase price allocation. Therefore, disclosure of the purchase price allocation to the tangible and intangible assets acquired and liabilities assumed is not practicable.

106

ITEM 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 

None.

ITEM 9A.    CONTROLS AND PROCEDURES 

(a)   EVALUATION OF DISCLOSURE CONTROL AND PROCEDURES

Our management is responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)) for our Company to ensure that the information required to be disclosed by us in reports that we file or submit under the Exchange Act was (i) recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, to allow timely decisions regarding required disclosures. Our management, under the supervision and with participation of our chief executive officer (“CEO”) and chief financial officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures. Based on such evaluation, our CEO and CFO have concluded that our disclosure controls and procedures were effective as of July 1, 2017.

(b)   MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act). Our management, including our CEO and CFO, conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in the Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on its evaluation under the framework in the Internal Control-Integrated Framework (2013), our management concluded that our internal control over financial reporting was effective as of July 1, 2017.

The effectiveness of the Company’s internal control over financial reporting as of July 1, 2017 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which appears in this Annual Report on Form 10-K under Item 8.

(c)   REMEDIATION OF MATERIAL WEAKNESS IN INTERNAL CONTROLS OVER FINANCIAL REPORTING

As described in Item 9A. Controls and Procedures in our Annual Report on Form 10-K for the fiscal year ended July 2, 2016 and Item 4 of our fiscal 2017 Form 10-Qs, we identified a material weakness related to the design of certain internal controls related to the accounting for the interim income tax provision. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

During fiscal 2017, in response to the material weakness identified, management has evaluated the design and operating effectiveness of internal controls related to the interim income tax provision and has implemented additional controls related to the preparation and review of the interim income tax provision.

During fiscal 2017, management tested the remedial controls related to the material weakness described above for a sufficient period of time and management has concluded, through testing, that by the end of the fourth quarter of fiscal 2017, these controls were operating effectively. Therefore, we have concluded that the material weakness previously identified in the Company’s internal control over financial reporting has been remediated as of July 1, 2017.

(d)   CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

There have been no changes in our internal control over financial reporting as defined in Exchange Act Rule 13a-15(f) that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

107

ITEM 9B.    OTHER INFORMATION 

On August 25, 2017, the Compensation Committee of the Board of Directors approved the grant of 90,000 performance-based RSUs (“PSUs”) to Mr. Khaykin and 45,000 PSUs to Mr. Maletira, in each case, effective as of August 28, 2017, pursuant to the Company’s 2003 Plan. The PSUs will vest upon achievement of a Network and Service Enablement ("NSE") operating income margin rate target (the “Achievement Metric”) for two consecutive quarters within the period commencing on the first day of the second quarter of fiscal year 2018 and ending on the last day of the third quarter of fiscal year 2019 (the “Measurement Period”). If the Achievement Metric is determined by the Compensation Committee to have been satisfied, 50% of each executive officer’s PSUs will vest on such determination date; 25% of each executive officer’s PSUs will vest 24 months from the first day of the Measurement Period; and 25% of each executive officer’s PSUs will vest 36 months from the first day of the Measurement Period. The vested PSUs will be settled for shares of Company common stock as soon as practicable following the date on which PSUs vest.  The vesting and settlement of the PSUs is subject to the executive officer being continually employed through each vesting date.

PART III

ITEM 10.    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 

Information regarding the Company’s executive officers and directors required by this Item is incorporated by reference to the section entitled “Proposal One—Elections of Directors” in the Company’s Definitive Proxy Statement in connection with the 2017 Annual Meeting of Stockholders (the “Proxy Statement”), which will be filed with the Securities and Exchange Commission within 120 days of the fiscal year ended July 1, 2017. Information required by Item 405 of Regulation S-K is incorporated by reference to the section entitled “Beneficial Ownership Reporting Compliance” in the Proxy Statement.

The Company has adopted the “Viavi Code of Business Conduct” as its code of ethics, which is applicable to all employees, officers and directors of the Company. The full text of the Viavi Code of Business Conduct is available under Corporate Governance Information which can be found under the Investors tab on the Company’s website at www.viavisolutions.com.

We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding amendment to, or waiver from, a provision of our Code of Business Conduct by posting such information on our investor relations website under the heading “Governance-Governance Documents” at http://investor.viavisolutions.com/corporate-governance/default.aspx.

ITEM 11.    EXECUTIVE COMPENSATION

Information required by this item is incorporated by reference to the sections entitled “Executive Compensation,” “Director Compensation,” “Compensation Program Risk Assessment,” “Corporate Governance—Compensation Committee Interlocks and Insider Participation,” and “Compensation Committee Report” in the Proxy Statement.

ITEM 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 

Information regarding security ownership of certain beneficial owners and management is incorporated by reference to the section entitled “Security Ownership of Certain Beneficial Owners and Management” in the Proxy Statement.

Information regarding the Company’s stockholder approved and non-approved equity compensation plans is incorporated by reference to the section entitled “Equity Compensation Plans” in the Proxy Statement.

ITEM 13.    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 

Information required by this item is incorporated by reference to the sections entitled “Certain Relationships and Related Person Transactions,” and “Code of Ethics,” “Director Independence,” and “Board Committees and Meetings” under the “Corporate Governance” heading in the Proxy Statement.

ITEM 14.    PRINCIPAL ACCOUNTING FEES AND SERVICES 

Information required by this item is incorporated by reference to the section entitled “Audit and Non-Audit Fees” in the Proxy Statement.

108

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(a) The following items are filed as part of this Annual Report on Form 10-K: 

(1) Financial Statements:

	Page
Report of Independent Registered Public Accounting Firm	48
Consolidated Statements of Operations—Years Ended July 1, 2017, July 2, 2016, and June 27, 2015	49
Consolidated Statements of Comprehensive Income (Loss) —Years Ended July 1, 2017, July 2, 2016, and June 27, 2015	50
Consolidated Balance Sheets—July 1, 2017 and July 2, 2016	51
Consolidated Statements of Cash Flows—Years Ended July 1, 2017, July 2, 2016, and June 27, 2015	52
Consolidated Statements of Stockholders’ Equity—Years Ended July 1, 2017, July 2, 2016, and June 27, 2015	53
Notes to Consolidated Financial Statements	54

(2) Financial Statement Schedules:

All financial statement schedules have been omitted because the required information is not present in amounts sufficient to require submission of the schedule, not applicable, or because the required information is included in the Consolidated Financial Statements or Notes thereto.

(3) Exhibits:

See Item 15(b)

(b) Exhibits:

The following exhibits are filed herewith or are incorporated by reference to exhibits previously filed with the Securities and Exchange Commission.

		Incorporated by Reference			Filed
Exhibit No.	Exhibit Description	Form	Exhibit	Filing Date	Herewith
2.1	Agreement and Plan of Merger, dated December 6, 2013, by and among NI Holdings I, Inc., a Delaware corporation, the Company, Jade Acquisition I, Inc., a Delaware corporation and wholly owned subsidiary of the Company, Thoma Bravo, LLC, a Delaware limited liability company, solely in its capacity as Representative for NI Holdings’ stockholders, Thoma Bravo Fund X, L.P., a Delaware limited partnership, and Thoma Bravo Fund X-A., L.P., a Delaware limited partnership.	8-K	2.1	12/11/2013
2.2	Contribution Agreement by and between JDS Uniphase Corporation and Lumentum Operations LLC	8-K	2.1	8/5/2015
2.3	Membership Interest Transfer Agreement by and between JDS Uniphase Corporation and Lumentum Inc.	8-K	2.2	8/5/2015
2.4	Separation and Distribution Agreement by and between JDS Uniphase Corporation, Lumentum Holdings Inc. and Lumentum Operations LLC	8-K	2.3	8/5/2015
3.1	Restated Certificate of Incorporation	8-K	3.1	11/18/2013
3.2	Certificate of Amendment to Restated Certificate of Incorporation	8-K	3.1	8/5/2015
3.5	Amended and Restated Bylaws of Viavi Solutions Inc.	8-K	3.1	6/1/2016
4.1	Indenture, dated as of August 21, 2013, between JDS Uniphase Corporation and Wells Fargo Bank, National Association, as Trustee	8-K	4.1	8/21/2013
4.2	Form of 0.625% Senior Convertible Debentures due 2033	8-K	4.2	8/21/2013
4.3	Stockholder’s and Registration Rights Agreement by and between JDS Uniphase Corporation and Lumentum Holdings Inc.	8-K	4.1	8/5/2015
4.4	Indenture, dated as of March 3, 2017 between Viavi Solutions Inc. and Wells Fargo Bank, National Association as Trustee	8-K	4.1	3/6/2017

109

4.5	Form of 1.00% Senior Convertible Notes due 2024	8-K	4.2	3/6/2017
10.1	Employment Agreement between Oleg Khaykin and Viavi Solutions Inc. effective as of February 3, 2016	8-K	10.1	2/2/2016
10.2	Amended and Restated 1993 Flexible Stock Incentive Plan (Amended and Restated as of November 9, 2001)	10-Q	10.1	2/11/2002
10.3	Restated 1998 Employee Stock Purchase Plan	10-K	10.3	8/25/2015
10.4	Amended and Restated 1999 Canadian Employee Stock Purchase Plan (Amended and Restated as of July 31, 2002)	10-K	10.4	9/17/2002
10.5	Restated 2005 Acquisition Equity Incentive Plan	10-K	10.5	8/25/2015
10.6	2005 Acquisition Equity Incentive Plan Form of Stock Option Award Agreement	10-K	10.6	9/30/2005
10.7	2005 Acquisition Equity Incentive Plan Form of Restricted Stock Unit Award Agreement	10-K	10.7	9/30/2005
10.9	Form of Indemnification Agreement	8-K	10.9	4/20/2015
10.10	Restated 2003 Equity Incentive Plan	10-K	10.10	8/25/2015
10.11	Separation Agreement and General Release between Viavi Solutions Inc. and Thomas Waechter dated August 13, 2015	8-K	10.1	8/19/2015
10.12	Employment Agreement between Viavi Solutions Inc. and Richard Belluzzo dated August 19, 2015	8-K	10.2	8/19/2015
10.13	Tax Matters Agreement by and between JDS Uniphase Corporation and Lumentum Holdings Inc.	8-K	10.1	8/5/2015
10.14	Employee Matters Agreement by and between JDS Uniphase Corporation, Lumentum Holdings Inc. and Lumentum Operations LLC	8-K	10.2	8/5/2015
10.15	Intellectual Property Matters Agreement by and between JDS Uniphase Corporation and Lumentum Operations LLC	8-K	10.3	8/5/2015
10.16	Viavi Solutions Inc. 2015 Change of Control Benefits Plan, effective June 20, 2017	8-K	10.1	12/17/2015
10.17	2003 Equity Incentive Plan Form of Stock Option Award Agreement (for the U.S)	10-K	10.20	8/31/2010
10.18	2003 Equity Incentive Plan Form of Restricted Stock Unit Award Agreement (for the U.S)	10-K	10.24	8/31/2010
10.19	Viavi Solutions Inc. Executive Severance and Retention Plan	8-K	10.1	10/19/2015
10.20	Settlement Agreement, dated September 30, 2015 by and among Viavi Solutions Inc. and each of the signatories identified therein	8-K	10.1	10/1/2015
10.21	Viavi Solutions Inc. 2016 MSU Policy Summary	8-K	10.1	8/24/2015
21.1	Subsidiaries of Viavi Solutions Inc.				X
23.1	Consent of Independent Registered Public Accounting Firm (PricewaterhouseCoopers LLP)				X
31.1	Certification of the Chief Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.			3	X
31.2	Certification of the Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				X
32.1	Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
32.2	Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
101.INS	XBRL Instance				X
101.SCH	XBRL Taxonomy Extension Schema				X

110

101.CAL	XBRL Taxonomy Extension Calculation	X
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document	X
101.LAB	XBRL Taxonomy Extension Label Linkbase	X
101.PRE	XBRL Taxonomy Extension Presentation	X

111

ITEM 16.    10-K SUMMARY

None.

112

SIGNATURES

 Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 29, 2017	VIAVI SOLUTIONS INC.
	By:	/s/ AMAR MALETIRA
	Name:	Amar Maletira
	Title:	Executive Vice President and Chief Financial Officer
		(Duly Authorized Officer and Principal Financial and Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature	Title	Date
/s/ OLEG KHAYKIN	President and Chief Executive Officer	August 29, 2017
Oleg Khaykin	(Principal Executive Officer)
/s/ AMAR MALETIRA	Executive Vice President and Chief Financial Officer	August 29, 2017
Amar Maletira	(Principal Financial and Accounting Officer)
/s/ RICHARD BELLUZZO	Chairman	August 29, 2017
Richard Belluzzo
/s/ KEITH BARNES	Director	August 29, 2017
Keith Barnes
/s/ TOR BRAHAM	Director	August 29, 2017
Tor Braham
/s/ TIMOTHY E. CAMPOS	Director	August 29, 2017
Timothy E. Campos
/s/ DONALD COLVIN	Director	August 29, 2017
Donald Colvin
/s/ MASOOD JABBAR	Director	August 29, 2017
Masood Jabbar
/s/ PAMELA STRAYER	Director	August 29, 2017
Pamela Strayer

113

EX-21.1

Exhibit 21.1

Viavi Solutions Inc.

List of Subsidiaries

as of July 1, 2017

Name of Entity		State or Other Jurisdiction of Incorporation or Organization
DOMESTIC
1	Acterna LLC	Delaware
2	Acterna WG International Holdings LLC	Delaware
3	JDSU ACQUISITION IX, LLC	Delaware
4	JDSU ACQUISITION XII, LLC	Delaware
5	JDSU Acterna Holdings LLC	Delaware
6	NI Holdings I, Inc.	Delaware
7	NI Holdings II, Inc.	Delaware
8	Optical Coating Laboratory, LLC	Delaware
9	TTC International Holdings Inc.	Delaware
INTERNATIONAL
10	Acterna France SAS	France
11	Flex Co., Ltd.	Beijing
12	JDSU Benelux B.V.	Netherlands
13	JDSU do Brasil Ltda. & Cia	Brazil
14	JDSU Holdings GmbH	Germany
15	JDSU International GmbH	Germany
16	TTC Asia Pacific Ltd.	Hong Kong
17	Viavi Solutions (Beijing) Co., Ltd.	Beijing
18	Viavi Solutions (Greater China) Limited	Hong Kong
19	Viavi Solutions (Hong Kong) Limited	Hong Kong
20	Viavi Solutions (Shenzhen) Co., Ltd.	China
21	Viavi Solutions (Suzhou) Co., Ltd.	China
22	Viavi Solutions AB	Sweden
23	Viavi Solutions Australia Pty Ltd	Australia
24	Viavi Solutions Austria GmbH	Austria
25	Viavi Solutions Canada Inc.	Canada
26	Viavi Solutions de Mexico S.A. de C.V.	Mexico
27	Viavi Solutions Deutschland GmbH	Germany
28	Viavi Solutions France SAS	France
29	Viavi Solutions Haberleşme, Test ve Ölçüm Teknolojileri Ticaret Limited Şirketi	Turkey
30	Viavi Solutions India Pvt. Ltd.	India
31	Viavi Solutions Italia S.R.L.	Italy
32	Viavi Solutions Japan K.K.	Japan
33	Viavi Solutions Korea Ltd	Korea
34	Viavi Solutions Malaysia Sdn Bhd	Malaysia
35	Viavi Solutions Polska Sp.z.o.o.	Poland
36	Viavi Solutions Schweiz AG	Switzerland
37	Viavi Solutions Singapore Pte. Ltd.	Singapore
38	Viavi Solutions Spain, S.A.	Spain
39	Viavi Solutions UK Limted	United Kingdom
40	Viavi Solutions World Holdings GmbH & Co KG	Germany

EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-91827, 333-39436, 333-48930, 333-70858, 333-75590 and 333-185491) and Form S-8 (Nos. 333-39423, 333-62465, 333-70339, 333-81911, 333-81909, 333-90301, 333-91313, 333-96481, 333-36114, 333-40696, 333-46846, 333-50176, 333-50502, 333-53642, 333-55182, 333-55560, 333-55796, 333-58718, 333-74226, 333-99745, 333-110497, 333-125647, 333-128737, 333-139182, 333-149399, 333-185492, 333-201893 and 333-209482) of Viavi Solutions Inc. of our report dated August 29, 2017 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PRICEWATERHOUSECOOPERS LLP

San Jose, California

August 29, 2017

EX-31.1

Exhibit 31.1

VIAVI SOLUTIONS INC.

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Oleg Khaykin, certify that:

1. I have reviewed this Annual Report on Form 10-K of Viavi Solutions Inc.; 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: August 29, 2017

/s/ OLEG KHAYKIN

Oleg Khaykin
President and Chief Executive Officer
(Principal Executive Officer)

EX-31.2

Exhibit 31.2

VIAVI SOLUTIONS INC.

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Amar Maletira, certify that:

1. I have reviewed this Annual Report on Form 10-K of Viavi Solutions Inc.; 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: August 29, 2017

/s/ AMAR MALETIRA

Amar Maletira

Executive Vice President and Chief Financial Officer

(Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

VIAVI SOLUTIONS INC.

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Viavi Solutions Inc. (the "Company") for the year ended July 1, 2017 as filed with the Securities and Exchange Commission (the "Report"), I, Oleg Khaykin, President and Chief Executive Officer (Principal Executive Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.

Dated: August 29, 2017

/s/ OLEG KHAYKIN

Oleg Khaykin

President and Chief Executive Officer

(Principal Executive Officer)

EX-32.2

Exhibit 32.2

VIAVI SOLUTIONS INC.

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Viavi Solutions Inc. (the "Company") for the year ended July 1, 2017 as filed with the Securities and Exchange Commission (the "Report"), I, Amar Maletira, Executive Vice President and Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed, “filed” with the Securities and Exchange Commission.

Dated: August 29, 2017

/s/ AMAR MALETIRA

Amar Maletira

Executive Vice President and Chief Financial Officer

(Principal Financial and Accounting Officer)

XML

Document and Entity Information - USD ($) $ in Billions	12 Months Ended
	Jul. 01, 2017	Jul. 28, 2017	Dec. 31, 2016
Document and Entity Information
Entity Registrant Name	VIAVI SOLUTIONS INC.
Entity Central Index Key	0000912093
Document Type	10-K
Document Period End Date	Jul. 01, 2017
Amendment Flag	false
Current Fiscal Year End Date	--07-01
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 1.9
Entity Common Stock, Shares Outstanding		227,547,102
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	FY

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Revenues:
Product revenue	$ 726.4	$ 808.8	$ 771.2
Service revenue	85.0	97.5	102.7
Total net revenues	811.4	906.3	873.9
Cost of revenues:
Product cost of revenues	260.9	278.1	259.1
Service cost of revenues	50.2	61.2	62.8
Amortization of acquired technologies	14.3	17.3	31.9
Total cost of revenues	325.4	356.6	353.8
Gross profit	486.0	549.7	520.1
Operating expenses:
Research and development	136.3	166.4	173.3
Selling, general and administrative	300.5	351.1	376.3
Impairment of goodwill	0.0	91.4	0.0
Amortization of other intangibles	14.0	14.6	19.5
Restructuring and related charges	21.6	10.5	26.8
Total operating expenses	472.4	634.0	595.9
Income (loss) from operations	13.6	(84.3)	(75.8)
Interest and other income, net	13.1	2.5	3.7
Gain on sale of investments	203.1	71.6	0.1
Interest expense	(43.2)	(35.7)	(33.3)
Income (loss) from continuing operations before income taxes	186.6	(45.9)	(105.3)
Provision for income taxes	21.3	4.5	26.1
Income (loss) from continuing operations, net of taxes	165.3	(50.4)	(131.4)
Income (loss) from discontinued operations, net of taxes	1.6	(48.8)	43.3
Net income (loss)	$ 166.9	$ (99.2)	$ (88.1)
Net income (loss) per share from - basic:
Continuing operations (usd per share)	$ 0.72	$ (0.22)	$ (0.57)
Discontinued operations (usd per share)	0.01	(0.20)	0.19
Net income (loss) (usd per share)	0.73	(0.42)	(0.38)
Net income (loss) per share from - diluted:
Continuing operations (usd per share)	0.70	(0.22)	(0.57)
Discontinued operations (usd per share)	0.01	(0.20)	0.19
Net income (loss) (usd per share)	$ 0.71	$ (0.42)	$ (0.38)
Shares used in per-share calculation - basic (in shares)	229.9	234.0	232.7
Shares used in per-share calculation - diluted (in shares)	234.5	234.0	232.7

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 166.9	$ (99.2)	$ (88.1)
Other comprehensive (loss) income:
Net change in cumulative translation adjustment, net of tax	4.8	(32.0)	(55.4)
Net change in available-for-sale investments, net of tax:
Unrealized holding gains (losses) arising during period	92.1	177.3	(0.4)
Less: reclassification adjustments included in net income (loss)	(201.9)	(69.6)	0.0
Net change in defined benefit obligation, net of tax:
Unrealized actuarial gains (loss) arising during period	0.7	(10.6)	(3.7)
Amortization of actuarial losses	1.9	0.7	0.4
Net change in accumulated other comprehensive (loss) income	(102.4)	65.8	(59.1)
Comprehensive income (loss)	$ 64.5	$ (33.4)	$ (147.2)

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016
Current assets:
Cash and cash equivalents	$ 1,004.4	$ 482.9
Short-term investments	432.2	484.7
Restricted cash	11.2	12.2
Accounts receivable, net	120.4	148.4
Inventories, net	48.0	51.4
Prepayments and other current assets	50.8	32.1
Total current assets	1,667.0	1,211.7
Property, plant and equipment, net	136.9	133.0
Goodwill	151.6	152.1
Intangibles, net	31.1	59.9
Deferred income taxes	109.5	108.8
Other non-current assets	14.4	12.6
Total assets	2,110.5	1,678.1
Current liabilities:
Accounts payable	32.6	47.0
Accrued payroll and related expenses	43.8	44.9
Deferred revenue	60.2	78.6
Accrued expenses	30.8	24.9
Other current liabilities	61.4	31.0
Total current liabilities	228.8	226.4
Long-term debt	931.4	583.3
Other non-current liabilities	163.9	179.1
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred Stock, $0.001 par value; 1 million shares authorized; 1 share at July 1, 2017 and July 2, 2016, issued and outstanding	0.0	0.0
Common Stock, $0.001 par value; 1 billion shares authorized; 228 million shares at July 1, 2017 and 232 million shares at July 2, 2016, issued and outstanding	0.2	0.2
Additional paid-in capital	70,184.4	70,059.8
Accumulated deficit	(69,305.8)	(69,380.7)
Accumulated other comprehensive (loss) income	(92.4)	10.0
Total stockholders’ equity	786.4	689.3
Total liabilities and stockholders’ equity	$ 2,110.5	$ 1,678.1

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jul. 01, 2017	Jul. 02, 2016
Statement of Financial Position [Abstract]
Preferred Stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred Stock, shares authorized	1,000,000	1,000,000
Preferred Stock, shares issued	1	1
Preferred Stock, shares outstanding	1	1
Common Stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common Stock, shares authorized	1,000,000,000	1,000,000,000
Common Stock, shares issued	228,000,000	232,000,000
Common Stock, shares outstanding	228,000,000	232,000,000

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016		Jun. 27, 2015
OPERATING ACTIVITIES:
Net income (loss)	$ 166.9	$ (99.2)		$ (88.1)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation expense	29.4	38.1		80.8
Amortization of acquired technologies and other intangibles	28.3	32.5		59.2
Stock-based compensation	33.2	44.0		66.9
Amortization of debt issuance costs and accretion of debt discount	34.6	28.8		27.3
Amortization of discount and premium on investments, net	0.8	0.8		3.2
Impairment of goodwill	0.0	91.4		0.0
Gain on sales of investments	(203.1)	(71.6)		(0.1)
Loss on disposal of long-lived assets	5.7	1.5		1.1
Loss on extinguishment of debt	1.1	0.0		0.0
Other	4.8	2.1		7.1
Changes in operating assets and liabilities, net of impact of Lumentum distribution:
Accounts receivable	24.5	23.4		(12.5)
Inventories	(1.6)	(2.6)		(6.0)
Other current and non-currents assets	(17.4)	5.1		(9.0)
Accounts payable	(14.8)	(2.1)		(10.1)
Income taxes payable	(0.2)	(1.5)		(21.3)
Deferred revenue, current and non-current	(27.4)	(2.4)		3.2
Deferred taxes, net	1.5	0.6		19.8
Accrued payroll and related expenses	(15.4)	(25.2)		(32.4)
Accrued expenses and other current and non-current liabilities	29.1	(10.8)		(6.8)
Net cash provided by operating activities	80.0	52.9		82.3
INVESTING ACTIVITIES:
Purchases of available-for-sale investments	(679.4)	(422.4)		(562.7)
Maturities of available-for-sale investments	470.4	395.7		574.8
Sales of available-for-sale investments	355.2	287.3		71.4
Changes in restricted cash	0.2	14.0		6.0
Acquisition of businesses, net of cash acquired	0.0	(0.9)		0.0
Capital expenditures	(38.6)	(35.5)		(101.5)
Proceeds from the sale of assets	5.9	6.0		6.2
Net cash provided by (used in) investing activities	113.7	244.2		(5.8)
FINANCING ACTIVITIES:
Proceeds from sale of Lumentum Holdings Inc. Series A Preferred Stock	0.0	35.8		0.0
Cash contribution to Lumentum Holdings Inc.	0.0	(137.6)		0.0
Proceeds from issuance of senior convertible debt	460.0	0.0		0.0
Payment of debt issuance costs	(8.9)	0.0		0.0
Repurchase and retirement of common stock	(92.0)	(44.5)		(4.8)
Payment of financing obligations	(0.8)	(5.9)		(23.3)
Redemption of convertible debt	(45.4)	0.0		0.0
Proceeds from exercise of employee stock options and employee stock purchase plan	12.4	4.5		20.8
Net cash provided by (used in) financing activities	325.3	(147.7)		(7.3)
Effect of exchange rates on cash and cash equivalents	2.5	(14.4)		(18.5)
Net increase in cash and cash equivalents	521.5	135.0		50.7
Cash and cash equivalents at beginning of period	482.9	347.9	[1]	297.2
Cash and cash equivalents at end of period	1,004.4	482.9		347.9	[1]
Supplemental disclosure of cash flow information
Cash paid for interest	6.7	6.6		6.5
Cash paid for taxes	$ 23.1	$ 31.8		$ 23.8

[1] Cash and cash equivalents at June 27, 2015 included $13.4 million in current assets of the discontinued operations of Lumentum Holdings Inc.

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) $ in Millions	Jun. 27, 2015 USD ($)
Spinoff | Lumentum
Cash and cash equivalents	$ 13.4

XML

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Balance at Jun. 28, 2014	$ 1,187.7	$ 0.2	$ 69,957.0	$ (68,780.6)	$ 11.1
Balance (in shares) at Jun. 28, 2014		230.4
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(88.1)			(88.1)
Comprehensive income (loss)	(59.1)				(59.1)
Shares issued under employee stock plans, net of tax effects	(1.2)		(1.2)
Shares issued under employee stock plans, net of tax effects (in shares)		5.3
Stock-based compensation	66.9		66.9
Repurchases of common stock	(4.8)			(4.8)
Repurchases of common stock (in shares)		(0.4)
Balance (in shares) at Jun. 27, 2015		235.3
Balance at Jun. 27, 2015	1,101.4	$ 0.2	70,022.7	(68,873.5)	(48.0)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(99.2)			(99.2)
Distribution of Lumentum Holdings Inc.	(371.3)			(363.5)	(7.8)
Comprehensive income (loss)	65.8				65.8
Shares issued under employee stock plans, net of tax effects	(6.9)		(6.9)
Shares issued under employee stock plans, net of tax effects (in shares)		4.5
Stock-based compensation	44.0		44.0
Repurchases of common stock	(44.5)			(44.5)
Repurchases of common stock (in shares)		(7.3)
Balance (in shares) at Jul. 02, 2016		232.5
Balance at Jul. 02, 2016	689.3	$ 0.2	70,059.8	(69,380.7)	10.0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	166.9			166.9
Comprehensive income (loss)	(102.4)				(102.4)
Shares issued under employee stock plans, net of tax effects	(1.9)		(1.9)
Shares issued under employee stock plans, net of tax effects (in shares)		5.6
Stock-based compensation	33.2		33.2
Repurchases of common stock	(92.0)			(92.0)
Repurchases of common stock (in shares)		(10.5)
Issuance of senior convertible notes	99.9		99.9
Reacquisition of 2033 Notes equity component	(6.6)		(6.6)
Balance (in shares) at Jul. 01, 2017		227.6
Balance at Jul. 01, 2017	$ 786.4	$ 0.2	$ 70,184.4	$ (69,305.8)	$ (92.4)

XML

Basis of Presentation

12 Months Ended

Jul. 01, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Note 1. Basis of Presentation

Description of Business

Viavi Solutions Inc. (“Viavi,” also referred to as “the Company,” “we,” “our,” and “us”), formerly JDS Uniphase Corporation (“JDSU”), is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises and their ecosystems, supported by a worldwide channel community including Viavi Velocity Solution Partners. The Velocity program (“Velocity”) allows the Company to optimize the use of direct or partner sales depending on application and sales volume. Velocity expands the Company’s reach into new market segments as well as expands the capability to sell and deliver solutions. Viavi’s solutions deliver end-to-end visibility across physical, virtual and hybrid networks, enabling customers to optimize connectivity, quality of experience and profitability. Viavi is also a leader in high performance thin film optical coatings, providing light management solutions to anti-counterfeiting, consumer and industrial, government and healthcare and other markets.

Lumentum Separation

On August 1, 2015 (the “Separation Date”), Viavi completed the distribution of approximately 80.1% of the outstanding shares of Lumentum Holdings Inc. (“Lumentum”) common stock (the “Distribution”). Concurrent with the Distribution, JDSU was renamed Viavi Solutions Inc. and, at the time of the Distribution, retained ownership of approximately 19.9% of Lumentum’s outstanding shares. Lumentum was formed to hold Viavi’s communications and commercial optical products business segment (“CCOP”) and the WaveReady product line and, as a result of the Distribution, is now an independent public company trading under the symbol “LITE” on The Nasdaq Stock Market (“NASDAQ”). The Distribution was made to Viavi’s stockholders of record as of the close of business on July 27, 2015 (the “Record Date”), who received one share of Lumentum common stock for every five shares of Viavi common stock held as of the close of business on the Record Date and not sold prior to August 4, 2015, the ex-dividend date. The historical results of operations and the financial position have been recasted to present the Lumentum business as discontinued operations as described in “Note 3. Discontinued Operations.” Unless noted otherwise, discussion in the Notes to Consolidated Financial Statements pertains to continuing operations.

Fiscal Years

The Company utilizes a 52-53 week fiscal year ending on the Saturday closest to June 30th. The Company’s fiscal 2017 was a 52-week year ending on July 1, 2017. The Company’s fiscal 2016 and 2015 were 53-week and 52-week fiscal years ending on July 2, 2016, and June 27, 2015, respectively.

Principles of Consolidation

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the Company and its wholly-owned subsidiaries. All inter-company accounts and transactions have been eliminated.

Use of Estimates

The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements, the reported amount of net revenues and expenses and the disclosure of commitments and contingencies during the reporting periods. The Company bases estimates on historical experience and on various assumptions about the future that are believed to be reasonable based on available information. The Company’s reported financial positions or results of operations may be materially different under changed conditions or when using different estimates and assumptions, particularly with respect to significant accounting policies. If estimates or assumptions differ from actual results, subsequent periods are adjusted to reflect more current information.

Cash and Cash Equivalents

The Company considers highly liquid instruments such as treasury bills, commercial paper and other money market instruments with original maturities of 90 days or less at the time of purchase to be cash equivalents. Cash equivalents also include certain term deposit with financial institutions that the Company can liquidate with 30-day advance notice without incurring penalty.

Restricted Cash

At July 1, 2017 and July 2, 2016, the Company’s short-term restricted cash balances were $11.2 million and $12.2 million, respectively, and the Company’s long-term restricted cash balances were $6.8 million and $6.0 million, respectively. These balances primarily include interest-bearing investments in bank certificates of deposit and money market funds which act as collateral supporting the issuance of letters of credit and performance bonds for the benefit of third parties. Refer to the Company’s “Note 16. Commitments and Contingencies” for more information.

Investments

The Company’s investments in debt securities and marketable equity securities, including the Company’s ownership of Lumentum’s common stock, are primarily classified as available-for-sale investments or trading securities and are recorded at fair value. The cost of securities sold is based on the specific identification method. Unrealized gains and losses resulting from changes in fair value on available-for-sale investments, net of tax, are reported within accumulated other comprehensive income (loss), a separate component of stockholders’ equity. Unrealized gains or losses on trading securities resulting from changes in fair value are recognized in current earnings. The Company’s short-term investments, which are classified as current assets, include certain securities with stated maturities of longer than twelve months as they are highly liquid and available to support current operations.

The Company periodically reviews these investments for impairment. If a debt security’s fair value is below amortized cost and the Company either intends to sell the security or it is more likely than not that the Company will be required to sell the security before its anticipated recovery, the Company records an other-than-temporary impairment charge to current earnings for the entire amount of the impairment; if a debt security’s fair value is below amortized cost and the Company does not expect to recover the entire amortized cost of the security, the Company separates the other-than-temporary impairment into the portion of the loss related to credit factors, or the credit loss portion, and the portion of the loss that is not related to credit factors, or the non-credit loss portion. The credit loss portion is the difference between the amortized cost of the security and the Company’s best estimate of the present value of the cash flows expected to be collected from the debt security. The non-credit loss portion is the residual amount of the other-than-temporary impairment. The credit loss portion is recorded as a charge to income (loss), and the non-credit loss portion is recorded as a separate component of other comprehensive (loss) income.

Fair Value of Financial Instruments

The carrying amounts of certain of the Company’s financial instruments, including cash equivalents, accounts receivable, accounts payable, and deferred compensation liability, approximate fair value because of their short maturities. Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. There is an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the assumptions about the factors that market participants would use in valuing the asset or liability.

Estimates of fair value of fixed-income securities are based on third party, market-based pricing sources which the Company believes to be reliable. These estimates represent the third parties’ good faith opinion as to what a buyer in the marketplace would pay for a security in a current sale. For instruments that are not actively traded, estimates may be based on current treasury yields adjusted by an estimated market credit spread for the specific instrument. The fair market value of the Company’s 0.625% Senior Convertible Notes due 2033 and 1.00% Senior Convertible Notes due 2024 fluctuates with interest rates and with the market price of the stock, but does not affect the carrying value of the debt on the balance sheet. Refer to the Company’s “Note 10. Debt” for more information.

Inventories

Inventory is valued at standard cost, which approximates actual cost computed on a first-in, first-out basis, not in excess of net realizable market value. The Company assesses the valuation on a quarterly basis and writes down the value for estimated excess and obsolete inventory based upon estimates of future demand, including warranty requirements. Our inventories include material, labor, and manufacturing overhead costs.

Property, Plant and Equipment

Property, plant and equipment are stated at cost. Depreciation is computed by the straight-line method over the following estimated useful lives of the assets: 10 to 50 years for building and improvements, 2 to 20 years for machinery and equipment, and 2 to 5 years for furniture, fixtures, software and office equipment. Leasehold improvements are amortized by the straight-line method over the shorter of the estimated useful lives of the assets or the term of the lease. Demonstration units, which are Company products used for demonstration purposes for customers and/or potential customers and generally not intended to be sold, have an estimated useful life of 3 to 5 years and are amortized by the straight-line method.

Costs related to software acquired, developed or modified solely to meet the Company’s internal requirements and for which there are no substantive plans to market are capitalized in accordance with the authoritative guidance on accounting for the costs of computer software developed or obtained for internal use. Only costs incurred after the preliminary planning stage of the project and after management has authorized and committed funds to the project are eligible for capitalization. Costs capitalized for computer software developed or obtained for internal use are included in property, plant and equipment, net on the Consolidated Balance Sheets.

Goodwill

Goodwill represents the excess of the purchase price of an acquired enterprise or assets over the fair value of the identifiable assets acquired and liabilities assumed. The Company tests for impairment of goodwill on an annual basis in the fourth quarter and at any other time when events occur or circumstances indicate that the carrying amount of goodwill may not be recoverable. Refer to “Note 8. Goodwill” for more information.

Circumstances that could trigger an impairment test include, but are not limited to, a significant adverse change in the business climate or legal factors, an adverse action or assessment by a regulator, change in customers, target market and strategy, unanticipated competition, loss of key personnel, or the likelihood that a reporting unit or significant portion of a reporting unit will be sold or otherwise disposed.

An assessment of qualitative factors may be performed to determine whether it is necessary to perform the quantitative goodwill impairment test. If the result of the qualitative assessment is that it is more likely than not (i.e., greater than 50% likelihood) that the fair value of a reporting unit is less than its carrying amount, then the quantitative test is required. Otherwise, no further testing is required.

Under the quantitative test, if the carrying amount of the reporting unit goodwill exceeds the implied fair value of that goodwill, an impairment loss is recorded in the Consolidated Statements of Operations as “impairment of goodwill.” Measurement of the fair value of a reporting unit is based on one or more of the following fair value measures: using present value techniques of estimated future cash flows, or using valuation techniques based on multiples of earnings or revenue, or a similar performance measure.

In the fourth quarter of fiscal 2017, the Company early adopted the new accounting guidance issued by the FASB that eliminated the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, any impairment charge would be based on the excess of a reporting unit's carrying amount over its fair value.

Intangible Assets

Intangible assets consist primarily of purchased intangible assets through acquisitions. Purchased intangible assets primarily include acquired developed technologies (developed and core technology), customer relationships, proprietary know-how, trade secrets, and trademarks and trade names. Intangible assets are amortized using the straight-line method over the estimated economic useful lives of the assets, which is the period during which expected cash flows support the fair value of such intangible assets. Refer to “Note 9. Acquired Developed Technology and Other Intangibles” for more information.

Long-lived Asset Valuation (Property, Plant and Equipment and Intangible Assets Subject to Amortization)

Long-lived assets held and used

The Company tests long-lived assets for recoverability, at the asset group level, when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to, significant decreases in the market price of the asset, significant adverse changes in the business climate or legal factors, accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset, current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset, or current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life.

 Recoverability is assessed based on the difference between the carrying amount of the asset and the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset. An impairment loss is recognized when the carrying amount is not recoverable and exceeds the fair value.

Pension and Other Postretirement Benefits

In the fourth quarter of fiscal 2016 the Company early adopted the authoritative guidance issued by the FASB that provides a practical expedient permitting an entity to measure defined benefit plan assets and obligations using the month-end that is closest to the entity’s fiscal year-end and apply that practical expedient consistently from year to year. The Company has adopted the month-end date of June 30, which is the closest month-end to the Company’s fiscal year as the measurement date for all of the Company's qualified and the non-qualified pension plans in certain countries beginning in fiscal 2016. Measurement dates for prior periods are not impacted. 

The funded status of the Company’s retirement-related benefit plans is recognized on the Consolidated Balance Sheets. The funded status is measured as the difference between the fair value of plan assets and the benefit obligation at fiscal year end, the measurement date. For defined benefit pension plans, the benefit obligation is the projected benefit obligation (“PBO”) and for the non-pension postretirement benefit plan the benefit obligation is the accumulated postretirement benefit obligation (“APBO”). The PBO represents the actuarial present value of benefits expected to be paid upon its employee’s retirement. The APBO represents the actuarial present value of postretirement benefits attributed to employee services already rendered. Unfunded or partially funded plans, with the benefit obligation exceeding the fair value of plan assets, are aggregated and recorded as a retirement and non-pension postretirement benefit obligation equal to this excess. The current portion of the retirement-related benefit obligation represents the actuarial present value of benefits payable in the next 12 months in excess of the fair value of plan assets, measured on a plan-by-plan basis. This liability is recorded in other current liabilities in the Consolidated Balance Sheets.

Net periodic pension cost is recorded in the Consolidated Statements of Operations and includes service cost, interest cost, expected return on plan assets, amortization of prior service cost (credit), and (gains) losses previously recognized as a component of accumulated other comprehensive income (loss). Service cost represents the actuarial present value of participant benefits attributed to services rendered by employees in the current year. Interest cost represents the time value of money cost associated with the passage of time. (Gains) losses arise as a result of differences between actual experience and assumptions or as a result of changes in actuarial assumptions. Prior service cost (credit) represents the cost of benefit improvements attributable to prior service granted in plan amendments. (Gains) losses and prior service cost (credit) not recognized as a component of net periodic pension cost in the Consolidated Statements of Operations as they arise are recognized as a component of accumulated other comprehensive income (loss) on the Consolidated Balance Sheets, net of tax. Those (gains) losses and prior service cost (credit) are subsequently recognized as a component of net periodic pension cost pursuant to the recognition and amortization provisions of the authoritative guidance.

The measurement of the benefit obligation and net periodic pension cost is based on the Company’s estimates and actuarial valuations provided by third-party actuaries, and are approved by management. These valuations reflect the terms of the plans and use participant-specific information such as compensation, age and years of service, as well as certain assumptions, including estimates of discount rates, expected return on plan assets, rate of compensation increases, and mortality rates. The Company evaluates these assumptions periodically but not less than annually. In estimating the expected return on plan assets, the Company considers historical returns on plan assets, diversification of plan investments, adjusted for forward-looking considerations, inflation assumptions and the impact of the active management of the plan’s invested assets.

Concentration of Credit and Other Risks

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments, restricted cash, trade receivables and foreign currency forward contracts. The Company’s cash and cash equivalents and short-term investments are held in safekeeping by large, creditworthy financial institutions. The Company invests its excess cash primarily in U.S. government and agency bonds securities, corporate securities, money market funds, asset-backed securities, other investment-grade securities and certificates of deposit. The Company has established guidelines relative to credit ratings, diversification and maturities that seek to maintain safety and liquidity of these investments. The Company’s foreign exchange derivative instruments expose the Company to credit risk to the extent that the counterparties may be unable to meet the terms of the agreements. The Company seeks to mitigate such risk by limiting its counterparties to major financial institutions and by spreading such risk across several major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from such risk is monitored by the Company on an ongoing basis.

The Company performs credit evaluations of its customers’ financial condition and generally does not require collateral from its customers. These evaluations require significant judgment and are based on a variety of factors including, but not limited to, current economic trends, historical payment, bad debt write-off experience, and financial review of the customer.

The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. When the Company becomes aware that a specific customer is unable to meet its financial obligations, the Company records a specific allowance to reflect the level of credit risk in the customer’s outstanding receivable balance. In addition, the Company records additional allowances based on certain percentages of aged receivable balances. These percentages take into account a variety of factors including, but not limited to, current economic trends, historical payment and bad debt write-off experience. The Company classifies bad debt expenses as selling, general and administrative (“SG&A”) expense.

The Company is not able to predict changes in the financial stability of its customers. Any material change in the financial status of any one customer or a group of customers could have a material adverse effect on the Company’s results of operations and financial condition. Although such losses have been within management’s expectations to date, there can be no assurance that such allowances will continue to be adequate. The Company has significant trade receivables concentrated in the telecommunications industry. While the Company’s allowance for doubtful accounts balance is based on historical loss experience along with anticipated economic trends, unanticipated financial instability in the telecommunications industry could lead to higher than anticipated losses.

As of July 1, 2017 and July 2, 2016, one customer represented 10% or more of our total accounts receivable, net.

During fiscal 2017, 2016 and 2015, certain customers generated 10% or more of total net revenues. Refer to "Note 17. Operating Segments and Geographic Information" for more information.

The Company relies on a limited number of suppliers for a number of key components contained in our products. The Company also relies on a limited number of significant independent contract manufacturers for the production of certain key components and subassemblies contained in our products.

The Company generally uses a rolling twelve month forecast based on anticipated product orders, customer forecasts, product order history and backlog to determine its materials requirements. Lead times for the parts and components that the Company orders vary significantly and depend on factors such as the specific supplier, contract terms and demand for a component at a given time. If the forecast does not meet actual demand, the Company may have excess or shortfalls of some materials and components, as well as excess inventory purchase commitments. The Company could experience reduced or delayed product shipments or incur additional inventory write-downs and cancellation charges or penalties, which would increase costs and could have a material adverse impact on the Company’s results of operations.

Foreign Currency Forward Contracts

The Company conducts its business and sells its products to customers primarily in North America, Europe and Asia. In the normal course of business, the Company’s financial position is routinely subject to market risks associated with foreign currency rate fluctuations due to balance sheet positions in foreign currencies. The Company evaluates foreign exchange risks and utilizes foreign currency forward contracts to reduce such risks, hedging the gains or losses generated by the re-measurement of significant foreign currency denominated monetary assets and liabilities. The fair value of these contracts is reflected as other current assets or other current liabilities and the change in fair value of these foreign currency forward contracts is recorded as gain or loss in the Company’s Consolidated Statements of Operations as a component of interest and other income, net. The gain or loss from the change in fair value of these foreign currency forward contracts largely offsets the change in fair value of the foreign currency denominated monetary assets and liabilities, which is also recorded as a component of interest and other income, net.

Foreign Currency Translation

Assets and liabilities of non-U.S. subsidiaries that operate in a local currency environment, where that local currency is the functional currency, are translated into U.S. dollars at exchange rates in effect at the balance sheet date, with the resulting translation adjustments directly recorded as a component of accumulated other comprehensive income (loss) on the Consolidated Balance Sheets. Income and expense accounts are translated at the prior month end exchange rates, which are deemed to approximate the exchange rate when the income and expense are recognized. Gains and losses from re-measurement of monetary assets and liabilities that are denominated in currencies other than the respective functional currencies are included in the Consolidated Statements of Operations as a component of interest and other income, net.

Revenue Recognition

The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when it has persuasive evidence of an arrangement, delivery has occurred, the sales price is fixed or determinable and collectibility is reasonably assured. Delivery does not occur until products have been shipped or services have been provided, risk of loss has transferred and in cases where formal acceptance is required, customer acceptance has been obtained or customer acceptance provisions have lapsed. In situations where a formal acceptance is required but the acceptance only relates to whether the product meets its published specifications, revenue is recognized upon delivery provided that all other revenue recognition criteria are met. Historical return rates are monitored on a product-by-product basis. In addition, some distributor agreements allow for partial return of products and/or price protection under certain conditions within limited time periods. Such return rights are generally limited to contractually defined, short-term stock rotation and defective or damaged product. We maintain reserves for sales returns and price adjustments based on historical experience and other qualitative factors. As new products or distributors are introduced, these historical rates are used to establish initial sales returns reserves and are adjusted as better information becomes available. We also have market development incentive programs for certain distributors whereby rebates are offered based upon exceeding volume goals. Estimated rebates, sales returns and other such allowances are deducted from revenue.

In addition to the aforementioned general policies, the following are the specific revenue recognition policies for multiple-element arrangements and for each major category of revenue.

Multiple-Element Arrangements

When a sales arrangement contains multiple deliverables, such as sales of products that include services, the multiple deliverables are evaluated to determine whether there are one or more units of accounting. Where there is more than one unit of accounting, then the entire fee from the arrangement is allocated to each unit of accounting based on the relative selling price. Under this approach, the selling price of a unit of accounting is determined by using a selling price hierarchy which requires the use of vendor-specific objective evidence (“VSOE”) of fair value if available, third-party evidence (“TPE”) if VSOE is not available, or best estimate of selling price (“BESP”) if neither VSOE nor TPE is available. Revenue is recognized when the revenue recognition criteria for each unit of accounting are met.

The Company establishes VSOE of selling price using the price charged for a deliverable when sold separately and, in remote circumstances, using the price established by management having the relevant authority. TPE of selling price is established by evaluating similar and interchangeable competitor goods or services in sales to similarly situated customers. When VSOE or TPE is not available, the Company then uses BESP. Generally, the Company is not able to determine TPE because its product strategy differs from that of others in our markets, and the extent of customization varies among comparable products or services from its peers. The Company establishes BESP using historical selling price trends and considering multiple factors including, but not limited to geographies, market conditions, competitive landscape, internal costs, gross margin objectives, and pricing practices. When determining BESP, the Company applies significant judgment in establishing pricing strategies and evaluating market conditions and product lifecycles.

To the extent a deliverable(s) in a multiple-element arrangement is subject to specific guidance (for example, software that is subject to the authoritative guidance on software revenue recognition), the Company allocates the fair value of the units of accounting using relative selling price and that unit of accounting is accounted for in accordance with the specific guidance. Some product offerings include hardware that are integrated with or sold with software that delivers the functionality of the equipment. The Company believes this equipment is not considered software-related and would therefore be excluded from the scope of the authoritative guidance on software revenue recognition.

Hardware

Revenue from hardware sales is recognized when the product is shipped to the customer and when there are no unfulfilled obligations from the Company that affect the customer’s final acceptance of the arrangement. Any cost of warranties and remaining obligations that are inconsequential or perfunctory are accrued when the corresponding revenue is recognized.

Services

Revenue from services and system maintenance is recognized on a straight-line basis over the term of the service. Revenue from professional service engagements is recognized once its delivery obligation is fulfilled. Revenue related to extended warranty and product maintenance contracts is deferred and recognized on a straight-line basis over the delivery period. The Company also generates service revenue from hardware repairs and calibration which is recognized as revenue upon completion of the service.

Software

The Company’s software arrangements generally consist of a perpetual license fee, installation services and Post-Contract Support (“PCS”) as well as other non-software deliverables.

VSOE of fair value for PCS is established based on the renewal rate or the bell curve methodology. Non-software and software-related arrangements are bifurcated based on a relative selling price using BESP. The software related elements are bifurcated into separate units of accounting if VSOE of fair value has been established for the undelivered element(s) and the functionality of the delivered element(s) is not dependent on the undelivered element(s).

Revenue from multiple-element software arrangements that include installation services, is deferred until installation service obligation for the software solution is fulfilled. If VSOE has been established for the undelivered elements, the software, installation services and non-software elements are recognized upon completion of delivery and the PCS is recognized ratably over the remaining support contract term. If VSOE has not been established for the undelivered element, the software related elements are recognized ratably over the remaining support period.

Warranty

The Company provides reserves for the estimated costs of product warranties at the time revenue is recognized. It estimates the costs of its warranty obligations based on its historical experience of known product failure rates, use of materials to repair or replace defective products and service delivery costs incurred in correcting product failures. In addition, from time to time, specific warranty accruals may be made if unforeseen technical problems arise.

Shipping and Handling Costs

The Company records costs related to shipping and handling of revenue in cost of sales for all periods presented.

Advertising Expense

The Company expenses advertising costs as incurred. Advertising costs totaled $2.1 million, $2.6 million and $1.7 million in fiscal 2017, 2016 and 2015, respectively.

Research and Development (“R&D”) Expense

Costs related to R&D, which primarily consists of labor and benefits, supplies, facilities, consulting and outside service fees, are charged to expense as incurred. The authoritative guidance allows for capitalization of software development costs incurred after a product’s technological feasibility has been established until the product is available for general release to the public. To date, the period between achieving technological feasibility, which the Company has defined as the establishment of a working model and typically occurs when beta testing commences, and the general availability of such software has been very short. Accordingly, software development costs have been expensed as incurred.

Stock-Based Compensation

Stock-based compensation is measured at grant date, and recognized in expense over the requisite service period based on the fair value of the equity award. The fair value of the time-based Full Value Awards is based on the closing market price of the Company’s common stock on the grant date of the award. The Company uses the Monte Carlo simulation to estimate the fair value of Full Value Awards with market conditions (“MSUs”). The Company estimates the fair value of stock options and employee stock purchase plan awards (“ESPP”) using the Black-Scholes Merton (“BSM”) option-pricing model. This option-pricing model requires the input of assumptions, including the award’s expected life and the price volatility of the underlying stock.

The Company estimates the expected forfeiture rate pursuant to the authoritative guidance, and only recognizes expense for those shares expected to vest. When estimating forfeitures, the Company considers voluntary termination behavior as well as future workforce reduction programs. Estimated forfeiture is trued up to actual forfeiture as the equity awards vest. The total fair value of the equity awards, net of forfeiture, is recorded on a straight-line basis over the requisite service period of the awards for each separately vesting period of the award, except for MSUs, which are amortized based upon graded vesting method.

Income Taxes

In accordance with the authoritative guidance on accounting for income taxes, the Company recognizes income taxes using an asset and liability approach. This approach requires the recognition of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in its consolidated financial statements or tax returns. The measurement of current and deferred taxes is based on provisions of the enacted tax law and the effects of future changes in tax laws or rates are not anticipated.

The authoritative guidance provides for recognition of deferred tax assets if the realization of such deferred tax assets is more likely than not to occur based on an evaluation of both positive and negative evidence and the relative weight of the evidence. With the exception of certain international jurisdictions, the Company has determined that at this time it is more likely than not that deferred tax assets attributable to the remaining jurisdictions will not be realized, primarily due to uncertainties related to its ability to utilize its net operating loss carryforwards before they expire. Accordingly, the Company has established a valuation allowance for such deferred tax assets. If there is a change in the Company’s ability to realize its deferred tax assets for which a valuation allowance has been established, then its tax provision may decrease in the period in which it determines that realization is more likely than not. Likewise, if the Company determines that it is not more likely than not that our deferred tax assets will be realized, then a valuation allowance may be established for such deferred tax assets and the Company’s tax provision may increase in the period in which we make the determination.

The authoritative guidance on accounting for uncertainty in income taxes prescribes the recognition threshold and measurement attributes for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Additionally, it provides guidance on recognition, classification, and disclosure of tax positions. The Company is subject to income tax audits by the respective tax authorities in all of the jurisdictions in which it operates. The determination of tax liabilities in each of these jurisdictions requires the interpretation and application of complex and sometimes uncertain tax laws and regulations. The Company recognizes liabilities based on its estimate of whether, and the extent to which, additional tax liabilities are more likely than not. If the Company ultimately determines that the payment of such a liability is not necessary, then it reverses the liability and recognizes a tax benefit during the period in which the determination is made that the liability is no longer necessary.

The recognition and measurement of current taxes payable or refundable and deferred tax assets and liabilities requires that the Company make certain estimates and judgments. Changes to these estimates or a change in judgment may have a material impact on the Company’s tax provision in a future period.

Restructuring Accrual

In accordance with authoritative guidance on accounting for costs associated with exit or disposal activities, generally costs associated with restructuring activities are recognized when they are incurred. However, in the case of operating and direct financing leases, the expense is estimated and accrued when the property is vacated. Given the significance of, and the timing of the execution of such activities, this process is complex and involves periodic reassessments of estimates made from the time the property was vacated, including evaluating real estate market conditions for expected vacancy periods and sub-lease income.

Additionally, a liability for post-employment benefits for workforce reductions related to restructuring activities is recorded when payment is probable, and the amount is reasonably estimable. The Company continually evaluates the adequacy of the remaining liabilities under its restructuring initiatives. Although the Company believes that these estimates accurately reflect the costs of its restructuring plans, actual results may differ, thereby requiring the Company to record additional liabilities or reverse a portion of existing liabilities.

Loss Contingencies

The Company is subject to the possibility of various loss contingencies arising in the ordinary course of business. The Company considers the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as its ability to reasonably estimate the amount of loss in determining loss contingencies. An estimated loss is accrued when it is probable that an asset has been impaired or a liability has been incurred and the amount of loss can be reasonably estimated. The Company regularly evaluates current information available to determine whether such accruals should be adjusted and whether new accruals are required.

Asset Retirement Obligations (“ARO”)

ARO are legal obligations associated with the retirement of long-lived assets pertaining to leasehold improvements. These liabilities are initially recorded at fair value and the related asset retirement costs are capitalized by increasing the carrying amount of the related assets by the same amount as the liability. Asset retirement costs are subsequently depreciated over the useful lives of the related assets. Subsequent to initial recognition, the Company records period-to-period changes in the ARO liability resulting from the passage of time and revisions to either the timing or the amount of the original estimate of undiscounted cash flows. The Company derecognizes ARO liabilities when the related obligations are settled. As of July 1, 2017 and July 2, 2016, the Consolidated Balance Sheets included ARO of $0.3 million and $0.2 million, respectively, in other current liabilities and $3.3 million and $3.5 million, respectively, in other non-current liabilities. The activities and balances for ARO are as follows (in millions):

	Balance at Beginning of Period		Liabilities Incurred	Liabilities Settled		Accretion Expense	Revisions to Estimates		Balance at End of Period
Year ended July 1, 2017	$	3.7	0.1	(0.1	)	0.2	(0.3	)	$	3.6
Year ended July 2, 2016	$	4.4	0.4	(0.9	)	0.2	(0.4	)	$	3.7

XML

Recently Issued Accounting Pronouncements

12 Months Ended

Jul. 01, 2017

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Recently Issued Accounting Pronouncements

Note 2. Recently Issued Accounting Pronouncements

In May 2017, the Financial Accounting Standards Board (“FASB”) issued guidance that clarifies the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under the relevant authoritative guidance. The guidance is to be applied prospectively, and is effective for the Company in the first quarter of fiscal 2019. Early adoption is permitted. The Company does not anticipate the adoption of this guidance to have a material impact on its consolidated financial statements, absent any award(s) modified on or after adoption date.

In November 2016, the FASB issued guidance that will require that the amounts generally described as restricted cash and restricted cash equivalents would be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period amounts shown on the statement of cash flows. The new guidance also requires certain disclosures to supplement the statement of cash flows. The guidance is effective for the Company in the first quarter of fiscal 2019. Other than changes in the presentation within the statements of cash flows and additional required disclosures, the adoption of this new accounting guidance will not have an impact on the consolidated financial statements.

In October 2016, the FASB issued guidance that requires entities to recognize at the transaction date the income tax consequences of intra-entity transfer of an asset other than inventory. The guidance is effective for the Company in the first quarter of fiscal 2019. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In June 2016, the FASB issued guidance that changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. The guidance is effective for the Company in the first quarter of fiscal 2021 and earlier adoption is permitted. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In March 2016, the FASB issued guidance which simplifies several aspects of accounting for share-based payment award transactions including income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The guidance is effective for the Company in the first quarter of fiscal 2018. The most significant impact from this guidance upon adoption for the Company relates to the classification of employee tax paid by withholding shares of restricted stock units on the statements of cash flows and excess tax benefit. Upon adoption, the related cash flows will be classified as financing activity, from the current classification as operating activity and all prior periods presented will be retrospectively adjusted to reflect this change. The employee tax paid by withholding shares totaled $14.3 million and $11.4 million in fiscal 2017 and 2016, respectively. In addition, the guidance requires that the excess tax benefits to be recorded on the income statement as opposed to additional paid-in-capital. Due to the Company’s valuation allowance on its deferred tax assets, no income tax benefit is expected to be recognized upon adoption. All other aspects of the guidance are not expected to have a material effect on the Company’s consolidated financial statements.

In February 2016, the FASB issued guidance regarding both operating and financing leases, requiring lessees to recognize on their balance sheets “right-of-use assets” and corresponding lease liabilities, measured on a discounted basis over the lease term. Virtually all leases will be subject to this treatment except leases that meet the definition of a “short-term lease.” The guidance requires a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The guidance is effective for the Company in the first quarter of fiscal 2020. While the Company is not yet in a position to assess the full impact of the application of the new guidance, the Company expects adoption of this guidance will materially increase the assets and liabilities recorded on its Consolidated Balance Sheets.

In May 2014, the FASB issued new authoritative guidance related to revenue recognition from contracts with customers. This new guidance will replace current U.S. GAAP guidance on this topic and eliminate industry-specific guidance. The new guidance provides a unified model to determine when and how revenue is recognized. The core principle of the new guidance is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This new guidance allows for either full retrospective adoption or modified retrospective adoption. The FASB deferred the effective date for this new guidance by one year to December 15, 2017 for annual reporting periods beginning after such date. Earlier application of this new guidance is permitted. The Company currently anticipates adopting the guidance in the first quarter of fiscal 2019 using the full retrospective method, reflecting the application of the new standard in each prior reporting period.

In preparation for the implementation and adoption of the new guidance, the Company has established a cross-functional team and implementation plan to identify processes, systems and internal controls over financial reporting impacted by the new guidance. The implementation plan includes comparison of the Company’s historical accounting policies and practices to the requirements of the new guidance, and identifying differences from applying the requirements of the new guidance to the Company’s contracts, consolidated financial statements and related disclosures.

While the Company’s assessment of the potential impacts of the new guidance is not yet complete, initially the Company believes the most significant impact on the accounting for contracts with customers will be for certain arrangements that include sales of software solutions bundled with post-contract support (PCS) and/or services, where VSOE has not been established for the PCS and/or the services. Due to lack of VSOE under the current guidance, the Company defers recognition of any revenue attributable to such arrangements until the services lacking VSOE are complete. Such revenue is then recognized ratably over the remaining support term. The requirement to have VSOE for undelivered elements to enable the separation of the revenue for delivered software is eliminated under the new guidance and the Company will be required to allocate total contract revenue to each element (referred to as a distinct performance obligation under the new standard) based on either an established or estimated standalone selling price. Accordingly, a portion of the revenue for these types of contracts with customers will be recognized when the software or software solution is transferred to the customer. Dependent on contract-specific terms, the Company expects the actual revenue recognition treatment and timing will vary under the new guidance for some of these arrangements. The Company will continue to evaluate the impact of this new guidance on its consolidated financial statements and related disclosures.

XML

Discontinued Operations

12 Months Ended

Jul. 01, 2017

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Note 3. Discontinued Operations

On August 1, 2015, the Company completed the separation of the Lumentum business (the “Separation”) and made a tax-free distribution of approximately 80.1% of the outstanding shares of Lumentum common stock to Viavi shareholders who received one share of Lumentum common stock for every five shares of Viavi common stock held as of the close of business on July 27, 2015 (the “Record Date”) and not sold prior to August 4, 2015 (the “ex-dividend date”). In connection with the Separation Viavi agreed to contribute $137.6 million all of which was contributed during fiscal 2016. As of the Distribution, Viavi retained ownership of approximately 19.9%, or 11.7 million shares, of Lumentum’s outstanding common stock. Lumentum was formed to hold Viavi’s CCOP business and the WaveReady product line. As a result of the Distribution, Lumentum is now an independent public company trading under the symbol “LITE” on The Nasdaq Stock Market (“NASDAQ”). The Company agreed not to liquidate the retained shares during the first six months following the Distribution. However, in connection with a private letter ruling from the Internal Revenue Service, the Company committed to liquidate these shares within three years from the Distribution. As of July 1, 2017, the Company had sold all of its ownership of Lumentum’s common stock. Refer to “Note 7. Investments, Forward Contracts and Fair Value Measurements” for more information.

In connection with the Separation, the Company entered into a Contribution Agreement, Separation and Distribution Agreement, a Tax Matters Agreement, Employee Matters Agreement, Securities Purchase Agreement, a Supply Agreement, and an Intellectual Property Matters Agreement with Lumentum and others.

The Contribution Agreement identifies the assets to be transferred, the liabilities to be assumed and the contracts to be assigned and it provides for when and how these transfers, assumptions and assignments will occur.

The Separation and Distribution Agreement governs the separation of the CCOP and WaveReady business, the transfer of assets and other matters related to Viavi’s relationship with Lumentum.

The Tax Matters Agreement governs the respective rights, responsibilities and obligations of Lumentum and Viavi with respect to tax liabilities and benefits, tax attributes, tax contests, tax returns, and certain other tax matters.

The Employee Matters Agreement governs the compensation and employee benefit obligations with respect to the current and former employees and non-employee directors of Lumentum and Viavi, and generally allocates liabilities and responsibilities relating to employee compensation, benefit plans and programs. The Employee Matters Agreement provides that employees of Lumentum will no longer participate in benefit plans sponsored or maintained by Viavi.

The Securities Purchase Agreement with the Company, Lumentum and Amada Holdings Co., Ltd. (“Amada”) set forth terms whereby the Company received 40,000 shares of Lumentum’s Series A Preferred Stock (“Series A Preferred Stock”) pursuant to a binding commitment to sell the Series A Preferred Stock to Amada following the Separation. Upon Separation, in connection with the agreement, during the first quarter of fiscal 2016 the Company sold 35,805 shares of the Series A Preferred Stock to Amada for $35.8 million and the remaining 4,195 shares of the Series A Preferred Stock were canceled. The $35.8 million is included as a part of financing activities in the Statement of Cash Flows.

The Supply Agreement outlines that Viavi will supply test equipment to Lumentum and Lumentum will supply components related to the Company’s metro, fiber and optical product lines and development services related to smart transceivers. The most significant component of the Supply Agreement is $15.0 million related to the sale of certain optical test equipment to Lumentum from the date of the agreement through July 2, 2016, of which the company recorded $14.1 million of net revenue during the fiscal year ended July 2, 2016.

The Intellectual Property Matters Agreement outlines the intellectual property rights and technology transferred to Lumentum upon the Separation, as well as the intellectual property and technology both companies can license from each other. In addition it outlines non-compete restrictions between Viavi and Lumentum.

As the separation of the Lumentum business represented a strategic shift that had and will have a major effect on the Company’s operations and financial results, the results of operations of the Lumentum business are presented separately as discontinued operations for the years endedJuly 1, 2017 , July 2, 2016 and June 27, 2015 in accordance with the authoritative guidance.

As of the Separation Date, Lumentum became a stand-alone public company that separately reports its financial results. Due to the difference between the basis of presentation for discontinued operations and the basis of presentation as a stand-alone company, the financial results of Lumentum included within discontinued operations for the Company may not be indicative of actual financial results of Lumentum as a stand-alone company.

In connection with the Separation, $7.8 million of accumulated other comprehensive loss, net of income taxes, related to foreign currency translation adjustments and the pension plan obligation was transferred to Lumentum on the Separation Date.

The Company also transferred deferred tax assets of $29.5 million, deferred tax liabilities of $1.0 million, current income tax payables of $3.3 million, an income tax receivable of $1.3 million and other long-term liabilities related to uncertain tax positions totaling $0.1 million on the Separation date. The Company utilized approximately $1.0 billion of federal net operating losses to offset income recognized as a result of the Separation and the license of Lumentum’s intellectual property to a foreign subsidiary.

The removal of Lumentum’s net assets and equity related adjustments upon the Separation are presented as an increase of Viavi's accumulated deficit in the Consolidated Statements of Stockholders’ Equity and represents a non-cash financing activity, excluding the cash transferred. Refer to “Note 14. Stock-Based Compensation” for information on modifications to stock-based compensation awards as a result of the Distribution.

The following table summarizes results from discontinued operations of the Lumentum business included in the Consolidated Statement of Operations (in millions):

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Net revenues	$	—		$	66.5		$	835.2
Cost of revenues	—			49.8			569.1
Amortization of acquired technologies	—			0.6			7.5
Gross profit	—			16.1			258.6
Operating expenses:
Research and development	—			12.5			139.9
Selling, general and administrative	(0.8		)	24.7			87.5
Restructuring charges	—			0.1			7.7
Total operating expenses	(0.8		)	37.3			235.1
Income (loss) from operations	0.8			(21.2		)	23.5
Interest and other income, net	—			—			(1.1		)
Income (loss) before income taxes	0.8			(21.2		)	22.4
(Benefit from) provision for income taxes	(0.8		)	27.8			(20.9		)
Net income (loss) from discontinued operations (1)	$	1.6		$	(49.0	)	$	43.3

(1)  No income or expense relating to the Lumentum business was recorded after the Separation Date.

During the fiscal year ended July 1, 2017, the Net income from discontinued operations had a benefit of $0.8 million related to the true up of contractual obligations between the company and Lumentum per the Tax Matters Agreement and the Company recognized a tax benefit of $0.8 million relating to the income taxes incurred as a result of the Separation.

During the fiscal year endedJuly 2, 2016, the income tax provision for discontinued operations of $27.8 million included approximately $6.2 million cash taxes that are due to federal and state authorities as a result of the Separation. In addition, approximately $19.0 million of the income tax provision for discontinued operations related to the income tax intraperiod tax allocation rules in relation to continuing operations and other comprehensive income.

Net income (loss) from discontinued operations also includes other costs incurred by the Company to separate Lumentum. These costs include transaction charges, advisory and consulting fees, of $16.5 million and $21.4 million for the years endedJuly 2, 2016 and June 27, 2015, respectively.

The following table presents supplemental cash flow information: depreciation expense, amortization expense, stock-based compensation expense and capital expenditures of the Lumentum business (in millions):

	Years Ended
	July 2, 2016		June 27, 2015
Operating activities:
Depreciation expense	$	3.7	$	43.4
Amortization expense	0.6		7.9
Stock-based compensation expense	1.6		19.4
Investing activities:
Capital expenditures	$	5.8	$	55.9

(1) No depreciation expense, amortization expense, stock based compensation expense and capital expenditures relating to the Lumentum business are presented after the Separation Date.

XML

Earnings Per Share

12 Months Ended

Jul. 01, 2017

Earnings Per Share [Abstract]

Earnings Per Share

Note 4. Earnings Per Share

Basic net income (loss) per share is computed by dividing net income (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by dividing net income (loss) for the period by the weighted average number of shares of common stock and potentially dilutive common stock outstanding during the period. The dilutive effect of outstanding ESPP, Full Value Awards, and options is reflected in diluted net income (loss) per share by application of the treasury stock method. The calculation of diluted net income (loss) per share excludes all anti-dilutive common shares.

The following table sets forth the computation of basic and diluted net income (loss) per share (in millions, except per share data):

	Years Ended
	July 1, 2017		July 2, 2016			June 27, 2015
Numerator:
Income (loss) from continuing operations, net of taxes	$	165.3	$	(50.4	)	$	(131.4	)
Income (loss) from discontinued operations, net of taxes	1.6		(48.8		)	43.3
Net income (loss)	$	166.9	$	(99.2	)	$	(88.1	)
Denominator:
Weighted-average number of common shares outstanding
Basic	229.9		234.0			232.7
Effect of dilutive securities from stock-based benefit plans	4.6		—			—
Diluted	234.5		234.0			232.7
Net income (loss) per share from - basic:
Continuing operations	$	0.72	$	(0.22	)	$	(0.57	)
Discontinued operations	0.01		(0.20		)	0.19
Net income (loss)	$	0.73	$	(0.42	)	$	(0.38	)
Net income (loss) per share from - diluted:
Continuing operations	$	0.70	$	(0.22	)	$	(0.57	)
Discontinued operations	0.01		(0.20		)	0.19
Net income (loss)	$	0.71	$	(0.42	)	$	(0.38	)

The following table sets forth the weighted-average potentially dilutive securities excluded from the computation of the diluted net income (loss) per share because their effect would have been anti-dilutive (in millions):

	Years Ended
	July 1, 2017 (2)(3)	July 2, 2016 (1)(2)	June 27, 2015 (1)(2)
Stock options and ESPP	0.9	3.4	3.6
Full Value Awards	0.6	10.9	10.3
Total potentially dilutive securities	1.5	14.3	13.9

(1) As the Company incurred a net loss from continuing operations in the period, potential dilutive securities from employee stock options, employee stock purchase plan (“ESPP”) and restricted stock units (“RSUs”) have been excluded from the diluted net loss per share computations as their effects were deemed anti-dilutive.

(2) The Company’s 0.625% Senior Convertible Notes due 2033 are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $11.28 per share is payable in cash, shares of the Company’s common stock or a combination of both at the Company’s election. Refer to “Note 10. Debt” for more details.

(3) The Company’s 1.00% Senior Convertible Notes due 2024 are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $13.22 per share is payable in cash, shares of the Company’s common stock or a combination of both at the Company’s election. Refer to “Note 10. Debt” for more details.

XML

Accumulated Other Comprehensive Income (Loss)

12 Months Ended

Jul. 01, 2017

Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]

Accumulated Other Comprehensive Income (Loss)

Note 5. Accumulated Other Comprehensive Income (Loss)

 The Company’s accumulated other comprehensive income (loss) consists of the accumulated net unrealized gains and losses on available-for-sale investments, foreign currency translation adjustments and change in unrealized components of defined benefit obligations.

At July 1, 2017 and July 2, 2016, the changes in accumulated other comprehensive income (loss) by component net of tax were as follows (in millions):

	Unrealized gains (losses)  on available-for-sale  investments (1)			Foreign currency translation adjustments			Change in unrealized components of defined benefit obligations, net of tax (2)			Total
Beginning balance as of July 2, 2016	$	104.5		$	(70.1	)	$	(24.4	)	$	10.0
Other comprehensive income before reclassification	92.1			4.8			0.7			97.6
Amounts reclassified from accumulated other comprehensive income (loss)	(201.9		)	—			1.9			(200.0		)
Net current period other comprehensive (loss) income	(109.8		)	4.8			2.6			(102.4		)
Ending balance as of July 1, 2017	$	(5.3	)	$	(65.3	)	$	(21.8	)	$	(92.4	)

(1) Activity before reclassifications to the Consolidated Statements of Operations during the year ended July 1, 2017 primarily relates to a $92.6 million unrealized gain on the marketable equity securities of Lumentum held by Viavi. The amount reclassified out of accumulated other comprehensive income (loss) represents the gross realized gain from available-for-sale securities included as “gain on sale of investments" in the Consolidated Statement of Operations for the year ended July 1, 2017. There was no tax impact for the fiscal year 2017.

(2) Activity before reclassifications to the Consolidated Statements of Operations during the year ended July 1, 2017 relates to the unrealized actuarial gain of $2.1 million, net of income tax expense of $1.4 million. The amount reclassified out of accumulated other comprehensive income (loss) represents the amortization of actuarial losses included as a component of selling, general and administrative expense (“SG&A”) in the Consolidated Statement of Operations for the year ended July 1, 2017. Refer to “Note 15. Employee Pension and Other Benefit Plans” for more details on the computation of net periodic cost for pension plans.

XML

Balance Sheet and Other Details

12 Months Ended

Jul. 01, 2017

Balance Sheet and Other Details

Balance Sheet and Other Details

Note 6. Balance Sheet and Other Details

Accounts receivable reserves and allowances

The components of accounts receivable reserves and allowances were as follows (in millions):

	July 1, 2017		July 2, 2016
Allowance for doubtful accounts	$	1.6	$	2.2
Sales allowance	3.4		2.5
Total accounts receivable reserves and allowances	$	5.0	$	4.7

The activities and balances for allowance for doubtful accounts are as follows (in millions):

	Balance at Beginning of Period		Charged to Costs and Expenses			Deduction (1)			Balance at End of Period
Year Ended July 1, 2017	$	2.2	$	(0.2	)	$	(0.4	)	$	1.6
Year Ended July 2, 2016	2.4		0.3			(0.5		)	2.2
Year Ended June 27, 2015	2.9		0.3			(0.8		)	2.4

(1) Represents the effect of currency translation adjustments and write-offs of uncollectible accounts, net of recoveries.

Inventories, net

The components of inventories, net were as follows (in millions):

	July 2, 2016		July 2, 2016
Finished goods	$	24.9	$	29.1
Work in process	10.3		7.5
Raw materials	12.8		14.8
Inventories, net	$	48.0	$	51.4

Prepayments and other current assets

The components of prepayments and other current assets were as follows (in millions):

	July 1, 2017		July 2, 2016
Prepayments	$	8.3	$	10.4
Other current assets	42.5		21.7
Prepayments and other current assets	$	50.8	$	32.1

Property, plant and equipment, net

The components of property, plant and equipment, net were as follows (in millions):

	July 1, 2017			July 2, 2016
Land	$	14.5		$	14.6
Buildings and improvements	31.4			32.4
Machinery and equipment	225.8			218.7
Furniture, fixtures, software and office equipment	111.2			120.5
Leasehold improvements	58.1			54.3
Construction in progress	17.8			10.3
Property, plant and equipment, gross	458.8			450.8
Less: Accumulated depreciation	(321.9		)	(317.8		)
Property, plant and equipment, net	$	136.9		$	133.0

Other current liabilities

The components of other current liabilities were as follows (in millions):

	July 1, 2017		July 2, 2016
Customer prepayments	$	35.2	$	0.4
Restructuring accrual	8.8		13.3
Income tax payable	3.3		3.3
Warranty accrual	2.9		2.6
VAT liabilities	2.2		2.3
Deferred compensation plan	2.0		2.4
Other	7.0		6.7
Other current liabilities	$	61.4	$	31.0

Other non-current liabilities

The components of other non-current liabilities were as follows (in millions):

	July 1, 2017		July 2, 2016
Pension and post-employment benefits	$	99.4	$	103.0
Financing obligation	27.8		28.7
Long-term deferred revenue	14.0		22.7
Other	22.7		24.7
Other non-current liabilities	$	163.9	$	179.1

Interest and other income, net

The components of interest and other income, net were as follows (in millions):

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Interest income	$	11.1		5.9			$	4.6
Foreign exchange gains (loss), net	0.9			(2.6		)	(3.8		)
Proceeds from Nortel (1)	—			—			2.2
Loss on extinguishment of debt (2)	(1.1		)	—			—
Other income (expense), net	2.2			(0.8		)	0.7
Interest and other income, net	$	13.1		$	2.5		$	3.7

(1) During fiscal 2015, the Company received proceeds of $2.2 million from the Fair Fund established to provide compensation for losses incurred in connection with investments in Nortel Networks Corporation (“Nortel”) securities from the SEC’s claims against Nortel.

(2) During fiscal 2017, the Company repurchased $40.0 million aggregate principal amount of the 2033 Notes for $45.4 million in cash. In connection with the repurchase, a loss on extinguishment of $1.1 million was recognized. Refer to “Note 10. Debt” for more information.

XML

Investments and Fair Value Measurements

12 Months Ended

Jul. 01, 2017

Investments and Fair Value Measurements [Abstract]

Investments and Fair Value Measurements

Note 7. Investments, Forward Contracts and Fair Value Measurements

Available-For-Sale Investments

The Company’s investments in marketable debt securities were primarily classified as available-for-sale investments. As of July 1, 2017, the Company’s available-for-sale securities were as follows (in millions):

	Amortized Cost/ Carrying Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Available-for-sale securities:
U.S. treasuries	$	56.8	$	—	$	(0.1	)	$	56.7
U.S. agencies	45.0		—		(0.1		)	44.9
Municipal bonds and sovereign debt instruments	4.4		—		—			4.4
Asset-backed securities	71.5		—		(0.4		)	71.1
Corporate securities	326.1		0.1		(0.2		)	326.0
Certificates of deposit	6.0		—		—			6.0
Total available-for-sale securities	$	509.8	$	0.1	$	(0.8	)	$	509.1

The Company generally classifies debt securities as cash equivalents, short-term investments or other non-current assets based on the stated maturities; however, certain securities with stated maturities of longer than twelve months which are highly liquid and available to support current operations are also classified as short-term investments. As of July 1, 2017, of the total estimated fair value, $78.2 million was classified as cash equivalents, $430.2 million was classified as short-term investments and $0.7 million was classified as other non-current assets.

As of July 1, 2017, the Company had sold all of its ownership of Lumentum common stock in connection with the Separation. The Lumentum common stock was previously classified as available-for-sale marketable equity securities. During fiscal 2017, the Company sold 7.2 million Lumentum common shares and recognized gross gains of $203.0 million, reflected in "gain on sale of investments" in the Company’s Consolidated Statements of Operations. The sale resulted in no tax effect. The realized gain is also reflected within the operating activities section of the Consolidated Statements of Cash Flows, while the cash proceeds received are reflected in “sales of available-for-sale investments” within the investing activities section.

 In addition to the amounts presented above, as of July 1, 2017, the Company’s short-term investments classified as trading securities related to the deferred compensation plan were $2.0 million, of which $0.5 million was invested in debt securities, $0.3 million was invested in money market instruments and funds and $1.2 million was invested in equity securities. Trading securities are reported at fair value, with the unrealized gains or losses resulting from changes in fair value recognized in the Company’s Consolidated Statements of Operations as a component of interest and other income, net.

During the year endedJuly 1, 2017, July 2, 2016 and June 27, 2015, the Company recorded no other-than-temporary impairment charges in each respective period.

As of July 1, 2017, the Company’s total gross unrealized losses on available-for-sale securities, aggregated by type of investment instrument, were as follows (in millions):

	Less than 12 Months			Greater than 12 Months			Total
U.S. treasuries and agencies	$	(0.2	)	—			$	(0.2	)
Asset-backed securities	(0.1		)	$	(0.3	)	$	(0.4	)
Corporate securities	(0.2		)	—			(0.2		)
Total gross unrealized losses	$	(0.5	)	$	(0.3	)	$	(0.8	)

As of July 1, 2017, contractual maturities of the Company’s debt securities classified as available-for-sale securities were as follows (in millions):

	Amortized Cost/Carrying Cost		Estimated Fair Value
Amounts maturing in less than 1 year	$	365.3	$	365.2
Amounts maturing in 1 - 5 years	143.5		143.2
Amounts maturing in more than 5 years	1.0		0.7
Total debt available-for-sale securities	$	509.8	$	509.1

 As of July 2, 2016, the Company’s available-for-sale securities were as follows (in millions):

	Amortized Cost/ Carrying Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Debt securities:
U.S. treasuries	$	46.1	$	—	$	—		$	46.1
U.S. agencies	24.9		—		—			24.9
Municipal bonds and sovereign debt instruments	2.0		—		—			2.0
Asset-backed securities	50.4		0.1		(0.3		)	50.2
Corporate securities	224.5		0.2		(0.1		)	224.6
Total debt securities	347.9		0.3		(0.4		)	347.8
Marketable equity securities	62.1		109.2		—			171.3
Total available-for-sale securities	$	410.0	$	109.5	$	(0.4	)	$	519.1

 As of July 2, 2016, of the total estimated fair value of debt securities, $36.1 million was classified as cash equivalents, $311.1 million was classified as short-term investments and $0.6 million was classified as other non-current assets.

Marketable equity securities consisted of the Company’s ownership of 7.2 million shares of Lumentum common stock remaining as of July 2, 2016 in connection with the Separation. These securities are stated at fair value, with change in unrealized gains and losses reported in other comprehensive income, net of tax and are classified as short-term investments on the Consolidated Balance Sheet as of July 2, 2016 at $171.3 million. The Company sold 4.5 million Lumentum common shares during the third and fourth quarters of fiscal 2016 and recognized gross realized gain of $71.5 million, reflected in "Gain on sale of investments" in the Company’s Consolidated Statements of Operations. The sale resulted in $2.0 million tax effect related to the intraperiod tax allocation rules. 

In addition to the amounts presented above, as of July 2, 2016, the Company’s short-term investments classified as trading securities, related to the deferred compensation plan, were $2.4 million, of which $0.3 million was invested in debt securities, $0.8 million was invested in money market instruments and funds and $1.3 million was invested in equity securities.

As of July 2, 2016, the Company’s total gross unrealized losses on available-for-sale securities, aggregated by type of investment instrument, were as follows (in millions):

	Less than 12 Months			Greater than 12 Months			Total
Asset-backed securities	$	—		$	(0.3	)	$	(0.3	)
Corporate securities	(0.1		)	—			(0.1		)
Total gross unrealized losses	$	(0.1	)	$	(0.3	)	$	(0.4	)

Fair Value Measurements

Assets measured at fair value as of July 1, 2017 and July 2, 2016 are summarized below (in millions):

	Fair Value Measurement as of						Fair Value Measurement as of
	July 1, 2017						July 2, 2016
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Debt available-for-sale securities:
U.S. treasuries	$	56.7	$	56.7	$	—	$	46.1	$	46.1	$	—
U.S. agencies	44.9		—		44.9		24.9		—		24.9
Municipal bonds and sovereign debt instruments	4.4		—		4.4		2.0		—		2.0
Asset-backed securities	71.1		—		71.1		50.2				50.2
Corporate securities	326.0		—		326.0		224.6		—		224.6
Certificate of deposits	6.0		—		6.0		—
Total debt available-for-sale securities	509.1		56.7		452.4		347.8		46.1		301.7
Marketable equity securities	—		—		—		171.3		171.3		—
Money market funds	726.4		726.4		—		274.4		274.4		—
Trading securities	2.0		2.0		—		2.4		2.4		—
Foreign currency forward contracts	7.3		—		7.3		—
Total assets (1)	$	1,244.8	$	785.1	$	459.7	$	795.9	$	494.2	$	301.7
Liability:
Foreign currency forward contracts	1.3		—		1.3		—		—		—
Total liabilities (2)	$	1.3	$	—	$	1.3	$	—	$	—	$	—

(1) $789.2 million in cash and cash equivalents, $432.2 million in short-term investments, $11.0 million in restricted cash, $7.3 million in other current assets, and $5.1 million in other non-current assets on the Company’s Consolidated Balance Sheets as of July 1, 2017. $295.4 million in cash and cash equivalents, $484.7 million in short-term investments, $11.3 million in restricted cash, and $4.5 million in other non-current assets on the Company’s Consolidated Balance Sheets as of July 2, 2016.

(2) $1.3 million in other current liabilities on the Company’s Consolidated Balance Sheets as of July 1, 2017.

Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. There is an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the assumptions about the factors that market participants would use in valuing the asset or liability.

The Company’s cash and investment instruments are classified within Level 1 or Level 2 of the fair value hierarchy based on quoted prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.

• Level 1 includes financial instruments for which quoted market prices for identical instruments are available in active markets. Level 1 assets of the Company include money market funds, U.S. Treasury securities, and marketable equity securities as they are traded with sufficient volume and frequency of transactions. 

• Level 2 includes financial instruments for which the valuations are based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 2 instruments of the Company generally include certain U.S. and foreign government and agency securities, commercial paper, corporate and municipal bonds and notes, asset-backed securities, certificates of deposit, and foreign currency forward contracts. To estimate their fair value, the Company utilizes pricing models based on market data. The significant inputs for the valuation model usually include benchmark yields, reported trades, broker and dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data, and industry and economic events. 

• Level 3 includes financial instruments for which fair value is derived from valuation based on inputs that are unobservable and significant to the overall fair value measurement. As of July 1, 2017 and July 2, 2016, the Company did not hold any Level 3 investment securities.

Non-Designated Foreign Currency Forward Contracts

The Company has foreign subsidiaries that operate and sell the Company’s products in various markets around the world. As a result, the Company is exposed to foreign exchange risks. The Company utilizes foreign exchange forward contracts to manage foreign currency risk associated with foreign currency denominated monetary assets and liabilities, primarily certain short-term intercompany receivables and payables, and to reduce the volatility of earnings and cash flows related to foreign-currency transactions. The Company does not use these foreign currency forward contracts for trading purposes.

As of July 1, 2017, the Company had forward contracts that were effectively closed but not settled with the counterparties by year end. Therefore, the fair value of these contracts of $7.3 million and $1.3 million is reflected as prepayments and other current assets and other current liabilities in the Consolidated Balance Sheets as of July 1, 2017, respectively.

The forward contracts outstanding and not effectively closed, with a term of less than 120 days, were transacted near year end; therefore, the fair value of the contracts is not significant. As of July 1, 2017 and July 2, 2016, the notional amounts of the forward contracts the Company held to purchase foreign currencies were $134.3 million and $110.0 million, respectively, and the notional amounts of forward contracts the Company held to sell foreign currencies were $25.4 million and $55.2 million, respectively.

The change in the fair value of these foreign currency forward contracts is recorded as gain or loss in the Company’s Consolidated Statements of Operations as a component of interest and other income, net. The cash flows related to the settlement of foreign currency forward contracts are classified as operating activities. The foreign exchange forward contracts earned a gain of $3.3 million and incurred a loss of $9.6 million for the years ended July 1, 2017 and July 2, 2016 respectively.

XML

Goodwill

12 Months Ended

Jul. 01, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

Note 8. Goodwill

The following table presents the changes in goodwill allocated to the Company’s reportable segments (in millions):

	Network Enablement			Service Enablement			Optical Security and Performance Products		Total
Balance as of June 27, 2015 (1)	$	154.5		$	92.7		$	8.3	$	255.5
Goodwill allocation - WaveReady (3)	(6.0		)	—			—		$	(6.0	)
Currency translation and other adjustments	(4.7		)	(1.3		)	—		$	(6.0	)
Goodwill impairment charge	—			(91.4		)	—		(91.4		)
Balance as of July 2, 2016 (2)	$	143.8		$	—		$	8.3	$	152.1
Currency translation	(0.5		)	—			—		$	(0.5	)
Balance as of July 1, 2017 (4)	$	143.3		$	—		$	8.3	$	151.6

(1) Gross goodwill balances for NE, SE and OSP were $456.4 million, $273.9 million and $92.8 million, respectively as of June 27, 2015. Accumulated impairment for NE, SE and OSP was $301.9 million, $181.2 million and $84.5 million, respectively as of June 27, 2015.

(2) Gross goodwill balances for NE, SE and OSP were $445.7 million, $272.6 million and $92.8 million, respectively as of July 2, 2016. Accumulated impairment for NE, SE and OSP was $301.9 million, $272.6 million and $84.5 million, respectively as of July 2, 2016.

(3) Amount represents a release of the relative fair value of goodwill in our NE reporting unit related to the WaveReady products line, which is now a part of Lumentum as of the Separation Date. Refer to “Note 3. Discontinued Operations” for more information about the Separation.

(4) Gross goodwill balances for NE, SE and OSP were $445.2 million, $272.6 million and $92.8 million, respectively as of July 1, 2017. Accumulated impairment for NE, SE and OSP was $301.9 million, $272.6 million and $84.5 million, respectively as of July 1, 2017.

The following table presents gross goodwill and aggregate impairment balances for the fiscal years ended July 1, 2017, and July 2, 2016 (in millions):

	years ended
	July 1, 2017			July 2, 2016
Gross goodwill balance	$	810.6		$	811.1
Accumulated impairment losses	(659.0		)	(659.0		)
Net goodwill balance	$	151.6		$	152.1

Impairment of Goodwill

The Company reviews goodwill for impairment annually during the fourth quarter of the fiscal year or more frequently if events or circumstances indicate that an impairment loss may have occurred. The Company determined that, based on its organizational structure and the financial information that is provided to and reviewed by management during fiscal 2017 and 2016, its reporting units were NE, SE and OSP.

Fiscal 2017

During the fourth quarter of fiscal 2017, the Company early adopted the new authoritative guidance that eliminated the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, any impairment charge would be based on the excess of a reporting unit's carrying amount over its fair value.

During the fourth quarter of fiscal 2017, the Company performed the quantitative goodwill impairment test in accordance with the authoritative guidance for impairment test of the NE reporting unit. The fair value of NE was determined based on a combination of the income approach, which estimates the fair value based on the future discounted cash flows, and the market approach, which estimates the fair value based on multiples of earnings or revenue, or a similar performance measure. Based on the first step of the analysis, the Company determined that the fair value of NE is above its carrying amount.

The Company reviewed goodwill of the OSP reporting unit under the qualitative assessment of the authoritative guidance for impairment testing. The Company concluded that it was more likely than not that the fair value of OSP exceeded its carrying amount. In assessing the qualitative factors, the Company considered the impact of key factors, including changes in industry and competitive environment, market capitalization, earnings multiples, budgeted-to-actual operating performance from prior year, and consolidated company stock price and performance. As such, it was not necessary to perform the first step of the goodwill impairment test at this time.

The Company recorded no impairment charge in accordance with its annual impairment test.

Fiscal 2016

Interim Review

During the first quarter of fiscal 2016, the Company released the relative fair value of goodwill in its NE reporting unit related to the WaveReady products line which became part of Lumentum as of the Separation Date. In connection with this change in the NE reporting unit, the Company performed a goodwill impairment test for its NE reporting unit under the qualitative assessment of the authoritative guidance for impairment testing. The Company concluded that it was more likely than not that the fair value of the NE reporting unit exceeded its carrying amount. There were no events or changes in circumstances which triggered an impairment review for the remaining reporting units.

Annual Review

During the fourth quarter the Company performed the goodwill impairment test for all its reporting units under the two-step quantitative goodwill impairment test in accordance with the authoritative guidance. Other than noted above, there were no other triggering events during the interim periods of fiscal 2016. Thus, the Company reviewed goodwill for impairment during the fourth quarter, in line with the completion of its annual operating plan for fiscal 2017.

Under the first step of the authoritative guidance for impairment testing, the fair value of the NE and OSP reporting units was determined based on a combination of the income approach, which estimates the fair value based on the future discounted cash flows, and the market approach, which estimates the fair value based on multiples of earnings or revenue, or a similar performance measure. The market approach estimates the fair value of the business based on a comparison of the reporting unit to comparable publicly traded companies in similar lines of business. Due to lack of comparability with its peer companies, the fair value of the SE reporting unit was determined only utilizing the income approach. The Company assumed a cash flow period of 10 years, long-term annual growth rates of 3.0% to 7.0%, discount rates of 14.0% to 17.0% and terminal value growth rates of 3.0% to 5.0%. The Company believes that the assumptions and rates used in the impairment test are reasonable, but they are judgmental, and variations in any of the assumptions or rates could result in materially different calculations of impairment amounts. The determination of the estimated fair value of goodwill required the use of significant unobservable inputs which are considered Level 3 fair value measurements. The sum of the fair values of the reporting units was reconciled to the Company’s current market capitalization plus an estimated control premium. Based on the first step of the authoritative guidance for impairment testing, the Company concluded that the fair value of all reporting units, except SE, were in excess of their carrying value. The fair value of the SE reporting unit was lower than the carrying value based on the completion of its annual operating plan for fiscal 2017 in the fourth quarter which revealed a longer investment cycle being needed for certain growth products within SE, coupled with a decline in the reporting unit’s revenue and operating profitability in fiscal 2016 as compared to fiscal 2015 when goodwill was last tested for impairment.

The second step of the goodwill impairment test involved performing a hypothetical purchase price allocation to determine the implied fair value of the SE reporting unit’s goodwill. This process is complex and required judgment in the development of assumptions that affected the determination of the fair value of the SE reporting unit’s individual assets and liabilities, including previously unrecognized intangible assets. Based on the step two analysis, the Company determined that all of the SE goodwill balance of $91.4 million was impaired and therefore recorded an impairment charge in the fourth quarter of fiscal 2016 in the accompanying Consolidated Statements of Operations. Prior to completing the goodwill impairment test, the Company tested the recoverability of the SE long-lived assets (other than goodwill) and concluded that such assets were not impaired.

Fiscal 2015

Interim Review

As the Company reorganized its NSE segment into two reportable segments, NE and SE, during the first quarter of fiscal 2015, goodwill allocated to the new NE and SE reporting units was reviewed under the two-step quantitative goodwill impairment test in accordance with the authoritative guidance.

The fair value of the new reporting units was determined based on a combination of the income approach, which estimates the fair value based on the future discounted cash flows, and the market approach, which estimates the fair value based on multiples of earnings or revenue, or a similar performance measure. Based on the first step of the analysis, the Company determined that the fair value of each reporting unit is significantly above its carrying amount. As such, the Company was not required to perform step two of the analysis. The Company recorded no impairment charge as a result of the interim period impairment test performed during the three months ended September 27, 2014. There were no events or changes in circumstances which triggered an impairment review for the remaining reporting units.

Annual Review

During the fourth quarter, the Company reviewed the goodwill of all its reporting units under the qualitative assessment of the authoritative guidance for impairment testing. The Company concluded that it was more likely than not that the fair value of the reporting units with goodwill exceeded its carrying amount. In assessing the qualitative factors, the Company considered the impact of key factors, including changes in industry and competitive environment, budgeted-to-actual operating performance from prior year, and consolidated company stock price and performance. As such, it was not necessary to perform the two-step goodwill impairment test at that time and the Company recorded no impairment charge as a result of its annual impairment test.

XML

Acquired Developed Technology and Other Intangibles

12 Months Ended

Jul. 01, 2017

Acquired Developed Technology and Other Intangibles

Acquired Developed Technology and Other Intangibles

Note 9. Acquired Developed Technology and Other Intangibles

The following tables present details of the Company’s acquired developed technology, customer relationships and other intangibles (in millions):

As of July 1, 2017	Gross Carrying Amount		Accumulated Amortization			Net
Acquired developed technology	$	369.3	$	(352.0	)	$	17.3
Customer relationships	94.9		(81.3		)	13.6
Other (1)	9.9		(9.7		)	0.2
Total intangibles	$	474.1	$	(443.0	)	$	31.1

As of July 2, 2016	Gross Carrying Amount		Accumulated Amortization			Net
Acquired developed technology	$	369.3	$	(337.3	)	$	32.0
Customer relationships	95.6		(68.0		)	27.6
Other (1)	10.8		(10.5		)	0.3
Total intangibles	475.7		(415.8		)	59.9

(1) Other intangibles consist of customer backlog, non-competition agreements, patents, proprietary know-how and trade secrets, trademarks and trade names.

Fiscal 2016

During the first quarter of fiscal 2016, the Company completed its in-process research and development (“IPR&D”) project related to the fiscal 2014 acquisition of Trendium. Accordingly, $1.8 million was transferred from indefinite life intangible assets to acquired developed technology intangible assets with a useful life of thirty-six months.

Fiscal 2015

During fiscal 2015, the Company completed its IPR&D project related to the fiscal 2014 acquisition of Network Instruments. Accordingly, $1.7 million was transferred from indefinite life intangible assets to acquired developed technology intangible assets and the Company began amortizing over its useful life of fifty-two months. Also during fiscal 2015, the Company recorded a $3.6 million IPR&D impairment charge for an ongoing project related to the fiscal 2014 acquisition of Trendium in accordance with the authoritative accounting guidance. The charge was recorded to Research and development (“R&D”) expense in the Consolidated Statements of Operations.

During fiscal 2017, 2016 and 2015, the Company recorded $28.3 million, $31.9 million and $51.4 million, respectively, of amortization related to acquired developed technology and other intangibles. The following table presents details of the Company’s amortization (in millions):

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Cost of revenues	$	14.3	$	17.3	$	31.9
Operating expense	14.0		14.6		19.5
Total	$	28.3	$	31.9	$	51.4

Based on the carrying amount of acquired developed technology, customer relationships and other intangibles as of July 1, 2017, and assuming no future impairment of the underlying assets, the estimated future amortization is as follows (in millions):

Fiscal Years
2018	$	20.1
2019	9.3
2020	1.4
2021	0.3
Total amortization	$	31.1

XML

Debt

12 Months Ended

Jul. 01, 2017

Debt Disclosure [Abstract]

Debt

Note 10. Debt

As of July 1, 2017 and July 2, 2016, the Company’s long-term debt on the Consolidated Balance Sheets represented the carrying amount of the liability component, net of unamortized debt discounts and issuance cost, of the Senior Convertible Notes as discussed below. The following table presents the carrying amounts of the liability and equity components (in millions):

	July 1, 2017			July 2, 2016
Principal amount of 0.625% Senior Convertible Notes	$	610.0		$	650.0
Principal amount of 1.00% Senior Convertible Notes	460.0			—
Unamortized discount of liability component	(129.4		)	(61.7		)
Unamortized debt issuance cost (1)	(9.2		)	(5.0		)
Carrying amount of liability component	$	931.4		$	583.3
Carrying amount of equity component (2)	$	229.7		$	134.4

(1) In April 2015, the Financial Accounting Standards Board ("FASB") issued new authoritative guidance to simplify the presentation of debt issuance costs by requiring debt issuance costs to be presented as a deduction from the corresponding liability, consistent with debt discounts or premiums. This guidance was effective for the Company in the first quarter of fiscal 2017 for its convertible debt, and was applied retrospectively for all periods reported.

(2) Included in additional paid-in-capital on the Consolidated Balance Sheets.

The Company was in compliance with all debt covenants and held no short term debt as of July 1, 2017 and July 2, 2016.

1.00% Senior Convertible Notes (“2024 Notes”)

On March 3, 2017, the Company issued $400 million aggregate principal amount of 1.00% Senior Convertible Notes due 2024 (the “2024 Notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. On March 22, 2017, the Company issued an additional $60 million upon exercise of the over-allotment option of the initial purchasers. The total proceeds from the 2024 Notes amounted to $451.1 million after issuance costs. The 2024 Notes are an unsecured obligation of the Company and bear interest at an annual rate of 1.00% payable in cash semi-annually in arrears on March 1 and September 1 of each year. The 2024 Notes mature on March 1, 2024 unless earlier converted or repurchased.

Under certain circumstances and during certain periods, the 2024 Notes may be converted at the option of the holders into cash up to the principal amount, with the remaining amount converted into cash, shares of the Company’s common stock, or a combination of cash and shares of the Company’s common stock at the Company’s election. The initial conversion price is $13.22 per share, representing a 32.5% premium to the closing sale price of the Company’s common stock on the pricing date, February 27, 2017, which will be subject to customary anti-dilution adjustments.

The 2024 Notes may be converted at any time on or prior to the close of business on the business day immediately preceding December 1, 2023, in multiples of $1,000 principal amount, at the option of the holder only under the following circumstances: (i) on any date during any calendar quarter beginning after June 30, 2017 (and only during such calendar quarter) if the closing price of Viavi’s common stock was more than 130% of the then current conversion price for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading-day period ending on the last trading day of the previous calendar quarter, (ii)if the Company distributes to all or substantially all holders of our common stock rights or warrants (other than pursuant to a stockholder rights plan) entitling them to purchase, for a period of 45 calendar days or less, shares of our common stock at a price less than the average closing sale price of our common stock for the ten trading days preceding the declaration date for such distribution, (iii) if the Company distributes to all or substantially all holders of our common stock, cash or other assets, debt securities or rights to purchase our securities (other than pursuant to a stockholder rights plan), at a per share value exceeding 10% of the closing sale price of our common stock on the trading day preceding the declaration date for such distribution, (iv) if the Company is party to a specified transaction, a fundamental change or a make-whole fundamental change (each as defined in the Indenture), or (v) during the five consecutive business-day period immediately following any 10 consecutive trading-day period in which the trading price per $1,000 principal amount of the Notes for each day during such 10 consecutive trading-day period was less than 98% of the product of the closing sale price of Viavi’s common stock and the applicable conversion rate on such date. During the periods from, and including, December 1, 2023 until the close of business on the business day immediately preceding the maturity date, holders of the Notes may convert the Notes regardless of the circumstances described in the immediately preceding sentence.

Holders of the 2024 Notes may require Viavi to repurchase for cash all or a portion of the Notes upon the occurrence of a fundamental change (as defined in the Indenture) at a repurchase price equal to 100% of the principal amount of the 2024 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the date of repurchase.

The Indenture provides for customary events of default, including payment defaults, breaches of covenants, failure to pay certain judgments and certain events of bankruptcy, insolvency and reorganization. If an event of default occurs and is continuing, the principal amount of the 2024 Notes, plus accrued and unpaid interest, if any, may be declared immediately due and payable, subject to certain conditions set forth in the Indenture. These amounts automatically become due and payable if an event of default relating to certain events of bankruptcy, insolvency or reorganization occurs.

In accordance with the authoritative accounting guidance, the Company separated the 2024 Notes into liability and equity components. The carrying value of the liability component at issuance was calculated as the present value of its cash flows using a discount rate of 4.8% based on the 7-year swap rate plus credit spread as of the issuance date. The credit spread for the Company is based on the historical average “yield to worst” rate for BB rated issuers. The difference between the 2024 Notes principal and the carrying value of the liability component, representing the value of conversion premium assigned to the equity component, was recorded as a debt discount on the issuance date and is being accreted using the effective interest rate of 4.8% over the period from the issuance date through March 1, 2024 as a non-cash charge to interest expense. The carrying value of the liability component was determined to be $358.1 million, and the equity component, or debt discount, of the 2024 Notes was determined to be $101.9 million. As of July 1, 2017, the expected remaining term of the 2024 Notes is 6.7 years.

In connection with the issuance of the 2024 Notes, the Company incurred $8.9 million of issuance costs, which were bifurcated into the debt issuance costs (attributable to the liability component) of $6.9 million and the equity issuance costs (attributable to the equity component) of $2.0 million based on their relative values. The debt issuance costs were capitalized and are being amortized to interest expense using the effective interest rate method from issuance date through March 1, 2024. The equity issuance costs were netted against the equity component in additional paid-in capital at the issuance date. As of July 1, 2017, the unamortized portion of the debt issuance costs related to the 2024 Notes was $6.6 million, which was included as a direct reduction from the carrying amount of the debt on the Consolidated Balance Sheets.

Based on quoted market prices as of July 1, 2017, the fair value of the 2024 Notes was approximately $481.7 million. The 2024 Notes are classified within Level 2 as they are not actively traded in markets.

0.625% Senior Convertible Notes (“2033 Notes”)

On August 21, 2013, the Company issued $650.0 million aggregate principal amount of 0.625% Senior Convertible Notes due 2033 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The proceeds from the 2033 Notes amounted to $636.3 million after issuance costs. The 2033 Notes are an unsecured obligation of the Company and bear interest at an annual rate of 0.625% payable in cash semi-annually in arrears on February 15 and August 15 of each year. The 2033 Notes mature on August 15, 2033 unless earlier converted, redeemed or repurchased.

Under certain circumstances and during certain periods, the 2033 Notes may be converted at the option of the holders into cash up to the principal amount, with the remaining amount converted into cash, shares of the Company’s common stock, or a combination of cash and shares of the Company’s common stock at the Company’s election. The initial conversion price is $18.83 per share, representing a 40.0% premium to the closing sale price of the Company’s common stock on the pricing date, August 15, 2013, which will be subject to customary anti-dilution adjustments. Holders may convert the 2033 Notes at any time on or prior to the close of business on the business day immediately preceding February 15, 2033, and other than during the period from, and including, February 15, 2018 until the close of business on the business day immediately preceding August 20, 2018, in multiples of $1,000 principal amount, under the following circumstances:

• on any date during any calendar quarter beginning after December 31, 2013 (and only during such calendar quarter) if the closing price of the Company’s common stock was more than 130% of the then current conversion price for at least 20 trading days during the 30 consecutive trading-day period ending the last trading day of the previous calendar quarter; 

• if the 2033 Notes are called for redemption; 

• upon the occurrence of specified corporate events; 

• if the Company is party to a specified transaction, a fundamental change or a make-whole fundamental change (each as defined in the indenture of the 2033 Notes); or 

• during the five consecutive business-day period immediately following any 10 consecutive trading-day period in which the trading price per $1,000 principal amount of the 2033 Notes for each day of such 10 consecutive trading-day period was less than 98% of the product of the closing sale price of the Company’s common stock and the applicable conversion rate on such date.

During the periods from, and including, February 15, 2018 until the close of business on the business day immediately preceding August 20, 2018 and from, and including, February 15, 2033 until the close of business on the business day immediately preceding the maturity date, holders may convert the 2033 Notes at any time, regardless of the foregoing circumstances.

In the fourth quarter of fiscal 2015, holders of the 2033 Notes were given notice of the planned separation of the Lumentum business and the right to convert any debentures they own from the date of notice through the end of the business day preceding the ex-dividend date. No holders of the 2033 Notes exercised the conversion right before it expired.

Following the separation of the Lumentum business on August 1, 2015, the conversion price per share was adjusted pursuant to the terms of the 2033 Notes relating to the occurrence of a spin-off event. Effective as of the end of the business day on August 17, 2015, the initial conversion price per share was adjusted to $11.28 per share of the Company’s common stock traded on NASDAQ under the ticker symbol “VIAV.”

Holders of the 2033 Notes may require the Company to purchase all or a portion of the 2033 Notes on each of August 15, 2018, August 15, 2023 and August 15, 2028, or upon the occurrence of a fundamental change, in each case, at a price equal to 100% of the principal amount of the 2033 Notes to be purchased, plus accrued and unpaid interest to, but excluding the purchase date. The Company may redeem all or a portion of the 2033 Notes for cash at any time on or after August 20, 2018, at a redemption price equal to 100% of the principal amount of the 2033 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.

In accordance with the authoritative accounting guidance, the Company separated the 2033 Notes into liability and equity components. The carrying value of the liability component at issuance was calculated as the present value of its cash flows using a discount rate of 5.4% based on the 5-year swap rate plus credit spread as of the issuance date. The credit spread for the Company is based on the historical average “yield to worst” rate for BB rated issuers. The difference between the 2033 Notes principal and the carrying value of the liability component, representing the value of conversion premium assigned to the equity component, was recorded as a debt discount on the issuance date and is being accreted using the effective interest rate of 5.4% over the period from the issuance date through August 15, 2018 as a non-cash charge to interest expense. The carrying value of the liability component was determined to be $515.6 million, and the equity component, or debt discount, of the 2033 Notes was determined to be $134.4 million. As of July 1, 2017, the expected remaining term of the 2033 Notes is 1.1 years.

In connection with the issuance of the 2033 Notes, the Company incurred $13.7 million of issuance costs, which were bifurcated into the debt issuance costs, attributable to the liability component of $10.9 million and the equity issuance costs, attributable to the equity component of $2.8 million based on their relative values. The debt issuance costs were capitalized and are being amortized to interest expense using the effective interest rate method from issuance date through August 15, 2018. The equity issuance costs were netted against the equity component in additional paid-in capital at the issuance date. As of July 1, 2017, the unamortized portion of the debt issuance costs related to the 2033 Notes was $2.6 million, which was included as a direct reduction from the carrying amount of the debt on the Consolidated Balance Sheets.

During fiscal 2017, the Company repurchased $40.0 million aggregate principal amount of the notes for $45.4 million in cash. In connection with the repurchase, a loss on extinguishment of $1.1 million was recognized in interest and other income, net in compliance with the authoritative guidance. After giving effect to the repurchase, the total amount of 0.625% Senior Convertible Notes outstanding as of July 1, 2017 was $610.0 million.

Based on quoted market prices as of July 1, 2017 and July 2, 2016, the fair value of the 2033 Notes was approximately $676.1 million and $633.0 million. The 2033 Notes are classified within Level 2 as they are not actively traded in markets.

Interest Expense

The following table presents the interest expense for contractual interest, amortization of debt issuance cost and accretion of debt discount (in millions):

	Years ended
	July 1, 2017		July 2, 2016
Interest expense-contractual interest	$	5.5	$	4.1
Amortization of debt issuance cost	2.5		2.1
Accretion of debt discount	32.1		26.7

XML

Restructuring and Related Charges

12 Months Ended

Jul. 01, 2017

Restructuring and Related Activities [Abstract]

Restructuring and Related Charges

Note 11. Restructuring and Related Charges

The Company has initiated various strategic restructuring events primarily intended to reduce its costs, consolidate its operations, rationalize the manufacturing of its products and align its businesses in response to market conditions. As of July 1, 2017 and July 2, 2016, the Company’s total restructuring accrual was $11.0 million and $18.0 million, respectively. During fiscal years 2017, 2016 and 2015 the Company recorded restructuring and related charges of $21.6 million, $10.5 million and $26.8 million, respectively. The Company’s restructuring charges can include severance and benefit costs to eliminate a specified number of positions, facilities and equipment costs to vacate facilities and consolidate operations, and lease termination costs. The timing of associated cash payments is dependent upon the type of restructuring charge and can extend over multiple periods.

Summary of Restructuring Plans

The adjustments to the accrued restructuring expenses related to all of the Company’s restructuring plans described below for the fiscal year endedJuly 1, 2017 were as follows (in millions):

	Balance as of July 2, 2016		Fiscal Year 2017 Charges (Releases)			Cash Settlements			Non-cash Settlements and Other Adjustments			Balance as of July 1, 2017
Fiscal 2017 Plan
OSP Restructuring Plan (1)	$	—	$	0.8		$	—		$	—		$	0.8
Focused NSE Restructuring Plan (1) (2)	—		21.3			(16.5		)	0.1			4.9
Other Plans (2)	—		0.4			(0.4		)	—			—
Fiscal 2016 Plan
NE, SE and Shared Services Agile Restructuring Plan (1) (2)	8.6		(0.7		)	(7.7		)	—			0.2
NE and SE Agile Restructuring Plan (1)	0.8		(0.1		)	(0.3		)	—			0.4
Fiscal 2015 Plan
NE, SE and Shared Service Separation Restructuring Plan (1) (2)	1.4		(0.2		)	(1.1		)	—			0.1
Plans Prior to Fiscal 2015
NE Product Strategy Restructuring Plan (1)	1.5		—			(0.5		)	(0.1		)	0.9
NE Lease Restructuring Plan (2)	4.0		0.1			(1.5		)	—			2.6
Other Plans (1) (2)	1.7		—			(0.6		)	—			1.1
Total	$	18.0	$	21.6		$	(28.6	)	$	—		$	11.0

(1) Plan type includes workforce reduction cost.

(2) Plan type includes lease exit cost.

As of July 1, 2017 and July 2, 2016, $2.2 million and $4.7 million, respectively, of our restructuring liability was long-term in nature and included as a component of Other non-current liabilities, with the remaining short-term portion included as a component of Other current liabilities on the Consolidated Balance Sheets.

Fiscal 2017 Plans

OSP Restructuring Plan

During the fourth quarter of fiscal 2017, Management approved a plan within the OSP business segment to realign its operations and exit from the printed security product portfolio. As a result, a restructuring charge of $0.8 million was recorded for severance and employee benefits for approximately 30 employees in manufacturing and SG&A functions locatedin the United States. Payments related to the severance and benefits accrual are expected to be paid by the end of the third quarter of fiscal 2018.

Focused NSE Restructuring Plan

During the third and second quarters of fiscal 2017, Management approved a plan within the NE and SE business segments as part of Viavi’s continued strategy to improve profitability in the Company’s Network and Service Enablement (NSE) business by narrowing the scope of the Service Enablement business and reducing costs by streamlining NSE operations. As a result, a restructuring charge of $21.0 million was recorded for severance and employee benefits for approximately 300 employees in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia. Payments related to the severance and benefits accrual are expected to be paid in the second quarter of fiscal 2018.

Fiscal 2016 Plans

NE, SE and Shared Service Agile Restructuring Plan

During the fourth quarter of fiscal 2016, Management approved a plan within the NE and SE business segment and Shared Services function for organizational alignment and consolidation as part of the Company’s continued commitment for a more cost effective organization. As a result, approximately 170 employees primarily in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the first quarter of fiscal 2018.

NE and SE Agile Restructuring Plan

During the second quarter of fiscal 2016, Management approved a plan primarily impacting the NE and SE business segments as part of Company’s ongoing commitment for an agile and more efficient operating structure. As a result, approximately 40 employees primarily in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the second quarter of fiscal 2018.

Fiscal 2015 Plans

NE, SE and Shared Service Separation Restructuring Plan

During the second, third and fourth quarters of fiscal 2015, Management approved a plan to eliminate certain positions in its shared services functions in connection with the Company’s plan to split into two separate public companies. Further, Management consolidated its operations, sales and R&D organizations and eliminated positions within the NE and SE segments to align to the Company’s product market strategy and lower manufacturing costs in connection with the Separation. As a result, approximately 330 employees in manufacturing, R&D and SG&A functions located in North America, Latin America, Europe and Asia were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the third quarter of fiscal 2018. During the fourth quarter of fiscal 2015, Management also approved a plan in the NE and SE segment to exit the space in Roanoke, Virginia. As of July 2, 2016, the Company exited the workspace in Roanoke under the plan and all payment were paid by the end of the fourth quarter of fiscal 2017.

Plans Prior to Fiscal 2015

NE Product Strategy Restructuring Plan

During the third quarter of fiscal 2014, Management approved a NE plan to realign its services, support and product resources in response to market conditions in the mobile assurance market and to increase focus on software products and next generation solutions through acquisitions and R&D. As a result, approximately 60 employees primarily in SG&A and manufacturing functions located in North America, Latin America, Asia and Europe were impacted. Payments related to the remaining severance and benefits accrual are expected to be paid by the end of the first quarter of fiscal 2020.

NE Lease Restructuring Plan

During the second quarter of fiscal 2014, Management approved a NE plan to exit the remaining space in Germantown, Maryland. As of June 28, 2014, the Company exited the space in Germantown under the plan. The fair value of the remaining contractual obligations, net of sublease income, as of July 1, 2017 was $2.6 million. Payments related to the Germantown lease costs are expected to be paid by the end of the second quarter of fiscal 2019.

As of July 1, 2017, the restructuring accrual for other plans that commenced prior to fiscal year 2015 was $1.1 million, which consists of immaterial accruals from various restructuring plans.

XML

Income Taxes

12 Months Ended

Jul. 01, 2017

Income Tax Disclosure [Abstract]

Income Taxes

Note 12. Income Taxes

The Company’s income (loss) before income taxes consisted of the following (in millions):

	Years Ended
	July 1, 2017		July 2, 2016			June 27, 2015
Domestic	$	94.7	$	(110.9	)	$	(173.1	)
Foreign	91.9		65.0			67.8
Income (loss) before income taxes	$	186.6	$	(45.9	)	$	(105.3	)

The Company’s income tax expense (benefit) consisted of the following (in millions):

	Years Ended
	July 1, 2017		July 2, 2016			June 27, 2015
Federal:
Current	$	—	$	—		$	0.1
Deferred	1.0		(26.2		)	2.3
	1.0		(26.2		)	2.4
State:
Current	0.2		—			(0.1		)
Deferred	—		(1.5		)	0.1
	0.2		(1.5		)	—
Foreign:
Current	18.0		21.3			17.9
Deferred	2.1		10.9			5.8
	20.1		32.2			23.7
Total income tax expense	$	21.3	$	4.5		$	26.1

The federal deferred tax expense primarily relates to the amortization of tax deductible goodwill. The foreign current expense primarily relates to the Company’s profitable operations in certain foreign jurisdictions. The foreign deferred tax expense primarily relates to the use of deferred tax assets in profitable foreign jurisdictions.

There was no material tax benefit associated with exercise of stock options for the fiscal years ended July 1, 2017, July 2, 2016 and June 27, 2015.

A reconciliation of the Company’s income tax expense (benefit) at the federal statutory rate to the income tax expense at the effective tax rate is as follows (in millions):

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Income tax expense (benefit) computed at federal statutory rate	$	65.3		$	(16.1	)	$	(36.8	)
Goodwill impairment	—			19.4			—
Intraperiod allocation	—			(20.7		)	—
Foreign rate differential	(6.6		)	(2.0		)	(2.3		)
Valuation allowance	(27.4		)	18.2			56.7
Research and experimentation benefits and other tax credits	(1.4		)	(1.1		)	(0.9		)
Reversal of previously accrued taxes	(0.2		)	—			(0.8		)
Permanent items	(9.1		)	6.7			8.0
Other	0.7			0.1			2.2
Income tax expense	$	21.3		$	4.5		$	26.1

The components of the Company’s net deferred taxes consisted of the following (in millions):

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Gross deferred tax assets:
Tax credit carryforwards	$	150.6		$	141.0		$	131.4
Net operating loss carryforwards	1,875.4			1,846.3			2,226.1
Capital loss carryforwards	102.4			145.9			4.1
Inventories	5.4			6.1			6.7
Accruals and reserves	30.3			27.4			30.2
Investments	0.7			34.4			0.7
Other	51.9			60.3			55.5
Acquisition-related items	55.5			65.2			59.9
Gross deferred tax assets	2,272.2			2,326.6			2,514.6
Valuation allowance	(2,097.8		)	(2,174.3		)	(2,334.5		)
Deferred tax assets	174.4			152.3			180.1
Gross deferred tax liabilities:
Acquisition-related items	(6.5		)	(13.2		)	(20.9		)
Undistributed foreign earnings	(3.0		)	—			(4.7		)
Other	(57.3		)	(31.1		)	(44.5		)
Deferred tax liabilities	(66.8		)	(44.3		)	(70.1		)
Total net deferred tax assets	$	107.6		$	108.0		$	110.0

As of July 1, 2017, the Company had federal, state and foreign tax net operating loss carryforwards of $5,115.1 million, $762.2 million and $624.0 million, respectively, and federal, state and foreign research and other tax credit carryforwards of $103.9 million, $40.7 million and $1.4 million, respectively. Under current guidance, approximately $117.7 million of the net operating losses when realized, would have been credited to additional paid-in capital. The Company’s policy is to account for the utilization of tax attributes under a with-and-without approach. Upon the Company’s adoption of the new guidance on share-based payment awards in fiscal 2018, we expect our deferred tax assets related to the $117.7 million net operating losses to increase which will be offset by a corresponding increase in our valuation allowance. The tax net operating loss, tax credit and capital loss carryforwards will start to expire in calendar 2018 and at various other dates through 2037 if not utilized. Utilization of the tax net operating losses may be subject to a substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code and similar state and foreign provisions. Loss carryforward limitations may result in the expiration or reduced utilization of a portion of the Company’s net operating losses.

U.S. income and foreign withholding taxes associated with the repatriation of earnings of foreign subsidiaries have not been provided on $373.3 million of undistributed earnings for certain foreign subsidiaries. The Company intends to reinvest these earnings indefinitely outside of the United States. The Company estimates that an additional $21.5 million of U.S. income or foreign withholding taxes would have to be provided if these earnings were repatriated back to the U.S.

The valuation allowance decreased by $76.5 million in fiscal 2017, decreased by $160.2 million in fiscal 2016, and increased by $12.7 million in fiscal 2015. The decrease during fiscal 2017 was primarily due to the utilization of deferred tax assets and the increase in deferred tax liabilities as result of the issuance of convertible debt. The decrease during fiscal 2016 was primarily related to the Lumentum transaction. The increase during fiscal 2015 was primarily related to an increase in the deferred tax assets and intangible amortization. The following table provides information about the activity of our deferred tax valuation allowance (in millions):

Deferred Tax Valuation Allowance	Balance at Beginning of Period		Additions Charged to Expenses or Other Accounts(1)		Deductions Credited to Expenses or Other Accounts(2)			Balance at End of Period
Year Ended July 1, 2017	$	2,174.3	$	44.7	$	(121.2	)	$	2,097.8
Year Ended July 2, 2016	$	2,334.5	$	227.5	$	(387.7	)	$	2,174.3
Year Ended June 27, 2015	$	2,321.8	$	39.5	$	(26.8	)	$	2,334.5

(1) Additions include current year additions charged to expenses and current year build due to increases in net deferred tax assets, return to provision true-ups, other adjustments.

(2) Deductions include current year releases credited to expenses and current year reductions due to decreases in net deferred tax assets, return to provision true-ups, other adjustments and increases in deferred tax liabilities.

Under current guidance, approximately $514.7 million of the valuation allowance as of July 1, 2017 was attributable to pre-fiscal 2006 windfall stock option deductions, the benefit of which would have been credited to paid-in-capital if and when realized through a reduction in income tax payable. Beginning with fiscal 2006, the Company began to track the windfall stock option deductions off-balance sheet. If and when realized, the tax benefit associated with those deductions would have been credited to additional paid-in-capital. Upon the Company’s adoption of the new guidance on share-based payment awards in fiscal 2018, the benefit if realized will no longer be credited to additional paid-in capital.

During fiscal 2016, the Company recognized a tax expense of $8.9 million related to a one-time increase in valuation allowance associated with deferred tax assets transferred to Lumentum in connection with the Separation. The tax expense was partially offset by a deferred tax benefit of $9.5 million related to the write off of tax deductible goodwill and a tax benefit of $20.7 million related to the income tax intraperiod tax allocation rules for discontinued operations and other comprehensive income.

A reconciliation of unrecognized tax benefits between June 28, 2014 and July 1, 2017 is as follows (in millions):

Balance at June 28, 2014	$	38.3
Additions based on tax positions related to current year	1.9
Reductions for lapse of statute of limitations	(3.3		)
Reductions due to foreign currency rate fluctuations	(0.1		)
Balance at June 27, 2015	36.8
Additions based on tax positions related to current year	5.1
Reductions for lapse of statute of limitations	(0.2		)
Balance at July 2, 2016	41.7
Additions based on tax positions related to current year	1.6
Additions based on tax positions related to prior year	0.9
Reduction based on tax positions related to prior year	(3.5		)
Reductions for lapse of statute of limitations	(1.8		)
Balance at July 1, 2017	$	38.9

The unrecognized tax benefits relate primarily to the allocations of revenue and costs among the Company’s global operations and the validity of some U.S. tax credits. Included in the balance of unrecognized tax benefits at July 1, 2017 are $3.0 million of tax benefits that, if recognized, would impact the effective tax rate. Also included in the balance of unrecognized tax benefits at July 1, 2017 are $36.0 million of tax benefits that, if recognized, would result in adjustments to the valuation allowance and are included in deferred taxes and other non-current tax liabilities, net in the Consolidated Balance Sheets.

The Company’s policy is to recognize accrued interest and penalties related to unrecognized tax benefits within the income tax provision. The amount of interest and penalties accrued as of July 1, 2017 and July 2, 2016 was approximately $1.8 million and $1.7 million, respectively. During fiscal 2017, the Company’s accrued interest and penalties increased by $0.1 million primarily relating to the lapse of statute in a non-US jurisdiction. The unrecognized tax benefits that may be recognized during the next twelve months is approximately $0.1 million.

The Company is routinely subject to various federal, state and foreign audits by taxing authorities. The Company believes that adequate amounts have been provided for any adjustments that may result from these examinations.

The following table summarizes the Company’s major tax jurisdictions and the tax years that remain subject to examination by such jurisdictions as of July 1, 2017:

Tax Jurisdictions	Tax Years
United States	2014 and onward
Canada	2016 and onward
China	2012 and onward
France	2014 and onward
Germany	2014 and onward
Korea	2012 and onward
United Kingdom	2016 and onward

XML

Stockholders' Equity

12 Months Ended

Jul. 01, 2017

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Note 13. Stockholders' Equity

Repurchase of Common Stock

Fiscal 2017

In September 2016, the Board of Directors increased the Company’s previously authorized stock repurchase program from $100 million to $150 million. Under the revised repurchase authorization, the Company may repurchase up to $150 million of the Company’s common stock from time to time at the discretion of the Company’s management. This stock repurchase authorization expires on December 31, 2017.

During fiscal 2017, the Company repurchased approximately 10.5 million shares of common stock in open market purchases at an average price of $8.75 per share under the stock repurchase program authorized on February 1, 2016. The total purchase price of these repurchases under the stock repurchase program of $92.0 million was reflected as a decrease to common stock based on the stated par value per share with the remainder charged to accumulated deficit.

Fiscal 2016

In November 2015, the Company entered into a $40.0 million accelerated share repurchase agreement (the “ASR”) with a financial institution that was completed during the third quarter of fiscal 2016. Upon making the upfront payment of $40.0 million, the Company received an initial delivery of 5.3 million shares from the financial institution during the second quarter of fiscal 2016, which were retired and recorded as a $32.0 million reduction to stockholder’s equity on the Consolidated Balance Sheet. During the third quarter of fiscal 2016 the ASR was completed and an additional 1.3 million shares were delivered from the financial institution, based on the final settlement price of $6.05 per share, which were retired and recorded as an $8.0 million reduction to stockholder’s equity on the Consolidated Balance Sheet. The Company reflects the repurchase of common stock under the ASR in the period the shares are delivered for the purposes of calculating earnings per share.

On February 1, 2016, the Company’s Board of Directors authorized a stock repurchase program under which the Company may purchase shares of its common stock worth up to an aggregate purchase price of $100.0 million through open market or private transactions between February 1, 2016 and February 1, 2017. During the fourth quarter of fiscal 2016, the Company repurchased approximately 0.7 million shares of common stock in open market purchases at an average price of $6.60 per share under the stock repurchase program authorized on February 1, 2016. The total purchase price of these repurchases under the stock repurchase program of $4.5 million was reflected as a decrease to common stock based on the stated par value per share with the remainder charged to accumulated deficit.

Fiscal 2015

During the first quarter of fiscal 2015, the Company repurchased approximately 0.4 million shares of common stock in open market purchases at an average price of $11.93 per share under the stock repurchase program authorized on May 21, 2014. The total purchase price of these repurchases under the stock repurchase program of $60.0 million was reflected as a decrease to common stock based on the stated par value per share with the remainder charged to accumulated deficit.

All common shares repurchased during fiscal 2017, 2016 and 2015 under this program have been canceled and retired.

Preferred Stock

The Company’s Board of Directors has authority to issue up to 1,000,000 shares of undesignated preferred stock and to determine the powers, preferences and rights and the qualifications, limitations or restrictions granted to or imposed upon any wholly unissued shares of undesignated preferred stock and to fix the number of shares constituting any series and the designation of such series, without the consent of the Company’s stockholders. The preferred stock could be issued with voting, liquidation, dividend and other rights superior to those of the holders of common stock. Subsequent issuance of any preferred stock by the Company’s Board of Directors, under some circumstances, could have the effect of delaying, deferring or preventing a change in control.

XML

Stock-Based Compensation

12 Months Ended

Jul. 01, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation

Note 14. Stock-Based Compensation

Stock-Based Benefit Plans

Stock Option Plans

As of July 1, 2017, the Company had 8.8 million shares of stock options and Full Value Awards issued and outstanding to employees and directors under the Restated 2005 Acquisition Equity Incentive Plan (“the 2005 Plan”), Restated 2003 Equity Incentive Plan (“the 2003 Plan”), inducement grants in connection with the appointment of our new CEO in fiscal 2016 and various other plans the Company assumed through acquisitions. The exercise price for stock options is equal to the fair value of the underlying stock at the date of grant. The Company issues new shares of common stock upon exercise of stock options. Options generally become exercisable over a three- or four-year period and, if not exercised, expire from five to ten years after the date of grant.

On November 14, 2012, the Company’s shareholders approved two amendments to the 2003 Plan. The first amendment increased the number of shares that may be issued under this plan by 10,000,000 shares. The second amendment extended the 2003 Plan’s terms for an additional ten year period after the date of approval of the amendment. On December 5, 2014, the Company’s shareholders approved another amendment to the 2003 Plan to increase the number of shares that may be issued under the plan by 9,000,000 shares. On August 1, 2015, following the Separation, the number of shares available for grant and all outstanding awards were automatically adjusted pursuant to the terms of the 2003 Plan and the 2005 Plan.

As of July 1, 2017, 15.4 million shares of common stock, primarily under the 2003 Plan and the 2005 Plan, were available for grant.

Employee Stock Purchase Plans

In June 1998, the Company adopted the 1998 Employee Stock Purchase Plan, as amended (the “1998 Purchase Plan”). The 1998 Purchase Plan, which became effective August 1, 1998, provides eligible employees with the opportunity to acquire an ownership interest in the Company through periodic payroll deductions and provides a discounted purchase price as well as a look-back period. The 1998 Purchase Plan is structured as a qualified employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986. However, the 1998 Purchase Plan is not intended to be a qualified pension, profit sharing or stock bonus plan under Section 401(a) of the Internal Revenue Code of 1986 and is not subject to the provisions of the Employee Retirement Income Security Act of 1974. The 1998 Purchase Plan will terminate upon the earlier of August 1, 2018 or the date on which all shares available for issuance have been sold. On August 1, 2015, following the Separation, the number of shares available for issuance was automatically adjusted pursuant to the terms of the 1998 Purchase Plan. As of July 1, 2017, 4.8 million shares remained available for issuance. The 1998 Purchase Plan provides a 5% discount and a six month look-back period.

Full Value Awards

Full Value Awards refer to RSUs (time-based, non-performance shares) and MSUs (market-based, performance shares) that are granted with the exercise price equal to zero and are converted to shares immediately upon vesting. These Full Value Awards are performance-based with market conditions, time-based or a combination of both and expected to vest over one to four years. The fair value of the time-based Full Value Awards is based on the closing market price of the Company’s common stock on the date of award.

Stock-Based Compensation

The impact on the Company’s results of operations of recording stock-based compensation expense by function for fiscal 2017, 2016 and 2015 was as follows (in millions):

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Cost of revenue	$	3.6	$	4.8	$	4.2
Research and development	5.7		8.4		8.1
Selling, general and administrative	23.9		29.2		35.2
Total stock-based compensation expense	$	33.2	$	42.4	$	47.5

Approximately $0.7 million of stock-based compensation expense was capitalized to inventory at July 1, 2017.

Impact on Stock-based Compensation Due to Separation

In connection with the separation of the Lumentum business on August 1, 2015 and in accordance with the Employee Matters Agreement, the Company made certain adjustments to the exercise price and number of shares underlying stock-based compensation awards with the intention of preserving the economic value of the awards for Viavi employees. These adjustments resulted in a modification of equity awards with total incremental stock-based compensation of $13.6 million, to be amortized over the remaining service periods of the underlying awards.

Unless otherwise noted, share amounts and grant-date fair values for periods prior to the Separation Date represent the Company’s historical information and have not been adjusted to remove grants made to employees who transferred to Lumentum as part of the Separation. Refer to “Note 3. Discontinued Operations” for more information about the Separation.

Impact on Stock-based Compensation Due to Amendments in the Change of Control Benefits Plan

During the year ended June 27, 2015, the Company amended its Change of Control Benefits Plan (the “Plan”) to add a spin-off of certain Company assets to the circumstances that could trigger benefits under the Plan, as well as other revisions. The Chief Executive Officer of the Company and the Chairman of the Compensation Committee approved the separation of certain executives in the current fiscal year. Pursuant to the Plan, upon termination, all unvested equity awards that have been granted or issued to certain terminated executives become immediately vested and stock options shall become fully exercisable with an extended exercise period of two years from the termination date.

The amendments resulted in a modification of equity awards for six executives and total incremental stock-based compensation of $6.3 million, which was amortized over the period between the modification date and the termination dates of the executives.

Stock Option Activity

The following is a summary of stock option activities (amount in millions except per share amounts):

	Options Outstanding
	Number of Shares		Weighted-Average Exercise Price (1)
Balance as of June 28, 2014	3.5		$	10.13
Exercised	(0.9	)	7.58
Canceled	(0.1	)	14.54
Balance as of June 27, 2015	2.5		10.84
Granted	1.2		5.95
Exercised	(0.7	)	4.74
Canceled	(0.4	)	10.52
Net adjustment due to the separation	0.5
Balance as of July 2, 2016	3.1		5.91
Granted	—		—
Exercised	(1.6	)	5.66
Canceled	—		—
Balance as of July 1, 2017	1.5		$	6.16
Expected to vest	1.4		$	6.18

(1) Weighted average exercise price is calculated using exercise prices prior to the Separation and after the Separation.

The total intrinsic value of options exercised during the year ended July 1, 2017 was $5.9 million. In connection with these exercises, the tax benefit realized by the Company was immaterial due to the fact that the Company has no material benefit in foreign jurisdictions and a full valuation allowance on its domestic deferred tax assets. As of July 1, 2017, $1.5 million of unrecognized stock-based compensation expense related to stock options remains to be amortized. That cost is expected to be recognized over an estimated amortization period of 2.6 years.

The following table summarizes significant ranges of outstanding and exercisable options as of July 1, 2017, adjusted to reflect the impact of the Lumentum separation.

	Options Outstanding						Options Exercisable
Range of Exercise Prices	Number of Shares	Weighted Average Remaining Contractual Term (in years)	Weighted Average Exercise Price		Aggregate Intrinsic Value (in millions)		Number of Shares	Weighted Average Remaining Contractual Term (in years)	Weighted Average Exercise Price		Aggregate Intrinsic Value (in millions)
$3.28 - $3.28	104,352	0.12	$	3.28			104,352	0.12	$	3.28
$5.74 - $5.74	132,544	0.92	5.74				132,544	0.92	5.74
$5.95 - $5.95	1,180,257	6.62	5.95				295,065	6.62	5.95
$11.82 - $11.82	107,412	1.87	11.82				107,412	1.87	11.82
	1,524,565	5.35	$	6.16	$	6.8	639,373	3.58	$	6.46	$	2.7

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value, based on the Company’s closing stock price of $10.53 as of July 1, 2017, which would have been received by the option holders had all option holders exercised their options as of that date. The total number of in-the-money options exercisable as of July 1, 2017 was 0.5 million.

Employee Stock Purchase Plan Activity

The expense related to the plan is recorded on a straight-line basis over the relevant subscription period.

The following summarizes the shares issued and the fair market value at purchase date, pursuant to the Company’s ESPP during the year ended July 1, 2017:

Purchase date	July 29, 2016		January 31, 2017
Shares issued	410,737		269,102
Fair market value at purchase date	$	4.76	$	6.77

As of July 1, 2017, there was $0.1 million of unrecognized stock-based compensation cost related to ESPP remains to be amortized. The cost will be recognized in the first quarter of fiscal 2018.

Full Value Awards Activity

A summary of the status of the Company’s non-vested Full Value Awards as of July 1, 2017 and changes during the same period is presented below (amount in millions, except per share amounts):

	Full Value Awards
	Performance Shares (1)		Non-Performance Shares		Total Number of Shares		Weighted-average grant-dated fair value
Non-vested at June 28, 2014	1.1		8.3		9.4		$	13.19
Awards granted	0.7		5.3		6.0		11.78
Awards vested	(0.8	)	(4.4	)	(5.2	)	12.96
Awards forfeited	—		(1.4	)	(1.4	)	13.10
Non-vested at June 27, 2015	1.0		7.8		8.8		12.36
Awards granted	0.7		6.1		6.8		5.75
Awards vested	(0.7	)	(4.8	)	(5.5	)	6.01
Awards forfeited	(0.4	)	(1.8	)	(2.2	)	7.89
Net adjustment due to the separation	0.4		1.1		1.5
Non-vested at July 2, 2016	1.0		8.4		9.4		6.55
Awards granted	0.6		3.7		4.3		7.86
Awards vested	(0.6	)	(4.5	)	(5.1	)	6.66
Awards forfeited	—		(1.3	)	(1.3	)	6.83
Non-vested at July 1, 2017	1.0		6.3		7.3		$	7.17

(1) Performance Shares refer to the Company’s MSU awards, where the actual number of shares awarded upon vesting may be higher or lower than the target amount depending on the achievement of the relevant market conditions. The majority of MSUs vest in equal annual installments over three to four years based on the attainment of certain total shareholder return performance measures and the employee’s continued service through the vest date. The aggregate grant-date fair value of MSUs granted during fiscal 2017, 2016 and 2015 were estimated to be $3.3 million, $3.7 million and $9.4 million respectively, and were calculated using a Monte Carlo simulation.

As of July 1, 2017, $31.4 million of unrecognized stock-based compensation cost related to Full Value Awards remains to be amortized. That cost is expected to be recognized over an estimated amortization period of 1.75 years.

Full Value Awards are converted into shares upon vesting. Shares equivalent in value to the minimum withholding taxes liability on the vested shares are withheld by the Company for the payment of such taxes. During fiscal 2017, 2016 and 2015, the Company paid $14.3 million, $11.4 million and $22.1 million, respectively, and classified the payments as operating cash outflows in the Consolidated Statements of Cash Flows.

Valuation Assumptions

The Company estimates the fair value of the MSUs on the date of grant using a Monte Carlo simulation with the following assumptions:

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Volatility of common stock	33.2	%	33.8	%	40.8	%
Average volatility of peer companies	36.9	%	52.9	%	53.4	%
Average correlation coefficient of peer companies	0.1856		0.1103		0.2156
Risk-free interest rate	0.7	%	0.8	%	0.6	%

The Company estimates the fair value of Stock Options and ESPP using a BSM valuation model. The fair value is estimated on the date of grant using the BSM option valuation model with the following weighted-average assumptions:

	Stock Options		Employee Stock Purchase Plans
	July 2, 2016		July 1, 2017		July 2, 2016		June 27, 2015
Expected term (in years)	5.2		0.5		0.5		0.5
Expected volatility	42.3	%	33.4	%	45.7	%	37.9	%
Risk-free interest rate	1.2	%	0.5	%	0.4	%	0.1	%

Expected Term: The Company's expected term for stock options was calculated utilizing the simplified method in accordance with the authoritative guidance. The Company used the simplified method as the Company does not have sufficient historical share option exercise data due to the limited number of shares granted as well as changes in the Company's business following the Separation, rendering existing historical experience less reliable in formulating expectations for current grants. The Company’s expected term for ESPP is in line with the six month look-back period of its ESPP.

Expected Volatility: The Company has limited trading history following the Separation; therefore, the expected volatility for stock options was based on the historical volatility of the Company's common stock and its peers. For grants prior to the Separation and for ESPP grants, the Company determined that a combination of the implied volatility of its traded options and historical volatility of its stock price based on the expected term of the equity instrument most appropriately reflects market expectation of future volatility. Implied volatility is based on traded options of the Company’s common stock with a remaining maturity of four and a half months or greater.

Risk-Free Interest Rate: The Company bases the risk-free interest rate used in the BSM valuation method on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term.

Expected Dividend: The BSM valuation model calls for a single expected dividend yield as an input. The Company has not paid and does not anticipate paying any dividends in the near future.

XML

Employee Pension and Other Benefit Plans

12 Months Ended

Jul. 01, 2017

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Employee Pension and Other Benefit Plans

Note 15. Employee Pension and Other Benefit Plans

Employee 401(k) Plans

The Company sponsors the Viavi Solutions 401(k) Plan (the “401(k) Plan”), a Defined Contribution Plan under ERISA, which provides retirement benefits for its eligible employees through tax deferred salary deductions. The 401(k) Plan allows employees to contribute up to 50% of their annual compensation, with contributions limited to $18,000 in calendar year 2017 as set by the Internal Revenue Service.

For all eligible participants who have completed 180 days of service with Viavi, the 401(k) Plan provided for a 100% match of employees’ contributions up to the first 3% of annual compensation and 50% match on the next 2% of compensation. All matching contributions are made in cash and vest immediately. The Company’s matching contributions to the 401(k) Plan were $4.1 million, $4.7 million, and $4.8 million in fiscal 2017, 2016 and 2015, respectively.

Deferred Compensation Plan

The Company also provides for the benefit of certain eligible employees in the U.S. a non-qualified retirement plan. This plan is designed to permit employee deferral of a portion of salaries in excess of certain tax limits and deferral of bonuses. This plan’s assets are designated as trading securities on the Company’s Consolidated Balance Sheets. Refer to “Note 7. Investments, Forward Contracts and Fair Value Measurements” for more information. Effective January 1, 2011, the Company suspended all employee contributions into the plan.

Employee Defined Benefit Plans

The Company sponsors significant qualified and non-qualified pension plans for certain past and present employees in the U.K. and Germany. The Company also is responsible for the non-pension post-retirement benefit obligation assumed from a past acquisition. In connection with the Separation, the Company transferred the liabilities and assets of the Switzerland defined benefit pension plans to Lumentum in the amount of $6.7 million and $4.6 million, respectively.

Most of the plans have been closed to new participants and no additional service costs are being accrued, except for certain plans in Germany assumed in connection with an acquisition during fiscal 2010. Benefits are generally based upon years of service and compensation or stated amounts for each year of service. As of July 1, 2017, the U.K. plan was partially funded while the other plans were unfunded. The Company’s policy for funded plans is to make contributions equal to or greater than the requirements prescribed by law or regulation. For unfunded plans, the Company pays the post-retirement benefits when due. Future estimated benefit payments are summarized below. No other required contributions are expected in fiscal 2018, but the Company, at its discretion, can make contributions to one or more of the defined benefit plans.

The Company accounts for its obligations under these pension plans in accordance with the authoritative guidance which requires the Company to record its obligation to the participants, as well as the corresponding net periodic cost. The Company determines its obligation to the participants and its net periodic cost principally using actuarial valuations provided by third-party actuaries. The obligation the Company records on its Consolidated Balance Sheets is reflective of the total PBO and the fair value of plan assets.

The following table presents the components of the net periodic benefit cost for the pension and benefits plans (in millions):

	Years Ended
Pension Benefits	2017			2016			2015
Service cost	$	0.3		$	0.2		$	0.2
Interest cost	2.1			3.0			3.7
Expected return on plan assets	(1.1		)	(1.5		)	(1.6		)
Recognized net actuarial losses	1.9			0.7			0.4
Provision for legal proceeding	—			8.4			—
Net periodic cost	$	3.2		$	10.8		$	2.7

The Company’s accumulated other comprehensive income includes unrealized net actuarial (gains)/losses. The amount expected to be recognized in net periodic benefit cost during fiscal 2018 is $1.4 million. Refer to “Note 16. Commitments and Contingencies” for further information on the provision for legal proceeding.

The changes in the benefit obligations and plan assets of the pension and benefits plans were (in millions):

	Pension Benefit Plans
	2017			2016
Change in benefit obligation
Benefit obligation at beginning of year	$	134.6		$	121.2
Service cost	0.3			0.2
Interest cost	2.1			3.0
Actuarial (gains) losses	(1.2		)	14.5
Benefits paid	(4.2		)	(4.7		)
Provision for legal proceeding	—			8.4
Foreign exchange impact	1.8			(8.0		)
Benefit obligation at end of year	$	133.4		$	134.6
Change in plan assets
Fair value of plan assets at beginning of year	$	27.2		$	30.2
Actual return on plan assets	2.0			1.8
Employer contributions	4.0			4.6
Benefits paid	(4.2		)	(4.7		)
Foreign exchange impact	(0.7		)	(4.7		)
Fair value of plan assets at end of year	$	28.3		$	27.2
Funded status	$	(105.1	)	$	(107.4	)
Accumulated benefit obligation	$	133.0		$	133.9

	Pension Benefit Plans
	2017			2016
Amount recognized in the Consolidated Balance Sheets at end of year:
Current liabilities	$	6.8		$	5.5
Non-current liabilities	98.3			101.9
Net amount recognized at end of year	$	105.1		$	107.4
Amount recognized in accumulated other comprehensive income (loss) at end of year:
Actuarial losses, net of tax	$	(21.8	)	$	(24.4	)
Net amount recognized at end of year	$	(21.8	)	$	(24.4	)
Other changes in plan assets and benefit obligations recognized in other comprehensive income (loss):
Net actuarial gain (loss)	$	0.7		$	(10.6	)
Amortization of accumulated net actuarial losses	1.9			0.7
Total recognized in other comprehensive income (loss)	$	2.6		$	(9.9	)

As of July 1, 2017 and July 2, 2016, the liability balances related to the post retirement benefit plan were $1.1 million and $1.1 million respectively. The liability balances were included in other non-current liabilities on the Consolidated Balance Sheets.

During fiscal 2017, the Company contributed GBP 0.5 million or approximately USD 0.6 million, while in fiscal 2016, the Company contributed GBP 0.5 million or approximately USD 0.7 million to its U.K. pension plan. These contributions allowed the Company to comply with regulatory funding requirements.

Assumptions

Underlying both the calculation of the PBO and net periodic cost are actuarial valuations. These valuations use participant-specific information such as salary, age, years of service, and assumptions about interest rates, compensation increases and other factors. At a minimum, the Company evaluates these assumptions annually and makes changes as necessary.

The discount rate reflects the estimated rate at which the pension benefits could be effectively settled. In developing the discount rate, the Company considered the yield available on an appropriate AA corporate bond index, adjusted to reflect the term of the scheme’s liabilities as well as a yield curve model developed by the Company’s actuaries.

The expected return on assets was estimated by using the weighted average of the real expected long term return (net of inflation) on the relevant classes of assets based on the target asset mix and adding the chosen inflation assumption.

The following table summarizes the weighted average assumptions used to determine net periodic cost and benefit obligation for the Company’s U.K. and German pension plans:

	Pension Benefit Plans
	2017		2016		2015
Weighted-average assumptions used to determine net period cost:
Discount rate	2.1	%	2.1	%	3.0	%
Expected long-term return on plan assets	4.8		5.3		5.8
Rate of pension increase	2.2		2.3		2.3
Weighted-average assumptions used to determine benefit obligation at end of year:
Discount rate	2.0	%	1.7	%	2.6	%
Rate of pension increase	2.3		2.1		2.2

Investment Policies and Strategies

The Company’s investment objectives for its funded pension plan are to ensure that there are sufficient assets available to pay out members’ benefits as and when they arise and that should the plan be discontinued at any point in time there would be sufficient assets to meet the discontinuance liabilities.

To achieve the objectives, the trustees of the U.K. pension plan are responsible for regularly monitoring the funding position and managing the risk by investing in assets expected to outperform the increase in value of the liabilities in the long term and by investing in a diversified portfolio of assets in order to minimize volatility in the funding position. The trustees invest in a range of frequently traded funds (“pooled funds”) rather than direct holdings in individual securities to maintain liquidity, achieve diversification and reduce the potential for risk concentration. The funded plan assets are managed by professional third-party investment managers.

Fair Value Measurement of Plan Assets

The following table sets forth the U.K. plan assets at fair value and the percentage of assets allocations as of July 1, 2017 (in millions, except percentage data):

							Fair value measurement as of
							July 1, 2017
	Target Allocation		Total		Percentage of Plan Assets		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Global equity	40	%	$	11.7	41.3	%	$	—	$	11.7
Fixed income	40	%	10.7		37.8	%	—		10.7
Other	20	%	5.8		20.5	%	—		5.8
Cash			0.1		0.4	%	0.1		—
Total assets			$	28.3	100.0	%	$	0.1	$	28.2

The following table sets forth the plan’s assets at fair value and the percentage of assets allocations as of July 2, 2016 (in millions, except percentage data).

							Fair value measurement as of
							July 2, 2016
	Target Allocation		Total		Percentage of Plan Assets		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Global equity	40	%	$	10.5	38.6	%	$	—	$	10.5
Fixed income	40	%	10.7		39.3	%	—		10.7
Other	20	%	5.4		19.9	%	—		5.4
Cash			0.6		2.2	%	0.6		—
Total assets			$	27.2	100.0	%	$	0.6	$	26.6

The Company’s pension assets consist of multiple institutional funds (“pension funds”) of which the fair values are based on the quoted prices of the underlying funds. Pension funds are classified as Level 2 assets since such funds are not directly traded in active markets.

Global equity consists of several index funds that invest primarily in U.K. equities and other overseas equities.

Fixed income consists of several funds that invest primarily in index-linked Gilts (over 5 year), sterling-denominated investment grade corporate bonds, and overseas government bonds.

Other consists of several funds that primarily invest in global equities, bonds, private equity, global real estate and infrastructure funds.

Future Benefit Payments

The following table reflects the total expected benefit payments to defined benefit pension plan participants. These payments have been estimated based on the same assumptions used to measure the Company’s PBO at year end and include benefits attributable to estimated future compensation increases.

(in millions)	Pension Benefit Plans
2018	$	7.5
2019	6.1
2020	5.5
2021	5.7
2022	6.1
2023 - 2027	29.7
Thereafter	44.5
Total	$	105.1

Timing of the payment relating to the legal proceeding, which is included in the above table under “Thereafter,” is not yet determined. Refer to “Note 16. Commitments and Contingencies” for further information.

XML

Commitments and Contingencies

12 Months Ended

Jul. 01, 2017

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 16. Commitments and Contingencies

Operating Leases

The Company leases certain real and personal property from unrelated third parties under non-cancelable operating leases that expire at various dates through fiscal 2023. Certain leases require the Company to pay property taxes, insurance and routine maintenance, and include escalation clauses. As of July 1, 2017, future minimum annual lease payments under non-cancelable operating leases were as follows (in millions):

2018	$	18.8
2019	16.7
2020	12.2
2021	10.1
2022	6.1
Thereafter	0.5
Total minimum operating lease payments	$	64.4

Included in the future minimum lease payments table above is $3.7 million related to lease commitments in connection with the Company’s restructuring and related activities. Refer to “Note 11. Restructuring and Related Charges” for more information.

The aggregate future minimum rentals to be received under non-cancelable subleases totaled $2.9 million as of July 1, 2017. Rental expense relating to building and equipment was $12.1 million, $13.8 million and $14.3 million in fiscal 2017, 2016 and 2015, respectively.

Purchase Obligations

Purchase obligations of $56.8 million as of July 1, 2017, represent legally-binding commitments to purchase inventory and other commitments made in the normal course of business to meet operational requirements. Although open purchase orders are considered enforceable and legally binding, the terms generally allow the option to cancel, reschedule and adjust the requirements based on the Company’s business needs prior to the delivery of goods or performance of services. Obligations to purchase inventory and other commitments are generally expected to be fulfilled within one year.

The Company depends on a limited number of contract manufacturers, subcontractors, and suppliers for raw materials, packages and standard components. The Company generally purchases these single or limited source products through standard purchase orders or one-year supply agreements and has no significant long-term guaranteed supply agreements with such vendors. While the Company seeks to maintain a sufficient safety stock of such products and maintains on-going communications with its suppliers to guard against interruptions or cessation of supply, the Company’s business and results of operations could be adversely affected by a stoppage or delay of supply, substitution of more expensive or less reliable products, receipt of defective parts or contaminated materials, increases in the price of such supplies, or the Company’s inability to obtain reduced pricing from its suppliers in response to competitive pressures.

Financing Obligations - Eningen and Santa Rosa

Eningen

On December 16, 2011, the Company executed and closed the sale and leaseback transaction of certain buildings and land in Eningen, Germany (the “Eningen Transactions”). The Company sold approximately 394,217 square feet of land, nine buildings with approximately 386,132 rentable square feet, and parking areas. The Company leased back approximately 158,154 rentable square feet comprised of two buildings and a portion of a basement of another building (the “Leased Premises”). The lease term is 10 years with the right to cancel a certain portion of the lease after 5 years.

Concurrent with the sale and lease back, the Company has provided collateral in case of a default by the Company relative to future lease payments for the Leased Premises. Due to this continuing involvement, the related portion of the cash proceeds and transaction costs, associated with the Leased Premises and other buildings which the Company continues to occupy, was recorded under the financing method in accordance with the authoritative guidance on leases and sales of real estate. Accordingly, the carrying value of these buildings and associated land will remain on the Company’s books and the buildings will continue to be depreciated over their remaining useful lives. The portion of the proceeds received have been recorded as a financing obligation, a portion of the lease payments are recorded as a decrease to the financing obligation and a portion is recognized as interest expense. Imputed rental income from the buildings sold but not leased back and currently being occupied is recorded as a reduction in the financing obligation.

As of July 1, 2017, of the total financing obligation related to the Eningen Transactions, $0.1 million was included in Other current liabilities, and $3.9 million was included in Other non-current liabilities. As of July 2, 2016, of the total financing obligation related to the Eningen Transactions, $0.1 million was included in Other current liabilities, and $4.0 million was included in Other non-current liabilities.

Santa Rosa

On August 21, 2007, the Company entered into a sale and lease back of certain buildings and land in Santa Rosa, California (the “Santa Rosa Transactions”). The Company sold approximately 45 acres of land, 13 buildings with approximately 492,000 rentable square feet, a building pad, and parking areas. The Company leased back 7 buildings with approximately 286,000 rentable square feet. The net cash proceeds received from the transaction were $32.2 million. The lease terms range from a one-year lease with multiple renewal options to a ten-year lease with twofive-year renewal options.

The Company has an ongoing obligation to remediate environmental matters, impacting the entire site, as required by the North Coast Regional Water Quality Control Board which existed at the time of sale. Concurrent with the sale and lease back, the Company has issued an irrevocable letter of credit for $3.8 million as security for the remediation of the environmental matter that remains in effect until the issuance of a notice of no further action letter from the North Coast Regional Water Quality Control Board. In addition, the lease agreement for one building included an option to purchase at fair market value, at the end of the lease term. Due to these various forms of continuing involvement the transaction was recorded under the financing method in accordance with the authoritative guidance on leases and sales of real estate.

Accordingly, the value of the buildings and land will remain on the Company’s books and the buildings will continue to be depreciated over their remaining useful lives. The proceeds received have been recorded as a financing obligation, a portion of the lease payments are recorded as a decrease to the financing obligation and a portion is recognized as interest expense. Imputed rental income from the buildings sold but not leased back is recorded as a reduction in the financing obligation.

As of July 1, 2017, $0.8 million was included in Other current liabilities, and $23.9 million was included in Other non-current liabilities. As of July 2, 2016, $0.8 million was included in Other current liabilities, and $24.7 million was included in Other non-current liabilities.

The lease payments due under the agreement reset to fair market rental rates upon the Company’s execution of the renewal options.

Guarantees

In accordance with authoritative guidance which requires that upon issuance of a guarantee, the guarantor must recognize a liability for the fair value of the obligation it assumes under that guarantee. In addition, disclosures about the guarantees that an entity has issued, including a tabular reconciliation of the changes of the entity’s product warranty liabilities, are required.

The Company from time to time enters into certain types of contracts that contingently require the Company to indemnify parties against third-party claims. These contracts primarily relate to: (i) divestiture agreements, under which the Company may provide customary indemnifications to purchasers of the Company’s businesses or assets; (ii) certain real estate leases, under which the Company may be required to indemnify property owners for environmental and other liabilities, and other claims arising from the Company’s use of the applicable premises; and (iii) certain agreements with the Company’s officers, directors and employees, under which the Company may be required to indemnify such persons for liabilities arising out of their employment relationship.

The terms of such obligations vary. Generally, a maximum obligation is not explicitly stated. Because the obligated amounts of these types of agreements often are not explicitly stated, the overall maximum amount of the obligations cannot be reasonably estimated. Historically, the Company has not been obligated to make significant payments for these obligations, and no liabilities have been recorded for these obligations on the Consolidated Balance Sheets as of July 1, 2017 and July 2, 2016.

Outstanding Letters of Credit and Performance Bonds

As of July 1, 2017, the Company had standby letters of credit of $15.3 million and performance bonds of $2.7 million collateralized by restricted cash.

Product Warranties

In general, the Company offers a three-year warranty for most of its products. The Company provides reserves for the estimated costs of product warranties at the time revenue is recognized. The Company estimates the costs of its warranty obligations based on its historical experience of known product failure rates, use of materials to repair or replace defective products and service delivery costs incurred in correcting product failures. In addition, from time to time, specific warranty accruals may be made if unforeseen technical problems arise with specific products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.

The following table presents the changes in the Company’s warranty reserve during fiscal years 2017 and 2016 (in millions):

	Year Ended
	July 1, 2017			July 2, 2016
Balance as of beginning of period	$	4.9		$	3.7
Provision for warranty	4.2			3.9
Utilization of reserve	(3.8		)	(3.3		)
Adjustments related to pre-existing warranties (including changes in estimates)	0.5			0.6
Balance as of end of period	$	5.8		$	4.9

Legal Proceedings

In June 2016, the Company received a court decision regarding the validity of an amendment to a pension deed of trust related to one of its foreign subsidiaries which the Company contends contained an error requiring the Company to increase the pension plan’s benefit. The Company had subsequently further amended the deed to rectify the error. The court ruled that the amendment increasing the pension plan benefit was valid until the subsequent amendment. Prior to this decision, the Company, in consultation with outside legal counsel, believed that the pension deed of trust document was invalid or, alternatively, that the subsequent rectification should be applied retroactively. Under both scenarios, the Company believed that the likelihood of an increase in plan benefits was remote. While the Company is pursuing other legal arguments in this matter, such as appealing the court decision and pursuing a claim against the U.K. law firm responsible for the error, the Company determined that the likelihood of loss to be probable as of July 2, 2016 and July 1, 2017 and estimated the increase in liability to range from GBP 5.7 million (USD 7.4 million) to GBP 8.4 million (USD 10.9 million). The Company accrued GBP 5.7 million (USD 7.4 million), in accordance with authoritative guidance on contingencies. The accrual is included as a component of selling, general and administrative expense and included in pension and post-employment benefits, which is a component of other non-current liabilities, in the Company’s Consolidated Statement of Operations and Consolidated Balance Sheets, respectively.

The Company is subject to a variety of claims and suits that arise from time to time in the ordinary course of our business. While management currently believes that resolving claims against the Company, individually or in aggregate, will not have a material adverse impact on its financial position, results of operations or statement of cash flows, these matters are subject to inherent uncertainties and management’s view of these matters may change in the future. Were an unfavorable final outcome to occur, there exists the possibility of a material adverse impact on the Company’s financial position, results of operations or cash flows for the period in which the effect becomes reasonably estimable.

XML

Operating Segments and Geographic Information

12 Months Ended

Jul. 01, 2017

Segment Reporting [Abstract]

Operating Segments and Geographic Information

Note 17. Operating Segments and Geographic Information

The Company evaluates its reportable segments in accordance with the authoritative guidance on segment reporting. The Company’s Chief Executive Officer is the Company’s Chief Operating Decision Maker (“CODM”) pursuant to the guidance. The CODM allocates resources to the segments based on their business prospects, competitive factors, net revenue and operating results.

The Company’s reportable segments are:

(i) Network Enablement (“NE”):

NE provides testing solutions that access the network to perform build-out and maintenance tasks. These solutions include instruments, software and services to design, build, activate, certify, troubleshoot and optimize networks. The company also offers a range of product support and professional services such as repair, calibration, software support and technical assistance for our products

(ii) Service Enablement (“SE”):

SE solutions are embedded systems that yield network, service and application performance data. These solutions—including instruments, microprobes and software—monitor, collect and analyze network data to reveal the actual customer experience and to identify opportunities for new revenue streams and network optimization.

(iii) Optical Security and Performance Products (“OSP”):

OSP provides innovative, precision, high performance optical products for anti-counterfeiting, government, industrial, automotive and consumer electronic markets, including 3D sensing applications.

Changes to Segment Reporting

Following the Separation in the first quarter of fiscal 2016, the Company made changes to its segment measures to reflect how the CODM manages the business post-separation as described below.

The CODM manages the Company in two broad business categories: Network and Service Enablement ("NSE") and OSP. NSE operates in two segments, NE and SE, whereas OSP operates as a single segment. The CODM evaluates segment performance of the NSE business based on NE and SE segment gross margin and NSE operating margin as a whole. Operating expenses associated with the NSE business are not allocated to the NE and SE segments within NSE, as they are managed centrally at the business unit level. The CODM evaluates segment performance of the OSP business based on OSP segment operating margin. In addition, prior to the first quarter of fiscal 2016, the Company did not allocate certain corporate-level operating expenses associated with its shared-service function to its segment results. Beginning in the first quarter of fiscal 2016, the Company has allocated these corporate-level operating expenses to its segment results, with the exception of certain non-core operating and non-operating activities as discussed below.

The Company does not allocate stock-based compensation, acquisition-related charges, amortization of intangibles, restructuring and related charges, impairment of goodwill, non-operating income and expenses, or other charges unrelated to core operating performance to its segments because Management does not include this information in its measurement of the performance of the operating segments. These items are presented as “Reconciling Items” in the table below. Additionally, the Company does not specifically identify and allocate all assets by operating segment.

As a result of the Separation, the Company excluded the results of the Lumentum business which historically consisted of the CCOP segment and the WaveReady product line within the NE segment for all periods presented. Refer to “Note 3. Discontinued Operations” for more information on the Separation. Additionally, the Company’s Video Assurance product line was moved out of its NE segment and into its SE segment during the first quarter of fiscal 2016.

The segment information for all periods presented has been revised to be comparable with the changes implemented in the first quarter of fiscal 2016 in the Company’s segment reporting measures.

Information on reportable segments is as follows (in millions):

	Year Ended July 1, 2017
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Reconciling Items			Consolidated GAAP Measures
Net revenue	$	444.0		$	135.2		$	579.2		$	232.2		$	811.4		$	—		$	811.4
Gross profit	286.3			86.2			372.5			133.8			506.3			(20.3		)	486.0
Gross margin	64.5		%	63.8		%	64.3		%	57.6		%	62.4		%				59.9		%
Operating income							7.3			100.3			107.6			(94.0		)	13.6
Operating margin							1.3		%	43.2		%	13.3		%				1.7		%
	Year Ended July 2, 2016
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Reconciling Items			Consolidated GAAP Measures
Net revenue	$	504.6		$	153.6		$	658.2		$	248.1		$	906.3		$	—		$	906.3
Gross profit	329.7			99.4			429.1			143.1			572.2			(22.5		)	549.7
Gross margin	65.3		%	64.7		%	65.2		%	57.7		%	63.1		%				60.7		%
Operating income (loss)							12.7			102.9			115.6			(199.9		)	(84.3		)
Operating margin							1.9		%	41.5		%	12.8		%				(9.3		)%
	Year Ended June 27, 2015
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Reconciling Items			Consolidated GAAP Measures
Net revenue	$	506.8		$	174.3		$	681.1		$	192.8		$	873.9		$	—		$	873.9
Gross profit	333.9			119.2			453.1			104.3			557.4			(37.3		)	520.1
Gross margin	65.9		%	68.4		%	66.5		%	54.1		%	63.8		%				59.5		%
Operating income (loss)							(0.1		)	68.1			68.0			(143.8		)	(75.8		)
Operating margin							—		%	35.3		%	7.8		%				(8.7		)%

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Corporate reconciling items impacting gross profit:
Total segment gross profit	$	506.3		$	572.2		$	557.4
Stock-based compensation	(3.6		)	(4.8		)	(4.2		)
Amortization of intangibles	(14.3		)	(17.3		)	(31.9		)
Other charges unrelated to core operating performance	(2.4		)	(0.4		)	(1.2		)
GAAP gross profit	$	486.0		$	549.7		$	520.1
Corporate reconciling items impacting operating income:
Total segment operating income	$	107.6		$	115.6		$	68.0
Stock-based compensation	(33.2		)	(42.4		)	(47.5		)
Amortization of intangibles	(28.3		)	(31.9		)	(51.4		)
Impairment of goodwill	—			(91.4		)	—
Other charges unrelated to core operating performance (1)(2)(3)	(10.9		)	(23.7		)	(18.1		)
Restructuring and related charges	(21.6		)	(10.5		)	(26.8		)
GAAP operating income (loss) from continuing operations	$	13.6		$	(84.3	)	$	(75.8	)

(1) During the year ended July 1, 2017, other charges unrelated to core operating performance primarily consisted of $5.7 million loss on disposal of long-lived assets and $1.5 million of Viavi-specific charges related to the Separation.

(2) During the year endedJuly 2, 2016, other charges unrelated to core operating performance primarily consisted of (a) an $8.4 million charge related to a litigation ruling impacting our U.K. pension obligation, (b) $5.0 million of Viavi-specific charges related to the Separation and (c) $3.5 million of non-recurring incremental severance and related costs upon the exit of a key executive.

(3) During the year endedJune 27, 2015, other charges unrelated to core operating performance primarily consisted of $9.8 million of Viavi-specific charges related to the Separation and $3.6 million IPR&D impairment charge for an ongoing project related to the fiscal 2014 acquisition of Trendium as discussed in “Note 9. Acquired Developed Technology and Other Intangibles.”

The Company operates primarily in three geographic regions: Americas, Asia-Pacific, and Europe, Middle East and Africa (“EMEA”). Net revenue is assigned to the geographic region and country where our product is initially shipped. For example, certain customers may request shipment of our product to a contract manufacturer in one country, which may differ from the location of their end customers. The following table presents net revenue by the three geographic regions we operate in and net revenue from countries that exceeded 10% of our total net revenue (dollars in millions):

	Years Ended
	July 1, 2017				July 2, 2016				June 27, 2015
Americas:
United States	$	307.3	37.9	%	$	396.6	43.8	%	$	424.3	48.5	%
Other Americas	71.3		8.8	%	$	66.0	7.3	%	$	62.5	7.2	%
Total Americas	$	378.6	46.7	%	$	462.6	51.1	%	$	486.8	55.7	%
Asia-Pacific
Greater China	$	100.8	12.4	%	$	103.2	11.3	%	$	83.1	9.5	%
Other Asia	72.4		8.9	%	63.1		7.0	%	61.4		7.0	%
Total Asia-Pacific	$	173.2	21.3	%	$	166.3	18.3	%	$	144.5	16.5	%
EMEA:
Switzerland	$	124.0	15.3	%	$	135.6	15.0	%	$	97.7	11.2	%
Other EMEA	135.6		16.7	%	141.8		15.6	%	144.9		16.6	%
Total EMEA	$	259.6	32.0	%	$	277.4	30.6	%	$	242.6	27.8	%
Total net revenue	$	811.4	100.0	%	$	906.3	100.0	%	$	873.9	100.0	%

Following the separation from Lumentum, one customer served by our OSP segment generated 10% or more of Viavi net revenue from continuing operations during fiscal 2017, 2016 and 2015 as summarized below (in millions):

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Customer A - OSP customer	$	166.8	$	190.1	$	143.0

Property, plant and equipment, net were identified based on the operations in the corresponding geographic areas (in millions):

	Years Ended
	July 1, 2017		July 2, 2016
United States	$	76.0	$	85.6
Other Americas	4.4		4.3
China	41.1		27.3
Other Asia-Pacific	5.0		4.8
Germany	7.9		7.9
Other EMEA	2.5		3.1
Total property, plant and equipment, net	$	136.9	$	133.0

XML

Quarterly Financial Information (unaudited)

12 Months Ended

Jul. 01, 2017

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information (unaudited)

Note 18. Selected Quarterly Financial Information (unaudited)

The following table presents the Company’s selected quarterly financial information from the Consolidated Statements of Operations for fiscal 2017 and 2016 (in millions, except per share data):

	July 1, 2017		April 1, 2017		December 31, 2016		October 1, 2016		July 2, 2016			April 2, 2016		January 2, 2016		October 3, 2015
	(1) (2)		(2)		(2)		(2)		(1)(2)(3)			(1)(2)		(1)		(1)
Net revenue	$	198.1	$	196.0	$	206.5	$	210.8	$	224.1		$	220.4	$	232.1	$	229.7
Gross profit	119.2		117.0		124.7		125.1		136.1			131.3		141.8		140.5
Net income(loss) from continuing operations, net of tax	12.1		26.0		49.2		78.0		(64.5		)	28.8		1.0		(15.7		)
Net income (loss) from discontinued operations, net of tax	1.6		—		—		—		(3.4		)	5.0		3.0		(53.4		)
Net income (loss)	$	13.7	$	26.0	$	49.2	$	78.0	$	(67.9	)	$	33.8	$	4.0	$	(69.1	)
Net income (loss) per share from - basic:
Continuing operations (4)	$	0.05	$	0.11	$	0.21	$	0.34	$	(0.28	)	$	0.13	$	0.01	$	(0.07	)
Discontinued operations (4)	0.01		—		—		—		(0.01		)	0.02		0.01		(0.22		)
Net income (loss) (4)	$	0.06	$	0.11	$	0.21	$	0.34	$	(0.29	)	$	0.15	$	0.02	$	(0.29	)
Net income (loss) per share from - diluted:
Continuing operations (4)	$	0.05	$	0.11	$	0.21	$	0.33	$	(0.28	)	$	0.12	$	0.01	$	(0.07	)
Discontinued operations (4)	0.01		—		—		—		(0.01		)	0.02		0.01		(0.22		)
Net income (loss) (4)	$	0.06	$	0.11	$	0.21	$	0.33	$	(0.29	)	$	0.14	$	0.02	$	(0.29	)
Shares used in per-share calculation (basic)	227.3		229.4		230.5		232.4		232.7			232.0		234.9		236.0
Shares used in per-share calculation (diluted)	232.5		234.6		234.2		236.8		232.7			234.6		237.1		236.0

(1) During the first quarter of fiscal 2016, we completed the Separation. As a result, the operations of the Lumentum business have been presented as discontinued operations in all periods of the Company’s Consolidated Statement of Operations.

(2) During fiscal year ended 2017 and 2016, the Company recorded $203.0 million and $71.5 million, respectively, gain on sale of Lumentum common stock which was retained as part of the Separation of Lumentum. Refer to “Note 7. Investments, Forward Contracts and Fair Value Measurements”for more information.

(3) During the fourth quarter of fiscal 2016, the Company recorded a $91.4 million goodwill impairment charge related to the SE reporting unit.

(4) Net income (loss) per share is computed independently for each of the fiscal quarters presented. Therefore, the sum of the quarterly basic and diluted net income (loss) per share amounts may not equal the annual basic and diluted net income (loss) per share amount for the full fiscal years.

XML

Subsequent Events

12 Months Ended

Jul. 01, 2017

Subsequent Events [Abstract]

Subsequent Events

Note 19. Subsequent Events

Repurchase of Common Stock

Subsequent to our fiscal year ended July 1, 2017, the Company repurchased approximately 0.3 million shares of common stock purchases at an average price of $10.58 per share under the stock repurchase program authorized on February 1, 2016. All common shares repurchased have been canceled and retired.

Repurchase of 2033 Notes

Subsequent to our fiscal year ended July 1, 2017, the Company repurchased $146.5 million of our 2033 Notes for $162.0 million in cash.

Acquisition of Trilithic, Inc.

On August 9, 2017, the Company acquired Trilithic, Inc. (“Trilithic”), a privately-held provider of electronic test and measurement equipment for telecommunications service providers and will be part of NE operating segment. The Company acquired Trilithic for $55.0 million in cash, net of cash acquired, subject to working capital adjustments. The acquisition will be accounted for as a business combination in accordance with the authoritative guidance.

Due to the closing of this acquisition subsequent to the period end, the Company is currently determining the fair value of assets acquired and liabilities assumed necessary to develop the purchase price allocation. Therefore, disclosure of the purchase price allocation to the tangible and intangible assets acquired and liabilities assumed is not practicable.

XML

Basis of Presentation (Policies)

12 Months Ended

Jul. 01, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Fiscal Years

Fiscal Years

The Company utilizes a 52-53 week fiscal year ending on the Saturday closest to June 30th. The Company’s fiscal 2017 was a 52-week year ending on July 1, 2017. The Company’s fiscal 2016 and 2015 were 53-week and 52-week fiscal years ending on July 2, 2016, and June 27, 2015, respectively.

Principles of Consolidation

Principles of Consolidation

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the Company and its wholly-owned subsidiaries. All inter-company accounts and transactions have been eliminated.

Use of Estimates

Use of Estimates

The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements, the reported amount of net revenues and expenses and the disclosure of commitments and contingencies during the reporting periods. The Company bases estimates on historical experience and on various assumptions about the future that are believed to be reasonable based on available information. The Company’s reported financial positions or results of operations may be materially different under changed conditions or when using different estimates and assumptions, particularly with respect to significant accounting policies. If estimates or assumptions differ from actual results, subsequent periods are adjusted to reflect more current information.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers highly liquid instruments such as treasury bills, commercial paper and other money market instruments with original maturities of 90 days or less at the time of purchase to be cash equivalents.

Restricted Cash

Restricted Cash

At July 1, 2017 and July 2, 2016, the Company’s short-term restricted cash balances were $11.2 million and $12.2 million, respectively, and the Company’s long-term restricted cash balances were $6.8 million and $6.0 million, respectively. These balances primarily include interest-bearing investments in bank certificates of deposit and money market funds which act as collateral supporting the issuance of letters of credit and performance bonds for the benefit of third parties.

Investments

Investments

The Company’s investments in debt securities and marketable equity securities, including the Company’s ownership of Lumentum’s common stock, are primarily classified as available-for-sale investments or trading securities and are recorded at fair value. The cost of securities sold is based on the specific identification method. Unrealized gains and losses resulting from changes in fair value on available-for-sale investments, net of tax, are reported within accumulated other comprehensive income (loss), a separate component of stockholders’ equity. Unrealized gains or losses on trading securities resulting from changes in fair value are recognized in current earnings. The Company’s short-term investments, which are classified as current assets, include certain securities with stated maturities of longer than twelve months as they are highly liquid and available to support current operations.

The Company periodically reviews these investments for impairment. If a debt security’s fair value is below amortized cost and the Company either intends to sell the security or it is more likely than not that the Company will be required to sell the security before its anticipated recovery, the Company records an other-than-temporary impairment charge to current earnings for the entire amount of the impairment; if a debt security’s fair value is below amortized cost and the Company does not expect to recover the entire amortized cost of the security, the Company separates the other-than-temporary impairment into the portion of the loss related to credit factors, or the credit loss portion, and the portion of the loss that is not related to credit factors, or the non-credit loss portion. The credit loss portion is the difference between the amortized cost of the security and the Company’s best estimate of the present value of the cash flows expected to be collected from the debt security. The non-credit loss portion is the residual amount of the other-than-temporary impairment. The credit loss portion is recorded as a charge to income (loss), and the non-credit loss portion is recorded as a separate component of other comprehensive (loss) income.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The carrying amounts of certain of the Company’s financial instruments, including cash equivalents, accounts receivable, accounts payable, and deferred compensation liability, approximate fair value because of their short maturities. Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. There is an established hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the assumptions about the factors that market participants would use in valuing the asset or liability.

Estimates of fair value of fixed-income securities are based on third party, market-based pricing sources which the Company believes to be reliable. These estimates represent the third parties’ good faith opinion as to what a buyer in the marketplace would pay for a security in a current sale. For instruments that are not actively traded, estimates may be based on current treasury yields adjusted by an estimated market credit spread for the specific instrument. The fair market value of the Company’s 0.625% Senior Convertible Notes due 2033 and 1.00% Senior Convertible Notes due 2024 fluctuates with interest rates and with the market price of the stock, but does not affect the carrying value of the debt on the balance sheet.

Inventories

Inventories

Inventory is valued at standard cost, which approximates actual cost computed on a first-in, first-out basis, not in excess of net realizable market value. The Company assesses the valuation on a quarterly basis and writes down the value for estimated excess and obsolete inventory based upon estimates of future demand, including warranty requirements. Our inventories include material, labor, and manufacturing overhead costs.

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment are stated at cost. Depreciation is computed by the straight-line method over the following estimated useful lives of the assets: 10 to 50 years for building and improvements, 2 to 20 years for machinery and equipment, and 2 to 5 years for furniture, fixtures, software and office equipment. Leasehold improvements are amortized by the straight-line method over the shorter of the estimated useful lives of the assets or the term of the lease. Demonstration units, which are Company products used for demonstration purposes for customers and/or potential customers and generally not intended to be sold, have an estimated useful life of 3 to 5 years and are amortized by the straight-line method.

Costs related to software acquired, developed or modified solely to meet the Company’s internal requirements and for which there are no substantive plans to market are capitalized in accordance with the authoritative guidance on accounting for the costs of computer software developed or obtained for internal use. Only costs incurred after the preliminary planning stage of the project and after management has authorized and committed funds to the project are eligible for capitalization. Costs capitalized for computer software developed or obtained for internal use are included in property, plant and equipment, net on the Consolidated Balance Sheets.

Goodwill

Goodwill

Goodwill represents the excess of the purchase price of an acquired enterprise or assets over the fair value of the identifiable assets acquired and liabilities assumed. The Company tests for impairment of goodwill on an annual basis in the fourth quarter and at any other time when events occur or circumstances indicate that the carrying amount of goodwill may not be recoverable. Refer to “Note 8. Goodwill” for more information.

Circumstances that could trigger an impairment test include, but are not limited to, a significant adverse change in the business climate or legal factors, an adverse action or assessment by a regulator, change in customers, target market and strategy, unanticipated competition, loss of key personnel, or the likelihood that a reporting unit or significant portion of a reporting unit will be sold or otherwise disposed.

An assessment of qualitative factors may be performed to determine whether it is necessary to perform the quantitative goodwill impairment test. If the result of the qualitative assessment is that it is more likely than not (i.e., greater than 50% likelihood) that the fair value of a reporting unit is less than its carrying amount, then the quantitative test is required. Otherwise, no further testing is required.

Under the quantitative test, if the carrying amount of the reporting unit goodwill exceeds the implied fair value of that goodwill, an impairment loss is recorded in the Consolidated Statements of Operations as “impairment of goodwill.” Measurement of the fair value of a reporting unit is based on one or more of the following fair value measures: using present value techniques of estimated future cash flows, or using valuation techniques based on multiples of earnings or revenue, or a similar performance measure.

In the fourth quarter of fiscal 2017, the Company early adopted the new accounting guidance issued by the FASB that eliminated the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, any impairment charge would be based on the excess of a reporting unit's carrying amount over its fair value.

Intangible Assets

Intangible Assets

Intangible assets consist primarily of purchased intangible assets through acquisitions. Purchased intangible assets primarily include acquired developed technologies (developed and core technology), customer relationships, proprietary know-how, trade secrets, and trademarks and trade names. Intangible assets are amortized using the straight-line method over the estimated economic useful lives of the assets, which is the period during which expected cash flows support the fair value of such intangible assets.

Long-lived Asset Valuation (Property, Plant and Equipment and Intangible Assets Subject to Amortization)

Long-lived Asset Valuation (Property, Plant and Equipment and Intangible Assets Subject to Amortization)

Long-lived assets held and used

The Company tests long-lived assets for recoverability, at the asset group level, when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to, significant decreases in the market price of the asset, significant adverse changes in the business climate or legal factors, accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset, current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset, or current expectation that the asset will more likely than not be sold or disposed significantly before the end of its estimated useful life.

 Recoverability is assessed based on the difference between the carrying amount of the asset and the sum of the undiscounted cash flows expected to result from the use and the eventual disposal of the asset. An impairment loss is recognized when the carrying amount is not recoverable and exceeds the fair value.

Pension and Other Postretirement Benefits

Pension and Other Postretirement Benefits

In the fourth quarter of fiscal 2016 the Company early adopted the authoritative guidance issued by the FASB that provides a practical expedient permitting an entity to measure defined benefit plan assets and obligations using the month-end that is closest to the entity’s fiscal year-end and apply that practical expedient consistently from year to year. The Company has adopted the month-end date of June 30, which is the closest month-end to the Company’s fiscal year as the measurement date for all of the Company's qualified and the non-qualified pension plans in certain countries beginning in fiscal 2016. Measurement dates for prior periods are not impacted. 

The funded status of the Company’s retirement-related benefit plans is recognized on the Consolidated Balance Sheets. The funded status is measured as the difference between the fair value of plan assets and the benefit obligation at fiscal year end, the measurement date. For defined benefit pension plans, the benefit obligation is the projected benefit obligation (“PBO”) and for the non-pension postretirement benefit plan the benefit obligation is the accumulated postretirement benefit obligation (“APBO”). The PBO represents the actuarial present value of benefits expected to be paid upon its employee’s retirement. The APBO represents the actuarial present value of postretirement benefits attributed to employee services already rendered. Unfunded or partially funded plans, with the benefit obligation exceeding the fair value of plan assets, are aggregated and recorded as a retirement and non-pension postretirement benefit obligation equal to this excess. The current portion of the retirement-related benefit obligation represents the actuarial present value of benefits payable in the next 12 months in excess of the fair value of plan assets, measured on a plan-by-plan basis. This liability is recorded in other current liabilities in the Consolidated Balance Sheets.

Net periodic pension cost is recorded in the Consolidated Statements of Operations and includes service cost, interest cost, expected return on plan assets, amortization of prior service cost (credit), and (gains) losses previously recognized as a component of accumulated other comprehensive income (loss). Service cost represents the actuarial present value of participant benefits attributed to services rendered by employees in the current year. Interest cost represents the time value of money cost associated with the passage of time. (Gains) losses arise as a result of differences between actual experience and assumptions or as a result of changes in actuarial assumptions. Prior service cost (credit) represents the cost of benefit improvements attributable to prior service granted in plan amendments. (Gains) losses and prior service cost (credit) not recognized as a component of net periodic pension cost in the Consolidated Statements of Operations as they arise are recognized as a component of accumulated other comprehensive income (loss) on the Consolidated Balance Sheets, net of tax. Those (gains) losses and prior service cost (credit) are subsequently recognized as a component of net periodic pension cost pursuant to the recognition and amortization provisions of the authoritative guidance.

The measurement of the benefit obligation and net periodic pension cost is based on the Company’s estimates and actuarial valuations provided by third-party actuaries, and are approved by management. These valuations reflect the terms of the plans and use participant-specific information such as compensation, age and years of service, as well as certain assumptions, including estimates of discount rates, expected return on plan assets, rate of compensation increases, and mortality rates. The Company evaluates these assumptions periodically but not less than annually. In estimating the expected return on plan assets, the Company considers historical returns on plan assets, diversification of plan investments, adjusted for forward-looking considerations, inflation assumptions and the impact of the active management of the plan’s invested assets.

Concentration of Credit and Other Risks

Concentration of Credit and Other Risks

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments, restricted cash, trade receivables and foreign currency forward contracts. The Company’s cash and cash equivalents and short-term investments are held in safekeeping by large, creditworthy financial institutions. The Company invests its excess cash primarily in U.S. government and agency bonds securities, corporate securities, money market funds, asset-backed securities, other investment-grade securities and certificates of deposit. The Company has established guidelines relative to credit ratings, diversification and maturities that seek to maintain safety and liquidity of these investments. The Company’s foreign exchange derivative instruments expose the Company to credit risk to the extent that the counterparties may be unable to meet the terms of the agreements. The Company seeks to mitigate such risk by limiting its counterparties to major financial institutions and by spreading such risk across several major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from such risk is monitored by the Company on an ongoing basis.

The Company performs credit evaluations of its customers’ financial condition and generally does not require collateral from its customers. These evaluations require significant judgment and are based on a variety of factors including, but not limited to, current economic trends, historical payment, bad debt write-off experience, and financial review of the customer.

The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. When the Company becomes aware that a specific customer is unable to meet its financial obligations, the Company records a specific allowance to reflect the level of credit risk in the customer’s outstanding receivable balance. In addition, the Company records additional allowances based on certain percentages of aged receivable balances. These percentages take into account a variety of factors including, but not limited to, current economic trends, historical payment and bad debt write-off experience. The Company classifies bad debt expenses as selling, general and administrative (“SG&A”) expense.

The Company is not able to predict changes in the financial stability of its customers. Any material change in the financial status of any one customer or a group of customers could have a material adverse effect on the Company’s results of operations and financial condition. Although such losses have been within management’s expectations to date, there can be no assurance that such allowances will continue to be adequate. The Company has significant trade receivables concentrated in the telecommunications industry. While the Company’s allowance for doubtful accounts balance is based on historical loss experience along with anticipated economic trends, unanticipated financial instability in the telecommunications industry could lead to higher than anticipated losses.

As of July 1, 2017 and July 2, 2016, one customer represented 10% or more of our total accounts receivable, net.

During fiscal 2017, 2016 and 2015, certain customers generated 10% or more of total net revenues. Refer to "Note 17. Operating Segments and Geographic Information" for more information.

The Company relies on a limited number of suppliers for a number of key components contained in our products. The Company also relies on a limited number of significant independent contract manufacturers for the production of certain key components and subassemblies contained in our products.

The Company generally uses a rolling twelve month forecast based on anticipated product orders, customer forecasts, product order history and backlog to determine its materials requirements. Lead times for the parts and components that the Company orders vary significantly and depend on factors such as the specific supplier, contract terms and demand for a component at a given time. If the forecast does not meet actual demand, the Company may have excess or shortfalls of some materials and components, as well as excess inventory purchase commitments. The Company could experience reduced or delayed product shipments or incur additional inventory write-downs and cancellation charges or penalties, which would increase costs and could have a material adverse impact on the Company’s results of operations.

Foreign Currency Forward Contracts

Foreign Currency Forward Contracts

The Company conducts its business and sells its products to customers primarily in North America, Europe and Asia. In the normal course of business, the Company’s financial position is routinely subject to market risks associated with foreign currency rate fluctuations due to balance sheet positions in foreign currencies. The Company evaluates foreign exchange risks and utilizes foreign currency forward contracts to reduce such risks, hedging the gains or losses generated by the re-measurement of significant foreign currency denominated monetary assets and liabilities. The fair value of these contracts is reflected as other current assets or other current liabilities and the change in fair value of these foreign currency forward contracts is recorded as gain or loss in the Company’s Consolidated Statements of Operations as a component of interest and other income, net. The gain or loss from the change in fair value of these foreign currency forward contracts largely offsets the change in fair value of the foreign currency denominated monetary assets and liabilities, which is also recorded as a component of interest and other income, net.

Foreign Currency Translation

Foreign Currency Translation

Assets and liabilities of non-U.S. subsidiaries that operate in a local currency environment, where that local currency is the functional currency, are translated into U.S. dollars at exchange rates in effect at the balance sheet date, with the resulting translation adjustments directly recorded as a component of accumulated other comprehensive income (loss) on the Consolidated Balance Sheets. Income and expense accounts are translated at the prior month end exchange rates, which are deemed to approximate the exchange rate when the income and expense are recognized. Gains and losses from re-measurement of monetary assets and liabilities that are denominated in currencies other than the respective functional currencies are included in the Consolidated Statements of Operations as a component of interest and other income, net.

Revenue Recognition

Revenue Recognition

The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when it has persuasive evidence of an arrangement, delivery has occurred, the sales price is fixed or determinable and collectibility is reasonably assured. Delivery does not occur until products have been shipped or services have been provided, risk of loss has transferred and in cases where formal acceptance is required, customer acceptance has been obtained or customer acceptance provisions have lapsed. In situations where a formal acceptance is required but the acceptance only relates to whether the product meets its published specifications, revenue is recognized upon delivery provided that all other revenue recognition criteria are met. Historical return rates are monitored on a product-by-product basis. In addition, some distributor agreements allow for partial return of products and/or price protection under certain conditions within limited time periods. Such return rights are generally limited to contractually defined, short-term stock rotation and defective or damaged product. We maintain reserves for sales returns and price adjustments based on historical experience and other qualitative factors. As new products or distributors are introduced, these historical rates are used to establish initial sales returns reserves and are adjusted as better information becomes available. We also have market development incentive programs for certain distributors whereby rebates are offered based upon exceeding volume goals. Estimated rebates, sales returns and other such allowances are deducted from revenue.

In addition to the aforementioned general policies, the following are the specific revenue recognition policies for multiple-element arrangements and for each major category of revenue.

Multiple-Element Arrangements

When a sales arrangement contains multiple deliverables, such as sales of products that include services, the multiple deliverables are evaluated to determine whether there are one or more units of accounting. Where there is more than one unit of accounting, then the entire fee from the arrangement is allocated to each unit of accounting based on the relative selling price. Under this approach, the selling price of a unit of accounting is determined by using a selling price hierarchy which requires the use of vendor-specific objective evidence (“VSOE”) of fair value if available, third-party evidence (“TPE”) if VSOE is not available, or best estimate of selling price (“BESP”) if neither VSOE nor TPE is available. Revenue is recognized when the revenue recognition criteria for each unit of accounting are met.

The Company establishes VSOE of selling price using the price charged for a deliverable when sold separately and, in remote circumstances, using the price established by management having the relevant authority. TPE of selling price is established by evaluating similar and interchangeable competitor goods or services in sales to similarly situated customers. When VSOE or TPE is not available, the Company then uses BESP. Generally, the Company is not able to determine TPE because its product strategy differs from that of others in our markets, and the extent of customization varies among comparable products or services from its peers. The Company establishes BESP using historical selling price trends and considering multiple factors including, but not limited to geographies, market conditions, competitive landscape, internal costs, gross margin objectives, and pricing practices. When determining BESP, the Company applies significant judgment in establishing pricing strategies and evaluating market conditions and product lifecycles.

To the extent a deliverable(s) in a multiple-element arrangement is subject to specific guidance (for example, software that is subject to the authoritative guidance on software revenue recognition), the Company allocates the fair value of the units of accounting using relative selling price and that unit of accounting is accounted for in accordance with the specific guidance. Some product offerings include hardware that are integrated with or sold with software that delivers the functionality of the equipment. The Company believes this equipment is not considered software-related and would therefore be excluded from the scope of the authoritative guidance on software revenue recognition.

Hardware

Revenue from hardware sales is recognized when the product is shipped to the customer and when there are no unfulfilled obligations from the Company that affect the customer’s final acceptance of the arrangement. Any cost of warranties and remaining obligations that are inconsequential or perfunctory are accrued when the corresponding revenue is recognized.

Services

Revenue from services and system maintenance is recognized on a straight-line basis over the term of the service. Revenue from professional service engagements is recognized once its delivery obligation is fulfilled. Revenue related to extended warranty and product maintenance contracts is deferred and recognized on a straight-line basis over the delivery period. The Company also generates service revenue from hardware repairs and calibration which is recognized as revenue upon completion of the service.

Software

The Company’s software arrangements generally consist of a perpetual license fee, installation services and Post-Contract Support (“PCS”) as well as other non-software deliverables.

VSOE of fair value for PCS is established based on the renewal rate or the bell curve methodology. Non-software and software-related arrangements are bifurcated based on a relative selling price using BESP. The software related elements are bifurcated into separate units of accounting if VSOE of fair value has been established for the undelivered element(s) and the functionality of the delivered element(s) is not dependent on the undelivered element(s).

Revenue from multiple-element software arrangements that include installation services, is deferred until installation service obligation for the software solution is fulfilled. If VSOE has been established for the undelivered elements, the software, installation services and non-software elements are recognized upon completion of delivery and the PCS is recognized ratably over the remaining support contract term. If VSOE has not been established for the undelivered element, the software related elements are recognized ratably over the remaining support period.

Warranty

Warranty

The Company provides reserves for the estimated costs of product warranties at the time revenue is recognized. It estimates the costs of its warranty obligations based on its historical experience of known product failure rates, use of materials to repair or replace defective products and service delivery costs incurred in correcting product failures. In addition, from time to time, specific warranty accruals may be made if unforeseen technical problems arise.

Shipping and Handling Costs

Shipping and Handling Costs

The Company records costs related to shipping and handling of revenue in cost of sales for all periods presented.

Advertising Expense

Advertising Expense

The Company expenses advertising costs as incurred.

Research and Development (“R&D”) Expense

Research and Development (“R&D”) Expense

Costs related to R&D, which primarily consists of labor and benefits, supplies, facilities, consulting and outside service fees, are charged to expense as incurred. The authoritative guidance allows for capitalization of software development costs incurred after a product’s technological feasibility has been established until the product is available for general release to the public. To date, the period between achieving technological feasibility, which the Company has defined as the establishment of a working model and typically occurs when beta testing commences, and the general availability of such software has been very short. Accordingly, software development costs have been expensed as incurred.

Stock-Based Compensation

Stock-Based Compensation

Stock-based compensation is measured at grant date, and recognized in expense over the requisite service period based on the fair value of the equity award. The fair value of the time-based Full Value Awards is based on the closing market price of the Company’s common stock on the grant date of the award. The Company uses the Monte Carlo simulation to estimate the fair value of Full Value Awards with market conditions (“MSUs”). The Company estimates the fair value of stock options and employee stock purchase plan awards (“ESPP”) using the Black-Scholes Merton (“BSM”) option-pricing model. This option-pricing model requires the input of assumptions, including the award’s expected life and the price volatility of the underlying stock.

The Company estimates the expected forfeiture rate pursuant to the authoritative guidance, and only recognizes expense for those shares expected to vest. When estimating forfeitures, the Company considers voluntary termination behavior as well as future workforce reduction programs. Estimated forfeiture is trued up to actual forfeiture as the equity awards vest. The total fair value of the equity awards, net of forfeiture, is recorded on a straight-line basis over the requisite service period of the awards for each separately vesting period of the award, except for MSUs, which are amortized based upon graded vesting method.

Income Taxes

Income Taxes

In accordance with the authoritative guidance on accounting for income taxes, the Company recognizes income taxes using an asset and liability approach. This approach requires the recognition of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in its consolidated financial statements or tax returns. The measurement of current and deferred taxes is based on provisions of the enacted tax law and the effects of future changes in tax laws or rates are not anticipated.

The authoritative guidance provides for recognition of deferred tax assets if the realization of such deferred tax assets is more likely than not to occur based on an evaluation of both positive and negative evidence and the relative weight of the evidence. With the exception of certain international jurisdictions, the Company has determined that at this time it is more likely than not that deferred tax assets attributable to the remaining jurisdictions will not be realized, primarily due to uncertainties related to its ability to utilize its net operating loss carryforwards before they expire. Accordingly, the Company has established a valuation allowance for such deferred tax assets. If there is a change in the Company’s ability to realize its deferred tax assets for which a valuation allowance has been established, then its tax provision may decrease in the period in which it determines that realization is more likely than not. Likewise, if the Company determines that it is not more likely than not that our deferred tax assets will be realized, then a valuation allowance may be established for such deferred tax assets and the Company’s tax provision may increase in the period in which we make the determination.

The authoritative guidance on accounting for uncertainty in income taxes prescribes the recognition threshold and measurement attributes for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Additionally, it provides guidance on recognition, classification, and disclosure of tax positions. The Company is subject to income tax audits by the respective tax authorities in all of the jurisdictions in which it operates. The determination of tax liabilities in each of these jurisdictions requires the interpretation and application of complex and sometimes uncertain tax laws and regulations. The Company recognizes liabilities based on its estimate of whether, and the extent to which, additional tax liabilities are more likely than not. If the Company ultimately determines that the payment of such a liability is not necessary, then it reverses the liability and recognizes a tax benefit during the period in which the determination is made that the liability is no longer necessary.

The recognition and measurement of current taxes payable or refundable and deferred tax assets and liabilities requires that the Company make certain estimates and judgments. Changes to these estimates or a change in judgment may have a material impact on the Company’s tax provision in a future period.

Restructuring Accrual

Restructuring Accrual

In accordance with authoritative guidance on accounting for costs associated with exit or disposal activities, generally costs associated with restructuring activities are recognized when they are incurred. However, in the case of operating and direct financing leases, the expense is estimated and accrued when the property is vacated. Given the significance of, and the timing of the execution of such activities, this process is complex and involves periodic reassessments of estimates made from the time the property was vacated, including evaluating real estate market conditions for expected vacancy periods and sub-lease income.

Additionally, a liability for post-employment benefits for workforce reductions related to restructuring activities is recorded when payment is probable, and the amount is reasonably estimable. The Company continually evaluates the adequacy of the remaining liabilities under its restructuring initiatives. Although the Company believes that these estimates accurately reflect the costs of its restructuring plans, actual results may differ, thereby requiring the Company to record additional liabilities or reverse a portion of existing liabilities.

Loss Contingencies

Loss Contingencies

The Company is subject to the possibility of various loss contingencies arising in the ordinary course of business. The Company considers the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as its ability to reasonably estimate the amount of loss in determining loss contingencies. An estimated loss is accrued when it is probable that an asset has been impaired or a liability has been incurred and the amount of loss can be reasonably estimated. The Company regularly evaluates current information available to determine whether such accruals should be adjusted and whether new accruals are required.

Asset Retirement Obligations ("ARO")

Asset Retirement Obligations (“ARO”)

ARO are legal obligations associated with the retirement of long-lived assets pertaining to leasehold improvements. These liabilities are initially recorded at fair value and the related asset retirement costs are capitalized by increasing the carrying amount of the related assets by the same amount as the liability. Asset retirement costs are subsequently depreciated over the useful lives of the related assets. Subsequent to initial recognition, the Company records period-to-period changes in the ARO liability resulting from the passage of time and revisions to either the timing or the amount of the original estimate of undiscounted cash flows. The Company derecognizes ARO liabilities when the related obligations are settled.

Recently Issued Accounting Pronouncements

In May 2017, the Financial Accounting Standards Board (“FASB”) issued guidance that clarifies the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under the relevant authoritative guidance. The guidance is to be applied prospectively, and is effective for the Company in the first quarter of fiscal 2019. Early adoption is permitted. The Company does not anticipate the adoption of this guidance to have a material impact on its consolidated financial statements, absent any award(s) modified on or after adoption date.

In November 2016, the FASB issued guidance that will require that the amounts generally described as restricted cash and restricted cash equivalents would be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period amounts shown on the statement of cash flows. The new guidance also requires certain disclosures to supplement the statement of cash flows. The guidance is effective for the Company in the first quarter of fiscal 2019. Other than changes in the presentation within the statements of cash flows and additional required disclosures, the adoption of this new accounting guidance will not have an impact on the consolidated financial statements.

In October 2016, the FASB issued guidance that requires entities to recognize at the transaction date the income tax consequences of intra-entity transfer of an asset other than inventory. The guidance is effective for the Company in the first quarter of fiscal 2019. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In June 2016, the FASB issued guidance that changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. The guidance is effective for the Company in the first quarter of fiscal 2021 and earlier adoption is permitted. The Company is evaluating the impact of adopting this new accounting guidance on its consolidated financial statements.

In March 2016, the FASB issued guidance which simplifies several aspects of accounting for share-based payment award transactions including income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The guidance is effective for the Company in the first quarter of fiscal 2018. The most significant impact from this guidance upon adoption for the Company relates to the classification of employee tax paid by withholding shares of restricted stock units on the statements of cash flows and excess tax benefit. Upon adoption, the related cash flows will be classified as financing activity, from the current classification as operating activity and all prior periods presented will be retrospectively adjusted to reflect this change. The employee tax paid by withholding shares totaled $14.3 million and $11.4 million in fiscal 2017 and 2016, respectively. In addition, the guidance requires that the excess tax benefits to be recorded on the income statement as opposed to additional paid-in-capital. Due to the Company’s valuation allowance on its deferred tax assets, no income tax benefit is expected to be recognized upon adoption. All other aspects of the guidance are not expected to have a material effect on the Company’s consolidated financial statements.

In February 2016, the FASB issued guidance regarding both operating and financing leases, requiring lessees to recognize on their balance sheets “right-of-use assets” and corresponding lease liabilities, measured on a discounted basis over the lease term. Virtually all leases will be subject to this treatment except leases that meet the definition of a “short-term lease.” The guidance requires a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The guidance is effective for the Company in the first quarter of fiscal 2020. While the Company is not yet in a position to assess the full impact of the application of the new guidance, the Company expects adoption of this guidance will materially increase the assets and liabilities recorded on its Consolidated Balance Sheets.

In May 2014, the FASB issued new authoritative guidance related to revenue recognition from contracts with customers. This new guidance will replace current U.S. GAAP guidance on this topic and eliminate industry-specific guidance. The new guidance provides a unified model to determine when and how revenue is recognized. The core principle of the new guidance is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This new guidance allows for either full retrospective adoption or modified retrospective adoption. The FASB deferred the effective date for this new guidance by one year to December 15, 2017 for annual reporting periods beginning after such date. Earlier application of this new guidance is permitted. The Company currently anticipates adopting the guidance in the first quarter of fiscal 2019 using the full retrospective method, reflecting the application of the new standard in each prior reporting period.

In preparation for the implementation and adoption of the new guidance, the Company has established a cross-functional team and implementation plan to identify processes, systems and internal controls over financial reporting impacted by the new guidance. The implementation plan includes comparison of the Company’s historical accounting policies and practices to the requirements of the new guidance, and identifying differences from applying the requirements of the new guidance to the Company’s contracts, consolidated financial statements and related disclosures.

While the Company’s assessment of the potential impacts of the new guidance is not yet complete, initially the Company believes the most significant impact on the accounting for contracts with customers will be for certain arrangements that include sales of software solutions bundled with post-contract support (PCS) and/or services, where VSOE has not been established for the PCS and/or the services. Due to lack of VSOE under the current guidance, the Company defers recognition of any revenue attributable to such arrangements until the services lacking VSOE are complete. Such revenue is then recognized ratably over the remaining support term. The requirement to have VSOE for undelivered elements to enable the separation of the revenue for delivered software is eliminated under the new guidance and the Company will be required to allocate total contract revenue to each element (referred to as a distinct performance obligation under the new standard) based on either an established or estimated standalone selling price. Accordingly, a portion of the revenue for these types of contracts with customers will be recognized when the software or software solution is transferred to the customer. Dependent on contract-specific terms, the Company expects the actual revenue recognition treatment and timing will vary under the new guidance for some of these arrangements. The Company will continue to evaluate the impact of this new guidance on its consolidated financial statements and related disclosures.

XML

Basis of Presentation (Tables)

12 Months Ended

Jul. 01, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of asset retirement obligation

The activities and balances for ARO are as follows (in millions):

	Balance at Beginning of Period		Liabilities Incurred	Liabilities Settled		Accretion Expense	Revisions to Estimates		Balance at End of Period
Year ended July 1, 2017	$	3.7	0.1	(0.1	)	0.2	(0.3	)	$	3.6
Year ended July 2, 2016	$	4.4	0.4	(0.9	)	0.2	(0.4	)	$	3.7

XML

Discontinued Operations (Tables)

12 Months Ended

Jul. 01, 2017

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Discontinued Operations

The following table presents supplemental cash flow information: depreciation expense, amortization expense, stock-based compensation expense and capital expenditures of the Lumentum business (in millions):

	Years Ended
	July 2, 2016		June 27, 2015
Operating activities:
Depreciation expense	$	3.7	$	43.4
Amortization expense	0.6		7.9
Stock-based compensation expense	1.6		19.4
Investing activities:
Capital expenditures	$	5.8	$	55.9

(1) No depreciation expense, amortization expense, stock based compensation expense and capital expenditures relating to the Lumentum business are presented after the Separation Date.

The following table summarizes results from discontinued operations of the Lumentum business included in the Consolidated Statement of Operations (in millions):

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Net revenues	$	—		$	66.5		$	835.2
Cost of revenues	—			49.8			569.1
Amortization of acquired technologies	—			0.6			7.5
Gross profit	—			16.1			258.6
Operating expenses:
Research and development	—			12.5			139.9
Selling, general and administrative	(0.8		)	24.7			87.5
Restructuring charges	—			0.1			7.7
Total operating expenses	(0.8		)	37.3			235.1
Income (loss) from operations	0.8			(21.2		)	23.5
Interest and other income, net	—			—			(1.1		)
Income (loss) before income taxes	0.8			(21.2		)	22.4
(Benefit from) provision for income taxes	(0.8		)	27.8			(20.9		)
Net income (loss) from discontinued operations (1)	$	1.6		$	(49.0	)	$	43.3

(1)  No income or expense relating to the Lumentum business was recorded after the Separation Date.

XML

Earnings Per Share (Tables)

12 Months Ended

Jul. 01, 2017

Earnings Per Share [Abstract]

Schedule of computation of basic and diluted net (loss) income per share

The following table sets forth the computation of basic and diluted net income (loss) per share (in millions, except per share data):

	Years Ended
	July 1, 2017		July 2, 2016			June 27, 2015
Numerator:
Income (loss) from continuing operations, net of taxes	$	165.3	$	(50.4	)	$	(131.4	)
Income (loss) from discontinued operations, net of taxes	1.6		(48.8		)	43.3
Net income (loss)	$	166.9	$	(99.2	)	$	(88.1	)
Denominator:
Weighted-average number of common shares outstanding
Basic	229.9		234.0			232.7
Effect of dilutive securities from stock-based benefit plans	4.6		—			—
Diluted	234.5		234.0			232.7
Net income (loss) per share from - basic:
Continuing operations	$	0.72	$	(0.22	)	$	(0.57	)
Discontinued operations	0.01		(0.20		)	0.19
Net income (loss)	$	0.73	$	(0.42	)	$	(0.38	)
Net income (loss) per share from - diluted:
Continuing operations	$	0.70	$	(0.22	)	$	(0.57	)
Discontinued operations	0.01		(0.20		)	0.19
Net income (loss)	$	0.71	$	(0.42	)	$	(0.38	)

Schedule of weighted average potentially dilutive securities excluded from the computation because their effect would have been anti-dilutive

The following table sets forth the weighted-average potentially dilutive securities excluded from the computation of the diluted net income (loss) per share because their effect would have been anti-dilutive (in millions):

	Years Ended
	July 1, 2017 (2)(3)	July 2, 2016 (1)(2)	June 27, 2015 (1)(2)
Stock options and ESPP	0.9	3.4	3.6
Full Value Awards	0.6	10.9	10.3
Total potentially dilutive securities	1.5	14.3	13.9

(1) As the Company incurred a net loss from continuing operations in the period, potential dilutive securities from employee stock options, employee stock purchase plan (“ESPP”) and restricted stock units (“RSUs”) have been excluded from the diluted net loss per share computations as their effects were deemed anti-dilutive.

(2) The Company’s 0.625% Senior Convertible Notes due 2033 are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $11.28 per share is payable in cash, shares of the Company’s common stock or a combination of both at the Company’s election. Refer to “Note 10. Debt” for more details.

(3) The Company’s 1.00% Senior Convertible Notes due 2024 are not included in the table above. The par amount of convertible notes is payable in cash equal to the principal amount of the notes plus any accrued and unpaid interest and then the “in-the-money” conversion benefit feature at the conversion price above $13.22 per share is payable in cash, shares of the Company’s common stock or a combination of both at the Company’s election. Refer to “Note 10. Debt” for more details.

XML

Accumulated Other Comprehensive Income (Loss) (Tables)

12 Months Ended

Jul. 01, 2017

Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]

Schedule of components of accumulated other comprehensive income

At July 1, 2017 and July 2, 2016, the changes in accumulated other comprehensive income (loss) by component net of tax were as follows (in millions):

	Unrealized gains (losses)  on available-for-sale  investments (1)			Foreign currency translation adjustments			Change in unrealized components of defined benefit obligations, net of tax (2)			Total
Beginning balance as of July 2, 2016	$	104.5		$	(70.1	)	$	(24.4	)	$	10.0
Other comprehensive income before reclassification	92.1			4.8			0.7			97.6
Amounts reclassified from accumulated other comprehensive income (loss)	(201.9		)	—			1.9			(200.0		)
Net current period other comprehensive (loss) income	(109.8		)	4.8			2.6			(102.4		)
Ending balance as of July 1, 2017	$	(5.3	)	$	(65.3	)	$	(21.8	)	$	(92.4	)

(1) Activity before reclassifications to the Consolidated Statements of Operations during the year ended July 1, 2017 primarily relates to a $92.6 million unrealized gain on the marketable equity securities of Lumentum held by Viavi. The amount reclassified out of accumulated other comprehensive income (loss) represents the gross realized gain from available-for-sale securities included as “gain on sale of investments" in the Consolidated Statement of Operations for the year ended July 1, 2017. There was no tax impact for the fiscal year 2017.

(2) Activity before reclassifications to the Consolidated Statements of Operations during the year ended July 1, 2017 relates to the unrealized actuarial gain of $2.1 million, net of income tax expense of $1.4 million. The amount reclassified out of accumulated other comprehensive income (loss) represents the amortization of actuarial losses included as a component of selling, general and administrative expense (“SG&A”) in the Consolidated Statement of Operations for the year ended July 1, 2017. Refer to “Note 15. Employee Pension and Other Benefit Plans” for more details on the computation of net periodic cost for pension plans.

XML

Balance Sheet and Other Details (Tables)

12 Months Ended

Jul. 01, 2017

Balance Sheet and Other Details

Schedule of components of accounts receivable reserves and allowances

The components of accounts receivable reserves and allowances were as follows (in millions):

	July 1, 2017		July 2, 2016
Allowance for doubtful accounts	$	1.6	$	2.2
Sales allowance	3.4		2.5
Total accounts receivable reserves and allowances	$	5.0	$	4.7

Activities and balances for allowance for doubtful accounts

The activities and balances for allowance for doubtful accounts are as follows (in millions):

	Balance at Beginning of Period		Charged to Costs and Expenses			Deduction (1)			Balance at End of Period
Year Ended July 1, 2017	$	2.2	$	(0.2	)	$	(0.4	)	$	1.6
Year Ended July 2, 2016	2.4		0.3			(0.5		)	2.2
Year Ended June 27, 2015	2.9		0.3			(0.8		)	2.4

(1) Represents the effect of currency translation adjustments and write-offs of uncollectible accounts, net of recoveries.

Schedule of components of inventories

The components of inventories, net were as follows (in millions):

	July 2, 2016		July 2, 2016
Finished goods	$	24.9	$	29.1
Work in process	10.3		7.5
Raw materials	12.8		14.8
Inventories, net	$	48.0	$	51.4

Schedule of components of prepayments and other current assets

The components of prepayments and other current assets were as follows (in millions):

	July 1, 2017		July 2, 2016
Prepayments	$	8.3	$	10.4
Other current assets	42.5		21.7
Prepayments and other current assets	$	50.8	$	32.1

Schedule of components of property, plant and equipment

The components of property, plant and equipment, net were as follows (in millions):

	July 1, 2017			July 2, 2016
Land	$	14.5		$	14.6
Buildings and improvements	31.4			32.4
Machinery and equipment	225.8			218.7
Furniture, fixtures, software and office equipment	111.2			120.5
Leasehold improvements	58.1			54.3
Construction in progress	17.8			10.3
Property, plant and equipment, gross	458.8			450.8
Less: Accumulated depreciation	(321.9		)	(317.8		)
Property, plant and equipment, net	$	136.9		$	133.0

Schedule of components of other current liabilities

The components of other current liabilities were as follows (in millions):

	July 1, 2017		July 2, 2016
Customer prepayments	$	35.2	$	0.4
Restructuring accrual	8.8		13.3
Income tax payable	3.3		3.3
Warranty accrual	2.9		2.6
VAT liabilities	2.2		2.3
Deferred compensation plan	2.0		2.4
Other	7.0		6.7
Other current liabilities	$	61.4	$	31.0

Schedule of components of other non-current liabilities

The components of other non-current liabilities were as follows (in millions):

	July 1, 2017		July 2, 2016
Pension and post-employment benefits	$	99.4	$	103.0
Financing obligation	27.8		28.7
Long-term deferred revenue	14.0		22.7
Other	22.7		24.7
Other non-current liabilities	$	163.9	$	179.1

Schedule of components of interest and other income (expense), net

The components of interest and other income, net were as follows (in millions):

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Interest income	$	11.1		5.9			$	4.6
Foreign exchange gains (loss), net	0.9			(2.6		)	(3.8		)
Proceeds from Nortel (1)	—			—			2.2
Loss on extinguishment of debt (2)	(1.1		)	—			—
Other income (expense), net	2.2			(0.8		)	0.7
Interest and other income, net	$	13.1		$	2.5		$	3.7

(1) During fiscal 2015, the Company received proceeds of $2.2 million from the Fair Fund established to provide compensation for losses incurred in connection with investments in Nortel Networks Corporation (“Nortel”) securities from the SEC’s claims against Nortel.

(2) During fiscal 2017, the Company repurchased $40.0 million aggregate principal amount of the 2033 Notes for $45.4 million in cash. In connection with the repurchase, a loss on extinguishment of $1.1 million was recognized. Refer to “Note 10. Debt” for more information.

XML

Investments and Fair Value Measurements (Tables)

12 Months Ended

Jul. 01, 2017

Investments and Fair Value Measurements [Abstract]

Schedule of available-for-sale securities

As of July 1, 2017, the Company’s available-for-sale securities were as follows (in millions):

	Amortized Cost/ Carrying Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Available-for-sale securities:
U.S. treasuries	$	56.8	$	—	$	(0.1	)	$	56.7
U.S. agencies	45.0		—		(0.1		)	44.9
Municipal bonds and sovereign debt instruments	4.4		—		—			4.4
Asset-backed securities	71.5		—		(0.4		)	71.1
Corporate securities	326.1		0.1		(0.2		)	326.0
Certificates of deposit	6.0		—		—			6.0
Total available-for-sale securities	$	509.8	$	0.1	$	(0.8	)	$	509.1

 As of July 2, 2016, the Company’s available-for-sale securities were as follows (in millions):

	Amortized Cost/ Carrying Cost		Gross Unrealized Gains		Gross Unrealized Losses			Estimated Fair Value
Debt securities:
U.S. treasuries	$	46.1	$	—	$	—		$	46.1
U.S. agencies	24.9		—		—			24.9
Municipal bonds and sovereign debt instruments	2.0		—		—			2.0
Asset-backed securities	50.4		0.1		(0.3		)	50.2
Corporate securities	224.5		0.2		(0.1		)	224.6
Total debt securities	347.9		0.3		(0.4		)	347.8
Marketable equity securities	62.1		109.2		—			171.3
Total available-for-sale securities	$	410.0	$	109.5	$	(0.4	)	$	519.1

Schedule of gross unrealized losses on available-for-sale securities

As of July 2, 2016, the Company’s total gross unrealized losses on available-for-sale securities, aggregated by type of investment instrument, were as follows (in millions):

	Less than 12 Months			Greater than 12 Months			Total
Asset-backed securities	$	—		$	(0.3	)	$	(0.3	)
Corporate securities	(0.1		)	—			(0.1		)
Total gross unrealized losses	$	(0.1	)	$	(0.3	)	$	(0.4	)

As of July 1, 2017, the Company’s total gross unrealized losses on available-for-sale securities, aggregated by type of investment instrument, were as follows (in millions):

	Less than 12 Months			Greater than 12 Months			Total
U.S. treasuries and agencies	$	(0.2	)	—			$	(0.2	)
Asset-backed securities	(0.1		)	$	(0.3	)	$	(0.4	)
Corporate securities	(0.2		)	—			(0.2		)
Total gross unrealized losses	$	(0.5	)	$	(0.3	)	$	(0.8	)

Schedule of contractual maturities of available-for-sale securities

As of July 1, 2017, contractual maturities of the Company’s debt securities classified as available-for-sale securities were as follows (in millions):

	Amortized Cost/Carrying Cost		Estimated Fair Value
Amounts maturing in less than 1 year	$	365.3	$	365.2
Amounts maturing in 1 - 5 years	143.5		143.2
Amounts maturing in more than 5 years	1.0		0.7
Total debt available-for-sale securities	$	509.8	$	509.1

Schedule of assets measured at fair value

Assets measured at fair value as of July 1, 2017 and July 2, 2016 are summarized below (in millions):

	Fair Value Measurement as of						Fair Value Measurement as of
	July 1, 2017						July 2, 2016
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Debt available-for-sale securities:
U.S. treasuries	$	56.7	$	56.7	$	—	$	46.1	$	46.1	$	—
U.S. agencies	44.9		—		44.9		24.9		—		24.9
Municipal bonds and sovereign debt instruments	4.4		—		4.4		2.0		—		2.0
Asset-backed securities	71.1		—		71.1		50.2				50.2
Corporate securities	326.0		—		326.0		224.6		—		224.6
Certificate of deposits	6.0		—		6.0		—
Total debt available-for-sale securities	509.1		56.7		452.4		347.8		46.1		301.7
Marketable equity securities	—		—		—		171.3		171.3		—
Money market funds	726.4		726.4		—		274.4		274.4		—
Trading securities	2.0		2.0		—		2.4		2.4		—
Foreign currency forward contracts	7.3		—		7.3		—
Total assets (1)	$	1,244.8	$	785.1	$	459.7	$	795.9	$	494.2	$	301.7
Liability:
Foreign currency forward contracts	1.3		—		1.3		—		—		—
Total liabilities (2)	$	1.3	$	—	$	1.3	$	—	$	—	$	—

(1) $789.2 million in cash and cash equivalents, $432.2 million in short-term investments, $11.0 million in restricted cash, $7.3 million in other current assets, and $5.1 million in other non-current assets on the Company’s Consolidated Balance Sheets as of July 1, 2017. $295.4 million in cash and cash equivalents, $484.7 million in short-term investments, $11.3 million in restricted cash, and $4.5 million in other non-current assets on the Company’s Consolidated Balance Sheets as of July 2, 2016.

(2) $1.3 million in other current liabilities on the Company’s Consolidated Balance Sheets as of July 1, 2017.

XML

Goodwill (Tables)

12 Months Ended

Jul. 01, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of changes in goodwill

The following table presents the changes in goodwill allocated to the Company’s reportable segments (in millions):

	Network Enablement			Service Enablement			Optical Security and Performance Products		Total
Balance as of June 27, 2015 (1)	$	154.5		$	92.7		$	8.3	$	255.5
Goodwill allocation - WaveReady (3)	(6.0		)	—			—		$	(6.0	)
Currency translation and other adjustments	(4.7		)	(1.3		)	—		$	(6.0	)
Goodwill impairment charge	—			(91.4		)	—		(91.4		)
Balance as of July 2, 2016 (2)	$	143.8		$	—		$	8.3	$	152.1
Currency translation	(0.5		)	—			—		$	(0.5	)
Balance as of July 1, 2017 (4)	$	143.3		$	—		$	8.3	$	151.6

(1) Gross goodwill balances for NE, SE and OSP were $456.4 million, $273.9 million and $92.8 million, respectively as of June 27, 2015. Accumulated impairment for NE, SE and OSP was $301.9 million, $181.2 million and $84.5 million, respectively as of June 27, 2015.

(2) Gross goodwill balances for NE, SE and OSP were $445.7 million, $272.6 million and $92.8 million, respectively as of July 2, 2016. Accumulated impairment for NE, SE and OSP was $301.9 million, $272.6 million and $84.5 million, respectively as of July 2, 2016.

(3) Amount represents a release of the relative fair value of goodwill in our NE reporting unit related to the WaveReady products line, which is now a part of Lumentum as of the Separation Date. Refer to “Note 3. Discontinued Operations” for more information about the Separation.

(4) Gross goodwill balances for NE, SE and OSP were $445.2 million, $272.6 million and $92.8 million, respectively as of July 1, 2017. Accumulated impairment for NE, SE and OSP was $301.9 million, $272.6 million and $84.5 million, respectively as of July 1, 2017.

Schedule of gross goodwill and accumulated impairment balances

The following table presents gross goodwill and aggregate impairment balances for the fiscal years ended July 1, 2017, and July 2, 2016 (in millions):

	years ended
	July 1, 2017			July 2, 2016
Gross goodwill balance	$	810.6		$	811.1
Accumulated impairment losses	(659.0		)	(659.0		)
Net goodwill balance	$	151.6		$	152.1

XML

Acquired Developed Technology and Other Intangibles (Tables)

12 Months Ended

Jul. 01, 2017

Acquired Developed Technology and Other Intangibles

Schedule of acquired developed technology and other intangibles

The following tables present details of the Company’s acquired developed technology, customer relationships and other intangibles (in millions):

As of July 1, 2017	Gross Carrying Amount		Accumulated Amortization			Net
Acquired developed technology	$	369.3	$	(352.0	)	$	17.3
Customer relationships	94.9		(81.3		)	13.6
Other (1)	9.9		(9.7		)	0.2
Total intangibles	$	474.1	$	(443.0	)	$	31.1

As of July 2, 2016	Gross Carrying Amount		Accumulated Amortization			Net
Acquired developed technology	$	369.3	$	(337.3	)	$	32.0
Customer relationships	95.6		(68.0		)	27.6
Other (1)	10.8		(10.5		)	0.3
Total intangibles	475.7		(415.8		)	59.9

(1) Other intangibles consist of customer backlog, non-competition agreements, patents, proprietary know-how and trade secrets, trademarks and trade names.

Schedule of details of amortization expense

The following table presents details of the Company’s amortization (in millions):

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Cost of revenues	$	14.3	$	17.3	$	31.9
Operating expense	14.0		14.6		19.5
Total	$	28.3	$	31.9	$	51.4

Schedule of estimated future amortization

Based on the carrying amount of acquired developed technology, customer relationships and other intangibles as of July 1, 2017, and assuming no future impairment of the underlying assets, the estimated future amortization is as follows (in millions):

Fiscal Years
2018	$	20.1
2019	9.3
2020	1.4
2021	0.3
Total amortization	$	31.1

XML

Debt (Tables)

12 Months Ended

Jul. 01, 2017

Debt Disclosure [Abstract]

Schedule of carrying amounts of the liability and equity components of convertible debt

The following table presents the carrying amounts of the liability and equity components (in millions):

	July 1, 2017			July 2, 2016
Principal amount of 0.625% Senior Convertible Notes	$	610.0		$	650.0
Principal amount of 1.00% Senior Convertible Notes	460.0			—
Unamortized discount of liability component	(129.4		)	(61.7		)
Unamortized debt issuance cost (1)	(9.2		)	(5.0		)
Carrying amount of liability component	$	931.4		$	583.3
Carrying amount of equity component (2)	$	229.7		$	134.4

(1) In April 2015, the Financial Accounting Standards Board ("FASB") issued new authoritative guidance to simplify the presentation of debt issuance costs by requiring debt issuance costs to be presented as a deduction from the corresponding liability, consistent with debt discounts or premiums. This guidance was effective for the Company in the first quarter of fiscal 2017 for its convertible debt, and was applied retrospectively for all periods reported.

(2) Included in additional paid-in-capital on the Consolidated Balance Sheets.

Summary of effective interest rate and the interest expense for the contractual interest and the accretion of debt discount

The following table presents the interest expense for contractual interest, amortization of debt issuance cost and accretion of debt discount (in millions):

	Years ended
	July 1, 2017		July 2, 2016
Interest expense-contractual interest	$	5.5	$	4.1
Amortization of debt issuance cost	2.5		2.1
Accretion of debt discount	32.1		26.7

XML

Restructuring and Related Charges (Tables)

12 Months Ended

Jul. 01, 2017

Restructuring and Related Activities [Abstract]

Schedule of various restructuring plans

The adjustments to the accrued restructuring expenses related to all of the Company’s restructuring plans described below for the fiscal year endedJuly 1, 2017 were as follows (in millions):

	Balance as of July 2, 2016		Fiscal Year 2017 Charges (Releases)			Cash Settlements			Non-cash Settlements and Other Adjustments			Balance as of July 1, 2017
Fiscal 2017 Plan
OSP Restructuring Plan (1)	$	—	$	0.8		$	—		$	—		$	0.8
Focused NSE Restructuring Plan (1) (2)	—		21.3			(16.5		)	0.1			4.9
Other Plans (2)	—		0.4			(0.4		)	—			—
Fiscal 2016 Plan
NE, SE and Shared Services Agile Restructuring Plan (1) (2)	8.6		(0.7		)	(7.7		)	—			0.2
NE and SE Agile Restructuring Plan (1)	0.8		(0.1		)	(0.3		)	—			0.4
Fiscal 2015 Plan
NE, SE and Shared Service Separation Restructuring Plan (1) (2)	1.4		(0.2		)	(1.1		)	—			0.1
Plans Prior to Fiscal 2015
NE Product Strategy Restructuring Plan (1)	1.5		—			(0.5		)	(0.1		)	0.9
NE Lease Restructuring Plan (2)	4.0		0.1			(1.5		)	—			2.6
Other Plans (1) (2)	1.7		—			(0.6		)	—			1.1
Total	$	18.0	$	21.6		$	(28.6	)	$	—		$	11.0

(1) Plan type includes workforce reduction cost.

(2) Plan type includes lease exit cost.

XML

Income Taxes (Tables)

12 Months Ended

Jul. 01, 2017

Income Tax Disclosure [Abstract]

Schedule of income (loss) before income taxes

The Company’s income (loss) before income taxes consisted of the following (in millions):

	Years Ended
	July 1, 2017		July 2, 2016			June 27, 2015
Domestic	$	94.7	$	(110.9	)	$	(173.1	)
Foreign	91.9		65.0			67.8
Income (loss) before income taxes	$	186.6	$	(45.9	)	$	(105.3	)

Schedule of the Company's income tax expense (benefit)

The Company’s income tax expense (benefit) consisted of the following (in millions):

	Years Ended
	July 1, 2017		July 2, 2016			June 27, 2015
Federal:
Current	$	—	$	—		$	0.1
Deferred	1.0		(26.2		)	2.3
	1.0		(26.2		)	2.4
State:
Current	0.2		—			(0.1		)
Deferred	—		(1.5		)	0.1
	0.2		(1.5		)	—
Foreign:
Current	18.0		21.3			17.9
Deferred	2.1		10.9			5.8
	20.1		32.2			23.7
Total income tax expense	$	21.3	$	4.5		$	26.1

Schedule of reconciliation of the Company's income tax expense (benefit) at the federal statutory rate to the income tax expense (benefit) at the effective tax rate

A reconciliation of the Company’s income tax expense (benefit) at the federal statutory rate to the income tax expense at the effective tax rate is as follows (in millions):

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Income tax expense (benefit) computed at federal statutory rate	$	65.3		$	(16.1	)	$	(36.8	)
Goodwill impairment	—			19.4			—
Intraperiod allocation	—			(20.7		)	—
Foreign rate differential	(6.6		)	(2.0		)	(2.3		)
Valuation allowance	(27.4		)	18.2			56.7
Research and experimentation benefits and other tax credits	(1.4		)	(1.1		)	(0.9		)
Reversal of previously accrued taxes	(0.2		)	—			(0.8		)
Permanent items	(9.1		)	6.7			8.0
Other	0.7			0.1			2.2
Income tax expense	$	21.3		$	4.5		$	26.1

Schedule of the Company's net deferred taxes

The components of the Company’s net deferred taxes consisted of the following (in millions):

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Gross deferred tax assets:
Tax credit carryforwards	$	150.6		$	141.0		$	131.4
Net operating loss carryforwards	1,875.4			1,846.3			2,226.1
Capital loss carryforwards	102.4			145.9			4.1
Inventories	5.4			6.1			6.7
Accruals and reserves	30.3			27.4			30.2
Investments	0.7			34.4			0.7
Other	51.9			60.3			55.5
Acquisition-related items	55.5			65.2			59.9
Gross deferred tax assets	2,272.2			2,326.6			2,514.6
Valuation allowance	(2,097.8		)	(2,174.3		)	(2,334.5		)
Deferred tax assets	174.4			152.3			180.1
Gross deferred tax liabilities:
Acquisition-related items	(6.5		)	(13.2		)	(20.9		)
Undistributed foreign earnings	(3.0		)	—			(4.7		)
Other	(57.3		)	(31.1		)	(44.5		)
Deferred tax liabilities	(66.8		)	(44.3		)	(70.1		)
Total net deferred tax assets	$	107.6		$	108.0		$	110.0

Summary of activity of deferred tax valuation allowance

The following table provides information about the activity of our deferred tax valuation allowance (in millions):

Deferred Tax Valuation Allowance	Balance at Beginning of Period		Additions Charged to Expenses or Other Accounts(1)		Deductions Credited to Expenses or Other Accounts(2)			Balance at End of Period
Year Ended July 1, 2017	$	2,174.3	$	44.7	$	(121.2	)	$	2,097.8
Year Ended July 2, 2016	$	2,334.5	$	227.5	$	(387.7	)	$	2,174.3
Year Ended June 27, 2015	$	2,321.8	$	39.5	$	(26.8	)	$	2,334.5

(1) Additions include current year additions charged to expenses and current year build due to increases in net deferred tax assets, return to provision true-ups, other adjustments.

(2) Deductions include current year releases credited to expenses and current year reductions due to decreases in net deferred tax assets, return to provision true-ups, other adjustments and increases in deferred tax liabilities

Schedule of reconciliation of unrecognized tax benefits

A reconciliation of unrecognized tax benefits between June 28, 2014 and July 1, 2017 is as follows (in millions):

Balance at June 28, 2014	$	38.3
Additions based on tax positions related to current year	1.9
Reductions for lapse of statute of limitations	(3.3		)
Reductions due to foreign currency rate fluctuations	(0.1		)
Balance at June 27, 2015	36.8
Additions based on tax positions related to current year	5.1
Reductions for lapse of statute of limitations	(0.2		)
Balance at July 2, 2016	41.7
Additions based on tax positions related to current year	1.6
Additions based on tax positions related to prior year	0.9
Reduction based on tax positions related to prior year	(3.5		)
Reductions for lapse of statute of limitations	(1.8		)
Balance at July 1, 2017	$	38.9

Schedule of the tax years that remain subject to examination by the Company's major tax jurisdictions

The following table summarizes the Company’s major tax jurisdictions and the tax years that remain subject to examination by such jurisdictions as of July 1, 2017:

Tax Jurisdictions	Tax Years
United States	2014 and onward
Canada	2016 and onward
China	2012 and onward
France	2014 and onward
Germany	2014 and onward
Korea	2012 and onward
United Kingdom	2016 and onward

XML

Stock-Based Compensation (Tables)

12 Months Ended

Jul. 01, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of the impact on the entity's results of operations of recording stock-based compensation by function

The impact on the Company’s results of operations of recording stock-based compensation expense by function for fiscal 2017, 2016 and 2015 was as follows (in millions):

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Cost of revenue	$	3.6	$	4.8	$	4.2
Research and development	5.7		8.4		8.1
Selling, general and administrative	23.9		29.2		35.2
Total stock-based compensation expense	$	33.2	$	42.4	$	47.5

Schedule of stock options activities

The following is a summary of stock option activities (amount in millions except per share amounts):

	Options Outstanding
	Number of Shares		Weighted-Average Exercise Price (1)
Balance as of June 28, 2014	3.5		$	10.13
Exercised	(0.9	)	7.58
Canceled	(0.1	)	14.54
Balance as of June 27, 2015	2.5		10.84
Granted	1.2		5.95
Exercised	(0.7	)	4.74
Canceled	(0.4	)	10.52
Net adjustment due to the separation	0.5
Balance as of July 2, 2016	3.1		5.91
Granted	—		—
Exercised	(1.6	)	5.66
Canceled	—		—
Balance as of July 1, 2017	1.5		$	6.16
Expected to vest	1.4		$	6.18

(1) Weighted average exercise price is calculated using exercise prices prior to the Separation and after the Separation.

Schedule of significant ranges of outstanding and exercisable options

The following table summarizes significant ranges of outstanding and exercisable options as of July 1, 2017, adjusted to reflect the impact of the Lumentum separation.

	Options Outstanding						Options Exercisable
Range of Exercise Prices	Number of Shares	Weighted Average Remaining Contractual Term (in years)	Weighted Average Exercise Price		Aggregate Intrinsic Value (in millions)		Number of Shares	Weighted Average Remaining Contractual Term (in years)	Weighted Average Exercise Price		Aggregate Intrinsic Value (in millions)
$3.28 - $3.28	104,352	0.12	$	3.28			104,352	0.12	$	3.28
$5.74 - $5.74	132,544	0.92	5.74				132,544	0.92	5.74
$5.95 - $5.95	1,180,257	6.62	5.95				295,065	6.62	5.95
$11.82 - $11.82	107,412	1.87	11.82				107,412	1.87	11.82
	1,524,565	5.35	$	6.16	$	6.8	639,373	3.58	$	6.46	$	2.7

Schedule of employee stock purchase plan activity

The following summarizes the shares issued and the fair market value at purchase date, pursuant to the Company’s ESPP during the year ended July 1, 2017:

Purchase date	July 29, 2016		January 31, 2017
Shares issued	410,737		269,102
Fair market value at purchase date	$	4.76	$	6.77

Schedule of changes in nonvested Full Value Awards

A summary of the status of the Company’s non-vested Full Value Awards as of July 1, 2017 and changes during the same period is presented below (amount in millions, except per share amounts):

	Full Value Awards
	Performance Shares (1)		Non-Performance Shares		Total Number of Shares		Weighted-average grant-dated fair value
Non-vested at June 28, 2014	1.1		8.3		9.4		$	13.19
Awards granted	0.7		5.3		6.0		11.78
Awards vested	(0.8	)	(4.4	)	(5.2	)	12.96
Awards forfeited	—		(1.4	)	(1.4	)	13.10
Non-vested at June 27, 2015	1.0		7.8		8.8		12.36
Awards granted	0.7		6.1		6.8		5.75
Awards vested	(0.7	)	(4.8	)	(5.5	)	6.01
Awards forfeited	(0.4	)	(1.8	)	(2.2	)	7.89
Net adjustment due to the separation	0.4		1.1		1.5
Non-vested at July 2, 2016	1.0		8.4		9.4		6.55
Awards granted	0.6		3.7		4.3		7.86
Awards vested	(0.6	)	(4.5	)	(5.1	)	6.66
Awards forfeited	—		(1.3	)	(1.3	)	6.83
Non-vested at July 1, 2017	1.0		6.3		7.3		$	7.17

(1) Performance Shares refer to the Company’s MSU awards, where the actual number of shares awarded upon vesting may be higher or lower than the target amount depending on the achievement of the relevant market conditions. The majority of MSUs vest in equal annual installments over three to four years based on the attainment of certain total shareholder return performance measures and the employee’s continued service through the vest date. The aggregate grant-date fair value of MSUs granted during fiscal 2017, 2016 and 2015 were estimated to be $3.3 million, $3.7 million and $9.4 million respectively, and were calculated using a Monte Carlo simulation.

Schedule of assumptions used to estimate the fair value of awards on the date of grant

The Company estimates the fair value of the MSUs on the date of grant using a Monte Carlo simulation with the following assumptions:

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Volatility of common stock	33.2	%	33.8	%	40.8	%
Average volatility of peer companies	36.9	%	52.9	%	53.4	%
Average correlation coefficient of peer companies	0.1856		0.1103		0.2156
Risk-free interest rate	0.7	%	0.8	%	0.6	%

The Company estimates the fair value of Stock Options and ESPP using a BSM valuation model. The fair value is estimated on the date of grant using the BSM option valuation model with the following weighted-average assumptions:

	Stock Options		Employee Stock Purchase Plans
	July 2, 2016		July 1, 2017		July 2, 2016		June 27, 2015
Expected term (in years)	5.2		0.5		0.5		0.5
Expected volatility	42.3	%	33.4	%	45.7	%	37.9	%
Risk-free interest rate	1.2	%	0.5	%	0.4	%	0.1	%

XML

Employee Pension and Other Benefit Plans (Tables)

12 Months Ended

Jul. 01, 2017

Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]

Schedule of net periodic cost for the pension and benefits plans

The following table presents the components of the net periodic benefit cost for the pension and benefits plans (in millions):

	Years Ended
Pension Benefits	2017			2016			2015
Service cost	$	0.3		$	0.2		$	0.2
Interest cost	2.1			3.0			3.7
Expected return on plan assets	(1.1		)	(1.5		)	(1.6		)
Recognized net actuarial losses	1.9			0.7			0.4
Provision for legal proceeding	—			8.4			—
Net periodic cost	$	3.2		$	10.8		$	2.7

Schedule of changes in the benefit obligations and plan assets of the pension and benefits plans

The changes in the benefit obligations and plan assets of the pension and benefits plans were (in millions):

	Pension Benefit Plans
	2017			2016
Change in benefit obligation
Benefit obligation at beginning of year	$	134.6		$	121.2
Service cost	0.3			0.2
Interest cost	2.1			3.0
Actuarial (gains) losses	(1.2		)	14.5
Benefits paid	(4.2		)	(4.7		)
Provision for legal proceeding	—			8.4
Foreign exchange impact	1.8			(8.0		)
Benefit obligation at end of year	$	133.4		$	134.6
Change in plan assets
Fair value of plan assets at beginning of year	$	27.2		$	30.2
Actual return on plan assets	2.0			1.8
Employer contributions	4.0			4.6
Benefits paid	(4.2		)	(4.7		)
Foreign exchange impact	(0.7		)	(4.7		)
Fair value of plan assets at end of year	$	28.3		$	27.2
Funded status	$	(105.1	)	$	(107.4	)
Accumulated benefit obligation	$	133.0		$	133.9

Schedule of defined benefit plan amounts recognized and locations in financial statements

	Pension Benefit Plans
	2017			2016
Amount recognized in the Consolidated Balance Sheets at end of year:
Current liabilities	$	6.8		$	5.5
Non-current liabilities	98.3			101.9
Net amount recognized at end of year	$	105.1		$	107.4
Amount recognized in accumulated other comprehensive income (loss) at end of year:
Actuarial losses, net of tax	$	(21.8	)	$	(24.4	)
Net amount recognized at end of year	$	(21.8	)	$	(24.4	)
Other changes in plan assets and benefit obligations recognized in other comprehensive income (loss):
Net actuarial gain (loss)	$	0.7		$	(10.6	)
Amortization of accumulated net actuarial losses	1.9			0.7
Total recognized in other comprehensive income (loss)	$	2.6		$	(9.9	)

Schedule of assumptions used to determine net periodic cost and benefit obligation

The following table summarizes the weighted average assumptions used to determine net periodic cost and benefit obligation for the Company’s U.K. and German pension plans:

	Pension Benefit Plans
	2017		2016		2015
Weighted-average assumptions used to determine net period cost:
Discount rate	2.1	%	2.1	%	3.0	%
Expected long-term return on plan assets	4.8		5.3		5.8
Rate of pension increase	2.2		2.3		2.3
Weighted-average assumptions used to determine benefit obligation at end of year:
Discount rate	2.0	%	1.7	%	2.6	%
Rate of pension increase	2.3		2.1		2.2

Schedule of percentage of asset allocations and plan's assets at fair value

The following table sets forth the U.K. plan assets at fair value and the percentage of assets allocations as of July 1, 2017 (in millions, except percentage data):

							Fair value measurement as of
							July 1, 2017
	Target Allocation		Total		Percentage of Plan Assets		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Global equity	40	%	$	11.7	41.3	%	$	—	$	11.7
Fixed income	40	%	10.7		37.8	%	—		10.7
Other	20	%	5.8		20.5	%	—		5.8
Cash			0.1		0.4	%	0.1		—
Total assets			$	28.3	100.0	%	$	0.1	$	28.2

The following table sets forth the plan’s assets at fair value and the percentage of assets allocations as of July 2, 2016 (in millions, except percentage data).

							Fair value measurement as of
							July 2, 2016
	Target Allocation		Total		Percentage of Plan Assets		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)
Assets:
Global equity	40	%	$	10.5	38.6	%	$	—	$	10.5
Fixed income	40	%	10.7		39.3	%	—		10.7
Other	20	%	5.4		19.9	%	—		5.4
Cash			0.6		2.2	%	0.6		—
Total assets			$	27.2	100.0	%	$	0.6	$	26.6

Schedule of total expected benefit payments to defined benefit pension plan participants

The following table reflects the total expected benefit payments to defined benefit pension plan participants. These payments have been estimated based on the same assumptions used to measure the Company’s PBO at year end and include benefits attributable to estimated future compensation increases.

(in millions)	Pension Benefit Plans
2018	$	7.5
2019	6.1
2020	5.5
2021	5.7
2022	6.1
2023 - 2027	29.7
Thereafter	44.5
Total	$	105.1

Timing of the payment relating to the legal proceeding, which is included in the above table under “Thereafter,” is not yet determined. Refer to “Note 16. Commitments and Contingencies” for further information.

XML

Commitments and Contingencies (Tables)

12 Months Ended

Jul. 01, 2017

Commitments and Contingencies Disclosure [Abstract]

Schedule of future minimum annual lease payments under non-cancellable operating leases

As of July 1, 2017, future minimum annual lease payments under non-cancelable operating leases were as follows (in millions):

2018	$	18.8
2019	16.7
2020	12.2
2021	10.1
2022	6.1
Thereafter	0.5
Total minimum operating lease payments	$	64.4

Schedule of changes in the entity's warranty reserve

The following table presents the changes in the Company’s warranty reserve during fiscal years 2017 and 2016 (in millions):

	Year Ended
	July 1, 2017			July 2, 2016
Balance as of beginning of period	$	4.9		$	3.7
Provision for warranty	4.2			3.9
Utilization of reserve	(3.8		)	(3.3		)
Adjustments related to pre-existing warranties (including changes in estimates)	0.5			0.6
Balance as of end of period	$	5.8		$	4.9

XML

Operating Segments and Geographic Information (Tables)

12 Months Ended

Jul. 01, 2017

Segment Reporting [Abstract]

Schedule of information on reportable segments

The segment information for all periods presented has been revised to be comparable with the changes implemented in the first quarter of fiscal 2016 in the Company’s segment reporting measures.

Information on reportable segments is as follows (in millions):

	Year Ended July 1, 2017
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Reconciling Items			Consolidated GAAP Measures
Net revenue	$	444.0		$	135.2		$	579.2		$	232.2		$	811.4		$	—		$	811.4
Gross profit	286.3			86.2			372.5			133.8			506.3			(20.3		)	486.0
Gross margin	64.5		%	63.8		%	64.3		%	57.6		%	62.4		%				59.9		%
Operating income							7.3			100.3			107.6			(94.0		)	13.6
Operating margin							1.3		%	43.2		%	13.3		%				1.7		%
	Year Ended July 2, 2016
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Reconciling Items			Consolidated GAAP Measures
Net revenue	$	504.6		$	153.6		$	658.2		$	248.1		$	906.3		$	—		$	906.3
Gross profit	329.7			99.4			429.1			143.1			572.2			(22.5		)	549.7
Gross margin	65.3		%	64.7		%	65.2		%	57.7		%	63.1		%				60.7		%
Operating income (loss)							12.7			102.9			115.6			(199.9		)	(84.3		)
Operating margin							1.9		%	41.5		%	12.8		%				(9.3		)%
	Year Ended June 27, 2015
	Network and Service Enablement
	Network Enablement			Service Enablement			Network and Service Enablement			Optical Security and Performance Products			Total Segment Measures			Reconciling Items			Consolidated GAAP Measures
Net revenue	$	506.8		$	174.3		$	681.1		$	192.8		$	873.9		$	—		$	873.9
Gross profit	333.9			119.2			453.1			104.3			557.4			(37.3		)	520.1
Gross margin	65.9		%	68.4		%	66.5		%	54.1		%	63.8		%				59.5		%
Operating income (loss)							(0.1		)	68.1			68.0			(143.8		)	(75.8		)
Operating margin							—		%	35.3		%	7.8		%				(8.7		)%

	Years Ended
	July 1, 2017			July 2, 2016			June 27, 2015
Corporate reconciling items impacting gross profit:
Total segment gross profit	$	506.3		$	572.2		$	557.4
Stock-based compensation	(3.6		)	(4.8		)	(4.2		)
Amortization of intangibles	(14.3		)	(17.3		)	(31.9		)
Other charges unrelated to core operating performance	(2.4		)	(0.4		)	(1.2		)
GAAP gross profit	$	486.0		$	549.7		$	520.1
Corporate reconciling items impacting operating income:
Total segment operating income	$	107.6		$	115.6		$	68.0
Stock-based compensation	(33.2		)	(42.4		)	(47.5		)
Amortization of intangibles	(28.3		)	(31.9		)	(51.4		)
Impairment of goodwill	—			(91.4		)	—
Other charges unrelated to core operating performance (1)(2)(3)	(10.9		)	(23.7		)	(18.1		)
Restructuring and related charges	(21.6		)	(10.5		)	(26.8		)
GAAP operating income (loss) from continuing operations	$	13.6		$	(84.3	)	$	(75.8	)

(1) During the year ended July 1, 2017, other charges unrelated to core operating performance primarily consisted of $5.7 million loss on disposal of long-lived assets and $1.5 million of Viavi-specific charges related to the Separation.

(2) During the year endedJuly 2, 2016, other charges unrelated to core operating performance primarily consisted of (a) an $8.4 million charge related to a litigation ruling impacting our U.K. pension obligation, (b) $5.0 million of Viavi-specific charges related to the Separation and (c) $3.5 million of non-recurring incremental severance and related costs upon the exit of a key executive.

(3) During the year endedJune 27, 2015, other charges unrelated to core operating performance primarily consisted of $9.8 million of Viavi-specific charges related to the Separation and $3.6 million IPR&D impairment charge for an ongoing project related to the fiscal 2014 acquisition of Trendium as discussed in “Note 9. Acquired Developed Technology and Other Intangibles.”

The following table presents net revenue by the three geographic regions we operate in and net revenue from countries that exceeded 10% of our total net revenue (dollars in millions):

	Years Ended
	July 1, 2017				July 2, 2016				June 27, 2015
Americas:
United States	$	307.3	37.9	%	$	396.6	43.8	%	$	424.3	48.5	%
Other Americas	71.3		8.8	%	$	66.0	7.3	%	$	62.5	7.2	%
Total Americas	$	378.6	46.7	%	$	462.6	51.1	%	$	486.8	55.7	%
Asia-Pacific
Greater China	$	100.8	12.4	%	$	103.2	11.3	%	$	83.1	9.5	%
Other Asia	72.4		8.9	%	63.1		7.0	%	61.4		7.0	%
Total Asia-Pacific	$	173.2	21.3	%	$	166.3	18.3	%	$	144.5	16.5	%
EMEA:
Switzerland	$	124.0	15.3	%	$	135.6	15.0	%	$	97.7	11.2	%
Other EMEA	135.6		16.7	%	141.8		15.6	%	144.9		16.6	%
Total EMEA	$	259.6	32.0	%	$	277.4	30.6	%	$	242.6	27.8	%
Total net revenue	$	811.4	100.0	%	$	906.3	100.0	%	$	873.9	100.0	%

Following the separation from Lumentum, one customer served by our OSP segment generated 10% or more of Viavi net revenue from continuing operations during fiscal 2017, 2016 and 2015 as summarized below (in millions):

	Years Ended
	July 1, 2017		July 2, 2016		June 27, 2015
Customer A - OSP customer	$	166.8	$	190.1	$	143.0

Property, plant and equipment, net were identified based on the operations in the corresponding geographic areas (in millions):

	Years Ended
	July 1, 2017		July 2, 2016
United States	$	76.0	$	85.6
Other Americas	4.4		4.3
China	41.1		27.3
Other Asia-Pacific	5.0		4.8
Germany	7.9		7.9
Other EMEA	2.5		3.1
Total property, plant and equipment, net	$	136.9	$	133.0

XML

Quarterly Financial Information (unaudited) (Tables)

12 Months Ended

Jul. 01, 2017

Quarterly Financial Information Disclosure [Abstract]

Schedule of quarterly consolidated statements

The following table presents the Company’s selected quarterly financial information from the Consolidated Statements of Operations for fiscal 2017 and 2016 (in millions, except per share data):

	July 1, 2017		April 1, 2017		December 31, 2016		October 1, 2016		July 2, 2016			April 2, 2016		January 2, 2016		October 3, 2015
	(1) (2)		(2)		(2)		(2)		(1)(2)(3)			(1)(2)		(1)		(1)
Net revenue	$	198.1	$	196.0	$	206.5	$	210.8	$	224.1		$	220.4	$	232.1	$	229.7
Gross profit	119.2		117.0		124.7		125.1		136.1			131.3		141.8		140.5
Net income(loss) from continuing operations, net of tax	12.1		26.0		49.2		78.0		(64.5		)	28.8		1.0		(15.7		)
Net income (loss) from discontinued operations, net of tax	1.6		—		—		—		(3.4		)	5.0		3.0		(53.4		)
Net income (loss)	$	13.7	$	26.0	$	49.2	$	78.0	$	(67.9	)	$	33.8	$	4.0	$	(69.1	)
Net income (loss) per share from - basic:
Continuing operations (4)	$	0.05	$	0.11	$	0.21	$	0.34	$	(0.28	)	$	0.13	$	0.01	$	(0.07	)
Discontinued operations (4)	0.01		—		—		—		(0.01		)	0.02		0.01		(0.22		)
Net income (loss) (4)	$	0.06	$	0.11	$	0.21	$	0.34	$	(0.29	)	$	0.15	$	0.02	$	(0.29	)
Net income (loss) per share from - diluted:
Continuing operations (4)	$	0.05	$	0.11	$	0.21	$	0.33	$	(0.28	)	$	0.12	$	0.01	$	(0.07	)
Discontinued operations (4)	0.01		—		—		—		(0.01		)	0.02		0.01		(0.22		)
Net income (loss) (4)	$	0.06	$	0.11	$	0.21	$	0.33	$	(0.29	)	$	0.14	$	0.02	$	(0.29	)
Shares used in per-share calculation (basic)	227.3		229.4		230.5		232.4		232.7			232.0		234.9		236.0
Shares used in per-share calculation (diluted)	232.5		234.6		234.2		236.8		232.7			234.6		237.1		236.0

(1) During the first quarter of fiscal 2016, we completed the Separation. As a result, the operations of the Lumentum business have been presented as discontinued operations in all periods of the Company’s Consolidated Statement of Operations.

(2) During fiscal year ended 2017 and 2016, the Company recorded $203.0 million and $71.5 million, respectively, gain on sale of Lumentum common stock which was retained as part of the Separation of Lumentum. Refer to “Note 7. Investments, Forward Contracts and Fair Value Measurements”for more information.

(3) During the fourth quarter of fiscal 2016, the Company recorded a $91.4 million goodwill impairment charge related to the SE reporting unit.

(4) Net income (loss) per share is computed independently for each of the fiscal quarters presented. Therefore, the sum of the quarterly basic and diluted net income (loss) per share amounts may not equal the annual basic and diluted net income (loss) per share amount for the full fiscal years.

XML

Basis of Presentation - Additional Information (Details) - USD ($) $ in Millions		12 Months Ended
	Aug. 01, 2015	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015	Mar. 03, 2017
Lumentum Separation
Percentage of outstanding shares distributed	80.10%
Stock conversion ratio in distribution	0.2
Restricted Cash
Restricted cash		$ 11.2	$ 12.2
Long-term restricted cash balances		6.8	6.0
Advertising Expense
Advertising cost during the period		$ 2.1	$ 2.6	$ 1.7
Customer A - OSP customer | Customer Concentration Risk | Accounts receivable, net
Concentration of Credit and Other Risks
Concentration risk percentage, more than		10.00%	10.00%
Lumentum
Lumentum Separation
Percentage of outstanding shares distributed	80.10%
Ownership percentage	19.90%
Building and improvements | Minimum
Property, Plant and Equipment
Estimated useful lives		10 years
Building and improvements | Maximum
Property, Plant and Equipment
Estimated useful lives		50 years
Machinery and equipment | Minimum
Property, Plant and Equipment
Estimated useful lives		2 years
Machinery and equipment | Maximum
Property, Plant and Equipment
Estimated useful lives		20 years
Furniture and fixtures | Minimum
Property, Plant and Equipment
Estimated useful lives		2 years
Furniture and fixtures | Maximum
Property, Plant and Equipment
Estimated useful lives		5 years
Software | Minimum
Property, Plant and Equipment
Estimated useful lives		2 years
Software | Maximum
Property, Plant and Equipment
Estimated useful lives		5 years
Office equipment | Minimum
Property, Plant and Equipment
Estimated useful lives		2 years
Office equipment | Maximum
Property, Plant and Equipment
Estimated useful lives		5 years
Demonstration units | Minimum
Property, Plant and Equipment
Estimated useful lives		3 years
Demonstration units | Maximum
Property, Plant and Equipment
Estimated useful lives		5 years
Convertible Debt | 0.625% Senior Convertible Notes
Fair Value of Financial Instruments
Interest rate on senior convertible notes		0.625%
Convertible Debt | 1.00% Senior Convertible Notes
Fair Value of Financial Instruments
Interest rate on senior convertible notes		1.00%			1.00%

XML

Basis of Presentation - Asset Retirement Obligations (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016
Asset Retirement Obligations
Asset retirement obligations included in other current liabilities	$ 0.3	$ 0.2
Asset retirement obligations included in other non-current liabilities	3.3	3.5
Changes in asset retirement obligations:
Balance at Beginning of Period	3.7	4.4
Liabilities Incurred	0.1	0.4
Liabilities Settled	(0.1)	(0.9)
Accretion Expense	0.2	0.2
Revisions to Estimates	(0.3)	(0.4)
Balance at End of Period	$ 3.6	$ 3.7

XML

Recently Issued Accounting Pronouncements (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2018	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Full Value Awards
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Employee tax paid by withholding shares		$ 14.3	$ 11.4	$ 22.1
Forecast | Accounting Standards Update 2016-09
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Tax benefit recognized related to excess tax benefit from share-based payment award transactions	$ 0.0

XML

Discontinued Operations - Additional Information (Details) - USD ($)		3 Months Ended								12 Months Ended
	Aug. 01, 2015	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Oct. 01, 2016	Jul. 02, 2016	Apr. 02, 2016	Jan. 02, 2016	Oct. 03, 2015	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Discontinued Operations
Percentage of outstanding shares distributed	80.10%
Stock conversion ratio in distribution	0.2
Cash contributions agreed to in spin-off	$ 137,600,000
Proceeds from sale of Lumentum Holdings Inc. Series A Preferred Stock										$ 0	$ 35,800,000	$ 0
Net revenue under Supply Agreement		$ 198,100,000	$ 196,000,000	$ 206,500,000	$ 210,800,000	$ 224,100,000	$ 220,400,000	$ 232,100,000	$ 229,700,000	811,400,000	906,300,000	873,900,000
Accumulated other comprehensive loss transferred to Lumentum	7,800,000
Net operating losses used to offset income and gain recognized on separation											1,000,000,000
Spinoff | Lumentum
Discontinued Operations
Deferred tax assets	29,500,000
Deferred tax liabilities	1,000,000
Income taxes payable	3,300,000
Current income tax receivables	1,300,000
Other long-term liabilities related to uncertain tax positions	100,000
Net income tax (benefit) provision for discontinued operations										$ (800,000)	27,800,000	(20,900,000)
Transaction, advisory and other costs to effect the separation											16,500,000	$ 21,400,000
Spinoff | Lumentum | Discontinued Operations
Discontinued Operations
Net income tax provision											19,000,000
Spinoff | Lumentum | Federal and State
Discontinued Operations
Net income tax (benefit) provision for discontinued operations											6,200,000
Lumentum | Supply Commitment
Discontinued Operations
Supply Agreement with Lumentum amount	$ 15,000,000
Net revenue under Supply Agreement											14,100,000
Amada | Series A Preferred Stock
Discontinued Operations
Number of shares sold (in shares)									35,805
Proceeds from sale of Lumentum Holdings Inc. Series A Preferred Stock									$ 35,800,000		$ 35,800,000
Shares canceled in transaction (in shares)									4,195
Lumentum
Discontinued Operations
Retained ownership percentage	19.90%
Shares held in investment (in shares)	11,700,000
Minimum holding period for retained interest	6 months
Maximum holding period for retained interest	3 years
Lumentum
Discontinued Operations
Percentage of outstanding shares distributed	80.10%
Lumentum | Viavi Solutions | Series A Preferred Stock
Discontinued Operations
Number of shares sold (in shares)	40,000

XML

Discontinued Operations - Statement of Operations (Details) - Spinoff - Lumentum - USD ($) $ in Millions	12 Months Ended			23 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015	Jul. 01, 2017
Discontinued Operations
Net revenues	$ 0.0	$ 66.5	$ 835.2
Cost of revenues	0.0	49.8	569.1
Amortization of acquired technologies	0.0	0.6	7.5
Gross profit	0.0	16.1	258.6
Operating expenses:
Research and development	0.0	12.5	139.9
Selling, general and administrative	(0.8)	24.7	87.5
Restructuring charges	0.0	0.1	7.7
Total operating expenses	(0.8)	37.3	235.1
Income (loss) from operations	0.8	(21.2)	23.5
Interest and other income, net	0.0	0.0	(1.1)
Income (loss) before income taxes	0.8	(21.2)	22.4
(Benefit from) provision for income taxes	(0.8)	27.8	(20.9)
Net income (loss) from discontinued operations	$ 1.6	$ (49.0)	$ 43.3	$ 0.0

XML

Discontinued Operations - Supplemental Cash Flows (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Operating activities:
Depreciation expense	$ 29.4	$ 38.1	$ 80.8
Amortization of other intangibles	14.0	14.6	19.5
Stock-based compensation expense	$ 33.2	42.4	47.5
Spinoff | Discontinued Operations | Lumentum
Operating activities:
Depreciation expense		3.7	43.4
Amortization of other intangibles		0.6	7.9
Stock-based compensation expense		1.6	19.4
Investing activities:
Capital expenditures		$ 5.8	$ 55.9

XML

Earnings Per Share - Computation of Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended								12 Months Ended
	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Oct. 01, 2016	Jul. 02, 2016	Apr. 02, 2016	Jan. 02, 2016	Oct. 03, 2015	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Numerator:
Income (loss) from continuing operations, net of taxes	$ 12.1	$ 26.0	$ 49.2	$ 78.0	$ (64.5)	$ 28.8	$ 1.0	$ (15.7)	$ 165.3	$ (50.4)	$ (131.4)
Income (loss) from discontinued operations, net of taxes	1.6	0.0	0.0	0.0	(3.4)	5.0	3.0	(53.4)	1.6	(48.8)	43.3
Net income (loss)	$ 13.7	$ 26.0	$ 49.2	$ 78.0	$ (67.9)	$ 33.8	$ 4.0	$ (69.1)	$ 166.9	$ (99.2)	$ (88.1)
Weighted-average number of common shares outstanding
Basic (in shares)	227.3	229.4	230.5	232.4	232.7	232.0	234.9	236.0	229.9	234.0	232.7
Effect of dilutive securities from stock-based benefit plans (in shares)									4.6	0.0	0.0
Diluted (in shares)	232.5	234.6	234.2	236.8	232.7	234.6	237.1	236.0	234.5	234.0	232.7
Net income (loss) per share from - basic:
Continuing operations (usd per share)	$ 0.05	$ 0.11	$ 0.21	$ 0.34	$ (0.28)	$ 0.13	$ 0.01	$ (0.07)	$ 0.72	$ (0.22)	$ (0.57)
Discontinued operations (usd per share)	0.01	0.00	0.00	0.00	(0.01)	0.02	0.01	(0.22)	0.01	(0.20)	0.19
Net income (loss) (usd per share)	0.06	0.11	0.21	0.34	(0.29)	0.15	0.02	(0.29)	0.73	(0.42)	(0.38)
Net income (loss) per share from - diluted:
Continuing operations (usd per share)	0.05	0.11	0.21	0.33	(0.28)	0.12	0.01	(0.07)	0.70	(0.22)	(0.57)
Discontinued operations (usd per share)	0.01	0.00	0.00	0.00	(0.01)	0.02	0.01	(0.22)	0.01	(0.20)	0.19
Net income (loss) (usd per share)	$ 0.06	$ 0.11	$ 0.21	$ 0.33	$ (0.29)	$ 0.14	$ 0.02	$ (0.29)	$ 0.71	$ (0.42)	$ (0.38)

XML

Earnings Per Share - Weighted-Average Potentially Dilutive Securities (Details) - $ / shares shares in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015	Mar. 03, 2017	Aug. 21, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	1.5	14.3	13.9
Convertible Debt | Senior Convertible Notes due 2033
Convertible notes
Interest rate on senior convertible notes	0.625%
Conversion price of debt (in dollars per share)	$ 11.28				$ 18.83
Convertible Debt | Senior Convertible Notes due 2024
Convertible notes
Interest rate on senior convertible notes	1.00%			1.00%
Conversion price of debt (in dollars per share)	$ 13.22
Stock options and ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	0.9	3.4	3.6
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	0.6	10.9	10.3

XML

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Changes in accumulated other comprehensive income (loss) by component
Balance	$ 689.3	$ 1,101.4	$ 1,187.7
Other comprehensive income (loss) before reclassification	97.6
Amounts reclassified from accumulated other comprehensive income	(200.0)
Net change in accumulated other comprehensive (loss) income	(102.4)	65.8	(59.1)
Balance	786.4	689.3	1,101.4
Unrealized net actuarial gain	2.1
Tax expense for unrealized net actuarial gains	1.4
Marketable equity securities | Lumentum
Changes in accumulated other comprehensive income (loss) by component
Unrealized gain on marketable equity securities	92.6
Tax impact for unrealized holding gains on marketable equity securities	0.0
Total
Changes in accumulated other comprehensive income (loss) by component
Balance	10.0	(48.0)	11.1
Net change in accumulated other comprehensive (loss) income	(102.4)	65.8	(59.1)
Balance	(92.4)	10.0	$ (48.0)
Unrealized gains (losses) on available-for-sale investments
Changes in accumulated other comprehensive income (loss) by component
Balance	104.5
Other comprehensive income (loss) before reclassification	92.1
Amounts reclassified from accumulated other comprehensive income	(201.9)
Net change in accumulated other comprehensive (loss) income	(109.8)
Balance	(5.3)	104.5
Foreign currency translation adjustments, net of tax
Changes in accumulated other comprehensive income (loss) by component
Balance	(70.1)
Other comprehensive income (loss) before reclassification	4.8
Amounts reclassified from accumulated other comprehensive income	0.0
Net change in accumulated other comprehensive (loss) income	4.8
Balance	(65.3)	(70.1)
Defined benefit obligation, net of tax
Changes in accumulated other comprehensive income (loss) by component
Balance	(24.4)
Other comprehensive income (loss) before reclassification	0.7
Amounts reclassified from accumulated other comprehensive income	1.9
Net change in accumulated other comprehensive (loss) income	2.6
Balance	$ (21.8)	$ (24.4)

XML

Balance Sheet and Other Details - Accounts Receivable Reserves and Allowances (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Allowance for doubtful accounts
Accounts receivable reserves and allowances
Total accounts receivable reserves and allowances	$ 2.2	$ 2.4	$ 2.9
Activities and balances for allowance for doubtful accounts and allowance for sales returns
Balance at Beginning of Period	2.2	2.4	2.9
Charged to Costs and Expenses	(0.2)	0.3	0.3
Deduction	(0.4)	(0.5)	(0.8)
Balance at End of Period	1.6	2.2	$ 2.4
Sales allowance
Accounts receivable reserves and allowances
Total accounts receivable reserves and allowances	2.5	2.5
Activities and balances for allowance for doubtful accounts and allowance for sales returns
Balance at Beginning of Period	2.5
Balance at End of Period	3.4	2.5
Total accounts receivable reserves and allowances
Accounts receivable reserves and allowances
Total accounts receivable reserves and allowances	4.7	4.7
Activities and balances for allowance for doubtful accounts and allowance for sales returns
Balance at Beginning of Period	4.7
Balance at End of Period	$ 5.0	$ 4.7

XML

Balance Sheet and Other Details - Inventories (Details) - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016
Inventories, net
Finished goods	$ 24.9	$ 29.1
Work in process	10.3	7.5
Raw materials	12.8	14.8
Inventories, net	$ 48.0	$ 51.4

XML

Balance Sheet and Other Details - Prepayments and Other Current Assets (Details) - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016
Prepayments and other current assets
Prepayments	$ 8.3	$ 10.4
Other current assets	42.5	21.7
Prepayments and other current assets	$ 50.8	$ 32.1

XML

Balance Sheet and Other Details - Property, Plant and Equipment, Net (Details) - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016
Property, Plant and Equipment
Property, plant and equipment, gross	$ 458.8	$ 450.8
Less: Accumulated depreciation	(321.9)	(317.8)
Property, plant and equipment, net	136.9	133.0
Land
Property, Plant and Equipment
Property, plant and equipment, gross	14.5	14.6
Buildings and improvements
Property, Plant and Equipment
Property, plant and equipment, gross	31.4	32.4
Machinery and equipment
Property, Plant and Equipment
Property, plant and equipment, gross	225.8	218.7
Furniture, fixtures, software and office equipment
Property, Plant and Equipment
Property, plant and equipment, gross	111.2	120.5
Leasehold improvements
Property, Plant and Equipment
Property, plant and equipment, gross	58.1	54.3
Construction in progress
Property, Plant and Equipment
Property, plant and equipment, gross	$ 17.8	$ 10.3

XML

Balance Sheet and Other Details - Other Current Liabilities (Details) - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016
Other current liabilities
Customer prepayments	$ 35.2	$ 0.4
Restructuring accrual	8.8	13.3
Income tax payable	3.3	3.3
Warranty accrual	2.9	2.6
VAT liabilities	2.2	2.3
Deferred compensation plan	2.0	2.4
Other	7.0	6.7
Other current liabilities	$ 61.4	$ 31.0

XML

Balance Sheet and Other Details - Other Non-Current Liabilities (Details) - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016
Other non-current liabilities
Pension and post-employment benefits	$ 99.4	$ 103.0
Financing obligation	27.8	28.7
Long-term deferred revenue	14.0	22.7
Other	22.7	24.7
Other non-current liabilities	$ 163.9	$ 179.1

XML

Balance Sheet and Other Details - Interest and Other Income, Net (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Interest and other income (expense), net
Interest income	$ 11.1	$ 5.9	$ 4.6
Foreign exchange gains (loss), net	0.9	(2.6)	(3.8)
Proceeds from Nortel	0.0	0.0	2.2
Loss on extinguishment of debt	(1.1)	0.0	0.0
Other income (expense), net	2.2	(0.8)	0.7
Interest and other income (expense), net	13.1	2.5	3.7
Debt
Cash paid in debt repurchase	45.4	0.0	0.0
Loss on extinguishment of debt	1.1	$ 0.0	$ 0.0
0.625% Senior Convertible Notes | Convertible Debt
Interest and other income (expense), net
Loss on extinguishment of debt	(1.1)
Debt
Aggregate amount of debt repurchased	40.0
Cash paid in debt repurchase	45.4
Loss on extinguishment of debt	$ 1.1

XML

Investments and Fair Value Measurements - Amortized Cost to Fair Value Reconciliation (Details) - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	$ 509.8	$ 410.0
Gross Unrealized Gains	0.1	109.5
Gross Unrealized Losses	(0.8)	(0.4)
Available-for-sale Securities	509.1	519.1
Total debt securities
Available-For-Sale Investments
Amortized Cost/ Carrying Cost		347.9
Gross Unrealized Gains		0.3
Gross Unrealized Losses		(0.4)
Available-for-sale Securities		347.8
U.S. treasuries
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	56.8	46.1
Gross Unrealized Gains	0.0	0.0
Gross Unrealized Losses	(0.1)	0.0
Available-for-sale Securities	56.7	46.1
U.S. agencies
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	45.0	24.9
Gross Unrealized Gains	0.0	0.0
Gross Unrealized Losses	(0.1)	0.0
Available-for-sale Securities	44.9	24.9
Municipal bonds and sovereign debt instruments
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	4.4	2.0
Gross Unrealized Gains	0.0	0.0
Gross Unrealized Losses	0.0	0.0
Available-for-sale Securities	4.4	2.0
Asset-backed securities
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	71.5	50.4
Gross Unrealized Gains	0.0	0.1
Gross Unrealized Losses	(0.4)	(0.3)
Available-for-sale Securities	71.1	50.2
Corporate securities
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	326.1	224.5
Gross Unrealized Gains	0.1	0.2
Gross Unrealized Losses	(0.2)	(0.1)
Available-for-sale Securities	326.0	224.6
Certificates of deposit
Available-For-Sale Investments
Amortized Cost/ Carrying Cost	6.0
Gross Unrealized Gains	0.0
Gross Unrealized Losses	0.0
Available-for-sale Securities	$ 6.0
Marketable equity securities
Available-For-Sale Investments
Amortized Cost/ Carrying Cost		62.1
Gross Unrealized Gains		109.2
Gross Unrealized Losses		0.0
Available-for-sale Securities		$ 171.3

XML

Investments and Fair Value Measurements - Gross Unrealized Losses on Available-For-Sale Securities (Details) - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016
Gross unrealized losses on available-for-sale securities
Less than 12 Months	$ (0.5)	$ (0.1)
Greater than 12 Months	(0.3)	(0.3)
Total	(0.8)	(0.4)
U.S. treasuries and agencies
Gross unrealized losses on available-for-sale securities
Less than 12 Months	(0.2)
Greater than 12 Months	0.0
Total	(0.2)
Asset-backed securities
Gross unrealized losses on available-for-sale securities
Less than 12 Months	(0.1)	0.0
Greater than 12 Months	(0.3)	(0.3)
Total	(0.4)	(0.3)
Corporate securities
Gross unrealized losses on available-for-sale securities
Less than 12 Months	(0.2)	(0.1)
Greater than 12 Months	0.0	0.0
Total	$ (0.2)	$ (0.1)

XML

Investments and Fair Value Measurements - Contractual Maturities of Debt Securities (Details) - Total debt securities $ in Millions	Jul. 01, 2017 USD ($)
Amortized Cost/Carrying Cost
Amounts maturing in less than 1 year	$ 365.3
Amounts maturing in 1 - 5 years	143.5
Amounts maturing in more than 5 years	1.0
Total debt available-for-sale securities	509.8
Estimated Fair Value
Amounts maturing in less than 1 year	365.2
Amounts maturing in 1 - 5 years	143.2
Amounts maturing in more than 5 years	0.7
Total debt available-for-sale securities	$ 509.1

XML

Investments and Fair Value Measurements - Additional Information (Details) - USD ($) shares in Millions, $ in Millions	6 Months Ended	12 Months Ended
	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015	Aug. 01, 2015
Investments
Available-for-sale Securities	$ 519.1	$ 509.1	$ 519.1
Other-than-temporary impairment loss		0.0	0.0	$ 0.0
Not designated | Foreign exchange forward contracts
Investments
Derivative asset, fair value		7.3
Derivative liability, fair value		1.3
Gains (losses) on derivatives		3.3	(9.6)
Not designated | Foreign exchange forward contracts | Held to purchase
Investments
Notional amount of forward contracts	110.0	134.3	110.0
Not designated | Foreign exchange forward contracts | Held to sell
Investments
Notional amount of forward contracts	55.2	25.4	55.2
Cash equivalents
Investments
Available-for-sale Securities	36.1	78.2	36.1
Short-term investments
Investments
Available-for-sale Securities	311.1	430.2	311.1
Other non-current assets
Investments
Available-for-sale Securities	0.6	0.7	0.6
Trading securities | Short-term investments
Investments
Deferred compensation plan assets	2.4	2.0	2.4
Trading securities | Short-term investments | Total debt securities
Investments
Deferred compensation plan assets	0.3	0.5	0.3
Trading securities | Short-term investments | Money market instruments and funds
Investments
Deferred compensation plan assets	0.8	0.3	0.8
Trading securities | Short-term investments | Marketable equity securities
Investments
Deferred compensation plan assets	1.3	1.2	1.3
Lumentum
Investments
Shares held in investment (in shares)					11.7
Marketable equity securities
Investments
Available-for-sale Securities	$ 171.3		171.3
Number of equity securities sold (in shares)	4.5
Gross realized gain (loss)	$ 71.5	203.0	71.5
Income tax effect on gross realized gain (loss)	2.0	$ 0.0
Marketable equity securities | Short-term investments
Investments
Available-for-sale Securities	$ 171.3		$ 171.3
Marketable equity securities | Lumentum
Investments
Shares held in investment (in shares)	7.2		7.2
Number of equity securities sold (in shares)		7.2

XML

Investments and Fair Value Measurements - Assets and Liabilities Measured at Fair Value (Details) - Recurring basis - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016
Cash and cash equivalents
Assets:
Total assets	$ 789.2	$ 295.4
Short-term investments
Assets:
Total assets	432.2	484.7
Restricted cash
Assets:
Total assets	11.0	11.3
Other current assets
Assets:
Total assets	7.3
Other non-current assets
Assets:
Total assets	5.1	4.5
Other current liabilities
Liability:
Total liabilities	1.3
Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets:
Total debt available-for-sale securities	56.7	46.1
Marketable equity securities	0.0	171.3
Money market funds	726.4	274.4
Trading securities	2.0	2.4
Foreign currency forward contracts	0.0
Total assets	785.1	494.2
Liability:
Foreign currency forward contracts	0.0	0.0
Total liabilities	0.0	0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. treasuries
Assets:
Total debt available-for-sale securities	56.7	46.1
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. agencies
Assets:
Total debt available-for-sale securities	0.0	0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Municipal bonds and sovereign debt instruments
Assets:
Total debt available-for-sale securities	0.0	0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Asset-backed securities
Assets:
Total debt available-for-sale securities	0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate securities
Assets:
Total debt available-for-sale securities	0.0	0.0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Certificates of deposit
Assets:
Total debt available-for-sale securities	0.0
Significant Other Observable Inputs (Level 2)
Assets:
Total debt available-for-sale securities	452.4	301.7
Marketable equity securities	0.0	0.0
Money market funds	0.0	0.0
Trading securities	0.0	0.0
Foreign currency forward contracts	7.3
Total assets	459.7	301.7
Liability:
Foreign currency forward contracts	1.3	0.0
Total liabilities	1.3	0.0
Significant Other Observable Inputs (Level 2) | U.S. treasuries
Assets:
Total debt available-for-sale securities	0.0	0.0
Significant Other Observable Inputs (Level 2) | U.S. agencies
Assets:
Total debt available-for-sale securities	44.9	24.9
Significant Other Observable Inputs (Level 2) | Municipal bonds and sovereign debt instruments
Assets:
Total debt available-for-sale securities	4.4	2.0
Significant Other Observable Inputs (Level 2) | Asset-backed securities
Assets:
Total debt available-for-sale securities	71.1	50.2
Significant Other Observable Inputs (Level 2) | Corporate securities
Assets:
Total debt available-for-sale securities	326.0	224.6
Significant Other Observable Inputs (Level 2) | Certificates of deposit
Assets:
Total debt available-for-sale securities	6.0
Total fair value
Assets:
Total debt available-for-sale securities	509.1	347.8
Marketable equity securities	0.0	171.3
Money market funds	726.4	274.4
Trading securities	2.0	2.4
Foreign currency forward contracts	7.3	0.0
Total assets	1,244.8	795.9
Liability:
Foreign currency forward contracts	1.3	0.0
Total liabilities	1.3	0.0
Total fair value | U.S. treasuries
Assets:
Total debt available-for-sale securities	56.7	46.1
Total fair value | U.S. agencies
Assets:
Total debt available-for-sale securities	44.9	24.9
Total fair value | Municipal bonds and sovereign debt instruments
Assets:
Total debt available-for-sale securities	4.4	2.0
Total fair value | Asset-backed securities
Assets:
Total debt available-for-sale securities	71.1	50.2
Total fair value | Corporate securities
Assets:
Total debt available-for-sale securities	326.0	224.6
Total fair value | Certificates of deposit
Assets:
Total debt available-for-sale securities	$ 6.0	$ 0.0

XML

Goodwill (Details) $ in Millions	3 Months Ended		12 Months Ended
	Jul. 02, 2016 USD ($)	Sep. 27, 2014 USD ($) subsegment	Jul. 01, 2017 USD ($) subsegment	Jul. 02, 2016 USD ($)	Jun. 27, 2015 USD ($)	Jul. 01, 2017 USD ($)	Jul. 02, 2016 USD ($)	Jun. 27, 2015 USD ($)
Changes in goodwill
Balance at the beginning of the period			$ 152.1	$ 255.5
Goodwill allocation - WaveReady				(6.0)
Currency translation and other adjustments			(0.5)	(6.0)
Goodwill impairment charge	$ (91.4)	$ 0.0	0.0	(91.4)	$ 0.0
Balance at the end of the period	152.1		151.6	152.1	255.5
Gross goodwill and accumulated impairment balances
Gross goodwill balance						$ 810.6	$ 811.1
Accumulated impairment losses						(659.0)	(659.0)
Net goodwill balance	152.1		152.1	255.5	255.5	151.6	152.1	$ 255.5
Impairment of goodwill	91.4	$ 0.0	0.0	$ 91.4	0.0
Discounted Cash Flow Approach
Gross goodwill and accumulated impairment balances
Discount period				10 years
Minimum | Discounted Cash Flow Approach
Gross goodwill and accumulated impairment balances
Long-term annual growth rate				3.00%
Discount rate				14.00%
Terminal growth rate				3.00%
Maximum | Discounted Cash Flow Approach
Gross goodwill and accumulated impairment balances
Long-term annual growth rate				7.00%
Discount rate				17.00%
Terminal growth rate				5.00%
Network Enablement
Changes in goodwill
Balance at the beginning of the period			143.8	$ 154.5
Goodwill allocation - WaveReady				(6.0)
Currency translation and other adjustments			(0.5)	(4.7)
Goodwill impairment charge				0.0
Balance at the end of the period	143.8		143.3	143.8	154.5
Gross goodwill and accumulated impairment balances
Gross goodwill balance						445.2	445.7	456.4
Accumulated impairment losses						(301.9)	(301.9)	(301.9)
Net goodwill balance	143.8		143.8	154.5	154.5	143.3	143.8	154.5
Impairment of goodwill				0.0
Service Enablement
Changes in goodwill
Balance at the beginning of the period			0.0	92.7
Goodwill allocation - WaveReady				0.0
Currency translation and other adjustments			0.0	(1.3)
Goodwill impairment charge				(91.4)
Balance at the end of the period	0.0		0.0	0.0	92.7
Gross goodwill and accumulated impairment balances
Gross goodwill balance						272.6	272.6	273.9
Accumulated impairment losses						(272.6)	(272.6)	(181.2)
Net goodwill balance	0.0		0.0	92.7	92.7	0.0	0.0	92.7
Impairment of goodwill				91.4
Optical Security and Performance Products
Changes in goodwill
Balance at the beginning of the period			8.3	8.3
Goodwill allocation - WaveReady				0.0
Balance at the end of the period	8.3		8.3	8.3	8.3
Gross goodwill and accumulated impairment balances
Gross goodwill balance						92.8	92.8	92.8
Accumulated impairment losses						(84.5)	(84.5)	(84.5)
Net goodwill balance	$ 8.3		$ 8.3	$ 8.3	$ 8.3	$ 8.3	$ 8.3	$ 8.3
Network and Service Enablement
Gross goodwill and accumulated impairment balances
Number of subsegments (in subsegment) | subsegment		2	2

XML

Acquired Developed Technology and Other Intangibles - Summary of Intangible Assets (Details) - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016
Acquired developed technology, customer relationships and other intangibles
Gross carrying amount of finite lived intangibles	$ 474.1	$ 475.7
Accumulated Amortization	(443.0)	(415.8)
Net carrying amount of finite lived intangibles	31.1	59.9
Acquired developed technology
Acquired developed technology, customer relationships and other intangibles
Gross carrying amount of finite lived intangibles	369.3	369.3
Accumulated Amortization	(352.0)	(337.3)
Net carrying amount of finite lived intangibles	17.3	32.0
Customer relationships
Acquired developed technology, customer relationships and other intangibles
Gross carrying amount of finite lived intangibles	94.9	95.6
Accumulated Amortization	(81.3)	(68.0)
Net carrying amount of finite lived intangibles	13.6	27.6
Other
Acquired developed technology, customer relationships and other intangibles
Gross carrying amount of finite lived intangibles	9.9	10.8
Accumulated Amortization	(9.7)	(10.5)
Net carrying amount of finite lived intangibles	$ 0.2	$ 0.3

XML

Acquired Developed Technology and Other Intangibles - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Oct. 03, 2015	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Acquired developed technology, customer relationships and other intangibles
Amortization expense		$ 28.3	$ 31.9	$ 51.4
Acquired developed technology
Acquired developed technology, customer relationships and other intangibles
Useful life of intangible assets	36 months			52 months
Network Instruments, LLC (Network Instruments) | Acquired developed technology
Acquired developed technology, customer relationships and other intangibles
Intangible assets transferred from indefinite to finite-lived intangible assets				$ 1.7
Trendium Inc. (Trendium) | Acquired developed technology
Acquired developed technology, customer relationships and other intangibles
Intangible assets transferred from indefinite to finite-lived intangible assets	$ 1.8
Trendium Inc. (Trendium) | In-process research and development
Acquired developed technology, customer relationships and other intangibles
Impairment charge				$ 3.6

XML

Acquired Developed Technology and Other Intangibles - Amortization (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Acquired Developed Technology and Other Intangibles [Abstract]
Cost of revenues	$ 14.3	$ 17.3	$ 31.9
Operating expense	14.0	14.6	19.5
Total	$ 28.3	$ 31.9	$ 51.4

XML

Acquired Developed Technology and Other Intangibles - Estimated Future Amortization (Details) $ in Millions	Jul. 01, 2017 USD ($)
Estimated future amortization expense
2018	$ 20.1
2019	9.3
2020	1.4
2021	0.3
Total amortization	$ 31.1

XML

Debt - Carrying Amounts of the Liability and Equity Components (Details) - USD ($) $ in Millions	Jul. 01, 2017	Mar. 03, 2017	Jul. 02, 2016	Aug. 21, 2013
Carrying amounts of the liability and equity components:
Carrying amount of liability component	$ 931.4		$ 583.3
Convertible Debt
Carrying amounts of the liability and equity components:
Unamortized discount of liability component	(129.4)		(61.7)
Unamortized debt issuance cost	(9.2)		(5.0)
Carrying amount of liability component	931.4		583.3
Carrying value of the equity component of convertible debt	229.7		134.4
Convertible Debt | 0.625% Senior Convertible Notes
Carrying amounts of the liability and equity components:
Principal amount of notes	$ 610.0		650.0
Carrying value of the equity component of convertible debt				$ 134.4
Interest rate on senior convertible notes	0.625%
Convertible Debt | 1.00% Senior Convertible Notes
Carrying amounts of the liability and equity components:
Principal amount of notes	$ 460.0		$ 0.0
Carrying value of the equity component of convertible debt	$ 101.9
Interest rate on senior convertible notes	1.00%	1.00%

XML

Debt - Additional Information (Details)			1 Months Ended	3 Months Ended	12 Months Ended
	Feb. 27, 2017	Aug. 21, 2013 USD ($) $ / shares	Mar. 31, 2017 USD ($)	Jun. 27, 2015 noteholder	Jul. 01, 2017 USD ($) d day $ / shares	Jul. 02, 2016 USD ($)	Jun. 27, 2015 USD ($)	Mar. 22, 2017 USD ($)	Mar. 03, 2017 USD ($)	Aug. 15, 2013
Debt
Short-term debt outstanding					$ 0	$ 0
Cash paid in debt repurchase					45,400,000	0	$ 0
Loss on extinguishment of debt					1,100,000	0	$ 0
Convertible Debt
Debt
Carrying value of the equity component of convertible debt					229,700,000	134,400,000
Unamortized debt issuance cost					$ 9,200,000	5,000,000
Convertible Debt | 1.00% Senior Convertible Notes
Debt
Interest rate on senior convertible notes					1.00%				1.00%
Aggregate principal amount of convertible debt								$ 60,000,000	$ 400,000,000
Total proceeds net of issuance costs			$ 451,100,000
Effective interest rate					4.80%
Initial conversion price (in dollars per share) | $ / shares					$ 13.22
Premium of initial conversion price over closing stock price	32.50%
Percentage of principal amount at which the entity may redeem some or all of the notes for cash					100.00%
Derivative term					7 years
Carrying value of the liability component					$ 358,100,000
Carrying value of the equity component of convertible debt					$ 101,900,000
Remaining term of convertible notes					6 years 8 months 12 days
Debt issuance costs incurred								8,900,000
Fair market value of convertible debt					$ 481,700,000
Amount outstanding					$ 460,000,000	0
Convertible Debt | 1.00% Senior Convertible Notes | Conversion criteria one
Debt
Percentage of the conversion price that the closing price of the entity's common stock must exceed in order for the notes to be convertible					130.00%
Number of trading days within 30 consecutive trading days in which the closing price of the entity's common stock must exceed the conversion price for the notes to be redeemable | day					20
Number of consecutive trading days during which the closing price of the entity's common stock must exceed the conversion price for at least 20 trading days in order for the notes to be redeemable					30 days
Convertible Debt | 1.00% Senior Convertible Notes | Conversion criteria two
Debt
Number of trading days within 30 consecutive trading days in which the closing price of the entity's common stock must exceed the conversion price for the notes to be redeemable | d					45
Trading days used to calculate stock price trigger | d					10
Convertible Debt | 1.00% Senior Convertible Notes | Conversion criteria three
Debt
Threshold premium of stock price trigger					10.00%
Convertible Debt | 1.00% Senior Convertible Notes | Conversion criteria five
Debt
Percentage of the conversion price that the closing price of the entity's common stock must exceed in order for the notes to be convertible					98.00%
Number of consecutive business days immediately following any 10 consecutive trading day period					5 days
Number of consecutive trading days during which the closing price of the entity's common stock must exceed the conversion price for at least 20 trading days in order for the notes to be redeemable					10 days
Convertible Debt | 1.00% Senior Convertible Notes, Liability Component
Debt
Debt issuance costs incurred								6,900,000
Unamortized debt issuance cost					$ 6,600,000
Convertible Debt | 1.00% Senior Convertible Notes, Equity Component
Debt
Debt issuance costs incurred								$ 2,000,000
Convertible Debt | 0.625% Senior Convertible Notes
Debt
Interest rate on senior convertible notes					0.625%
Aggregate principal amount of convertible debt		$ 650,000,000.0
Total proceeds net of issuance costs		$ 636,300,000
Effective interest rate		5.40%
Conversion price of debt (in dollars per share) | $ / shares		$ 18.83			$ 11.28
Conversion price of convertible debt as premium on closing price of common stock (as a percent)										40.00%
Principal amount used for debt instrument conversion		$ 1,000			$ 1,000
Number of consecutive business days immediately following any 10 consecutive trading day period					5 days
Number of consecutive trading days during which the closing price of the entity's common stock must exceed the conversion price for at least 20 trading days in order for the notes to be redeemable					30 days
Number of consecutive trading days before five consecutive business-days					10 days
Percentage of principal amount at which the entity may redeem some or all of the notes for cash		100.00%
Number of note holders exercising conversion rights before expiration notice | noteholder				0
Percentage of principal amount that the holder of the note may require the entity to repurchase the debt instrument		100.00%
Discount rate used to calculate the carrying value of the liability component of the convertible debt (as a percent)		5.40%
Variable rate basis on which disclount rate is based		5 years
Carrying value of the liability component		$ 515,600,000
Carrying value of the equity component of convertible debt		134,400,000
Remaining term of convertible notes					1 year 1 month 6 days
Deferred finance costs		13,700,000
Liability component, debt issuance cost		10,900,000
Equity component, debt issuance cost		$ 2,800,000
Aggregate amount of debt repurchased					$ 40,000,000
Cash paid in debt repurchase					45,400,000
Loss on extinguishment of debt					1,100,000
Fair market value of convertible debt					676,100,000	633,000,000
Amount outstanding					610,000,000	$ 650,000,000
Convertible Debt | 0.625% Senior Convertible Notes | Other non-current assets
Debt
Unamortized portion of debt issuance cost					$ 2,600,000
Convertible Debt | 0.625% Senior Convertible Notes | Minimum
Debt
Percentage of the conversion price that the closing price of the entity's common stock must exceed in order for the notes to be convertible					130.00%
Number of trading days within 30 consecutive trading days in which the closing price of the entity's common stock must exceed the conversion price for the notes to be redeemable | d					20
Convertible Debt | 0.625% Senior Convertible Notes | Maximum
Debt
Percentage of the trading price to the closing sale price of the entity's common stock					98.00%

XML

Debt - Interest Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016
Interest expense for the contractual interest and the amortization of debt discount
Interest expense-contractual interest	$ 5.5	$ 4.1
Amortization of debt issuance cost	2.5	2.1
Accretion of debt discount	$ 32.1	$ 26.7

XML

Restructuring and Related Charges - Additional Information (Details) $ in Millions	3 Months Ended				6 Months Ended	9 Months Ended	12 Months Ended
	Jul. 01, 2017 USD ($) employee	Jul. 02, 2016 USD ($) employee	Jan. 02, 2016 employee	Mar. 29, 2014 employee	Apr. 01, 2017 USD ($) employee	Jun. 27, 2015 company employee	Jul. 01, 2017 USD ($)	Jul. 02, 2016 USD ($)	Jun. 27, 2015 USD ($) company
Restructuring and Related Charges
Restructuring accrual	$ 11.0	$ 18.0					$ 11.0	$ 18.0
Restructuring and related charges							21.6	10.5	$ 26.8
Long-term restructuring liability	2.2	4.7					2.2	4.7
Number of new public entities (in company) | company						2			2
Non-cash settlements and other adjustments							0.0
OSP Restructuring Plan
Restructuring and Related Charges
Restructuring accrual	0.8	0.0					0.8	0.0
Restructuring and related charges							0.8
Non-cash settlements and other adjustments							0.0
Focused NSE Restructuring Plan
Restructuring and Related Charges
Restructuring accrual	4.9	0.0					4.9	0.0
Restructuring and related charges							21.3
Non-cash settlements and other adjustments							0.1
NE, SE, and Shared Service Agile Restructuring Plan
Restructuring and Related Charges
Restructuring accrual	0.2	8.6					0.2	8.6
Restructuring and related charges							(0.7)
Non-cash settlements and other adjustments							0.0
NE and SE Agile Restructuring Plan
Restructuring and Related Charges
Restructuring accrual	0.4	0.8					0.4	0.8
Restructuring and related charges							(0.1)
Non-cash settlements and other adjustments							0.0
NE, SE, and Shared Separation Restructuring Plan
Restructuring and Related Charges
Restructuring accrual	0.1	1.4					0.1	1.4
Restructuring and related charges							(0.2)
Non-cash settlements and other adjustments							0.0
NE Product Strategy Restructuring Plan
Restructuring and Related Charges
Restructuring accrual	0.9	1.5					0.9	1.5
Restructuring and related charges							0.0
Non-cash settlements and other adjustments							(0.1)
NE Lease Restructuring Plan
Restructuring and Related Charges
Restructuring accrual	2.6	4.0					2.6	4.0
Restructuring and related charges							0.1
Non-cash settlements and other adjustments							0.0
Contractual obligations under the operating lease, net of sublease income, fair value	2.6						2.6
Other Plans Prior to Fiscal 2015
Restructuring and Related Charges
Restructuring accrual	1.1	$ 1.7					1.1	$ 1.7
Restructuring and related charges							0.0
Non-cash settlements and other adjustments							$ 0.0
Severance | OSP Restructuring Plan
Restructuring and Related Charges
Restructuring and related charges	$ 0.8
Number of employees expected to be reduced (employee) | employee	30
Severance | Focused NSE Restructuring Plan
Restructuring and Related Charges
Restructuring and related charges					$ 21.0
Number of employees expected to be reduced (employee) | employee					300
Workforce Reduction | NE, SE, and Shared Service Agile Restructuring Plan
Restructuring and Related Charges
Number of employees expected to be reduced (employee) | employee		170
Workforce Reduction | NE and SE Agile Restructuring Plan
Restructuring and Related Charges
Number of employees expected to be reduced (employee) | employee			40
Workforce Reduction | NE, SE, and Shared Separation Restructuring Plan
Restructuring and Related Charges
Number of employees expected to be reduced (employee) | employee						330
Workforce Reduction | NE Product Strategy Restructuring Plan
Restructuring and Related Charges
Number of employees expected to be reduced (employee) | employee				60

XML

Restructuring and Related Charges - Summary of Restructuring Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Summary of various restructuring plans
Accrual balance at the beginning of the period	$ 18.0
Restructuring and related charges	21.6	$ 10.5	$ 26.8
Cash Settlements	(28.6)
Non-cash settlements and other adjustments	0.0
Accrual balance at the end of the period	11.0	18.0
OSP Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period	0.0
Restructuring and related charges	0.8
Cash Settlements	0.0
Non-cash settlements and other adjustments	0.0
Accrual balance at the end of the period	0.8	0.0
Focused NSE Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period	0.0
Restructuring and related charges	21.3
Cash Settlements	(16.5)
Non-cash settlements and other adjustments	0.1
Accrual balance at the end of the period	4.9	0.0
Other Plans
Summary of various restructuring plans
Accrual balance at the beginning of the period	0.0
Restructuring and related charges	0.4
Cash Settlements	(0.4)
Non-cash settlements and other adjustments	0.0
Accrual balance at the end of the period	0.0	0.0
NE, SE, and Shared Service Agile Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period	8.6
Restructuring and related charges	(0.7)
Cash Settlements	(7.7)
Non-cash settlements and other adjustments	0.0
Accrual balance at the end of the period	0.2	8.6
NE and SE Agile Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period	0.8
Restructuring and related charges	(0.1)
Cash Settlements	(0.3)
Non-cash settlements and other adjustments	0.0
Accrual balance at the end of the period	0.4	0.8
NE, SE, and Shared Separation Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period	1.4
Restructuring and related charges	(0.2)
Cash Settlements	(1.1)
Non-cash settlements and other adjustments	0.0
Accrual balance at the end of the period	0.1	1.4
NE Product Strategy Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period	1.5
Restructuring and related charges	0.0
Cash Settlements	(0.5)
Non-cash settlements and other adjustments	(0.1)
Accrual balance at the end of the period	0.9	1.5
NE Lease Restructuring Plan
Summary of various restructuring plans
Accrual balance at the beginning of the period	4.0
Restructuring and related charges	0.1
Cash Settlements	(1.5)
Non-cash settlements and other adjustments	0.0
Accrual balance at the end of the period	2.6	4.0
Other Plans Prior to Fiscal 2015
Summary of various restructuring plans
Accrual balance at the beginning of the period	1.7
Restructuring and related charges	0.0
Cash Settlements	(0.6)
Non-cash settlements and other adjustments	0.0
Accrual balance at the end of the period	$ 1.1	$ 1.7

XML

Income Taxes - Income (Loss) Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Income (loss) before income taxes
Domestic	$ 94.7	$ (110.9)	$ (173.1)
Foreign	91.9	65.0	67.8
Income (loss) before income taxes	$ 186.6	$ (45.9)	$ (105.3)

XML

Income Taxes - Income Tax Expense (Benefit) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Federal:
Current	$ 0.0	$ 0.0	$ 0.1
Deferred	1.0	(26.2)	2.3
Total Federal income tax expense (benefit)	1.0	(26.2)	2.4
State:
Current	0.2	0.0	(0.1)
Deferred	0.0	(1.5)	0.1
Total State income tax expense (benefit)	0.2	(1.5)	0.0
Foreign:
Current	18.0	21.3	17.9
Deferred	2.1	10.9	5.8
Total Foreign income tax expense	20.1	32.2	23.7
Total income tax expense	$ 21.3	$ 4.5	$ 26.1

XML

Income Taxes - Income Tax Rate Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Reconciliation of the Company's income tax expense (benefit) at the federal statutory rate to the income tax expense (benefit) at the effective tax rate
Income tax expense (benefit) computed at federal statutory rate	$ 65.3	$ (16.1)	$ (36.8)
Goodwill impairment	0.0	19.4	0.0
Intraperiod allocation	0.0	(20.7)	0.0
Foreign rate differential	(6.6)	(2.0)	(2.3)
Valuation allowance	(27.4)	18.2	56.7
Research and experimentation benefits and other tax credits	(1.4)	(1.1)	(0.9)
Reversal of previously accrued taxes	(0.2)	0.0	(0.8)
Permanent items	(9.1)	6.7	8.0
Other	0.7	0.1	2.2
Total income tax expense	$ 21.3	$ 4.5	$ 26.1

XML

Income Taxes - Components of Net Deferred Taxes (Details) - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Gross deferred tax assets:
Tax credit carryforwards	$ 150.6	$ 141.0	$ 131.4
Net operating loss carryforwards	1,875.4	1,846.3	2,226.1
Capital loss carryforwards	102.4	145.9	4.1
Inventories	5.4	6.1	6.7
Accruals and reserves	30.3	27.4	30.2
Investments	0.7	34.4	0.7
Other	51.9	60.3	55.5
Acquisition-related items	55.5	65.2	59.9
Gross deferred tax assets	2,272.2	2,326.6	2,514.6
Valuation allowance	(2,097.8)	(2,174.3)	(2,334.5)
Deferred tax assets	174.4	152.3	180.1
Gross deferred tax liabilities:
Acquisition-related items	(6.5)	(13.2)	(20.9)
Undistributed foreign earnings	(3.0)	0.0	(4.7)
Other	(57.3)	(31.1)	(44.5)
Deferred tax liabilities	(66.8)	(44.3)	(70.1)
Total net deferred tax assets	$ 107.6	$ 108.0	$ 110.0

XML

Income Taxes - Changes in Deferred Tax Valuation Allowance (Details) - Deferred Tax Valuation Allowance - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Valuation and Qualifying Accounts
Balance at Beginning of Period	$ 2,174.3	$ 2,334.5	$ 2,321.8
Additions Charged to Expenses or Other Accounts	44.7	227.5	39.5
Deductions Credited to Expenses or Other Accounts	(121.2)	(387.7)	(26.8)
Balance at End of Period	$ 2,097.8	$ 2,174.3	$ 2,334.5

XML

Income Taxes - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Income Tax Disclosure [Abstract]
Tax benefit associated with exercise of stock options	$ 0.0	$ 0.0	$ 0.0
Net operating loss carryforwards
Portion of net operating loss carryforwards, when realized, will be credited to additional paid-in-capital	117.7
Undistributed earnings of certain foreign subsidiaries	373.3
Estimated additional U.S. income or foreign withholding taxes that would have to be provided if earnings of foreign subsidiaries were repatriated to the U.S.	21.5
Increase (decrease) in deferred tax asset valuation allowances	(76.5)	(160.2)	$ 12.7
Valuation allowance attributable to pre-fiscal 2006 windfall stock option deductions	514.7
Offset to tax expense from write off of tax deductible goodwill		9.5
Portion of unrecognized tax benefits, if recognized, would impact the effective tax rate	3.0
Portion of unrecognized tax benefits, if recognized, would impact the valuation allowance	36.0
Accrued interest and penalties related to unrecognized tax benefits	1.8	1.7
Increase in accrued interest and penalties related to unrecognized tax benefits	0.1
Unrecognized tax benefits that may be recognized during the next twelve months	0.1
Federal
Net operating loss carryforwards
Operating loss carryforwards	5,115.1
Research and other tax credit carryforwards	103.9
State
Net operating loss carryforwards
Operating loss carryforwards	762.2
Research and other tax credit carryforwards	40.7
Foreign
Net operating loss carryforwards
Operating loss carryforwards	624.0
Research and other tax credit carryforwards	$ 1.4
Continuing operations
Net operating loss carryforwards
Income tax benefit intraperiod tax allocation related to other comprehensive income		20.7
Spin-off adjustment
Net operating loss carryforwards
Increase (decrease) in deferred tax asset valuation allowances		$ 8.9

XML

Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Reconciliation of unrecognized tax benefits
Balance at the beginning of the period	$ 41.7	$ 36.8	$ 38.3
Additions based on tax positions related to current year	1.6	5.1	1.9
Additions based on tax positions related to prior year	0.9
Reduction based on tax positions related to prior year	(3.5)
Reductions for lapse of statute of limitations	(1.8)	(0.2)	(3.3)
Reductions due to foreign currency rate fluctuations			(0.1)
Balance at the end of the period	$ 38.9	$ 41.7	$ 36.8

XML

Stockholders' Equity (Details) - USD ($)	1 Months Ended	3 Months Ended				12 Months Ended
	Nov. 30, 2015	Jul. 02, 2016	Apr. 02, 2016	Jan. 02, 2016	Sep. 27, 2014	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015	Sep. 30, 2016	Feb. 01, 2016
Stock Repurchase Program
Reduction in stockholders' equity for share repurchase						$ 92,000,000	$ 44,500,000	$ 4,800,000
Aggregate purchase price of common stock						$ 92,000,000	$ 44,500,000	$ 4,800,000
Common Stock | Share Repurchase Agreement February 2016
Stock Repurchase Program
Authorized amount under stock repurchase program									$ 150,000,000	$ 100,000,000
Shares delivered and retired (in shares)		700,000				10,500,000
Average repurchase price per share (in dollars per share)		$ 6.60				$ 8.75
Reduction in stockholders' equity for share repurchase						$ 92,000,000
Aggregate purchase price of common stock		$ 4,500,000
Common Stock | Share Repurchase Agreement November 2015
Stock Repurchase Program
Authorized amount under stock repurchase program	$ 40,000,000
Shares delivered and retired (in shares)			1,300,000	5,300,000
Average repurchase price per share (in dollars per share)			$ 6.05
Reduction in stockholders' equity for share repurchase			$ 8,000,000	$ 32,000,000
Aggregate purchase price of common stock	$ 40,000,000
Common Stock | Share Repurchase Program May 2014
Stock Repurchase Program
Average repurchase price per share (in dollars per share)					$ 11.93
Outstanding common stock repurchased (in shares)					400,000
Remaining authorized repurchase amount					$ 60,000,000
Series B Preferred Stock
Stock Repurchase Program
Number of undesignated preferred shares authorized to be issued (in shares)						1,000,000

XML

Stock-Based Compensation - Additional Information (Details) $ / shares in Units, $ in Millions			12 Months Ended
	Dec. 05, 2014 shares	Nov. 14, 2012 amendment shares	Jul. 01, 2017 USD ($) executive $ / shares shares	Jul. 02, 2016 USD ($)	Jun. 27, 2015 USD ($)	Aug. 01, 2015 USD ($)
Stock-Based Compensation
Stock options and Full Value Awards issued and outstanding (in shares) | shares			8,800,000
Shares of common stock available for grant (in shares) | shares			15,400,000
Stock-based compensation capitalized to inventory			$ 0.7
Total incremental stock-based compensation expense						$ 13.6
Extended exercise period for fully exercisable options resulted from modification			2 years
Number of executives impacted by plan modification (in executive) | executive			6
Incremental stock-based compensation cost			$ 6.3
Closing stock price of company (in dollars per share) | $ / shares			$ 10.53
Number of exercisable in-the-money options (in shares) | shares			500,000
Minimum remaining maturity period of traded options of the entity's common stock upon which implied volatility is based			6 months
Remaining maturity assumed for expected volatility			4 months 15 days
2003 Plan
Stock-Based Compensation
Number of additional amendments approved by shareholders | amendment		2
Common stock added to the pool of shares reserved for issuance under the plan (in shares) | shares	9,000,000	10,000,000
Additional term of plan after the date of approval of amendment		10 years
1998 Purchase Plan
Stock-Based Compensation
Shares of common stock available for grant (in shares) | shares			4,800,000
Discount rate provided under purchase plan			5.00%
Look-back period			6 months
Options
Stock-Based Compensation
Total intrinsic value of awards exercised (in dollars)			$ 5.9
Unrecognized stock-based compensation			$ 1.5
Estimated amortization period			2 years 7 months 6 days
Options | Minimum
Stock-Based Compensation
Vesting period			3 years
Stock awards expiration period			5 years
Options | Maximum
Stock-Based Compensation
Vesting period			4 years
Stock awards expiration period			10 years
Full Value Awards
Stock-Based Compensation
Exercise price (in dollars per share) | $ / shares			$ 0
Unrecognized stock-based compensation			$ 31.4
Estimated amortization period			1 year 9 months
Withholding taxes liability paid			$ 14.3	$ 11.4	$ 22.1
Full Value Awards | Minimum
Stock-Based Compensation
Vesting period			1 year
Full Value Awards | Maximum
Stock-Based Compensation
Vesting period			4 years
Employee Stock Purchase Plan
Stock-Based Compensation
Unrecognized stock-based compensation			$ 0.1

XML

Stock-Based Compensation - Stock-Based Compensation by Function (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 33.2	$ 42.4	$ 47.5
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	3.6	4.8	4.2
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	5.7	8.4	8.1
Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 23.9	$ 29.2	$ 35.2

XML

Stock-Based Compensation - Stock Option Activity (Details) - $ / shares shares in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Options Outstanding, Number of Shares
Outstanding at the beginning of the period (in shares)	3.1	2.5	3.5
Granted (in shares)	0.0	1.2
Exercised (in shares)	(1.6)	(0.7)	(0.9)
Cancelled (in shares)	0.0	(0.4)	(0.1)
Net adjustment due to the separation (in shares)		0.5
Outstanding at the end of the period (in shares)	1.5	3.1	2.5
Expected to vest (in shares)	1.4
Options Outstanding, Weighted-Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)	$ 5.91	$ 10.84	$ 10.13
Granted (in dollars per share)	0.00	5.95
Exercised (in dollars per share)	5.66	4.74	7.58
Cancelled (in dollars per share)	0.00	10.52	14.54
Outstanding at the end of the period (in dollars per share)	6.16	$ 5.91	$ 10.84
Expected to vest (in dollars per share)	$ 6.18

XML

Stock-Based Compensation - Range of Exercise Prices (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Jul. 01, 2017 USD ($) $ / shares shares
Options Outstanding
Number of Shares (in shares) | shares	1,524,565
Weighted Average Remaining Contractual Term (in years)	5 years 4 months 6 days
Weighted Average Exercise Price (in dollars per share)	$ 6.16
Aggregate Intrinsic Value (in dollars) | $	$ 6.8
Options Exercisable
Number of Shares (in shares) | shares	639,373
Weighted Average Remaining Contractual Term (in years)	3 years 6 months 29 days
Weighted Average Exercise Price (in dollars per share)	$ 6.46
Aggregate intrinsic value (in dollars) | $	$ 2.7
$3.28 - $3.28
Stock options outstanding and exercisable by exercise price range
Exercise price per share, low end of the range (in dollars per share)	$ 3.28
Exercise price per share, high end of the range (in dollars per share)	$ 3.28
Options Outstanding
Number of Shares (in shares) | shares	104,352
Weighted Average Remaining Contractual Term (in years)	1 month 13 days
Weighted Average Exercise Price (in dollars per share)	$ 3.28
Options Exercisable
Number of Shares (in shares) | shares	104,352
Weighted Average Remaining Contractual Term (in years)	1 month 13 days
Weighted Average Exercise Price (in dollars per share)	$ 3.28
$5.74 - $5.74
Stock options outstanding and exercisable by exercise price range
Exercise price per share, low end of the range (in dollars per share)	5.74
Exercise price per share, high end of the range (in dollars per share)	$ 5.74
Options Outstanding
Number of Shares (in shares) | shares	132,544
Weighted Average Remaining Contractual Term (in years)	11 months 1 day
Weighted Average Exercise Price (in dollars per share)	$ 5.74
Options Exercisable
Number of Shares (in shares) | shares	132,544
Weighted Average Remaining Contractual Term (in years)	11 months 1 day
Weighted Average Exercise Price (in dollars per share)	$ 5.74
$5.95 - $5.95
Stock options outstanding and exercisable by exercise price range
Exercise price per share, low end of the range (in dollars per share)	5.95
Exercise price per share, high end of the range (in dollars per share)	$ 5.95
Options Outstanding
Number of Shares (in shares) | shares	1,180,257
Weighted Average Remaining Contractual Term (in years)	6 years 7 months 13 days
Weighted Average Exercise Price (in dollars per share)	$ 5.95
Options Exercisable
Number of Shares (in shares) | shares	295,065
Weighted Average Remaining Contractual Term (in years)	6 years 7 months 13 days
Weighted Average Exercise Price (in dollars per share)	$ 5.95
$11.82 - $11.82
Stock options outstanding and exercisable by exercise price range
Exercise price per share, low end of the range (in dollars per share)	11.82
Exercise price per share, high end of the range (in dollars per share)	$ 11.82
Options Outstanding
Number of Shares (in shares) | shares	107,412
Weighted Average Remaining Contractual Term (in years)	1 year 10 months 13 days
Weighted Average Exercise Price (in dollars per share)	$ 11.82
Options Exercisable
Number of Shares (in shares) | shares	107,412
Weighted Average Remaining Contractual Term (in years)	1 year 10 months 13 days
Weighted Average Exercise Price (in dollars per share)	$ 11.82

XML

Stock-Based Compensation - Employee Stock Purchase Plan Activity (Details) - Employee Stock Purchase Plan - $ / shares	Jan. 31, 2017	Jul. 29, 2016
Stock-Based Compensation
Shares issued (in shares)	269,102	410,737
Fair market value at purchase date (in dollars per share)	$ 6.77	$ 4.76

XML

Stock-Based Compensation - Full Value Awards Activity (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Full Value Awards - Total
Full Value Awards, Total number of shares
Outstanding at the beginning of the period (in shares)	9.4	8.8	9.4
Awards granted (in shares)	4.3	6.8	6.0
Awards vested (in shares)	(5.1)	(5.5)	(5.2)
Awards forfeited (in shares)	(1.3)	(2.2)	(1.4)
Net adjustment due to the separation (in shares)		1.5
Outstanding at the end of the period (in shares)	7.3	9.4	8.8
Full Value Awards, Weighted-average grant-dated fair value
Outstanding at the beginning of the period (in dollars per share)	$ 6.55	$ 12.36	$ 13.19
Awards granted (in dollars per share)	7.86	5.75	11.78
Awards vested (in dollars per share)	6.66	6.01	12.96
Awards forfeited (in dollars per share)	6.83	7.89	13.10
Outstanding at the end of the period (in dollars per share)	$ 7.17	$ 6.55	$ 12.36
Full Value Awards - Total | Minimum
Full Value Awards, Weighted-average grant-dated fair value
Vesting period	1 year
Full Value Awards - Total | Maximum
Full Value Awards, Weighted-average grant-dated fair value
Vesting period	4 years
Full Value Awards - Performance shares
Full Value Awards, Total number of shares
Outstanding at the beginning of the period (in shares)	1.0	1.0	1.1
Awards granted (in shares)	0.6	0.7	0.7
Awards vested (in shares)	(0.6)	(0.7)	(0.8)
Awards forfeited (in shares)	0.0	(0.4)	0.0
Net adjustment due to the separation (in shares)		0.4
Outstanding at the end of the period (in shares)	1.0	1.0	1.0
Full Value Awards - Non-performance shares
Full Value Awards, Total number of shares
Outstanding at the beginning of the period (in shares)	8.4	7.8	8.3
Awards granted (in shares)	3.7	6.1	5.3
Awards vested (in shares)	(4.5)	(4.8)	(4.4)
Awards forfeited (in shares)	(1.3)	(1.8)	(1.4)
Net adjustment due to the separation (in shares)		1.1
Outstanding at the end of the period (in shares)	6.3	8.4	7.8
MSUs
Full Value Awards, Weighted-average grant-dated fair value
Aggregate grant-date fair value (in dollars)	$ 3.3	$ 3.7	$ 9.4
MSUs | Minimum
Full Value Awards, Weighted-average grant-dated fair value
Vesting period	3 years
MSUs | Maximum
Full Value Awards, Weighted-average grant-dated fair value
Vesting period	4 years

XML

Stock-Based Compensation - Valuation Assumptions (Details)	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
MSUs | Monte Carlo simulation
Valuation Assumptions
Expected volatility	33.20%	33.80%	40.80%
Average volatility of peer companies	36.90%	52.90%	53.40%
Average correlation coefficient of peer companies	0.1856	0.1103	0.2156
Risk-free interest rate	0.70%	0.80%	0.60%
Options | BSM
Valuation Assumptions
Expected term (in years)		5 years 2 months 12 days
Expected volatility		42.30%
Risk-free interest rate		1.20%
Employee Stock Purchase Plan | BSM
Valuation Assumptions
Expected term (in years)	6 months	6 months	6 months
Expected volatility	33.40%	45.70%	37.90%
Risk-free interest rate	0.50%	0.40%	0.10%

XML

Employee Pension and Other Benefit Plans - Additional Information (Details) £ in Millions		12 Months Ended
	Aug. 01, 2015 USD ($)	Jul. 01, 2017 USD ($)	Jul. 01, 2017 GBP (£)	Jul. 02, 2016 USD ($)	Jul. 02, 2016 GBP (£)	Jun. 27, 2015 USD ($)
Employee 401(k) Plans
Maximum contribution by an employee, as percentage of annual compensation		50.00%	50.00%
Maximum amount of contribution by an employee in a calendar year		$ 18,000
Period of service required for eligibility under matching contributions		180 days	180 days
Employer match of employee's contributions of the first 3% of eligible compensation (as a percent)		100.00%	100.00%
Percentage of eligible compensation, matched 100% by employer		3.00%	3.00%
Employer match of employee's contributions of the next 2% of eligible compensation (as a percent)		50.00%	50.00%
Percentage of eligible compensation, matched 50% by employer		2.00%	2.00%
Company's matching contribution to the plan		$ 4,100,000		$ 4,700,000		$ 4,800,000
Employee Defined Benefit Plans
Minimum maturity period for investment in index-linked Gilts		5 years	5 years
Required contributions expected in next fiscal year		$ 0
Pension Benefit Plans
Employee Defined Benefit Plans
Benefit obligation		133,400,000		134,600,000		$ 121,200,000
Future amortization of losses		1,400,000
Employer contributions		4,000,000		4,600,000
Other Post Retirement Benefit Plans
Employee Defined Benefit Plans
Benefit obligation		1,100,000		1,100,000
Switzerland
Employee Defined Benefit Plans
Transfer of liabilities from plan in spin-off	$ 6,700,000
Transfer of assets from plan in spin-off	$ 4,600,000
U.K. | Foreign Pension Plan
Employee Defined Benefit Plans
Employer contributions		$ 600,000	£ 0.5	$ 700,000	£ 0.5

XML

Employee Pension and Other Benefit Plans - Net Periodic Benefit Cost (Details) - Pension Benefit Plans - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Components of the net periodic cost for the pension and benefits plans
Service cost	$ 0.3	$ 0.2	$ 0.2
Interest cost	2.1	3.0	3.7
Expected return on plan assets	(1.1)	(1.5)	(1.6)
Recognized net actuarial losses	1.9	0.7	0.4
Provision for legal proceeding	0.0	8.4	0.0
Net periodic cost	$ 3.2	$ 10.8	$ 2.7

XML

Employee Pension and Other Benefit Plans - Changes in the Benefit Obligations and Plan Assets (Details) - Pension Benefit Plans - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Change in benefit obligation
Benefit obligation at beginning of year	$ 134.6	$ 121.2
Service cost	0.3	0.2	$ 0.2
Interest cost	2.1	3.0	3.7
Actuarial (gains) losses	(1.2)	14.5
Benefits paid	(4.2)	(4.7)
Provision for legal proceeding	0.0	8.4	0.0
Foreign exchange impact	1.8	(8.0)
Benefit obligation at end of year	133.4	134.6	121.2
Change in plan assets
Fair value of plan assets at beginning of year	27.2	30.2
Actual return on plan assets	2.0	1.8
Employer contributions	4.0	4.6
Benefits paid	(4.2)	(4.7)
Foreign exchange impact	(0.7)	(4.7)
Fair value of plan assets at end of year	28.3	27.2	$ 30.2
Funded status	(105.1)	(107.4)
Accumulated benefit obligation	$ 133.0	$ 133.9

XML

Employee Pension and Other Benefit Plans - Amounts Recognized on Financial Statements (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Amount recognized in the Consolidated Balance Sheets at end of year:
Non-current liabilities	$ 99.4	$ 103.0
Other changes in plan assets and benefit obligations recognized in other comprehensive income (loss):
Net actuarial gain (loss)	0.7	(10.6)	$ (3.7)
Amortization of accumulated net actuarial losses	1.9	0.7	$ 0.4
Pension Benefit Plans
Amount recognized in the Consolidated Balance Sheets at end of year:
Current liabilities	6.8	5.5
Non-current liabilities	98.3	101.9
Net amount recognized at end of year	105.1	107.4
Amount recognized in accumulated other comprehensive income (loss) at end of year:
Actuarial losses, net of tax	(21.8)	(24.4)
Net amount recognized at end of year	(21.8)	(24.4)
Other changes in plan assets and benefit obligations recognized in other comprehensive income (loss):
Net actuarial gain (loss)	0.7	(10.6)
Amortization of accumulated net actuarial losses	1.9	0.7
Total recognized in other comprehensive income (loss)	$ 2.6	$ (9.9)

XML

Employee Pension and Other Benefit Plans - Weighted Average Assumptions (Details) - Pension Benefit Plans	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Weighted-average assumptions used to determine net period cost:
Discount rate	2.10%	2.10%	3.00%
Expected long-term return on plan assets	4.80%	5.30%	5.80%
Rate of pension increase	2.20%	2.30%	2.30%
Weighted-average assumptions used to determine benefit obligation at end of year:
Discount rate	2.00%	1.70%	2.60%
Rate of pension increase	2.30%	2.10%	2.20%

XML

Employee Pension and Other Benefit Plans - Assets at Fair Value and Assets Allocations (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Asset category
Minimum maturity period for investment in index-linked Gilts	5 years
Pension Benefit Plans
Asset category
Fair value of total plan assets	$ 28.3	$ 27.2	$ 30.2
Percentage of Plan Assets	100.00%	100.00%
Pension Benefit Plans | Quoted Prices in Active Markets for Identical Assets (Level 1)
Asset category
Fair value of total plan assets	$ 0.1	$ 0.6
Pension Benefit Plans | Significant Other Observable Inputs (Level 2)
Asset category
Fair value of total plan assets	$ 28.2	$ 26.6
Pension Benefit Plans | Global equity
Asset category
Target Allocation	40.00%	40.00%
Fair value of total plan assets	$ 11.7	$ 10.5
Percentage of Plan Assets	41.30%	38.60%
Pension Benefit Plans | Global equity | Significant Other Observable Inputs (Level 2)
Asset category
Fair value of total plan assets	$ 11.7	$ 10.5
Pension Benefit Plans | Fixed income
Asset category
Target Allocation	40.00%	40.00%
Fair value of total plan assets	$ 10.7	$ 10.7
Percentage of Plan Assets	37.80%	39.30%
Pension Benefit Plans | Fixed income | Significant Other Observable Inputs (Level 2)
Asset category
Fair value of total plan assets	$ 10.7	$ 10.7
Pension Benefit Plans | Other
Asset category
Target Allocation	20.00%	20.00%
Fair value of total plan assets	$ 5.8	$ 5.4
Percentage of Plan Assets	20.50%	19.90%
Pension Benefit Plans | Other | Significant Other Observable Inputs (Level 2)
Asset category
Fair value of total plan assets	$ 5.8	$ 5.4
Pension Benefit Plans | Cash
Asset category
Fair value of total plan assets	$ 0.1	$ 0.6
Percentage of Plan Assets	0.40%	2.20%
Pension Benefit Plans | Cash | Quoted Prices in Active Markets for Identical Assets (Level 1)
Asset category
Fair value of total plan assets	$ 0.1	$ 0.6

XML

Employee Pension and Other Benefit Plans - Future Benefit Payments (Details) - Pension Benefit Plans $ in Millions	Jul. 01, 2017 USD ($)
Future Benefit Payments
2018	$ 7.5
2019	6.1
2020	5.5
2021	5.7
2022	6.1
2023 - 2027	29.7
Thereafter	44.5
Total	$ 105.1

XML

Commitments and Contingencies - Operating Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Future minimum operating lease payments
2018	$ 18.8
2019	16.7
2020	12.2
2021	10.1
2022	6.1
Thereafter	0.5
Total minimum operating lease payments	64.4
Lease commitments related to restructuring activities	3.7
Future minimum lease rentals receivable under non-cancelable subleases	2.9
Rental expense related to building and equipment	$ 12.1	$ 13.8	$ 14.3

XML

Commitments and Contingencies - Purchase Obligations (Details) $ in Millions	12 Months Ended
	Jul. 01, 2017 USD ($) agreement
Purchase Obligations
Legally-binding purchase commitment obligations | $	$ 56.8
Typical duration of supply agreements with single or limited source vendors	1 year
Long-term guaranteed supply agreements | agreement	0

XML

Commitments and Contingencies - Financing Obligations - Eningen and Santa Rosa (Details) $ in Millions	Dec. 16, 2011 ft² building	Aug. 21, 2007 USD ($) ft² a renewal_option building	Jul. 01, 2017 USD ($) building	Jul. 02, 2016 USD ($)
Financing Obligations
Financing obligation, noncurrent			$ 27.8	$ 28.7
Eningen
Financing Obligations
Area of land sold (in square feet) | ft²	394,217
Number of buildings sold | building	9
Area of property sold (in square feet) | ft²	386,132
Square feet of property leased back | ft²	158,154
Number of buildings leased back | building	2
Lease term	10 years
Minimum term before early cancellation clause takes effect	5 years
Financing obligation, current			0.1	0.1
Financing obligation, noncurrent			3.9	4.0
Santa Rosa
Financing Obligations
Number of buildings sold | building		13
Area of property sold (in square feet) | ft²		492,000
Square feet of property leased back | ft²		286,000
Number of buildings leased back | building		7
Net cash proceeds received from sale and lease back transaction		$ 32.2
Number of renewal options (in renewal option) | renewal_option		2
Renewal term		5 years
Area of land sold (in acres) | a		45
Letter of credit issued as a security			3.8
Financing obligation, current			0.8	0.8
Financing obligation, noncurrent			$ 23.9	$ 24.7
Number of buildings included in the option to purchase at the end of the lease term | building			1
Santa Rosa | Minimum
Financing Obligations
Lease term		1 year
Santa Rosa | Maximum
Financing Obligations
Lease term		10 years

XML

Commitments and Contingencies - Guarantees and Outstanding Letters of Credit and Performance Bonds (Details) - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016
Loss Contingencies [Line Items]
Guarantee liabilities	$ 0.0	$ 0.0
Standby letters of credit
Loss Contingencies [Line Items]
Contingency	15.3
Performance bonds
Loss Contingencies [Line Items]
Contingency	$ 2.7

XML

Commitments and Contingencies - Product Warranties (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 01, 2017	Jul. 02, 2016
Product Warranties
Warranty Term for most products	3 years
Changes in warranty reserve
Balance as of beginning of period	$ 4.9	$ 3.7
Provision for warranty	4.2	3.9
Utilization of reserve	(3.8)	(3.3)
Adjustments related to pre-existing warranties (including changes in estimates)	0.5	0.6
Balance as of end of period	$ 5.8	$ 4.9

XML

Commitments and Contingencies - Legal Proceedings (Details) - Amendment of pension for foreign subsidiary - Judicial ruling £ in Millions, $ in Millions	Jul. 01, 2017 USD ($)	Jul. 01, 2017 GBP (£)	Jul. 02, 2016 USD ($)	Jul. 02, 2016 GBP (£)
Loss Contingencies [Line Items]
Amount accrued	$ 7.4	£ 5.7
Minimum
Loss Contingencies [Line Items]
Estimate liability			$ 7.4	£ 5.7
Maximum
Loss Contingencies [Line Items]
Estimate liability	$ 10.9	£ 8.4

XML

Operating Segments and Geographic Information - Summary of Reportable Segments (Details) $ in Millions	3 Months Ended									12 Months Ended
	Jul. 01, 2017 USD ($)	Apr. 01, 2017 USD ($)	Dec. 31, 2016 USD ($)	Oct. 01, 2016 USD ($)	Jul. 02, 2016 USD ($)	Apr. 02, 2016 USD ($)	Jan. 02, 2016 USD ($)	Oct. 03, 2015 USD ($)	Sep. 27, 2014 subsegment	Jul. 01, 2017 USD ($) subsegment segment	Jul. 02, 2016 USD ($)	Jun. 27, 2015 USD ($)
Information on reportable segments
Number of broad business categories (in segment) | segment										2
Net revenue	$ 198.1	$ 196.0	$ 206.5	$ 210.8	$ 224.1	$ 220.4	$ 232.1	$ 229.7		$ 811.4	$ 906.3	$ 873.9
Gross profit	$ 119.2	$ 117.0	$ 124.7	$ 125.1	$ 136.1	$ 131.3	$ 141.8	$ 140.5		$ 486.0	$ 549.7	$ 520.1
Gross margin										59.90%	60.70%	59.50%
Operating income (loss)										$ 13.6	$ (84.3)	$ (75.8)
Operating margin										1.70%	(9.30%)	(8.70%)
Segment Measures
Information on reportable segments
Net revenue										$ 811.4	$ 906.3	$ 873.9
Gross profit										$ 506.3	$ 572.2	$ 557.4
Gross margin										62.40%	63.10%	63.80%
Operating income (loss)										$ 107.6	$ 115.6	$ 68.0
Operating margin										13.30%	12.80%	7.80%
Reconciling Items
Information on reportable segments
Net revenue										$ 0.0	$ 0.0	$ 0.0
Gross profit										(20.3)	(22.5)	(37.3)
Operating income (loss)										$ (94.0)	(199.9)	(143.8)
Network and Service Enablement
Information on reportable segments
Number of subsegments (in subsegment) | subsegment									2	2
Network and Service Enablement | Segment Measures
Information on reportable segments
Net revenue										$ 579.2	658.2	681.1
Gross profit										$ 372.5	$ 429.1	$ 453.1
Gross margin										64.30%	65.20%	66.50%
Operating income (loss)										$ 7.3	$ 12.7	$ (0.1)
Operating margin										1.30%	1.90%	0.00%
Network and Service Enablement | Network Enablement | Segment Measures
Information on reportable segments
Net revenue										$ 444.0	$ 504.6	$ 506.8
Gross profit										$ 286.3	$ 329.7	$ 333.9
Gross margin										64.50%	65.30%	65.90%
Network and Service Enablement | Service Enablement | Segment Measures
Information on reportable segments
Net revenue										$ 135.2	$ 153.6	$ 174.3
Gross profit										$ 86.2	$ 99.4	$ 119.2
Gross margin										63.80%	64.70%	68.40%
Optical Security and Performance Products | Segment Measures
Information on reportable segments
Net revenue										$ 232.2	$ 248.1	$ 192.8
Gross profit										$ 133.8	$ 143.1	$ 104.3
Gross margin										57.60%	57.70%	54.10%
Operating income (loss)										$ 100.3	$ 102.9	$ 68.1
Operating margin										43.20%	41.50%	35.30%

XML

Operating Segments and Geographic Information - Reconciliation to Gross Profit and Operating Income (Details) - USD ($) $ in Millions	3 Months Ended									12 Months Ended
	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Oct. 01, 2016	Jul. 02, 2016	Apr. 02, 2016	Jan. 02, 2016	Oct. 03, 2015	Sep. 27, 2014	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Information on reportable segments
Amortization of intangibles										$ (14.3)	$ (17.3)	$ (31.9)
Gross profit	$ 119.2	$ 117.0	$ 124.7	$ 125.1	$ 136.1	$ 131.3	$ 141.8	$ 140.5		486.0	549.7	520.1
Stock-based compensation										(33.2)	(42.4)	(47.5)
Amortization of intangibles										(14.0)	(14.6)	(19.5)
Impairment of goodwill					$ (91.4)				$ 0.0	0.0	(91.4)	0.0
Restructuring and related charges										(21.6)	(10.5)	(26.8)
Income (loss) from operations										13.6	(84.3)	(75.8)
Loss on disposal of long-lived assets										5.7	1.5	1.1
Separation related charges										1.5	5.0	9.8
Non-recurring charges related to litigation											8.4
Severance and related costs											3.5
In-process research and development | Trendium Inc. (Trendium)
Information on reportable segments
Impairment charge												3.6
Segment Measures
Information on reportable segments
Gross profit										506.3	572.2	557.4
Income (loss) from operations										107.6	115.6	68.0
Reconciling Items
Information on reportable segments
Stock-based compensation										(3.6)	(4.8)	(4.2)
Amortization of intangibles										(14.3)	(17.3)	(31.9)
Other charges unrelated to core operating performance										(2.4)	(0.4)	(1.2)
Gross profit										(20.3)	(22.5)	(37.3)
Stock-based compensation										(33.2)	(42.4)	(47.5)
Amortization of intangibles										(28.3)	(31.9)	(51.4)
Impairment of goodwill										0.0	(91.4)	0.0
Other charges unrelated to core operating performance										(10.9)	(23.7)	(18.1)
Restructuring and related charges										(21.6)	(10.5)	(26.8)
Income (loss) from operations										$ (94.0)	$ (199.9)	$ (143.8)

XML

Operating Segments and Geographic Information - Net Revenue by Geographic Region (Details) $ in Millions	3 Months Ended								12 Months Ended
	Jul. 01, 2017 USD ($) region	Apr. 01, 2017 USD ($)	Dec. 31, 2016 USD ($)	Oct. 01, 2016 USD ($)	Jul. 02, 2016 USD ($)	Apr. 02, 2016 USD ($)	Jan. 02, 2016 USD ($)	Oct. 03, 2015 USD ($)	Jul. 01, 2017 USD ($) region	Jul. 02, 2016 USD ($)	Jun. 27, 2015 USD ($)
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of geographic regions in which entity operates (in region) | region	3								3
Net revenue	$ 198.1	$ 196.0	$ 206.5	$ 210.8	$ 224.1	$ 220.4	$ 232.1	$ 229.7	$ 811.4	$ 906.3	$ 873.9
Geographic Concentration Risk | Net Revenue
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of net revenue									100.00%	100.00%	100.00%
Total Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue									$ 378.6	$ 462.6	$ 486.8
Total Americas | Geographic Concentration Risk | Net Revenue
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of net revenue									46.70%	51.10%	55.70%
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue									$ 307.3	$ 396.6	$ 424.3
United States | Geographic Concentration Risk | Net Revenue
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of net revenue									37.90%	43.80%	48.50%
Other Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue									$ 71.3	$ 66.0	$ 62.5
Other Americas | Geographic Concentration Risk | Net Revenue
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of net revenue									8.80%	7.30%	7.20%
Total Asia-Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue									$ 173.2	$ 166.3	$ 144.5
Total Asia-Pacific | Geographic Concentration Risk | Net Revenue
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of net revenue									21.30%	18.30%	16.50%
Greater China
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue									$ 100.8	$ 103.2	$ 83.1
Greater China | Geographic Concentration Risk | Net Revenue
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of net revenue									12.40%	11.30%	9.50%
Other Asia-Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue									$ 72.4	$ 63.1	$ 61.4
Other Asia-Pacific | Geographic Concentration Risk | Net Revenue
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of net revenue									8.90%	7.00%	7.00%
Total EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue									$ 259.6	$ 277.4	$ 242.6
Total EMEA | Geographic Concentration Risk | Net Revenue
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of net revenue									32.00%	30.60%	27.80%
Switzerland
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue									$ 124.0	$ 135.6	$ 97.7
Switzerland | Geographic Concentration Risk | Net Revenue
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of net revenue									15.30%	15.00%	11.20%
Other EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue									$ 135.6	$ 141.8	$ 144.9
Other EMEA | Geographic Concentration Risk | Net Revenue
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of net revenue									16.70%	15.60%	16.60%

XML

Operating Segments and Geographic Information - Customer Concentration Risk (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Oct. 01, 2016	Jul. 02, 2016	Apr. 02, 2016	Jan. 02, 2016	Oct. 03, 2015	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	$ 198.1	$ 196.0	$ 206.5	$ 210.8	$ 224.1	$ 220.4	$ 232.1	$ 229.7	$ 811.4	$ 906.3	$ 873.9
Customer Concentration Risk | Customer A - OSP customer | OSP
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue									$ 166.8	$ 190.1	$ 143.0

XML

Operating Segments and Geographic Information - Property, Plant and Equipment by Geographic Region (Details) - USD ($) $ in Millions	Jul. 01, 2017	Jul. 02, 2016
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property, plant and equipment, net	$ 136.9	$ 133.0
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property, plant and equipment, net	76.0	85.6
Other Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property, plant and equipment, net	4.4	4.3
China
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property, plant and equipment, net	41.1	27.3
Other Asia-Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property, plant and equipment, net	5.0	4.8
Germany
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property, plant and equipment, net	7.9	7.9
Other EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Total property, plant and equipment, net	$ 2.5	$ 3.1

XML

Quarterly Financial Information (unaudited) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended									6 Months Ended	12 Months Ended
	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Oct. 01, 2016	Jul. 02, 2016	Apr. 02, 2016	Jan. 02, 2016	Oct. 03, 2015	Sep. 27, 2014	Jul. 02, 2016	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Quarterly consolidated statements of operations
Net revenue	$ 198.1	$ 196.0	$ 206.5	$ 210.8	$ 224.1	$ 220.4	$ 232.1	$ 229.7			$ 811.4	$ 906.3	$ 873.9
Gross profit	119.2	117.0	124.7	125.1	136.1	131.3	141.8	140.5			486.0	549.7	520.1
Net income(loss) from continuing operations, net of tax	12.1	26.0	49.2	78.0	(64.5)	28.8	1.0	(15.7)			165.3	(50.4)	(131.4)
Income (loss) from discontinued operations, net of taxes	1.6	0.0	0.0	0.0	(3.4)	5.0	3.0	(53.4)			1.6	(48.8)	43.3
Net income (loss)	$ 13.7	$ 26.0	$ 49.2	$ 78.0	$ (67.9)	$ 33.8	$ 4.0	$ (69.1)			$ 166.9	$ (99.2)	$ (88.1)
Net income (loss) per share from - basic:
Continuing operations (usd per share)	$ 0.05	$ 0.11	$ 0.21	$ 0.34	$ (0.28)	$ 0.13	$ 0.01	$ (0.07)			$ 0.72	$ (0.22)	$ (0.57)
Discontinued operations (usd per share)	0.01	0.00	0.00	0.00	(0.01)	0.02	0.01	(0.22)			0.01	(0.20)	0.19
Net income (loss) (usd per share)	0.06	0.11	0.21	0.34	(0.29)	0.15	0.02	(0.29)			0.73	(0.42)	(0.38)
Net income (loss) per share from - diluted:
Continuing operations (usd per share)	0.05	0.11	0.21	0.33	(0.28)	0.12	0.01	(0.07)			0.70	(0.22)	(0.57)
Discontinued operations (usd per share)	0.01	0.00	0.00	0.00	(0.01)	0.02	0.01	(0.22)			0.01	(0.20)	0.19
Net income (loss) (usd per share)	$ 0.06	$ 0.11	$ 0.21	$ 0.33	$ (0.29)	$ 0.14	$ 0.02	$ (0.29)			$ 0.71	$ (0.42)	$ (0.38)
Shares used in per share calculation:
Shares used in per-share calculation - basic (in shares)	227.3	229.4	230.5	232.4	232.7	232.0	234.9	236.0			229.9	234.0	232.7
Diluted net income (loss) per share from: (in shares)	232.5	234.6	234.2	236.8	232.7	234.6	237.1	236.0			234.5	234.0	232.7
Available-For-Sale Investments
Impairment of goodwill					$ 91.4				$ 0.0		$ 0.0	$ 91.4	$ 0.0
Marketable equity securities
Available-For-Sale Investments
Gross realized gains										$ 71.5	$ 203.0	$ 71.5

XML

Subsequent Events (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		2 Months Ended	12 Months Ended
	Aug. 09, 2017	Aug. 29, 2017	Jul. 01, 2017	Jul. 02, 2016	Jun. 27, 2015
Subsequent Event [Line Items]
Cash paid in debt repurchase			$ 45.4	$ 0.0	$ 0.0
Payment to acquire business, net of cash acquired			0.0	$ 0.9	$ 0.0
0.625% Senior Convertible Notes | Convertible Debt
Subsequent Event [Line Items]
Aggregate amount of debt repurchased			40.0
Cash paid in debt repurchase			$ 45.4
Subsequent Event | Trilithic
Subsequent Event [Line Items]
Payment to acquire business, net of cash acquired	$ 55.0
Subsequent Event | 0.625% Senior Convertible Notes | Convertible Debt
Subsequent Event [Line Items]
Aggregate amount of debt repurchased		$ 146.5
Cash paid in debt repurchase		$ 162.0
Subsequent Event | Share Repurchase Agreement February 2016
Subsequent Event [Line Items]
Shares delivered and retired (in shares)		0.3
Average repurchase price per share (in dollars per share)		$ 10.58